UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One)
|
|
|
x
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the fiscal year ended December 31, 2013
|
OR
|
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the transition period from __________________ to __________________
|
1-13948
(Commission file number)
SCHWEITZER-MAUDUIT INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
62-1612879
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
100 North Point Center East, Suite 600
Alpharetta, Georgia
|
30022
|
(Address of principal executive offices)
|
(Zip Code)
|
1-800-514-0186
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
Title of each class
|
|
Name of each exchange on which registered
|
Common stock, par value $0.10 per share (together with associated preferred stock purchase rights)
|
|
New York Stock Exchange
|
Securities Registered Pursuant to Section 12(g) of the Act:
None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes
x
No
o
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes
o
No
x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes
x
No
o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes
x
No
o
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.
x
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer," “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
|
|
|
|
|
Large accelerated filer
x
|
Accelerated filer
o
|
Non-accelerated filer
o
|
Smaller reporting company
o
|
|
|
(Do not check if a smaller reporting company)
|
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes
o
No
x
The aggregate market value of the outstanding common stock, par value $0.10 per share (the “Common Stock”), held by non-affiliates of the registrant as of
June 28, 2013
(the last business day of the registrant's most recently completed second fiscal quarter) was
$1.5 billion
, based on the last sale price for the Common Stock of $49.88 per share as reported on the New York Stock Exchange on said date. For purposes of the foregoing sentence only, all directors and executive officers are assumed to be affiliates.
There were
30,399,784
shares of Common Stock issued and outstanding as of February 26, 2014.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the registrant's definitive Proxy Statement relating to its 2014 Annual Meeting of Stockholders scheduled to be
held on April 24, 2014 (the "2014 Proxy Statement") and filed pursuant to Regulation 14A are incorporated by reference into Part III of this Annual Report on Form 10-K.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC.
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
Page
|
|
|
Part I.
|
|
Item 1.
|
|
Business
|
|
|
|
|
|
Item 1A.
|
|
Risk Factors
|
|
|
|
|
|
Item 1B.
|
|
Unresolved Staff Comments
|
|
|
|
|
|
Item 2.
|
|
Properties
|
|
|
|
|
|
Item 3.
|
|
Legal Proceedings
|
|
|
|
|
|
Item 4.
|
|
Mine Safety Disclosures
|
|
|
|
Part II.
|
|
Item 5.
|
|
Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
|
|
|
|
|
|
Item 6.
|
|
Selected Financial Data
|
|
|
|
|
|
Item 7.
|
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
|
|
|
|
Item 7A.
|
|
Quantitative and Qualitative Disclosures about Market Risk
|
|
|
|
|
|
Item 8.
|
|
Financial Statements and Supplementary Data
|
|
|
|
|
|
Item 9.
|
|
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
|
|
|
|
|
|
Item 9A.
|
|
Controls and Procedures
|
|
|
|
|
|
Item 9B.
|
|
Other Information
|
|
|
|
Part III.
|
|
Item 10.
|
|
Directors, Executive Officers and Corporate Governance
|
|
|
|
|
|
Item 11.
|
|
Executive Compensation
|
|
|
|
|
|
Item 12.
|
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
|
|
|
|
|
|
Item 13.
|
|
Certain Relationships and Related Transactions and Director Independence
|
|
|
|
|
|
Item 14.
|
|
Principal Accountant Fees and Services
|
|
|
|
Part IV.
|
|
Item 15.
|
|
Exhibits and Financial Statement Schedules
|
|
|
|
Signatures
|
|
|
|
Glossary of Terms
|
|
PART I.
Item 1.
Business
GENERAL
Schweitzer-Mauduit International, Inc. (referred to, with its consolidated subsidiaries, as "we", "us", "our", the "Company", "SWM INTL" or "SWM" unless the context indicates otherwise) is a multinational diversified producer of premium specialty papers and resin-based products headquartered in the United States of America.
The Company was incorporated in Delaware in 1995 as a wholly-owned subsidiary of Kimberly-Clark Corporation (“Kimberly-Clark”). On November 30, 1995, Kimberly-Clark distributed its tobacco-related paper and other specialty paper products businesses conducted in the United States, France and Canada to the Company, through a distribution to Kimberly-Clark stockholders of all of the outstanding shares of common stock of the Company (the "spin-off").
Today, we manufacture and sell paper and reconstituted tobacco products to the tobacco industry as well as specialized paper products for use in other applications. We manufacture lightweight specialty papers, which are used in manufacturing ventilated cigarettes, and banded papers for the production of lower ignition propensity, or LIP, cigarettes and are the leading independent producer of reconstituted tobacco leaf, or RTL, used in producing blended cigarettes. We also manufacture resin-based plastic netting through an extrusion process, as well as certain meltblown products and machined plastic core tubes.
Tobacco industry products comprised approximately 93% to 94% of our consolidated net sales in each of the years 2011 through 2013. Our primary products sold to the tobacco industry include cigarette, plug wrap and base tipping papers, or Cigarette Papers, used to wrap various parts of a cigarette and RTL, which is used as a blend with virgin tobacco in cigarettes, reconstituted tobacco wrappers and binders for cigars. These products are sold directly to the major tobacco companies or their designated converters in the Americas, Europe, Asia and elsewhere. Our non-tobacco industry products are a diverse mix of products that includes low volume, high-value engineered papers and, commodity paper grades produced to maximize our machine utilization. In 2013, we acquired DelStar, Inc. ("DelStar"), a manufacturer of plastic netting and other resin-based products focused on the filtration and medical markets.
We conduct business in over 90 countries and operate 14 production locations worldwide, with facilities in the United States, Canada, France, Brazil, China and Poland. We also have a 50% equity interest in two joint ventures in China. The first, China Tobacco Mauduit (Jiangmen) Paper Industry Ltd., or CTM, produces cigarette and porous plug wrap papers and the second, whose facility is under construction, China Tobacco Schweitzer (Yunnan) Reconstituted Tobacco Co. Ltd., or CTS, will produce RTL.
Our wholly-owned, majority-owned and controlled subsidiaries are as follows: Schweitzer-Mauduit Canada, Inc., or SM-Canada; Schweitzer-Mauduit Spain, S.L., or SM-Spain, a holding company organized under the Spanish holding company regime and the primary foreign investment holding company for SWM; SWM RTL Philippines Inc. or RTLP; SWM Luxembourg S.à.r.l, or SWM Lux, a holding company incorporated in Luxembourg; SWM HoldCo 1 S à.r.l., or HoldCo 1, a holding company incorporated in Luxembourg, SWM HoldCo 2 S.à.r.l or HoldCo 2, a holding company incorporated in Luxembourg, SWM Acquisition Corp. I, or Acquisition Corp I, a holding company incorporated in Delaware and Schweitzer-Mauduit International China, Limited, or SM-China, a holding company incorporated in Hong Kong. SM-China owns 50% of the equity interest in CTM, a Sino-Foreign Equity Joint Venture with China National Tobacco Corporation, or CNTC, that manufactures and sells tobacco-related papers in China and 50% of the equity interest in CTS, a Sino-Foreign Equity Joint Venture with CNTC that will manufacture RTL. Both CTM and CTS are unconsolidated subsidiaries. We indirectly through SM-Spain have subsidiaries in France and the Philippines. SM-Spain owns directly 100% of Schweitzer-Mauduit Holding S.A.S., a French holding company, or SMH, and SMH owns 100% of Schweitzer-Mauduit Industries S.A.S., a French corporation, or SMI. Schweitzer-Mauduit International, Inc., SMH and SMI together own 100% of a second holding company, Schweitzer-Mauduit France S.A.S., a French corporation, or SMF, which holds our French paper operations. SMF directly owns 100% of Schweitzer-Mauduit Developpements S.A.S., a French corporation, or SMD, and SMD owns 100% of LTR Industries S.A.S., a French corporation, or LTRI, our French RTL operation. SMF directly owns 100% of two principal French operating subsidiaries, SWM Services S.A.S. (formerly known as Papeteries de Mauduit S.A.S.), or SWM-S, and Papeteries de
Saint-Girons S.A.S., or PdStG, as well as 100% of PDM Philippines Industries, Inc., or PPI. SMF indirectly owns the third principal French operating subsidiary, PDM Industries S.A.S., or PdM, as well as Papeteries de Malaucène S.A.S., or PdMal, and its subsidiary Malaucène Industries S.A.S., PdMal filed for liquidation during December 2011 and are no longer consolidated effective with the date of the filing. SWM HoldCo 1 owns directly 99.99% of the issued and outstanding shares of Schweitzer-Mauduit do Brasil Indústria e Comércio de Papel Ltda. (formerly known as Schweitzer-Mauduit do Brasil, S.A.), our Brazilian paper operations, or SWM-B. SWM Luxembourg owns 100% SWM RUS LLC, or SWM-RUS, a Russian company, Ipopema 94 Fundusz Inwestycyjny Zamkniêty Aktywów Niepublicznych, or Polish FIZ, a Poland company and 100% of SWM GP Luxembourg S.à.r.l, or SWM GP Lux, a Luxembourg. The Polish FIZ and SWM GP Lux own 99.9% and 0.1%, respectively, of SWM LP Luxembourg SCSP, or SWM LP Lux a Luxembourg company. SWM LP Lux owns 99.9% of SWM Poland Sp. z o.o., or SWM Poland, a Polish company and SWM Poland GP Sp z o.o. or SWM Poland GP owns the remaining 0.1%. SWM Acquisition Corp I, a holding company incorporated in Delaware directly owns 100% of DelStar, Inc., a Delaware company. DelStar, Inc. directly owns 100% of DelStar Holding Corp., a Delaware holding company which owns 100% of Coretc Tubing Corp., U.S. Netting Inc. and Delstar Technologies Inc., each Delaware companies. DelStar Technologies Inc., a company incorporated in Delaware owns 100% of two Chinese operating entities DelStar Technologies (Shanghai) Trading Corp. Ltd. and DelStar Technologies (Suzhou) Co. Ltd. We had no special purpose entities as of December 31, 2013.
Our principal executive office is located at 100 North Point Center East, Suite 600, Alpharetta, Georgia 30022-8246 and our telephone number at that address is 1-800-514-0186. Our stock is traded on the New York Stock Exchange, or NYSE, under the symbol "SWM".
AVAILABLE INFORMATION
Our Securities and Exchange Commission, or SEC, filings, which include this Annual Report on Form 10-K, Proxy Statements, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and all related amendments, are available, free of charge, on the Investor Relations section of our web site at
www.swmintl.com
. Information from our web site is not incorporated by reference into this Annual Report on Form 10-K. These reports are available soon after they are filed electronically with, or furnished to, the SEC. The web site allows access to historical financial information, press releases and quarterly earnings conference calls, our Code of Conduct, corporate governance guidelines, Board of Directors committee charters, as well as disclosure of any amendment to or waivers of our Code of Conduct granted to any of the principal executive officer, principal financial officer or principal accounting officer. The web site provides additional background information about us including information on our history, products and locations. Requests for information or to contact the audit committee chair, lead non-management director or to report concerns about accounting or other issues can be made in writing and sent to the Investor Relations Department at our principal executive office address listed below.
Our quarterly earnings conference calls are typically held the morning after our quarterly earnings releases and are available through our web site via a webcast. The tentative dates for our quarterly earnings conference calls related to 2014 financial results are May 7, 2014, August 6, 2014, November 5, 2014 and February 4, 2015. These dates are subject to change. Instructions on how to listen to the webcasts and updated information on times and actual dates are available through our web site at
www.swmintl.com
.
We have provided a Glossary of Terms at the end of this Annual Report on Form 10-K.
DESCRIPTION OF BUSINESS
Segment Financial Information
. We operate and manage three reportable segments based on product lines: Paper, Reconstituted Tobacco and Filtration. The Paper segment primarily produces Cigarette Papers such as cigarette (including LIP), plug wrap and base tipping papers used to wrap various parts of a cigarette for sale to cigarette manufacturers. The Paper segment also includes commercial and industrial products such as lightweight printing and writing papers, battery separator paper, drinking straw wrap, filter paper and other specialized papers. These non-tobacco industry products are generally sold directly to converters and other end-users or brokers. The Reconstituted Tobacco segment produces reconstituted tobacco leaf, or RTL, and wrapper and binder products for sale to cigarette and cigar manufacturers. The Filtration segment produces thermoplastic nets, nonwovens, laminates, and extruded components sold to manufacturers in liquid, air and water filtration, automotive, aerospace, healthcare, industrial, food and electronics industries.
Additional information regarding "Segment Performance" is included in Part II, Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operation. In addition, selected financial data for our segments is available in Note
19
, Segment Information, of the Notes to Consolidated Financial Statements. Reference is also made to Part I, Item 1A, Risk Factors, Market Risk, for a discussion regarding the risks associated with foreign operations.
Financial information about foreign and domestic operations, contained under the caption "Management's Discussion and Analysis of Financial Condition and Results of Operation" appearing in Part II, Item 7 herein and in Notes
11
,
12
,
15
and
19
("Restructuring and Impairment Activities," "Debt," "Income Taxes" and "Segment Information," respectively) to the Consolidated Financial Statements contained in "Financial Statements and Supplementary Data" in Part II, Item 8 herein, is incorporated in this Item 1 by reference.
Products.
We manufacture and sell paper and reconstituted tobacco products to the tobacco industry as well as specialized paper products for use in other applications. We also manufacture and sell thermoplastic nets, nonwovens, laminates, and extruded components.
Our Paper segment products include Cigarette Papers and commercial and industrial products including lightweight printing and writing papers, battery separator paper, drinking straw wrap, filter papers and other specialized papers. Each of the three principal types of Cigarette Papers - cigarette, plug wrap and base tipping papers - serves a distinct purpose in the function of a cigarette.
Cigarette paper
wraps the column of tobacco in a cigarette. Certain properties of cigarette paper, such as control of ignition propensity, basis weight, porosity, opacity, tensile strength, texture and burn rate must be controlled to tight tolerances. Many of these characteristics are critical to meet the requirements of high-speed production processes utilized by cigarette manufacturers as well as their desired attributes of finished cigarettes such as reduced deliveries of tobacco-related smoke constituents. In addition to the attributes and functional requirements of conventional cigarette papers, certain of our products facilitate our customers' design of LIP cigarettes to enhance their ability to self-extinguish when they are not actively being smoked, including papers sold under our registered trademark ALGINEX® and trademark GLUCIGEN
TM
. Our solutions pioneered this cigarette paper category.
Plug wrap paper
forms the outer layer of a cigarette filter and is used to hold the filter materials in a cylindrical form. Conventional plug wrap is manufactured on flat wire paper machines using wood pulp. Porous plug wrap, a highly air-permeable paper, is manufactured on inclined-wire paper machines using a furnish consisting of long-fibers, such as abaca, and wood pulp. Porosity, a measure of air-flow permeability, ranges from a typical level of less than 100 Coresta on conventional plug wrap to 35,000 Coresta on high-porosity papers.
Base tipping paper,
produced in white or tan/cork color, joins the filter element to the tobacco-filled column of the cigarette. The ability to produce tipping paper, which is both printable and glueable at high speeds, is critical to producing a cigarette with a distinctive finished appearance.
Certain of our non-tobacco industry products use a fiber blend consisting of long-fibers. These products are generally sold directly to converters and other end-users in North America and western Europe and through brokers in Brazil.
The non-tobacco industry products are a diverse mix that includes low volume, high-value engineered papers as well as commodity paper grades produced to maximize machine utilization.
Our Reconstituted Tobacco segment products include RTL which is used as a tobacco blend with virgin tobacco in cigarettes and reconstituted tobacco wrappers and binders for cigars. These products are sold directly to tobacco companies or their designated converters in the Americas, Europe, Asia and elsewhere.
RTL is used by manufacturers of cigarettes and other tobacco products as a means of recycling their tobacco by-products and to achieve product performance attributes. We currently produce reconstituted tobacco in two forms: leaf, or RTL, in France, which is manufactured by LTRI, and wrapper and binder in the United States. RTL is used by cigarette manufacturers primarily to blend with virgin tobacco as a design aid to achieve certain attributes of finished cigarettes, such as taste characteristics and reduced deliveries of tobacco-related smoke constituents, and to cost-effectively utilize tobacco leaf waste by-products. Wrapper and binder are reconstituted tobacco products used by manufacturers of machine-made cigars. Binder is used to hold the tobacco leaves in a cylindrical shape during the production process. Wrapper is used to cover the outside of the cigar, providing a uniform, finished appearance.
Our Filtration segment products include thermoplastic nets, nonwovens, laminates, and extruded components under the trade name DELSTAR®. We manufacture plastic and metal components used in a wide range of industries and markets, including liquid, air and water filtration, automotive, aerospace, healthcare, industrial, food and electronics.
Markets and Customers.
Our Paper and Reconstituted Tobacco segments supply the major, and many of the smaller, cigarette manufacturers including international tobacco companies, regional tobacco manufacturers and government monopolies.
Philip Morris International Inc., or PMI, Philip Morris-USA, a subsidiary of Altria Group Inc., Japan Tobacco Inc., or JT, and British American Tobacco, or BAT, are our four largest customers and together with their respective affiliates and designated converters, accounted for
57%
,
55%
and
54%
of the Company's 2013, 2012 and 2011 consolidated net sales, respectively. Although the total loss of one or more of these large customers could have a material adverse effect on our results of operations, this is not considered likely given the significant share that our capacity represents of the total worldwide supply available to meet the demand for cigarette-related fine papers. A material variation in demand from one or more of these customers or due to external factors such as government legislation or changes in consumer behavior, however, could result in a significant decline in demand for our products.
The Filtration segment supplies niche products to filtration, healthcare, and industrial manufacturers. These products are highly engineered, often customized and, in some cases, we are the sole supplier of certain products to our top customers, none of which represent more than 10% of the Company's net sales.
Sales and Distribution.
Essentially all tobacco-related products manufactured by both the Paper and Reconstituted Tobacco segments are sold by our marketing, sales and customer service organizations directly to cigarette manufacturers or their designated converters. Most of our Paper segment's non-tobacco related products, which represent approximately 6% to 10% of its net sales, are sold on a direct basis.
Filtration products are sold to customers by our marketing, sales and customer service organization on a direct basis.
The typical modes of transportation we utilize in the delivery of product to our customers include truck, rail and ocean-going vessels. As is typical in our industry, ownership of the product generally transfers to our customer upon shipment from our mills, except for certain export sales where ownership typically transfers at the foreign port or customer facility.
Competition
. We are the largest producer of Cigarette Papers in the world. LTRI is the leading independent producer of RTL for use in cigarettes. We do not sell our products directly to consumers or advertise our products in consumer media. The specialized nature of these tobacco-related papers requires unique research and development capability and special papermaking equipment and skills to meet exacting customer specifications. These factors have limited the number of competitors in each of the tobacco-related paper categories discussed separately below.
Paper
.
As the sole domestic producer of Cigarette Papers in North America, we believe that we have the majority supply position. PdM and PdStG, our indirect wholly-owned subsidiaries in France, and SWM-Poland sell most of their products in Europe. We believe SWM-B has the majority of the cigarette paper market in Brazil and in South America. Our principal competitors include delfortgroup AG, or Delfort, an Austrian corporation, Miquel y Costas & Miquel S.A., or Miquel y Costas, a Spanish corporation, Julius Glatz GmbH, an German company, and PT Bukit Muria Jaya, or BMJ, an Indonesian corporation. We believe that the bases of cigarette paper competition are price, consistent quality, security of supply, level of technical service and performance requirements of the customer's cigarette-making equipment.
We have developed, individually or in conjunction with customers, technologies to address the demand for cigarette paper for LIP cigarettes in the United States, Canada, Australia and the European Union, or EU. We believe that we are currently the leading producer of cigarette paper for LIP cigarettes and continue to actively develop the technologies for such products. We have license agreements with third parties which grant them the right to use certain of our LIP intellectual property, excluding ALGINEX® related intellectual properties.
We estimate that we hold a majority of industry share for high porosity plug wrap papers in each of the market segments in which we compete. Our competitors are Miquel y Costas and Delfort. We supply base tipping paper for North America, which is subsequently printed by converters. The principal competitors in Europe are Delfort and Julius Glatz. We estimate our Brazilian operation holds a large share for the base tipping paper market in South America, which is subsequently printed by converters. Our principal competitor in Latin America is Miquel y Costas. We believe that the bases for competition are consistent quality, price and, most importantly, the ability to meet the runability and printability requirements of converting equipment and high-speed cigarette-making machines.
We produce papers for lightweight printing and writing, battery separator papers, drinking straw wrap, filter papers and other specialized papers. We believe that price is the primary basis of competition for drinking straw wrap, printing and writing and filter papers, while consistent quality and customer service are believed to be the primary competitive factors for battery separator paper.
Reconstituted Tobacco
.
LTRI is the leading independent producer of RTL in the world. We believe that the basis of competition in this market is primarily quality. However, sales volumes are influenced by worldwide virgin tobacco prices and cigarette producers' various in-house tobacco reconstitution processes, as lower prices of virgin tobacco or other RTL forms may compete against reconstituted tobacco sales volumes.
LTRI's principal competitors are cigarette companies such as Philip Morris-USA, R.J. Reynolds Tobacco Company, Elets, an affiliate of Japan Tobacco Inc. which operates in Russia, and STMA (China), all of which produce RTL primarily for internal use. Huabao International Holdings Ltd, a Hong Kong company, provides tobacco reconstitution in China.
We estimate that approximately 35% of reconstituted cigar wrapper and binder used in the U.S. is produced internally by domestic cigar manufacturers. Our Reconstituted Tobacco segment's Ancram mill and Nuway Tobacco, a privately-held cast process manufacturer, produce the balance for U.S. demand which is not produced internally by domestic cigar manufacturers. The Ancram mill and DHT, a subsidiary of NV Deli Maatschappij, are the main suppliers to the European cigar manufacturers.
Filtration
.
Our resin-based, DelStar-branded products are leaders in their categories and compete against niche products made by Conwed, a subsidiary of Leucadia National Corp., Marshall Manufacturing Company, Johns Manville, a subsidiary of Berkshire Hathaway Inc., Hollingsworth and Vose Company, and Smith & Nephew plc. We believe our Filtration products compete primarily on product features, innovations and customer service.
Raw Materials and Energy.
Wood pulp is the primary fiber used in our operations. Our operations consumed approximately 72,000 metric tons of wood pulp in both 2013 and 2012, all of which was purchased. Our operations also use other cellulose fibers, the most significant of which are in the form of flax fiber and tobacco leaf by-products, as the primary raw materials for Cigarette Papers and reconstituted tobacco products, respectively. While tobacco leaf by-products are generally the property of the cigarette manufacturer for whom the reconstitution is contracted, we purchase some tobacco leaf by-products for use in the production of RTL and wrapper and binder products.
Flax straw is purchased and subsequently processed into flax tow at our processing facility in Canada. The flax tow is then converted into flax pulp at pulping facilities in the United States and France. Flax tow and flax pulp is also purchased on the open market. Certain specialty papers are manufactured by our operations in France, requiring small amounts of other cellulose fibers, all of which are purchased.
In addition to cellulose fibers, our operations use calcium carbonate as another significant raw material in the production of many of our paper products. Calcium carbonate, or chalk, is used in the production of Cigarette Papers, as well as in certain of our other paper products, to provide desired qualities and characteristics, such as opacity, as well as end-product performance attributes. All of our needs for calcium carbonate are purchased. Our Quimperlé mill in France and Pirahy mill in Brazil have on-site, vendor-operated, precipitated calcium carbonate plants which supply significant quantities toward the needs of those mills. For the balance of their needs, our mills also purchase calcium carbonate manufactured elsewhere. Our calcium carbonate purchase commitments are discussed in Note
18
, Commitments and Contingencies, of the Notes to Consolidated Financial Statements.
Manufacturing of resin-based products is highly dependent on polyethylene terephthalate, or PET, and nylon polypropylene resins. The Company has multiple sources of resin. Resin price fluctuations can impact profitability; such impacts are partially mitigated by contractual pricing adjustment mechanisms with customers.
We believe that our purchased raw materials are readily available from several sources and that the loss of a single supplier would not have a material adverse effect on our ability to procure needed raw materials from other suppliers.
The papermaking processes use significant amounts of energy, primarily electricity, natural gas and fuel oil to run the paper machines and other equipment used in the manufacture of pulp and paper. In France, Poland and in the United States, availability of energy is generally not expected to be an issue, although prices can fluctuate significantly. We enter into agreements to procure a portion of our energy requirements for future periods in order to reduce the uncertainty of future energy costs.
In France, we have entered into agreements with an energy cogeneration supplier whereby the supplier constructed and operates cogeneration facilities at our Spay and Quimperlé mills and supplies steam that is used in the operation of our mills. These cogeneration facilities provide energy cost savings and improved security of supply.
In Brazil, where production of electricity is heavily reliant upon hydroelectric plants, availability of electricity has been affected in the past by rain variations. Over the past few years the Brazilian government has taken action to improve distribution lines, which has provided a better balance of energy use throughout the country and mitigates the risk of lost energy. Our Brazilian business currently has a sufficient supply of energy to continue its current level of operation.
Additional information regarding agreements for the supply of energy is included in Note
18
,
Commitments and Contingencies, of the Notes to Consolidated Financial Statements.
Backlog and Seasonality.
We have historically experienced a steady flow of orders. Our facilities typically receive and ship orders within a 30-day period, except for RTL where orders are generally placed well in advance of delivery. We plan our manufacturing schedules and raw material purchases based on our evaluation of customer forecasts and current market conditions.
Within the Paper segment, the U.S. operations do not calculate or maintain records of order backlogs. Its largest customer Philip Morris-USA provides forecasts of future demand, but actual orders for Cigarette Papers are typically placed two weeks in advance of shipment. In France, Cigarette Papers order backlog was approximately $37 million and $19 million on December 31, 2013 and 2012, respectively. This represented approximately 35 and 12 days of sales for the French Paper operations in 2013 and 2012, respectively. The Polish and Brazilian operation do not calculate or maintain records of order backlogs. Souza Cruz, our Brazilian operation's largest customer, provides forecasts of its future demand, typically eight weeks in advance, in order for the Brazilian operations to manage production and ensure a sufficient supply to meet this customer's anticipated requirements.
The Reconstituted Tobacco segment's RTL business operates predominantly under a number of annual supply agreements. The order backlog for RTL was approximately $99 million and $145 million on December 31, 2013 and 2012, respectively, and is typically filled within one fiscal year.
In the Filtration segment, customer orders are generally manufactured and shipped within 30 days and, in certain instances, up to three months. As of December 31, 2013, the Filtration segment order backlog was approximately $22 million.
Sales of our paper and reconstituted tobacco products are subject to significant seasonal fluctuations. In the United States and Europe, customer shutdowns of one to two weeks in duration typically occur in July and December. In Brazil, customer orders are typically lower in December due to a January and February holiday season.
Research and Development
. We employ approximately 70 research and development personnel in research and laboratory facilities in Quimperlé and Spay, France, Santanésia, Brazil, Strykow, Poland, Alpharetta, Georgia, Middletown, Delaware and Austin, Texas. We are dedicated to developing product innovations and improvements to meet the needs of individual customers. The development of new components for tobacco products and the development of new non-tobacco products are the primary focuses of these research and development functions, including several development projects for our major customers. We expensed
$15.3 million
in 2013,
$9.9 million
in 2012 and
$9.2 million
in 2011 on research and development. We believe that our research and product development capabilities have played an important role in establishing our reputation for high quality, superior products.
Our commitment to research and development has enabled us, for example, to (i) produce high-performance papers designed to run on the high-speed manufacturing machines of our customers, (ii) produce papers to exacting specifications with very high uniformity, (iii) produce cigarette paper with extremely low basis weights, (iv) develop cigarette paper for LIP cigarettes, (v) produce highly porous cigarette and plug wrap papers, (vi) produce wrapper and binder tobacco reconstituted products, in a paper process, matching the specifications of machine-made cigars and (vii) produce papers and reconstituted tobacco products with other specifically engineered properties required for end-product performance attributes. The Filtration segment, acquired through the December 2013 purchase of DelStar, has a history of finding innovative design solutions, including products which improve the performance of customers' products and manufacturing operations. We believe that our commitment to research and development, coupled with our investment in new technology and equipment, has positioned us to take advantage of growth opportunities all around the world.
Patents and Trademarks
. As of December 31, 2013, we owned 253 patents and had pending 121 patent applications covering a variety of Cigarette Papers, RTL, cigar wrapper and binder and other products and processes in the United States, western Europe and several other countries. We believe that such patents, together with our papermaking expertise and technical sales support, have been instrumental in establishing us as the leading worldwide supplier of Cigarette Papers. We believe that patents have contributed to our position as the world's leading independent producer of papers used for LIP cigarettes. Our Filtration segment holds eight patents registered in China.
Management believes that our "ALGINEX®" water-based technology trademark and "GLUCIGEN
TM
" trademark for use in banded papers for the production of LIP cigarettes, and the "SWM" logo and trade names have been important contributors to the marketing of our products. In our Filtration segment, "DELSTAR®," "NALTEX®", "DELNET®", "DELPORE®", "STRATEX®", and "CORETEC®" are important trade names which have high industry acceptance for marketing our products.
Administrative and Court Proceedings Relating to Papers for Lower Ignition Propensity Cigarettes.
In December 2009, Miquel y Costas & Miquel S.A., Société Papéterie Leman SAS and delfortgroup AG filed Notices of Opposition to the European Patent Office's, or the EPO, grant of European Patent EP 1482815. The opponents contend that the claimed invention is not disclosed in a manner sufficiently clear and complete for it to be carried out by a person skilled in the art and that the claims were either not novel or lacked inventive step due to prior art references (including, among others, two earlier patents of SWM cited by the Examiner prior to granting the patent). The Company will continue to defend the grant of this patent by taking necessary actions including responding to further submissions by the opponents. Once the EPO considers that all positions have been fully briefed, it will hold a hearing before reaching a final conclusion on the oppositions. There is no mandated timetable by which the EPO must reach a decision. The outcome of this dispute would not prevent the Company from practicing its ALGINEX® LIP solution. The patent remains in effect and enforceable while the opposition proceedings are pending. In connection with its entrance into a worldwide LIP license agreement with SWM, delfortgroup has withdrawn its opposition and is no longer a party to these proceedings (though delfortgroup's arguments and evidence presented remain in the proceedings). The action remains open with the other parties.
On November 11, 2010, the EPO issued a Decision to Grant SWM European Patent No. 1333729. On December 8, 2010, Julius Glatz GmbH filed a Notice of Opposition to the grant of this patent. In September 2011, Papéteries du Leman, delfortgroup AG, and Miquel y Costas & Miquel S.A. each filed opposition papers and Glatz supplemented its previous filing. However, Papéteries du Leman failed to pay the opposition fee and consequently is not a party to the opposition proceedings. It subsequently refiled its opposition papers as third-party observations. The Company's response to the Notices of Opposition was timely filed. The Company believes that the EPO properly granted the patent and it intends to vigorously defend the patent. In connection with its entrance into a worldwide LIP license agreement with SWM, delfortgroup has withdrawn its opposition and is no longer a party to these proceedings (though delfortgroup's arguments and evidence presented will remain in the proceedings). The action remains open with the other parties.
A petition to reexamine United States Patent No. 6,725,867 filed by delfortgroup in 2010 is still pending. As a result of the worldwide LIP license agreement with SWM, delfortgroup has withdrawn from this proceeding. There are no other petitioners in the action.
On June 27, 2012, the EPO granted the Company's applications for two LIP-related patents, EP 2127544 and EP 2127545, that are based on divisional applications related to European Patent No. 1333729. Julius Glatz GmbH and Miquel y Costas & Miquel S.A. each filed Notices of Opposition to the grants of EP 2127544. Julius Glatz GmbH, Miquel y Costas & Miquel S.A. and Société Papéterie Leman SAS each filed Notices of Opposition to the grant of EP 2127545. The EPO issued communications requesting SWM to respond to the oppositions on May 7, 2013. The Company believes that the EPO properly granted the patents and it intends to vigorously defend the patents.
On September 12, 2012, the EPO granted the Company's LIP related patent, EP 2127543, that is based on a divisional application related to European Patent No. 1333729. Papéteries du Leman, Julius Glatz GmbH and Miquel y Costas & Miquel S.A. each filed Notices of Opposition, and the EPO issued a communication on July 23, 2013, requesting SWM to respond to the oppositions. The Company believes that the EPO properly granted the patent and it intends to vigorously defend the patent.
Employees
. As of December 31, 2013, we had approximately 3,000 regular, full-time, active employees.
North American Operations
.
Hourly employees at the Spotswood, New Jersey, and Ancram, New York mills are represented by locals of the United Steel Workers Union. The collective bargaining agreement at our Spotswood mill is a three-year agreement which is effective through July 28, 2016. The three-year collective bargaining agreement at our Ancram mill is effective through September 30, 2014. We believe employee and union relations continue to be positive at the Spotswood and Ancram mills.
The fiber operations of our Canadian subsidiary, our Newberry, South Carolina facility and DelStar facilities are non-union. We believe that employee relations are positive.
French Operations
.
Hourly employees at our Quimperlé, Spay, and Saint-Girons, France mills are union represented. From time to time, we undertake certain restructuring activities in France and elsewhere and this can impact our employee relations which we believe are generally as positive as other similarly situated French manufacturing operations.
Brazilian Operations
.
Hourly employees at the Pirahy mill are represented by a union. The one-year collective bargaining agreement at SWM-B was renewed through May 31, 2014. We believe that employee relations are positive and comparable to other similar Brazilian manufacturing operations.
Polish Operations
.
Employees at our Strykow, Poland facility are non-union. We believe that employee relations in Poland are positive.
Chinese Operations
.
Employees at our Suzhou, China facility are non-union. We believe that employee relations in China are positive.
Environmental Matters
. Capital expenditures for environmental controls to meet legal requirements and otherwise relating to the protection of the environment at our facilities in the United States, France, Brazil, Poland, China and Canada were
$1.0 million
in 2013 and are expected to be $1 million or less in each of the next two years, of which no material amounts were or are expected to be the result of environmental fines or settlements. These expenditures are not expected to have a material adverse effect on our financial condition, results of operations or competitive position; however, these estimates could be modified as a result of changes in our plans, changes in legal requirements or other factors.
Working Capital
. We normally maintain approximately 60 to 90 days of inventories to support our operations. Our sales terms average between 15 and 60 days for payment by our customers, dependent upon the products and markets served. With respect to our accounts payable, we typically carry approximately a 30 to 60 day level, in accordance with our purchasing terms, which vary by business location. The accounts payable balance varies in relationship to changes in our manufacturing operations, particularly due to changes in prices of wood pulp, resins and purchased energy and the level and timing of capital expenditures related to projects in progress.
Executive Officers
. The names and ages of our executive officers as of February 28, 2014, together with certain biographical information, are as follows:
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Position
|
Frédéric P. Villoutreix
|
|
49
|
|
|
Chairman of the Board and Chief Executive Officer
|
Jeffrey A. Cook
|
|
59
|
|
|
Executive Vice President, Chief Financial Officer and Treasurer
|
Stephen Dunmead
|
|
50
|
|
|
Chief Operating Officer
|
Michel Fievez
|
|
56
|
|
|
Executive Vice President, Reconstituted Tobacco Business
|
Patrick DeLuca
|
|
48
|
|
|
Executive Vice President, Global Paper
|
Greerson McMullen
|
|
51
|
|
|
General Counsel and Secretary
|
Robert Cardin
|
|
50
|
|
|
Corporate Controller
|
There are no family relationships between any of the directors, or any of our executive officers. None of our officers were selected pursuant to any arrangement or understanding between the officer and any person other than the Company. Our executive officers serve at the discretion of the Board of Directors and are elected annually by the Board.
Frédéric P. Villoutreix
was elected Chairman of the Board and Chief Executive Officer effective January 1, 2009. Mr. Villoutreix joined the Company on December 7, 2005, was elected Chief Operating Officer on February 1, 2006, and served as interim President, French Operations from December 2006 to June 2007. Mr. Villoutreix joined us in December 2005 from Compagnie de Saint-Gobain, a leading French multi-national manufacturer of engineered materials and products, where he worked since 1990. From 2001 to 2005, Mr. Villoutreix held key manufacturing positions in Europe and the United States with Saint-Gobain, including General Manager, World Construction Products and Stone, Luxembourg and Vice President, Abrasives Europe and Coated Abrasives World with 33 operating locations.
Jeffrey A. Cook
was appointed Executive Vice President, Chief Financial Officer and Treasurer in February 2012. Prior to joining SWM, he served as Chief Financial Officer since 2007 of Presstek Inc., a manufacturer and distributor of products for the commercial graphics industry, including printing presses, consumables and service. Mr. Cook began his career with General Electric and served in roles of increasing financial leadership including serving as Chief Financial Officer of GE Government Services Inc. from 1990 to 1993 and Vice President Finance of the Government Services Group of Lockheed Martin Corporation. From 1996 to 1997, he was Vice President and Chief Financial Officer of Bechtel Systems and Infrastructure, a division of Bechtel Group Inc. He was Vice President Finance of Moore North American, a division of Moore Corporation from 1997 to 2000. Mr. Cook served as Senior Vice President, Chief Financial Officer and Chief Information Officer of Kodak Polychrome Graphics, a joint venture between Eastman Kodak and Sun Chemical from 2000 to 2005.
Stephen Dunmead
has served as Chief Operating Officer since March 2013. Previously, Mr. Dunmead served as the Executive Vice President and General Manager of OM Group's Specialties Division. OM Group, Inc. is a leading global solutions provider of specialty chemicals, advanced materials and unique technologies. Mr. Dunmead joined OM Group in 1998 as Director of Research and Development, Powdered Metals Division, was appointed Chief Technology Officer in 2001, and during his 14-year tenure with the organization rose through the ranks to the Executive Vice President and General Manager position.
Michel Fievez
was appointed Executive Vice President, Reconstituted Tobacco Business during March 2010. He held the position of President - European Operations from June 2007 to March 2010. From 2003 to May 2007, Mr. Fievez served as General Manager One Side Coated Papers and then Vice President and General Manager Packaging, Metalizing and Office and Graphic with Ahlstrom Corporation. From 1998 to 2003, he held key manufacturing positions, including Managing Director, with Chesapeake Display and Packaging in Europe, and from 1994 to 1998, held the position of Vice President Manufacturing and Technology with Mead Packaging Europe.
Patrick DeLuca
has served as Executive Vice President, Global Paper since June 2013. Previously, he was Vice President and General Manager of the Advanced Materials Business at OM Group, Inc. Mr. DeLuca joined OM Group in 1998 as a Project Manager and was promoted repeatedly to roles of increasing scope and responsibility including Plant Manager, Director of Research and Development, Director of Corporate Engineering, Purchasing and Logistics, and Business Director for the Inorganics Business.
Greerson McMullen
has served as served as General Counsel & Secretary since May 2013. Previously, Mr. McMullen served as the Senior Vice President, General Counsel, Government Affairs & Secretary of the ServiceMaster Company since November 2007 (holding the Government Affairs title since March 2010). The ServiceMaster Company is a residential services company.
Robert Cardin
has served as our Corporate Controller since November 2013. Previously, Mr. Cardin served as Controller for Syncreon, a specialized provider of integrated logistics services to global industries, since 2011. Prior to that time he was employed by DENTSPLY International Inc., a worldwide manufacturer of dental products, as Assistant Corporate Controller from 2010 to 2011 and as Group Controller - Dental Consumables Business from 2004 to 2010.
Item 1A.
Risk Factors
Factors That May Affect Future Results
Many risk factors both within and outside of our control could have an adverse impact on our business, financial condition, results of operations and cash flows and on the market price of our common stock. While not an exhaustive list, the following important risk factors could affect our future results, including our actual results for 2014 and thereafter and could also cause our actual results to differ materially from those expressed in any forward-looking statements we have made or may make.
We expect our business to be impacted by governmental actions relating to tobacco products, as well as decreased demand for tobacco products relating to declining social acceptance of smoking in the United States and certain other countries.
In 2013, approximately 93% of our net sales were from products used by the tobacco industry in making cigarettes or other tobacco products. In recent years, governmental entities around the world, particularly in the United States, Brazil, Australia and western Europe, have taken, or have proposed, actions that had, and are likely to continue to have, the effect of reducing consumption of tobacco products which can, in turn, reduce demand for our products. Reports with respect to the possible harmful physical effects of cigarette smoking, including second-hand smoke, and use of other tobacco products have been publicized for many years. Such reports, together with actions to regulate, restrict or prohibit the sale, advertisement and promotion of tobacco products, including cigarettes and their components, to limit smoking in public places, to control or restrict additives that may be used in tobacco products and to increase taxes on such products, are intended to discourage the consumption of traditional cigarettes and other such products. In recent years, certain governmental entities, particularly in North America and Europe, have enacted, considered or proposed actions that would require cigarettes to meet specifications aimed at reducing their likelihood of igniting fires when the cigarettes are not actively being smoked. It is not possible to predict the additional legislation or regulations relating to tobacco products that may be enacted or the extent to which such legislation, regulations or the development of new products or technologies, such as e-cigarettes, may impact the design or formulation of our customers' products, the demand for traditional cigarettes and our business and financial performance.
Cigarette consumption in the United States and western Europe has declined, in part due to the actions described above, to the diminishing social acceptance of smoking and to private actions to restrict smoking. These declines have had an adverse effect on demand for our products in these regions and potentially other regions. We expect such factors will continue to reduce smoking levels and potentially adversely affect demand for our products. In addition, litigation is pending against major manufacturers of consumer tobacco products seeking damages for health problems allegedly resulting from the use of tobacco in various forms. It is not possible to predict the outcome of such litigation or the effect adverse developments in pending or future litigation may have on the tobacco industry or its demand for our products, but in the past, increases in taxes and litigation have adversely affected demand. In the U.S., the regulatory jurisdiction of the federal Food and Drug Administration was extended in 2009 to include tobacco products, which products are now subject to product component disclosure regulations, new controls on ingredients, and additional restrictions relating to marketing and labeling. The federal Food and Drug Administration could promulgate additional regulations to areas it has not to date regulated or has only lightly regulated such as certain cigars. In Brazil, regulations limit the use of additives to cigarettes. In the European Union, the Tobacco Products Directive regulates the content, effects, marketing and labeling of tobacco products, and both revisions to the Directive and the ongoing phase-in of the REACH regulation (Registration, Evaluation, Authorization, and Restriction of Chemical Substances) may further restrict product ingredients. Additionally, the World Health Organization is actively promoting tobacco regulation, and other countries worldwide are in the process of adopting some or all of these restrictions. The impact of these legislative and regulatory initiatives on the production and sale of our and our customers' products is not presently known but could adversely affect our results.
The overall demand in the U.S. and western Europe for conventional tobacco cigarettes has generally been declining in terms of volume of sales. In addition to the governmental actions referred to above, there is and continues to be a decline in the social acceptability of smoking and increased awareness of health risks relating to tobacco products. Such a decline could lead to certain merchants deciding not to sell tobacco products, thus potentially adversely impacting demand for our products.
Our technological advantages are unlikely to continue indefinitely.
We consider our intellectual property and patents to be a material asset. We have been at the forefront of developing new products and technology within our industries and have patented several of our innovations, particularly with regard to cigarette paper used to produce LIP cigarettes. This has enhanced our ability to sell products and to provide added function and other value to the products we sell allowing them to command higher margins. This advantage has also enabled us to license certain of our patents and know-how and earn royalty income from competitors and customers. Presently, we are seeing evidence of increasing efforts and activity by our competitors and some customers to develop and sell competitive products, particularly in the area of papers used for lower ignition propensity applications and e-cigarettes. Over time, we expect our competitors to develop competitive products that are designed to avoid our intellectual property or to license our innovations. Ultimately, our patents will expire. As we expand our production of LIP papers, RTL and our Filtration operations to more locations and countries, the risk of the loss of proprietary trade secrets will increase, and any significant loss would result in the loss of the competitive advantages provided by such trade secrets. While we cannot predict the impact or the timing of these trends and eventualities, they likely will reduce our sales and margins from the levels that we otherwise would have achieved.
Effectively policing our domestic and international intellectual property and patent rights is costly and may not be successful.
Our portfolio of granted patents varies by country, which could have an impact on any competitive advantage provided by patents in individual markets. We rely on patent, trademark, and other intellectual property laws of the United States and other countries to protect our intellectual property rights. In order to maintain the benefits of our patents, we may be required to enforce certain of our patents against infringement through judicial or administrative actions. However, we may be unable, or it may be uneconomic for us, to prevent third parties from using our intellectual property or infringing on our patents without our authorization, which may reduce any competitive advantage we have developed. If we have to litigate to protect these rights, any proceedings could be costly, time consuming, could divert management resources, and we may not prevail. We cannot guarantee that any United States or foreign patents, issued or pending, will continue to provide us with any competitive advantage or will not be successfully challenged by third parties.
We do not believe that any of our products infringe the valid intellectual property rights of third parties. However, we may be unaware of intellectual property rights of others that may cover some of our products or services or a court or other governmental body may come to a different conclusion from ours. In that event, we may be subject to significant claims for damages or disruptions to our operations. Effectively policing our intellectual property and patents is time-consuming and costly, and the steps taken by us may not prevent infringement of our intellectual property, patents or other proprietary rights in our products, technology and trademarks, particularly in foreign countries where in many instances the local laws or legal systems do not offer the same level of protection as in the United States.
In December 2009, Miquel y Costas & Miquel S.A., delfortgroup AG, and Société Papéterie Leman SAS filed Notices of Opposition to the European Patent Office's, or EPO, grant of European Patent EP 1482815. The opponents contend that the claimed invention is not disclosed in a manner sufficiently clear and complete for it to be carried out by a person skilled in the art and that the claims were either not novel or lacked inventive step due to prior art references, amongst others, two earlier patents of SWM, cited by the Examiner in granting the patent. The Company will continue to defend the grant of this patent by taking necessary actions including responding to further submissions by the opponents. Once the EPO considers that all positions have been fully briefed, it will hold a hearing to assist it in reaching a final conclusion on the oppositions. There is no mandated timetable by which the EPO must reach a decision. The outcome of this dispute would not prevent the Company from practicing its ALGINEX® LIP solution. The patent remains in effect and is enforceable while the opposition proceedings are pending. As a result of the world-wide LIP license agreement with SWM, delfortgroup has withdrawn its opposition and is no longer a party to these proceedings; although, delfortgroup's arguments and evidence presented remain in the proceedings. The action remains open with the other parties.
On November 11, 2010, the EPO issued a Decision to Grant SWM European Patent No. 1333729. On December 8, 2010, Julius Glatz GmbH filed a Notice of Opposition to the grant of this patent. In September 2011, Papéteries du Leman, Miquel y Costas & Miquel S.A. and delfortgroup AG each filed opposition papers and Glatz supplemented its previous filing. Papéteries du Leman failed to pay the opposition fee and thus is not a party to the opposition proceedings; however, it refiled its opposition papers as third-party observations. The Company believes that the EPO properly granted the patent and it intends to vigorously defend the patent. The patent remains in effect and is enforceable while the opposition proceedings are pending. As a result of the world-wide LIP license agreement with SWM, delfortgroup has withdrawn its opposition and is no longer a party to these proceedings; although, delfortgroup's arguments and evidence presented will remain in the proceedings. The action remains open with the other parties.
On June 27, 2012, the EPO granted the Company's applications for two LIP-related patents, EP 2127544 and EP 2127545, that are based on divisional applications related to European Patent No. 1333729. Julius Glatz GmbH and Miquel y Costas & Miquel S.A. each filed Notices of Opposition to the grants of EP 2127544. Julius Glatz GmbH, Miquel y Costas & Miquel S.A and Société Papéterie Leman SAS each filed Notices of Opposition to the grant of EP 2127545. The EPO issued communications requesting SWM to respond to the oppositions on May 7, 2013. The Company believes that the EPO properly granted the patents, and it intends to vigorously defend the patents. The patent remains in effect and is enforceable while the opposition proceedings are pending.
On September 12, 2012, the EPO granted the Company's LIP-related patent, EP 2127543, that is based on a divisional application related to EP 1333729. Papéteries du Leman, Julius Glatz GmbH and Miquel y Costas & Miquel S.A. each filed Notices of Opposition, and the EPO issued a communication on July 23, 2013, requesting SWM to respond to the oppositions. The Company believes that the EPO properly granted the patent, and it intends to vigorously defend the patent. The patent remains in effect and is enforceable while the opposition proceedings are pending.
Our financial performance can be significantly impacted by the cost of raw materials and energy.
Raw materials are a significant component of the cost of the products that we manufacture. The cost of wood pulp, which is the largest component of the raw materials that we use, and of resins by our Filtration segment are highly cyclical and can be more volatile than general consumer or producer inflationary changes in the general economy. For instance, during the period from January 2011 through September 2013, the U.S. list price of northern bleached softwood kraft pulp, or NBSK, a representative pulp grade that we use, ranged from a low of $830 per metric ton in September 2012 to a high of $1,035 per metric ton in June 2011. Also, over the last five years, the cost of polypropylene has fluctuated from 35 cents per pound to 105 cents per pound. We periodically enter into agreements with customers under which we agree to supply products at fixed prices. As a consequence, unanticipated increases in the costs of raw materials, or the lack of availability of such raw materials (due to force majeure or other reasons), can significantly impact our financial performance. Even where we do not have fixed-price agreements, we generally cannot pass through increases in raw material costs in a timely manner and in many instances are not able to pass through the entire increase to our customers.
Paper manufacturing is energy-intensive. In France, Poland and in the United States, availability of energy generally is reliable, although prices can fluctuate significantly based on variations in overall demand. Western Europe is becoming significantly dependent on energy supplies from the Commonwealth of Independent States, which in the past has demonstrated a willingness to restrict or cut off supplies of energy to certain customers. The volume of oil or gas flowing through pipeline systems that ultimately connect to western Europe also has been cut off or restricted in the past, and such actions have the capability of adversely impacting the supply of energy to western Europe and, consequently, the cost and availability of electricity to our European operations. In Brazil, where production of electricity is heavily reliant upon hydroelectric plants, availability of electricity can be, and has in the past been, affected by rain variations. Although our Brazilian business currently has a sufficient supply of energy to continue its current level of operation, there can be no assurance that we will have sufficient supply in the future. Due to the competitive pricing for most of our products, we typically are unable to fully pass through higher energy costs to our customers. Periodically, when we believe it is advantageous to do so, we enter into agreements to procure a portion of our energy for future periods in order to reduce the uncertainty of future energy costs. However, in recent years this has only marginally slowed the increase in energy costs due to the volatile changes in energy prices we have experienced.
Historically, we have experienced significant cost savings and productivity benefits relating to our ongoing Operational Excellence program; however, these benefits may not continue indefinitely.
Historically, we have experienced significant cost savings and productivity benefits relating to our ongoing Operational Excellence program that have supported our margins during periods of significant attrition in the Tobacco industry. We expect to continue to achieve significant savings and benefits from this program, however, in light of continued industry attrition, execution risks and other factors, should we be unable to continue to obtain these savings and benefits in line with historical achievements, our profitability and financial results could be adversely affected.
Because of the geographic diversity of our business, we are subject to a range of international risks.
We have manufacturing facilities in six countries, two joint ventures in China and sell products in over 90 countries, many of which are emerging and undeveloped markets. Our manufacturing operations, sales and results, depending on their location, are subject to various international business risks, including the following:
|
|
•
|
Foreign countries can impose significant import, export, excise and income tax and other regulatory restrictions on business, including limitations on repatriation of profits and proceeds of liquidated assets. While we attempt to manage our operations and international movements of cash from and amongst our foreign subsidiaries in a tax-efficient manner, unanticipated international movement of funds due to unexpected changes in our business or changes in tax and associated regulatory schemes could result in a material adverse impact on our financial condition or results of operations;
|
|
|
•
|
We are exposed to global as well as regional macroeconomic and microeconomic factors, which can affect demand and pricing for our products, including: unsettled political and economic conditions; expropriation; import and export tariffs; regulatory controls and restrictions; and inflationary and deflationary economies. These factors together with risks inherent in international operations, including risks associated with with any non-compliance with the U.S. Foreign Corrupt Practices Act, the 2013 Brazilian Clean Companies Act, the U.K. Bribery Act 2010, the 2013 Russian Law on Preventing Corruption and other non-U.S. anti-bribery law compliance, could adversely affect our results;
|
|
|
•
|
We participate in two joint ventures and have one manufacturing facility in China. One joint venture sells our products primarily to Chinese tobacco companies. The second joint venture is building a new reconstituted tobacco mill in China. Operations in China entail a number of risks including international and domestic political risks, the need to obtain operating and other permits from the government, changes in the policies or in our relations with government-owned or run customers and to operate within an evolving legal and economic system; and
|
|
|
•
|
Changes in international trade sanctions may restrict or prohibit us from transacting business with established customers. Since December 2012, we have held a license from the U.S. Office of Foreign Assets Control to continue selling reconstituted tobacco for distribution in Iran. Our continued sales of reconstituted tobacco in Iran are contingent on our successfully obtaining annual renewals of this license.
|
Changes in the laws and regulations described above, adverse interpretations or applications of such laws and regulations, and the outcome of various court and regulatory proceedings in Europe and Brazil could adversely impact the Company's business in a variety of ways, including increasing expenses, decreasing sales, limiting its ability to repatriate funds and generally limiting its ability to conduct business, all of which could adversely affect our operations and financial results.
Fluctuations in foreign currency exchange rates could adversely impact our financial condition and results of operations.
A significant portion of our revenues are generated from operations outside the United States. In addition, we maintain significant operations and acquire or manufacture many of our products outside the United States. The functional currency of our international subsidiaries is generally the local currency in which each subsidiary operates. In particular, a large portion of our commercial business is denominated in euros. Our consolidated financial statements are presented in U.S. dollars. Therefore, we must translate revenues, expenses, assets and liabilities from functional currencies into U.S. dollars at exchange rates in effect during, or at the end of the reporting period. As a result, our future revenues, costs and results of operations could be significantly affected by changes in foreign currency exchange rates, especially the euro to U.S. dollar exchange rate.
In addition, some of our sale and purchase transactions are denominated in a currency other than the local currency of our operations. As a result, changes in exchange rates between the currencies in which the transaction is denominated versus the local currency of our operation into which the transaction is being recorded can impact the amount of local currency recorded for such transaction. This can result in more or less local currency revenue or cost related to such transaction and thus have an effect on our operating profit. Currency transaction risk is mitigated partially in France because some of the revenue and expense transactions of our French subsidiaries are denominated in U.S. dollars, providing a degree of natural hedging. Our Brazilian and Polish operations are more fully exposed to currency transaction risk, especially as a result of U.S. dollar and euro denominated sales, respectively.
Changes in foreign currency exchange rates also impact the amount reported in other income (expense), net. For instance, when a non-local currency receivable or payable is not settled in the period in which it is incurred, we are required to record a gain or loss, as applicable, to reflect the impact of any change in the exchange rate as of the end of the period. We also have to reflect the translation rate impact on the carrying value of our foreign assets and liabilities as of the end of each period, which is recorded as Unrealized Translation Adjustment in Other Comprehensive Income.
We utilize a variety of practices to manage this risk, including operating and financing activities and, where considered appropriate, derivative instruments. All derivative instruments we use are either exchange traded or entered into with major financial institutions in order to reduce credit risk and risk of nonperformance by third parties. Counterparty risk cannot be eliminated and there can be no assurance that our efforts will be successful. We generally hedge foreign currency transactions risk primarily through the use of derivative instruments, including forward and swap contracts and, to a lesser extent, option contracts. The use of derivative instruments is intended to mitigate or reduce transactional level volatility in the results of foreign operations, but does not completely eliminate volatility. If our future revenues, costs and results of operations are significantly affected by economic conditions abroad and we are unable to effectively hedge these risks, they could materially adversely affect our results of operations and financial condition.
We are dependent upon the availability of credit, and changes in interest rates can impact our business.
We supplement operating cash flow with bank borrowings under a credit agreement with a syndicate of banks that matures in December 2018. To date, we have been able to access credit when needed and on commercially reasonable terms. However, deterioration of credit markets, including an economic crisis in the U.S. or elsewhere, whether or not caused by the U.S. or European debt ceiling, deficits and budget issues could have an adverse impact on our ability to negotiate new credit facilities or access or renew our existing one. Constraints on the availability of credit, or the unavailability of credit at reasonable interest rates, would negatively impact our business, including potentially impairing our ability to declare dividends, conduct share buy-backs and make acquisitions.
Our credit facility contains financial covenants that we have historically fulfilled, and we do not presently anticipate any events that would impair our ability to meet those covenants in the future. However, in the event of material unforeseen events that impact on our financial performance, particularly during a time when we have material amounts of debt, a situation could arise where we are unable to fully draw from our existing credit facility notwithstanding that there is otherwise available capacity.
We have a combination of variable and fixed-rate debt consisting of short-term and long-term instruments. We selectively hedge our exposure to interest rate increases on our variable rate long-term debt when we believe that it is practical to do so. We have utilized various forms of interest rate hedge agreements, including interest rate swap agreements and forward rate agreements. There can be no certainty that our hedging activities will be successful or fully protect us from interest rate exposure.
Seasonality can impact our business.
Sales of our Paper and Reconstituted Tobacco products in the United States, Europe and Brazil are subject to seasonal fluctuations. In the United States and Europe, customer shutdowns typically occur in July and December and historically have resulted in reduced net sales and operating profit during those two months. Additionally, our facilities occasionally shut down equipment to perform additional maintenance during these months or as a result of slow demand, resulting in higher product costs, higher maintenance expenses and reduced operating profit. In Brazil, customer orders are typically lower in December due to a holiday season during much of January and February.
We face competition from several established competitors and have limited market transparency.
Our four largest competitors are delfortgroup AG (Delfort), Julius Glatz GmbH (Glatz), Miquel y Costas & Miquel S.A. and PT BUKIT Muria Jaya (BMJ). All four primarily operate from modern and cost-effective mills in western Europe and Asia and are capable and long-standing suppliers to the tobacco industry. Further, three such competitors, Delfort, Glatz and BMJ, are privately held and the third, Miquel y Costas, is a closely held public company. Thus, their financial results and other business developments and strategies are not disclosed to the same extent as ours, which provides them some advantage in dealing with customers. Given the concentration of most of our competitors in western Europe, which has declining demand and has labor laws that make reducing capacity expensive and slow, excess capacity exists and therefore price competition is acute. We believe that all four competitors have good relationships with the multinational cigarette companies, as does the Company. The multinational cigarette companies have been known to use these close relationships to encourage the development of enhanced competition through supporting competitive products and facilities, especially when confronted with new, high-value technologies such as porous plug wrap in the past and LIP today.
As a result of the foregoing, the Company faces significant selling price, sales volume and new product risks from its competitors, especially during periods in which the Company's contracts with its major customers are subject to renewal or renegotiation.
Currently, fine papers used to produce cigarettes are only exported on a limited basis from available capacity in China and other Asian locations to western multinational cigarette companies due to government taxes and tariffs, which limit price competitiveness, as well as due to customer preferences. Should conditions change in this regard, capacity that currently is operating in China and elsewhere in Asia would present a risk to our competitive position in the developed world and elsewhere and place further pressure on our legacy paper production platforms.
Due to many of the factors described above, we have a limited ability to predict trends in the industry and there may be a time lag before we become aware of developing trends in the industry. In the RTL market segment, demand is a function, among other things, of smoke delivery regulations, the cigarette manufacturer's desire for a uniform and consistent product, the taste profile sought by cigarette manufacturers and the cost of recycling the tobacco by-product scraps relative to the cost of virgin tobacco products. Thus, our RTL business is also subject to competitive risk from lower cost virgin tobacco leaf or other, cheaper, cigarette fillers. These factors could result in lower volumes for our RTL business, resulting in downtime of certain production machines and, in some cases, accelerated depreciation or impairment charges for certain equipment as well as employee severance expenses associated with downsizing or restructuring activities.
Further, as a result of excess capacity in the tobacco-related papers industry and increased operating costs, competitive levels of selling prices for certain of the Company's products are not sufficient to cover those costs with a margin that the Company considers reasonable. Such competitive pressures have resulted, and could result in the future, in downtime of certain production machines and, in some cases, accelerated depreciation or impairment charges for certain equipment as well as employee severance expenses associated with downsizing or restructuring activities.
We are dependent upon a small number of customers for a significant portion of our sales. The loss of one or more of these customers could have a material adverse effect on our business.
Four customers accounted for over
57%
of our net sales in 2013. The loss of one or more of these customers, or a significant reduction in their purchases, particularly those that impact our value-added LIP papers or reconstituted tobacco, could have a material adverse effect on our results of operations and financial results. The enhanced capabilities provided by RTL in the area of product design and regulatory compliance are important to our customers. However, future RTL results could be adversely affected by fluctuations in customer inventories, changes in the cigarette tobacco blending approaches by our customers, changes in regulations and tariffs and the price of virgin tobacco leaf.
In addition, significant consolidation has occurred among our customers, thereby increasing our dependence upon a fewer number of customers and increasing the negotiating leverage of the customers that survive. If any of our customers were to change suppliers, in-source production of reconstituted tobacco or cigarette papers (including those used to produce LIP cigarettes), institute significant cost-cutting measures or experience financial difficulty, then these customers may substantially reduce their purchases from us, which could adversely impact our operations and financial results. In addition, adverse results in the negotiation of any of our significant customer contracts, the terms of which are typically negotiated every one to three years, could significantly impact our operations and financial results.
Our business is subject to various environmental risks.
Our facilities are subject to significant federal, state, local and foreign environmental protection laws with respect to air, water and other emissions as well as the disposal of solid waste. We believe we are operating in substantial compliance with these laws and regularly incur capital and operating expenditures in order to maintain future compliance. However, these laws may change, which could require changes in our practices, additional capital expenditures or loss of carbon credits, and we may discover aspects of our business that are not in compliance. Violation of these laws can result in the imposition of significant fines and remediation costs. In France, we presently have sufficient authorized capacity for our emissions of carbon dioxide. However, this authorization must be renewed every five years. We cannot predict that we will have sufficient authorized capacity to conduct our operations in France as presently conducted or to do so without having to make substantial capital expenditures in future years. There also is the possibility of regulation of carbon dioxide emissions in the U.S. It is not presently possible to assess what, if any, impact such regulations might have on our domestic U.S. operations.
We are a member of a potentially responsible party group (Global PRP Group) that has entered into a settlement with the State of New Jersey concerning the remediation of a landfill site in Middlesex County, New Jersey. The landfill remediation has been completed. We have established a reserve of less than $0.1 million that we believe is adequate to cover our ongoing liability, but we remain exposed to post-closure operating costs over an extended period of years that cannot be fully known or estimated at this time.
Although we are not aware of any environmental conditions at any of our facilities that could have a material adverse effect on our financial results, we own facilities in France, the U.S. and elsewhere that have been operated over the course of many decades. We may face higher disposal and clean-up costs to replace equipment or facilities containing materials that were compliant when installed, but are now considered contaminants. Additionally, as we sell closed facilities, we may be required to perform additional environmental evaluations that could identify items that might require remediation or other action, the nature, extent and cost of which are not presently known.
We are subject to various legal actions and other claims.
We regularly are involved in legal actions and other claims arising in the ordinary course of business and otherwise. We are also subject to many laws and regulations around the world. Despite our efforts, we cannot guarantee that we are in compliance with every such law or regulation. Because of the complexity of Brazilian tax laws and court systems, legal actions are a particular risk affecting our Brazilian operations. Although we believe that our positions in pending disputes about state and federal taxes are correct and will ultimately be upheld by Brazilian courts, the outcome of legal proceedings can be difficult to predict. An adverse result in one or more of these tax disputes could have a material adverse impact on our financial condition and results or operations. We are also subject a various other litigation in Brazil, including labor and workplace safety claims. Although we do not believe that any of the currently pending actions or claims against us will have a material adverse impact on our business or financial condition, we cannot provide any assurances in this regard. Information concerning some of these actions that currently are pending is contained in Note
18
, Commitments and Contingencies, of the Notes to Consolidated Financial Statements and in Part I, Item 3, “Legal Proceedings” of this report.
Our internal and external expansion plans and asset dispositions entail different and additional risks relative to the rest of our business.
We may from time to time consider acquisitions either within the tobacco industry or outside the industry in connection with our diversification initiatives, such as our recent acquisition of DelStar, Inc. This could involve confidential negotiations that are not publicly announced unless and until those negotiations result in a definitive agreement. Although we seek to maintain or improve the economic fundamentals of our business, it is possible that an acquisition could adversely impact our results, credit ratings or the outlook of our business. Also, acquisition opportunities are limited and present risks of failing to achieve strategic objectives or anticipated synergies or returns. There can be no assurance that we will be able to acquire attractive businesses on favorable terms, that we will realize the anticipated benefits or profits through acquisitions or that acquisitions will be accretive to earnings. Changes in our portfolio of businesses, assets and products, whether through acquisition, disposition or internal growth, present additional risks. Such activities, including diversification and our acquisition of DelStar, can lead us to incur unknown or new types of liabilities, subject us to new regulatory frameworks, new market risks, involve operations in new geographies with challenging labor, regulatory and tax regimes as well as the execution risks associated with such activities. The potential future expansion of our filtration operations could cause these operations, including DelStar, to face additional competition from larger and more established competitors than is currently the case.
The ability to dispose of idled assets and the value that may be obtained relative to their book value can result in significant impairment charges. Some of these risks manifested themselves in early 2011 when we announced suspension of construction of a wholly-owned reconstituted tobacco mill in the Philippines and could be encountered in other forms to the extent that we construct a new reconstituted tobacco mill in China through a 50% joint venture. Building a new mill or other facility is a major construction project and entails a number of risks, including the possibility that the contractors and sub-contractors who are expected to build the facility and supply the necessary equipment do not perform as expected, that there will be cost overruns or that design defects or omissions cause the facility to perform at less than projected efficiency or at less than projected capacity. In addition, commencement of production at a new site is time consuming and requires customer testing and acceptance by customers, and potentially by regulators, of the products that are produced. Also, while we anticipate sufficient demand for the site's output, there can be no assurances that the expected demand will materialize. For more information on our expansion plans, see Part II, Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operation" of this report.
We also expect to continue to expend resources to diversify and expand our product portfolio. Research and development and product diversification have several inherent risks, including technical success, market acceptance, new regulations and potential liabilities. We cannot guarantee that such efforts will succeed or that we will achieve a satisfactory return on such expenditures.
We may not successfully integrate acquisitions and may be unable to achieve anticipated cost savings or other synergies.
The integration of acquired companies’ operations involves a number of risks and presents financial, managerial and operational challenges. We may have difficulty, and may incur unanticipated expenses related to, integrating information systems, financial reporting activities, and integrating and retaining management and personnel from acquired companies. Additionally with respect to our DelStar Acquisition, we may not be able to achieve anticipated cost savings or commercial or growth synergies, for a number of reasons, including contractual constraints and obligations or an inability to take advantage of expected commercial opportunities, increased operating efficiencies or commercial expansion of key technologies. Failure to successfully integrate acquired companies may have an adverse effect on our business, results of operations, financial condition and cash flow.
Restructuring activities significantly impact our business.
We began significant restructuring activities in 2006 and 2007 in France and the United States, during 2007 in Brazil and during 2012 in the Philippines that have become part of an overall effort to improve an imbalance between demand for our products and our paper production capacity as well as improve our profitability and the quality of our products. We expect to continue these restructuring efforts from time to time. Restructuring of our existing operations, or as a results of acquisitions, involves issues that are complex, time-consuming and expensive and could significantly disrupt our business. The challenges involved in executing the actions that are part of our ongoing and, potentially future, restructuring plans include:
|
|
•
|
demonstrating to customers that the restructuring activities will not result in adverse changes in service standards or business focus;
|
|
|
•
|
consolidating administrative infrastructure and manufacturing operations while maintaining adequate controls throughout the execution of the restructuring;
|
|
|
•
|
preserving distribution, sales and other important relationships and resolving potential conflicts that may arise;
|
|
|
•
|
minimizing the diversion of management attention from ongoing business activities;
|
|
|
•
|
maintaining employee morale, retaining key employees, maintaining reasonable collective bargaining agreements and avoiding strikes, work stoppages or other forms of labor unrest while implementing restructuring programs that often include reductions in the workforce;
|
|
|
•
|
securing government approval of such plans, where necessary, and managing the litigation and associated liabilities that often are associated with restructuring actions;
|
|
|
•
|
coordinating and combining operations, which may be subject to additional constraints imposed by collective bargaining agreements and local laws and regulations; and
|
|
|
•
|
achieving the anticipated levels of net cost savings and efficiency as a result of the restructuring activities.
|
If we do not achieve expected benefits as a result of our legal entity realignment, the ability to achieve our financial guidance for operating results and cash-flow could be adversely affected.
We are re-examining our legal entity structure and certain internal business operations in order to allow us to improve our cash-flows, have easier access to our foreign cash, centralize certain internal business activities and reduce our overall effective tax rate. Initial steps to accomplish these objectives have been taken and are continuing. A significant portion of these activities is expected to be completed around the middle of 2014. However, we anticipate that there could be further activities in these respects after that.
Realignments present significant potential risks of events occurring that could delay, halt or adversely affect the success of the project, including delays encountered in finalizing the scope of, and implementing, the realignment, the failure to achieve targeted benefits or savings, the failure to follow appropriate regulatory requirements or internal processes and procedures and a potential decrease in employee morale. Further, despite obtaining certain tax rulings, there can be no assurance that the taxing authorities of the jurisdictions in which we operate, or to which we are otherwise deemed to have sufficient tax nexus, will not challenge the tax benefits that we expect to realize as a result of the realignment. In addition, changes to U.S. or non-U.S. tax laws may negatively impact the anticipated benefits of the proposed realignment. Any future benefits to our effective tax rate will also depend on our ability to operate our business in a manner consistent with the regulatory requirements for such a realignment including applicable taxing provisions, as well as us realizing our anticipated profits. Further, we expect to incur certain costs in connection with the realignment and we may incur additional cost that are not currently expected to be incurred.
To the extent these risks or circumstances occur, we may fail to achieve the future financial and business benefits that we anticipate as a result of the realignment and our future operating results, financial condition and cash-flows may be negatively impacted. Thus, there can also be no assurance that we will realize the expected future benefits of the restructuring.
One portion of our business is dependent upon a single mill; We have limited cross redundancy across our facilities.
Sales of reconstituted tobacco leaf products represent a substantial portion of our revenues and profits. We presently produce reconstituted tobacco leaf at only one facility located in France and wrapper and binder products at only one facility located in Ancram, New York. The loss of or the interruption of operations for a significant length of time due to a casualty event or otherwise at either facility could have a material adverse effect on our business. Further, in order to achieve operational efficiencies, among other reasons, we have limited ability to shift production across our various facilities, thus the loss of production at one facility may not be able to be mitigated by increased production at another.
Significant impairment charges could result from our evaluation of the Philippines RTL manufacturing site.
The Company suspended construction of its Philippines RTL manufacturing site during 2011. The carrying value of the partially constructed assets is evaluated for impairment at each reporting period by assessing the recoverability of the costs based on the undiscounted cash flows of the operation, the likelihood of its reactivation and any alternative uses for the equipment. This evaluation, along with potential declines in our RTL volumes, resulted in 2013 in an impairment of $37.2 million and could result in a decision to record a further impairment of some or a substantial portion of the net book value of the RTL Philippines property, plant and equipment, which was
$31.5 million
as of
December 31, 2013
.
A failure of a key information technology system or process or other unusual events could adversely affect our business.
We rely extensively on information technology systems, some of which are managed by third-party service providers, to analyze, process and manage transactions and data. We also rely heavily on the integrity of this data in managing our business. We or our service providers could experience errors, interruptions, delays or cessations of service in key portions of our information technology infrastructure, which could significantly disrupt our operations and be expensive time-consuming and resource-intensive to remedy.
Natural disasters, pandemics and other unusual events could interrupt one or more of our facilities in six different countries to varying degrees, which could adversely affect our results.
We rely on a limited number of key employees and may experience difficulty in retaining, attracting and hiring qualified new personnel in some areas of our business.
The loss of any of our key employees could adversely affect our business. Because our core products relate to the tobacco industry, we may experience difficulty in retaining and hiring qualified executives and other personnel. This may be caused by the health and social issues associated with the tobacco industry. The tobacco industry competes for talent with consumer products and other companies that enjoy greater acceptance. The loss of services of any key employees, including in our DelStar business, or our inability to attract, hire and retain personnel with requisite skills could restrict our ability to develop new products, enhance existing products in a timely manner, sell products or manage our business effectively. These factors could have a material adverse effect on our business, results of operations and financial condition.
Our business depends upon good relations with our employees.
We employ approximately 3,000 employees, including manufacturing employees represented by unions. Although we believe that employee and union relations are generally positive, there is no assurance that this will continue in the future. We may experience difficulties in maintaining appropriate relations with unions and employees in certain locations. Problems or changes affecting employees in certain locations may affect relations with our employees at other locations. The risk of labor disputes, work stoppages or other disruptions in production could adversely affect us especially in conjunction with potential restructuring activities. If we cannot successfully negotiate or renegotiate collective bargaining agreements, or if negotiations take an excessive amount of time, there may be a heightened risk of work stoppages. Work stoppages may be caused by the inability of national unions and the governments of countries in which the Company operates from reaching agreement, and are outside the control of the Company. Any work stoppage could have a material adverse effect on the productivity and profitability of a manufacturing facility or on our operations as a whole.
Increases in costs of pension benefits may reduce our profitability.
Our results of operations may be negatively affected by expenses we record for our defined benefit pension plans. Generally accepted accounting principles in the United States, or U.S. GAAP, require that we calculate income or expense for the plans using actuarial valuations. These valuations reflect assumptions about financial markets and other economic conditions, which may change based on changes in key economic indicators. We are required to make an annual measurement of plan assets and liabilities, which may result in increased funding obligations or negative changes in our stockholder equity. At the end of 2013, the combined projected benefit obligation of our U.S. and French pension and other postretirement healthcare plans was underfunded by
$23.8 million
. For a discussion regarding our pension obligations, see Note
16
. Postretirement and Other Benefits of the Notes to Condensed Consolidated Financial Statements in Part II, Item 8 and Other Factors Affecting Liquidity and Capital Resources in Part II, Item 7. Although expense and pension funding contributions are not directly related, key economic factors that affect expense would also likely affect the amount of cash we would contribute to pension plans as required under the Employee Retirement Income Security Act (ERISA) for U.S. plans. Failure to achieve expected returns on plan assets driven by various factors, which could include a continued environment of low interest rates or sustained market volatility, could also result in an increase to the amount of cash we would be required to contribute to pension plans.
Item 1B.
Unresolved Staff Comments
None.
Item 2.
Properties
As of December 31, 2013, we operated 14 production facilities (which include three fiber pulping operations) on four continents. In 2013, we acquired five facilities in our Filtration segment in connection with our acquisition of DelStar. The following are locations of our principal production facilities which are owned, except for the Strykow, Poland, Austin, Texas, Richland Pennsylvania, El Cajon, California and Suzhou, China facilities which are leased, as of December 31, 2013:
|
|
|
|
|
|
Paper Segment
Production Locations
|
|
Reconstituted Tobacco Segment
Production Locations
|
|
Filtration Segment
Production Locations
|
Spotswood Mill
|
|
LTR Industries Mill
|
|
Middletown Manufacturing Site
|
Spotswood, New Jersey
|
|
Spay, France
|
|
Middletown, Delaware
|
|
|
|
|
|
Papeteries de Saint-Girons Mill
|
|
Ancram Mill
|
|
U.S. Netting
|
Saint-Girons, France
|
|
Ancram, New York
|
|
Austin, Texas
|
|
|
|
|
|
Papeteries de Mauduit Mill
|
|
RTL Philippines Mill (construction suspended)
|
|
Tubing Operations
|
Quimperlé, France
|
|
Sto. Tomas, Philippines
|
|
Richland, Pennsylvania
|
|
|
|
|
|
Pirahy Mill
|
|
|
|
Tubing Operations
|
Piraí, Brazil
|
|
|
|
El Cajon, California
|
|
|
|
|
|
SWM-Poland
|
|
|
|
Suzhou Manufacturing Site
|
Strykow, Poland
|
|
|
|
Suzhou, China
|
|
|
|
|
|
Newberry Operation
|
|
|
|
|
Newberry, South Carolina
|
|
|
|
|
|
|
|
|
|
Fiber Operation
|
|
|
|
|
Manitoba, Canada
|
|
|
|
|
As of December 31, 2013, we had approximately 102,000 metric tons of annual paper production capacity and approximately 82,000 metric tons of annual reconstituted tobacco products production capacity, dependent upon the production mix. Capacity utilization increased in 2013 to 95% for paper products compared with 86% in 2012, while capacity utilization decreased to 92% for reconstituted tobacco products compared with 98% in 2012. Filtration product manufacturing lines operated at 74% capacity as of December 31, 2013. We also operate flax fiber processing operations in Canada and printing operations in France, Poland and the United States. We own each of these facilities and the associated operating equipment except for a flax tow storage facility in Winkler, Manitoba and the mill building in Strykow, Poland, which are leased.
We maintain administrative and sales offices in Alpharetta, Georgia, in Quimperlé and Spay, France, in Shanghai, China, in Piraí, Brazil, in Moscow, Russia, in Strykow, Poland, in Middletown, Delaware and in Bristol, England. Our world headquarters are also located in Alpharetta. All of these offices are owned except for those located in Alpharetta, Shanghai, Moscow, Bristol and Strykow which are leased.
We consider all of our facilities to be well-maintained, suitable for conducting our operations and business, and adequately insured, except for the RTL Philippines facility in Sto. Tomas, Philippines, which is being held in a mothballed state which would require additional construction work before operations commence.
Item 3.
Legal Proceedings
General
We are involved in various legal proceedings relating to contracts, commercial disputes, taxes, environmental issues, employment and workers' compensation claims, product liability and other matters. We periodically review the status of these proceedings with both inside and outside counsel. We believe that the ultimate disposition of these matters will not have a material effect on the results of operations in a given quarter or year. Below is a summary of our major outstanding litigation.
Litigation
Imposto sobre Circulação de Mercadorias e Serviços,
or ICMS, a form of value-added tax in Brazil, was assessed to our Brazilian subsidiary Schweitzer-Mauduit do Brasil Indústria e Comércio de Papel Ltda. in December of 2000. SWM-B received two assessments from the tax authorities of the State of Rio de Janeiro for unpaid ICMS taxes on certain raw materials from January 1995 through November 2000, collectively the Raw Materials Assessment.
The Raw Materials Assessment concerned the accrual and use by SWM-B of ICMS tax credits generated from the production and sale of certain non-tobacco related grades of paper sold domestically that are immune from the tax to offset ICMS taxes otherwise owed on the sale of products that are not immune. One of the two assessments, or Assessment 1 (case number 2001.001.115144-5), related in part to tax periods that predated our acquisition of the Pirahy mill in Pirai, Brazil and is covered in part by an indemnification from the sellers of the Pirahy mill. The second assessment, or Assessment 2 (case number 2001.001.064544-6), pertains exclusively to periods that SWM-B owned the Pirahy mill. While SWM-B would be primarily responsible for the full payment of the Assessment in the event of an ultimate unfavorable outcome, SWM-B is not aware of any difficulties that would be encountered in obtaining reimbursement of that portion of any payment resulting from Assessment 1 from the previous owners of the Pirahy mill under the indemnification.
SWM-B has contested the Raw Materials Assessment based on Article 150, VI of the Brazilian Federal Constitution of 1988, which grants immunity from ICMS taxes to papers used in the production of books, newspapers and periodicals, or immune papers, and the raw material inputs used to produce immune papers.
Both Raw Materials Assessments are presently on appeal in separate chambers of the Federal Supreme Court of Brazil. SWM-B won a favorable ruling in both assessments at the first level, then lost Assessment 1 on appeal and won Assessment 2 on appeal. Assessment 1 is before the court on SWM-B’s appeal of a procedural question which, if decided favorably, would invalidate Assessment 1. If decided against SWM-B, the lower court would be notified to send the case records to the Federal Supreme Court for a decision on the merits. Assessment 2 is before the Federal Supreme Court of Brazil on the State’s appeal on the merits and will be finally decided by the action of the chamber of the court hearing the matter, unless there is a prior decision by a chamber of the Federal Supreme Court on Assessment 1 that is in contradiction, in which case the conflict between the rulings of the different chambers would be decided by the Federal Supreme Court sitting as a whole. No docket entry has been made yet regarding argument on either assessment. Based on the foreign currency exchange rate at December 31, 2013, the Raw Materials Assessment totaled approximately
$39 million
, of which approximately
$17 million
is covered by the above-discussed indemnification.
More recently, SWM-B has received assessments from the tax authorities of the State of Rio de Janeiro for unpaid ICMS and Fundo Estadual de Combate à Pobreza (FECP) taxes on interstate purchases of electricity. The state issued three assessments against SWM-B, one for May 2006 - November 2007, a second for January 2008 - December 2010, and in October 2013, a third assessment for September 2011 - September 2013, collectively the Electricity Assessment. SWM-B has challenged all three Electricity Assessments in administrative proceedings before the state tax council (Junta de Revisão Fiscal) based on Resolution 1.610/89, which defers these taxes on electricity purchased by an "electricity-intensive consumer."
SWM-B's challenges to the first two Electricity Assessments were unsuccessful at the first administrative level, but different appeals chambers of the Junta de Revisão Fiscal have reached different conclusions about the assessments. On the first electricity assessment, one chamber of the Junta de Revisão Fiscal recognized that SWM-B is an electricity-intensive consumer but denied applicability of the tax deferral resolution. The first assessment is now on appeal before the full council of the Junta de Revisão Fiscal. Court proceedings are possible if the full administrative council issues an adverse decision. On the second electricity assessment, SWM-B won a favorable ruling at the second administrative level, which recognized that SWM-B is an electricity-intensive consumer and agreed that the tax deferral resolution applies. SWM-B's challenge to the third electricity assessment is pending at the first administrative level. Based on the foreign currency exchange rate at December 31, 2013, the electricity assessments totaled approximately $19 million.
SWM-B continues to vigorously contest the Raw Materials Assessment and the Electricity Assessment and believes that the assessments will ultimately be resolved in its favor. No liability has been recorded in our condensed consolidated financial statements for these assessments based on our evaluation of these matters under the facts and law as presently understood.
Environmental Matters
The Company's operations are subject to various nations' federal, state and local laws, regulations and ordinances relating to environmental matters. The nature of the Company's operations exposes it to the risk of claims with respect to various environmental matters, and there can be no assurance that material costs or liabilities will not be incurred in connection with such claims. While the Company has incurred in the past several years, and will continue to incur, capital and operating expenditures in order to comply with environmental laws and regulations, it believes that its future cost of compliance with environmental laws, regulations and ordinances, and its exposure to liability for environmental claims and its obligation to participate in the remediation and monitoring of certain hazardous waste disposal sites, will not have a material effect on its financial condition or results of operations. However, future events, such as changes in existing laws and regulations, or unknown contamination of sites owned, operated or used for waste disposal by the Company (including contamination caused by prior owners and operators of such sites or other waste generators) may give rise to additional costs which could have a material effect on its financial condition or results of operations.
Indemnification Matters
In connection with our spin-off from Kimberly-Clark in 1995, we undertook to indemnify and hold Kimberly-Clark harmless from claims and liabilities related to the businesses transferred to us that were not identified as excluded liabilities in the related agreements. As of December 31, 2013, there are no material claims pending under this indemnification.
Item 4.
Mine Safety Disclosures
Not applicable.
PART II.
Item 5.
Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Market Information
. Since November 30, 1995, our common stock, $0.10 par value per share, or Common Stock, has been listed on the New York Stock Exchange, trading under the symbol "SWM". On February 26, 2014, our stock closed at $47.41 per share.
The table below presents the high and low sales prices of our Common Stock on the New York Stock Exchange - Composite Transactions reporting system for the periods indicated.
|
|
|
|
|
|
|
|
|
|
High
|
|
Low
|
2014
|
|
|
|
First Quarter (through February 26, 2014)
|
$
|
51.23
|
|
|
$
|
42.53
|
|
|
|
|
|
2013
|
|
|
|
Fourth Quarter
|
$
|
63.53
|
|
|
$
|
47.72
|
|
Third Quarter
|
61.63
|
|
|
48.95
|
|
Second Quarter
|
51.26
|
|
|
38.64
|
|
First Quarter
|
42.50
|
|
|
35.87
|
|
|
|
|
|
2012
|
|
|
|
Fourth Quarter
|
$
|
39.40
|
|
|
$
|
32.03
|
|
Third Quarter
|
35.39
|
|
|
31.18
|
|
Second Quarter
|
35.49
|
|
|
32.01
|
|
First Quarter
|
36.50
|
|
|
30.59
|
|
Performance Graph.
The following graph compares the total cumulative stockholder return on our Common Stock during the period from December 31, 2008 through December 31, 2013, with the comparable cumulative total returns of the Wilshire 5000 Index and a self-constructed peer group which reflects, but is not exactly comparable to, the Dow Jones Paper Products Index. We have selected the following companies as our peer group: Neenah Paper Inc., P.H. Glatfelter Co., and Wausau Paper Corp.
The graph assumes that the value of the investments in the Common Stock and each index were $100 on December 31, 2008 and that all dividends were reinvested. The returns of the companies in the peer group have been weighted according to their market capitalization. The stock price performance shown on the graph below is not necessarily indicative of future price performance.
Comparison of Cumulative Five Year Return
Holders.
As of February 26, 2014, there were 2,197 stockholders of record.
Dividends.
We have declared and paid cash dividends on our Common Stock every fiscal quarter since the second quarter of 1996. We announced in February 2014 a dividend of $0.36 per share payable on March 20, 2014 to stockholders of record on February 28, 2014. Our Credit Agreement covenants require that we maintain certain financial ratios, as disclosed in Note
12
, Debt, of the Notes to Consolidated Financial Statements, none of which under normal business conditions materially limit our ability to pay such dividends. We will continue to assess our dividend policy in light of our cash generation, debt levels and ongoing requirements for cash to fund operations and to pursue possible strategic opportunities.
Recent Sales of Unregistered Securities.
We had no unregistered sales of equity securities during the fiscal year ended December 31, 2013.
Repurchases of Equity Securities.
The following table indicates the cost of and number of shares of the Company's common stock it has repurchased during 2013 and the remaining amount of share repurchases currently authorized by our Board of Directors as of
December 31, 2013
:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuer Purchases of Equity Securities
|
Period
|
|
Total
Number of
Shares
Purchased
|
|
Average
Price
Paid per
Share
|
|
Total Number of Shares
Purchased as Part of
Publicly Announced
Programs
|
|
Approximate Dollar Value of Shares that May Yet be Purchased Under the Programs
|
|
|
|
|
|
|
(# shares)
|
|
($ in millions)
|
|
($ in millions)
|
First Quarter 2013
|
|
43,458
|
|
|
$
|
38.03
|
|
|
—
|
|
|
$
|
—
|
|
|
|
Second Quarter 2013
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
|
Third Quarter 2013
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
|
October 2013
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
|
November 2013
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
|
December 2013
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
Total 2013
|
|
43,458
|
|
|
$
|
38.03
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
50.0
|
|
In September 2013, the Board of Directors authorized the repurchase of shares of SWM common stock during the period from November 8, 2013 to December 31, 2014 in an amount not to exceed $50.0 million. During 2014, 769,400 shares have been repurchased under this authorization for $35.0 through February 26, 2014.
The Company sometimes uses corporate 10b5-1 plans to allow for share repurchases to be made at predetermined stock price levels, without restricting such repurchases to specific windows of time. Future common stock repurchases will be dependent upon various factors, including the Company's stock price, strategic opportunities and cash availability.
Item 6.
Selected Financial Data
The following selected financial data should be read in conjunction with Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations," and the consolidated financial statements and related notes within this Annual Report on Form 10-K. The results of our San Pedro, Philippines, Medan, Indonesia and Malaucène, France mills have been retrospectively presented as discontinued operations for all periods, the first two of which were sold in 2013. The results for 2013 include results of operations of DelStar, Inc. which was acquired on December 12, 2013. All dollar amounts are in millions except per share amounts, statistical data and ratios.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
2013
|
|
2012
|
|
2011
|
|
2010
|
|
2009
|
Results of Operations
|
|
|
|
|
|
|
|
|
|
Net Sales
|
$
|
772.8
|
|
|
$
|
778.5
|
|
|
$
|
788.3
|
|
|
$
|
704.1
|
|
|
$
|
689.7
|
|
Cost of products sold
|
520.1
|
|
|
519.0
|
|
|
545.3
|
|
|
511.8
|
|
|
507.6
|
|
Gross Profit
|
252.7
|
|
|
259.5
|
|
|
243.0
|
|
|
192.3
|
|
|
182.1
|
|
Nonmanufacturing expenses
|
86.5
|
|
|
86.4
|
|
|
88.0
|
|
|
71.3
|
|
|
71.9
|
|
Provision for losses on business tax credits
|
—
|
|
|
—
|
|
|
15.9
|
|
|
—
|
|
|
—
|
|
Restructuring & impairment expense
|
41.3
|
|
|
21.4
|
|
|
14.0
|
|
|
11.6
|
|
|
23.9
|
|
Operating Profit
|
124.9
|
|
|
151.7
|
|
|
125.1
|
|
|
109.4
|
|
|
86.3
|
|
Income from Continuing Operations
|
78.5
|
|
|
104.1
|
|
|
92.1
|
|
|
72.7
|
|
|
58.2
|
|
(Loss) income from Discontinued Operations
|
(2.4
|
)
|
|
(24.3
|
)
|
|
0.5
|
|
|
(7.4
|
)
|
|
(22.6
|
)
|
Net Income
|
$
|
76.1
|
|
|
$
|
79.8
|
|
|
$
|
92.6
|
|
|
$
|
65.3
|
|
|
$
|
35.6
|
|
|
|
|
|
|
|
|
|
|
|
Net Income (Loss) Per Share- Basic:
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
$
|
2.51
|
|
|
$
|
3.33
|
|
|
$
|
2.73
|
|
|
$
|
2.00
|
|
|
$
|
1.86
|
|
(Loss) income from discontinued operations
|
(0.08
|
)
|
|
(0.79
|
)
|
|
0.02
|
|
|
(0.20
|
)
|
|
(0.72
|
)
|
Net income per share - Basic
|
$
|
2.43
|
|
|
$
|
2.54
|
|
|
$
|
2.75
|
|
|
$
|
1.80
|
|
|
$
|
1.14
|
|
|
|
|
|
|
|
|
|
|
|
Net Income (Loss) Per Share - Diluted:
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
$
|
2.49
|
|
|
$
|
3.29
|
|
|
$
|
2.71
|
|
|
$
|
1.96
|
|
|
$
|
1.81
|
|
(Loss) income from discontinued operations
|
(0.07
|
)
|
|
(0.78
|
)
|
|
0.02
|
|
|
(0.20
|
)
|
|
(0.71
|
)
|
Net income per share - Diluted
|
$
|
2.42
|
|
|
$
|
2.51
|
|
|
$
|
2.73
|
|
|
$
|
1.76
|
|
|
$
|
1.10
|
|
|
|
|
|
|
|
|
|
|
|
Cash Dividends Declared and Paid Per Share
|
$
|
1.26
|
|
|
$
|
0.45
|
|
|
$
|
0.30
|
|
|
$
|
0.30
|
|
|
$
|
0.30
|
|
EBITDA from Continuing Operations
(1)
|
$
|
171.7
|
|
|
$
|
195.4
|
|
|
$
|
163.3
|
|
|
$
|
145.1
|
|
|
$
|
124.5
|
|
Adjusted EBITDA from Continuing Operations
(1)
|
$
|
213.0
|
|
|
$
|
216.8
|
|
|
$
|
193.2
|
|
|
$
|
156.7
|
|
|
$
|
148.4
|
|
Percent of Net Sales
|
|
|
|
|
|
|
|
|
|
Gross Profit
|
32.7
|
%
|
|
33.3
|
%
|
|
30.8
|
%
|
|
27.3
|
%
|
|
26.4
|
%
|
Nonmanufacturing expenses
|
11.2
|
%
|
|
11.1
|
%
|
|
11.2
|
%
|
|
10.1
|
%
|
|
10.4
|
%
|
Financial Position
|
|
|
|
|
|
|
|
|
|
Capital spending
|
$
|
29.1
|
|
|
$
|
27.2
|
|
|
$
|
60.9
|
|
|
$
|
73.7
|
|
|
$
|
15.3
|
|
Depreciation and amortization
|
37.3
|
|
|
38.5
|
|
|
42.1
|
|
|
38.7
|
|
|
42.6
|
|
Total Assets
|
1,224.4
|
|
|
886.7
|
|
|
841.9
|
|
|
850.4
|
|
|
791.9
|
|
Total Debt
|
385.4
|
|
|
156.0
|
|
|
146
|
|
|
51.8
|
|
|
60.1
|
|
Total debt to capital ratio
|
40.7
|
%
|
|
23.4
|
%
|
|
23.5
|
%
|
|
9.0
|
%
|
|
11.1
|
%
|
|
|
(1)
|
Earnings before interest, taxes, depreciation and amortization (EBITDA) from Continuing Operations is a non-GAAP financial measure that is calculated by adding interest expense, income tax provision and depreciation and amortization expense to income from continuing operations, reduced by amortization of deferred revenue. Adjusted EBITDA from continuing operations is a non-GAAP financial measure that is calculated by adding restructuring and impairment expense and provision for losses on business tax credits to EBITDA from continuing operations. The Company believes investors' understanding of the Company's performance is enhanced by disclosing these non-GAAP financial measures as a reasonable basis for comparison of the Company's ongoing results of operations. Reconciliations to income from continuing operations are as follows ($ in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
2013
|
|
2012
|
|
2011
|
|
2010
|
|
2009
|
Income from Continuing Operations
|
$
|
78.5
|
|
|
$
|
104.1
|
|
|
$
|
92.1
|
|
|
$
|
72.7
|
|
|
$
|
58.2
|
|
Plus: Interest expense
|
2.9
|
|
|
3.3
|
|
|
2.3
|
|
|
1.6
|
|
|
4.0
|
|
Plus: Tax provision
|
53.0
|
|
|
49.5
|
|
|
32.8
|
|
|
39.3
|
|
|
24.8
|
|
Plus: Depreciation and amortization
|
37.3
|
|
|
38.5
|
|
|
42.1
|
|
|
38.7
|
|
|
42.6
|
|
Less: Amortization of deferred revenue
|
—
|
|
|
—
|
|
|
(6.0
|
)
|
|
(7.2
|
)
|
|
(5.1
|
)
|
EBITDA from Continuing Operations
|
171.7
|
|
|
195.4
|
|
|
163.3
|
|
|
145.1
|
|
|
124.5
|
|
Plus: Provision for losses on business tax credits
|
—
|
|
|
—
|
|
|
15.9
|
|
|
—
|
|
|
—
|
|
Plus: Restructuring and impairment expense
|
41.3
|
|
|
21.4
|
|
|
14.0
|
|
|
11.6
|
|
|
23.9
|
|
Adjusted EBITDA from Continuing Operations
|
$
|
213.0
|
|
|
$
|
216.8
|
|
|
$
|
193.2
|
|
|
$
|
156.7
|
|
|
$
|
148.4
|
|
Item 7.
Management's Discussion and Analysis of Financial Condition and Results of Operations
The following is a discussion of our results of operations and financial condition. This discussion should be read in conjunction with our consolidated financial statements and related notes included elsewhere in this report and the selected financial data included in Item 6. The discussion of our results of operations and financial condition includes various forward-looking statements about our markets, the demand for our products and our future prospects. These statements are based on certain assumptions that we consider reasonable. For information about risks and exposures relating to us and our business, you should read the section entitled "Factors That May Affect Future Results," in Part I, Item 1A of this Annual Report on Form 10-K and our Forward Looking Statement Legend at the end of this Item 7. Unless the context indicates otherwise, references to "SWM", "we", "us", "our", or similar terms include Schweitzer-Mauduit International, Inc. and our consolidated subsidiaries.
This Management's Discussion and Analysis of Financial Condition and Results of Operation is designed to provide a reader of our financial statements with an understanding of our recent performance, our financial condition and our prospects. The following will be discussed and analyzed:
|
|
•
|
Critical Accounting Policies and Estimates
|
|
|
•
|
Recent Accounting Pronouncements
|
|
|
•
|
Liquidity and Capital Resources
|
|
|
•
|
Other Factors Affecting Liquidity and Capital Resources
|
|
|
•
|
Contractual Obligations
|
|
|
•
|
Forward-Looking Statements
|
Summary
In 2013, SWM reported net income of
$76.1 million
on total net sales of
$772.8 million
. Compared to the prior year, net sales decreased
$5.7 million
due to the $21.9 million combined impact of lower volumes, price and mix, particularly in the Reconstituted Tobacco segment driven primarily by lower customer demand. This was partially offset by $13.2 million in foreign currency translation benefits and $4.2 million of revenue from DelStar, Inc. ("DelStar") which was acquired during the fourth quarter. Favorable currency benefits helped mitigate the revenue loss impact on operating profit and net income.
Cash provided by operations was
$178.1 million
in 2013 compared to
$174.6 million
in 2012. The
$3.5 million
increase was due primarily to a
$4.0 million
favorable year over year net change in working capital. Uses of cash during 2013 included $231.3 million to acquire DelStar, funded primarily through our credit facility,
$29.1 million
of capital spending and
$39.5 million
in cash dividends paid to SWM stockholders.
Return on invested capital (ROIC), adjusted to exclude the impact of restructuring-related costs, was 24.9 percent in 2013 compared to 23.5 percent in 2012. This measure reflects our determination to invest in products, projects and businesses that consistently yield returns in excess of our underlying cost of capital.
Recent Developments
On December 12, 2013, SWM acquired DelStar, Inc. or DelStar, a producer of specialty filtration materials, for $231.3 million, subject to customary post-closing adjustments. DelStar's suite of highly engineered resin materials, largely from filtration products such as reverse osmosis and other water filtration applications, are sold to a broad customer base in fast-growing water and industrial filtration segments. We believe the acquisition creates an attractive growth platform in an adjacent business area for SWM as we greatly expand our presence in advanced materials. In our discussion of results from operations in 2013, DelStar's results of operations since the closing are included in the Filtration segment.
In December 2013, we amended and restated our unsecured revolving credit facility, or Credit Agreement, to increase our borrowing capacity to $500 million. The increased borrowing capacity was used to pay for our acquisition of DelStar and other corporate uses. See Note
12
. Debt, for additional information.
On November 6, 2013, SWM announced an increase of its quarterly dividend to $0.36 per share. The increase is part of SWM's long-term capital allocation strategy which is focused on investing in our core business, returning one-third of free cash flow to stockholders via dividends and share repurchases while retaining flexibility to explore growth and diversification opportunities, including in current and adjacent industries.
Construction progress continues on our facility at our reconstituted tobacco joint venture in China, China Tobacco-Schweitzer (Yunnan) Reconstituted Tobacco Company Ltd., or CTS, which is on track to open in 2014 with an expected ramp to full capacity by 2016. We expect CTS to incur additional start-up expenses in 2014 compared to 2013 and achieve profitable operations in 2015.
In December 2013, we recorded a $37.2 million non-cash impairment charge to reduce the carrying value of the Company's mothballed RTL-Philippines facility following decreased near term RTL volume expectations.
During 2013, SWM sold its paper mill sites in San Pedro, Philippines and Medan, Indonesia, whose results were classified as discontinued operations.
We are monitoring the scheduled vote of Russia's legislature expected in May 2014 on whether to require LIP standards.
Critical Accounting Policies and Estimates
Our consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States, which require management to make estimates that affect the amounts of revenues, expenses, assets and liabilities reported and disclosure of contingencies. Changes in these estimates could have a significant impact on our results of operations, financial position, or cash flows. We discussed with the Audit Committee of the Board of Directors the estimates and judgments made for each of the following items and our accounting for and presentation of these items in the accompanying financial statements:
Accounting for Income Taxes
We must make assumptions, judgments and estimates to determine our current provision for income taxes and also our deferred income tax assets and liabilities and any valuation allowance to be recorded against a deferred income tax asset. Our judgments, assumptions and estimates take into account our interpretation of current tax laws. Changes in tax law or our interpretation of tax laws could significantly impact the amounts provided for income taxes in our consolidated financial statements. Our assumptions, judgments and estimates relative to the value of a deferred tax asset take into account projections of the amount and category of future taxable income. Actual operating results and the underlying amount and category of income in future years could render our current assumptions, judgments and estimates of recoverable net deferred taxes inaccurate. Any of the assumptions, judgments and estimates mentioned above could cause our actual income tax obligations to differ from our estimates, thus materially impacting our financial position, results of operations and cash flows.
We have available net operating loss carryforwards, or NOLs, and other various tax credits in the jurisdictions in which we operate, for which we recorded deferred tax assets totaling
$23.1 million
and
$4.1 million
, respectively, as of December 31, 2013. We record and maintain income tax valuation allowances to reduce deferred tax assets to an amount we estimate will be realizable more likely than not. Our deferred tax asset valuation allowances are primarily the result of uncertainties regarding the future realization of recorded tax benefits on tax loss carryforwards for certain entities. As a result, at December 31, 2013, we had
$20.3 million
of valuation allowances against certain of the deferred tax assets.
Expiration periods vary for our NOLs depending on the tax laws governing the jurisdiction where the NOL was generated. Under current tax laws, remaining NOLs in France and Brazil carry forward indefinitely, and NOLs in Spain, and the Philippines expire in 15 years and 3 years, respectively, subsequent to the year generated. We have recorded a valuation allowance to fully reserve our net deferred tax assets in Brazil, since we believe that we will not generate sufficient taxable income in Brazil within an acceptable period of time given the annual utilization limitation of 30% of taxable income. We have also recorded a valuation allowance to fully reserve the net deferred tax asset balance in the Philippines as this operation has been sold and we do not believe we will generate sufficient taxable income to utilize these assets.
We expect sufficient future taxable income in France to fully utilize the respective French NOL carryforward deferred tax assets. The Company's assumptions, judgments and estimates relative to the valuation of these net deferred tax assets take into account available positive and negative evidence of realizability, including recent financial performance, the ability to realize benefits of restructuring and other recent actions, projections of the amount and category of future taxable income and tax planning strategies. Actual future operating results and the underlying amount and category of income in future periods could differ from the Company's current assumptions, judgments and estimates. Although realization is not assured, the Company believes it is more likely than not that these net deferred tax assets at December 31, 2013, will be realized. Future operating losses in Brazil and the paper operations in France could result in recording additional valuation allowances in a future period which could be material to our results of operations in the period that such valuation allowance was recorded. If at a future date, the Company determines that the weight of the positive evidence is not sufficient to overcome the negative evidence, additional valuation allowances against these deferred tax assets to reduce the net deferred tax asset to an amount we believe will more likely than not be realizable would be recorded in the period such determination is made.
The Company was granted certain tax incentives in Poland for investment in a special economic zone. These incentives are in the form of credits granted in 2011 that are available to offset qualified taxable income through 2020. Based on granted incentives, commitments achieved, including maintaining certain employment levels, and qualified investment through December 31, 2013, the Company had a
$2.3 million
deferred tax asset at December 31, 2013 which has been partially reserved due to realignment of our legal entity structure and resulting change in taxable status of our Polish operations.
At December 31, 2013 and 2012, we had unrecognized tax benefits related to income taxes of
$1.8 million
and
$1.8 million
, respectively. Changes in tax laws or interpretations of tax laws or in our corporate structure, as well as outcomes of current and future audits conducted by foreign and domestic tax authorities, could materially impact the amounts provided for income taxes in our consolidated financial statements.
For additional information regarding income taxes and valuation allowances, see Note
15
, Income Taxes, of the Notes to Consolidated Financial Statements.
Accounting for Contingencies
We accrue an estimated loss by taking a charge to income when the likelihood that a future event, such as a legal proceeding, will result in a loss or the incurrence of a liability is probable and the amount of loss can be reasonably estimated. We disclose material contingencies if there is at least a reasonable possibility that a loss has been incurred. In determining whether a loss should be accrued, we evaluate, among other factors, the degree of probability of an unfavorable outcome and the ability to make a reasonable estimate of the amount of loss. Changes in these factors could materially impact our results of operations, financial position, or our cash flows.
For further information, please see “Litigation” in Part I, Item 3, “Legal Proceedings” and Note
18
, Commitments and Contingencies, of the Notes to Consolidated Financial Statements.
Property, Plant and Equipment Valuation
Paper manufacturing, which is our primary manufacturing process, is a capital intensive process. As a result, we make substantial investments in property, plant and equipment which are recorded at cost. Net property, plant and equipment comprised
32%
of our total assets as of December 31, 2013. Property, plant and equipment is depreciated on the straight-line method over the estimated useful lives of the assets. Paper machines and related equipment are not subject to substantial technological changes rendering them obsolete and are generally depreciated over estimated useful lives of 20 years. In the United States, banded cigarette paper production assets at the Spotswood Mill are generally depreciated over estimated useful lives of 5 years. When indications of impairment exist, we assess the likelihood of recovering the cost of long-lived assets based on our expectation of future profitability and undiscounted cash flow of the related asset group. These factors, along with management's plans with respect to the operations, are considered in assessing the recoverability of property, plant and equipment. Changes in management's estimates and plans could significantly impact our results of operations, financial position or cash flows.
As a result of excess capacity in the tobacco-related papers industry and increased purchased material and operating costs experienced in the last several years, competitive selling prices for certain of our products are not sufficient to cover our costs with a reasonable margin. Such competitive pressures have resulted in downtime of certain paper machines and, in some cases, accelerated depreciation or impairment of certain equipment. Over the past five years, we have restructured our operations to improve our competitiveness and profitability. As a result, we incurred significant charges related to asset impairments, accelerated depreciation and employee severances. Due to the closure of our mill in Malaucène, France, the activities of Malaucène have been presented as a discontinued operation and as a result of filing for liquidation in December 2011, the financial position of Malaucène has been deconsolidated. The results of Company's Indonesian and Philippines paper mills, which were sold during 2013, have been retrospectively presented as discontinued operations.
In 2011, the Company revised its Asian RTL expansion plans and suspended the construction of the Philippine greenfield site. Due to this change, the carrying value of partially constructed assets is evaluated for impairment at each reporting period by assessing the recoverability of the costs based on the undiscounted cash flows of the operation, likelihood of its reactivation and alternative uses for the equipment. The undiscounted cash flows were less than the carrying value of the assets. Management used significant judgment to develop assumptions, including forecasted sales volumes and projected operational performance. Based on an evaluation of the fair value at December 31, 2013, which used independent appraisals of certain assets, the Company recorded a
$37.2 million
impairment charge during 2013. The net book value of the RTL Philippines property, plant and equipment was
$31.5 million
as of December 31, 2013. During 2012, the Company expected a portion of the equipment would be sold to its RTL joint venture in China. As a result, that portion of the assets was determined to be a separate group of assets for purposes of the impairment analysis, and a separate impairment analysis was performed based on the expected cash flows of the projected sale and estimated costs to be incurred in connection with that sale. Based on the analysis that was performed, the expected proceeds net of the expected costs to be incurred was less than the carrying value of that equipment and an impairment loss of $3.1 million was recorded in 2012. As of December 31, 2012, that equipment was no longer expected to be sold and thus the equipment was included with the remainder of the assets as one group of assets again for purposes of the impairment analysis.
Management continues to evaluate how to operate our production facilities more effectively with reduced tobacco-related papers volumes. Further restructuring actions are possible that might require additional write-offs or accelerated depreciation of some equipment.
Business Combinations
Accounting for business combinations requires us to recognize, separately from goodwill, the assets acquired and the liabilities assumed (“net assets”) at their acquisition date fair values. Goodwill is measured as the excess of consideration transferred over the net assets acquired at their respective fair values as of the acquisition date. The estimated fair values are based upon quoted market prices and widely accepted valuation techniques, which require significant estimates and assumptions including, but not limited to, estimating future cash flows and developing appropriate discount rates. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we may record adjustments to the assets acquired and liabilities assumed with the corresponding adjustment to goodwill, based on new information obtained about the facts and circumstances that existed as of the acquisition date. Upon the conclusion of the measurement period or final determination of the values of net assets acquired, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations. See Note 3, DelStar Acquisition, of the Notes to Consolidated Financial Statements for additional information.
Recent Accounting Pronouncements
For a discussion regarding recent accounting pronouncements, see “Recent Accounting Pronouncements” included in Note 2, Summary of Significant Accounting Policies, of the Notes to Consolidated Financial Statements.
Results of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
2013
(1)
|
|
2012
|
|
2011
|
|
($ in millions, except per share amounts)
|
Net Sales
|
$
|
772.8
|
|
|
$
|
778.5
|
|
|
$
|
788.3
|
|
Cost of products sold
|
520.1
|
|
|
519.0
|
|
|
545.3
|
|
Gross Profit
|
252.7
|
|
|
259.5
|
|
|
243.0
|
|
Selling expense
|
20.9
|
|
|
21.9
|
|
|
21.4
|
|
Research expense
|
15.3
|
|
|
9.9
|
|
|
9.2
|
|
General expense
|
50.3
|
|
|
54.6
|
|
|
57.4
|
|
Total nonmanufacturing expenses
|
86.5
|
|
|
86.4
|
|
|
88.0
|
|
Provision for losses on business tax credits
|
—
|
|
|
—
|
|
|
15.9
|
|
Restructuring and impairment expense
|
41.3
|
|
|
21.4
|
|
|
14.0
|
|
Operating Profit
|
124.9
|
|
|
151.7
|
|
|
125.1
|
|
Interest expense
|
2.9
|
|
|
3.3
|
|
|
2.3
|
|
Other income (expense), net
|
5.7
|
|
|
1.2
|
|
|
(2.6
|
)
|
Income from Continuing Operations before Income Taxes and Income from Equity Affiliates
|
127.7
|
|
|
149.6
|
|
|
120.2
|
|
Provision for income taxes
|
53.0
|
|
|
49.5
|
|
|
32.8
|
|
Income from equity affiliates, net of income taxes
|
3.8
|
|
|
4.0
|
|
|
4.7
|
|
Income from Continuing Operations
|
78.5
|
|
|
104.1
|
|
|
92.1
|
|
(Loss) income from Discontinued Operations
|
(2.4
|
)
|
|
(24.3
|
)
|
|
0.5
|
|
Net Income
|
$
|
76.1
|
|
|
$
|
79.8
|
|
|
$
|
92.6
|
|
|
|
|
|
|
|
Net Income (Loss) Per Share - Basic:
|
|
|
|
|
|
Income per share from continuing operations
|
$
|
2.51
|
|
|
$
|
3.33
|
|
|
$
|
2.73
|
|
(Loss) income per share from discontinued operations
|
(0.08
|
)
|
|
(0.79
|
)
|
|
0.02
|
|
Net income per share - basic
|
$
|
2.43
|
|
|
$
|
2.54
|
|
|
$
|
2.75
|
|
|
|
|
|
|
|
Net Income (Loss) Per Share - Diluted:
|
|
|
|
|
|
Income per share from continuing operations
|
$
|
2.49
|
|
|
$
|
3.29
|
|
|
$
|
2.71
|
|
(Loss) income per share from discontinued operations
|
(0.07
|
)
|
|
(0.78
|
)
|
|
0.02
|
|
Net Income per share - diluted
|
$
|
2.42
|
|
|
$
|
2.51
|
|
|
$
|
2.73
|
|
(1)
Results during the year ended December 31, 2013 include the results of DelStar, Inc. since its acquisition on December 12, 2013.
Discontinued Operations
The results of the closed tipping mill in Malaucène, France, or Malaucène mill, the Medan, Indonesia mill, or Indonesia mill, and San Pedro, Philippines, or Philippines mill, have been classified as discontinued operations. As a result, all periods presented have been retrospectively recast to exclude the discontinued operations. During 2013, the Company sold its Indonesia mill and its Philippines mill. The 2013 loss from discontinued operations is primarily due to restructuring-related severance charges at the Philippines mill. The 2012 loss from discontinued operations is primarily due to an impairment charge on the long-lived assets of the Indonesia mill based on estimated future cash flows, being the expected selling price of the business, inventory write-downs, restructuring charges and asset impairment charges at the Philippines mill. During 2011, the Malaucène mill entered liquidation resulting in a loss of control for accounting consolidation purposes. The net deficit of Malaucène was removed from the consolidated accounts resulting in the 2011 recognition of a $6.4 million net gain. Malaucène's results of operations were included in the Company's discontinued operations through the date of the 2011 liquidation filing.
Year Ended
December 31, 2013
Compared with the
Year Ended
December 31, 2012
Net Sales
(dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2013
|
|
2012
|
|
Change
|
|
Percent Change
|
|
Consolidated Sales Volume Change
(Units)
|
Paper
|
$
|
543.4
|
|
|
$
|
545.0
|
|
|
$
|
(1.6
|
)
|
|
(0.3
|
)%
|
|
2
|
%
|
Reconstituted Tobacco
|
225.2
|
|
|
233.5
|
|
|
(8.3
|
)
|
|
(3.6
|
)
|
|
(10
|
)
|
Filtration
|
4.2
|
|
|
—
|
|
|
4.2
|
|
|
N.M.
|
|
|
N.M.
|
|
Total
|
$
|
772.8
|
|
|
$
|
778.5
|
|
|
$
|
(5.7
|
)
|
|
(0.7
|
)%
|
|
(3
|
)%
|
N.M. Not Meaningful
Net sales were
$772.8 million
in 2013 compared with
$778.5 million
in 2012. The
decrease
in net sales consisted of the following (dollars in millions):
|
|
|
|
|
|
|
|
|
Amount
|
|
Percent
|
Changes in product mix and selling prices
|
$
|
(25.9
|
)
|
|
(3.3
|
)%
|
Changes due to royalty income
|
(1.2
|
)
|
|
(0.1
|
)
|
Changes due to sales volume
|
4.0
|
|
|
0.5
|
|
Filtration segment revenue
|
4.2
|
|
|
0.5
|
|
Changes in currency exchange rates
|
13.2
|
|
|
1.7
|
|
Total
|
$
|
(5.7
|
)
|
|
(0.7
|
)%
|
Total unit sales volumes decreased by
3%
in the
year ended December 31, 2013
versus the prior year.
|
|
◦
|
Sales volumes for the Paper segment increased by
2%
|
|
|
◦
|
Sales volumes for the Reconstituted Tobacco segment decreased by
10%
|
The Paper segment net sales during the
year ended
December 31, 2013
of
$543.4 million
decreased by
$1.6 million
, or
0.3%
, versus
$545.0 million
in the prior year. The decrease in net sales was primarily the result of unfavorable product mix and changes in selling prices of $34.0 million and lower royalty revenue of $1.2 million. These unfavorable impacts were partially offset by $25.0 million favorable effect of higher volumes, including non-tobacco papers, and $8.6 million in favorable currency exchange.
The Reconstituted Tobacco segment net sales during the
year ended
December 31, 2013
of
$225.2 million
decreased by
$8.3 million
, or
3.6%
, compared with
$233.5 million
in the prior-year period. The decrease in net sales of the Reconstituted Tobacco segment resulted from the $21.0 million impact of lower volumes which was partially offset by $8.1 million in favorable average selling prices resulting from the mix of products sold and $4.6 million of favorable currency impacts.
The Filtration segment net sales were
$4.2 million
for the 2013 period since the closing of the DelStar acquisition on December 12, 2013.
Operating Expenses
(dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percent Change
|
|
Percent of Net Sales
|
|
2013
|
|
2012
|
|
Change
|
|
|
2013
|
|
2012
|
Net Sales
|
$
|
772.8
|
|
|
$
|
778.5
|
|
|
$
|
(5.7
|
)
|
|
(0.7
|
)%
|
|
100.0
|
%
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of products sold
|
520.1
|
|
|
519.0
|
|
|
1.1
|
|
|
0.2
|
|
|
67.3
|
|
|
66.7
|
|
Gross Profit
|
$
|
252.7
|
|
|
$
|
259.5
|
|
|
$
|
(6.8
|
)
|
|
(2.6
|
)%
|
|
32.7
|
%
|
|
33.3
|
%
|
The
$6.8 million
decrease in gross profit during the
year ended December 31, 2013
versus the prior year was primarily due to the $13.7 million negative impact of lower volume, $6.0 million from an unfavorable mix of products sold which included more non-tobacco volumes, and $3.7 million of higher wood pulp costs. The negative impacts were partially offset by $8.0 million in favorable currency translation, $6.6 million in savings from other costs of sales, including the Company's operational excellence program and $3.9 million in favorable energy, labor and other materials costs.
Nonmanufacturing Expenses
(dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percent Change
|
|
Percent of Net Sales
|
|
2013
|
|
2012
|
|
Change
|
|
|
2013
|
|
2012
|
Selling expense
|
$
|
20.9
|
|
|
$
|
21.9
|
|
|
$
|
(1.0
|
)
|
|
(4.6
|
)%
|
|
2.7
|
%
|
|
2.8
|
%
|
Research expense
|
15.3
|
|
|
9.9
|
|
|
5.4
|
|
|
54.5
|
|
|
2.0
|
|
|
1.3
|
|
General expense
|
50.3
|
|
|
54.6
|
|
|
(4.3
|
)
|
|
(7.9
|
)
|
|
6.5
|
|
|
7.0
|
|
Nonmanufacturing expenses
|
$
|
86.5
|
|
|
$
|
86.4
|
|
|
$
|
0.1
|
|
|
0.1
|
%
|
|
11.2
|
%
|
|
11.1
|
%
|
Nonmanufacturing expenses in the
year ended
December 31, 2013
increased by
$0.1 million
to
$86.5 million
from
$86.4 million
in the prior year due to higher expenditures on product diversification and growth initiatives which were partially offset by lower incentive compensation expenses.
Restructuring and Impairment Expense
The Company incurred total restructuring and impairment expense of
$41.3 million
in the
year ended
December 31, 2013
, primarily due to a $37.2 million impairment charge to reduce the carrying value of the Company's mothballed RTL-Philippines facility following decreased near term RTL volume expectations. Other 2013 restructuring expenses included $2.7 million of severance and early retirement expenses in the French operations for ongoing accruals over the remaining service lives of affected employees associated with previously announced actions and $0.7 million of termination fees to exit third-party service contracts in the U.S. and Europe.
In the
year ended
December 31, 2012
, the Company's restructuring and impairment expense of
$21.4 million
primarily included the following:
|
|
•
|
$16.9 million for an impairment charge to reduce the carrying value of the Company's Spotswood, New Jersey mill, which produces banded cigarette paper, following the amendment of the Company's supply agreement with Philip Morris USA, a subsidiary of Altria Group Inc.,
|
|
|
•
|
$3.7 million of charges in connection with the RTL Philippines site where construction was suspended, of which $3.1 million represented a non-cash impairment charge on certain of the equipment,
|
|
|
•
|
$1.6 million of costs to terminate a third-party printing agreement in the U.S. in conjunction with a restructuring of the U.S. LIP business, and
|
|
|
•
|
$2.4 million of severance and early retirement expenses in the French operations for ongoing accruals over the remaining service lives of affected employees related to previously announced actions.
|
Partially offsetting these expenses was a benefit of $2.5 million reversal of previously recorded special termination charges as a result of a change to French retirement laws during 2012 allowing earlier retirements for qualified workers, which will result in qualified workers receiving their government benefits earlier and, therefore, the workers will be paid less from the Company's early retirement plan.
Operating Profit
(dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percent Change
|
|
Return on Net Sales
|
|
2013
|
|
2012
|
|
Change
|
|
|
2013
|
|
2012
|
Paper
|
$
|
102.5
|
|
|
$
|
84.4
|
|
|
$
|
18.1
|
|
|
21.4
|
%
|
|
18.9
|
%
|
|
15.5
|
%
|
Reconstituted Tobacco
|
46.4
|
|
|
90.3
|
|
|
(43.9
|
)
|
|
(48.6
|
)
|
|
20.6
|
|
|
38.7
|
|
Filtration
|
(1.1
|
)
|
|
—
|
|
|
(1.1
|
)
|
|
N.M.
|
|
|
(26.2
|
)%
|
|
N.M.
|
Unallocated expenses
|
(22.9
|
)
|
|
(23.0
|
)
|
|
0.1
|
|
|
|
|
|
|
|
Total
|
$
|
124.9
|
|
|
$
|
151.7
|
|
|
$
|
(26.8
|
)
|
|
(17.7
|
)%
|
|
16.2
|
%
|
|
19.5
|
%
|
N.M. - Not meaningful
Operating profit was
$124.9 million
in the
year ended December 31, 2013
compared with
$151.7 million
during the prior year.
The Paper segment's operating profit in the
year ended December 31, 2013
was
$102.5 million
, an increase of
$18.1 million
from the prior year. The increase was primarily due to the following factors:
|
|
•
|
$15.5 million in lower restructuring and impairment expense primarily due to the $16.9 million Spotswood impairment charge during the first quarter of 2012;
|
•
$6.0 million in favorable currency impacts; and
•
$4.2 million improved inflationary costs, primarily other materials prices.
These positive factors were partially offset by $10.3 million in unfavorable mix of products sold and changes in average selling prices, $3.7 million in higher wood pulp costs, a $3.0 million impact from volume and $1.2 million of lower royalty income.
The Reconstituted Tobacco segment's operating profit in the
year ended December 31, 2013
was
$46.4 million
compared to
$90.3 million
in the prior year. The decrease was primarily due to a $37.2 million non-cash impairment charge on the RTL-Philippines facility, $10.7 million unfavorable impact of lower volumes and $2.8 million unfavorable fixed cost absorption due to lower production volumes partially offset by $3.8 million in improved pricing and favorable mix of products sold.
Non-Operating Expenses
Interest expense was
$2.9 million
in the
year ended December 31, 2013
, a decrease from
$3.3 million
in the
year ended December 31, 2012
. The decrease in interest expense is primarily due to lower interest rates and lower average debt balances in 2013 versus 2012. The weighted average effective interest rates on our debt facilities were approximately 1.5% and 1.6% for the years ended December 31, 2013 and 2012, respectively.
Other income, net was
$5.7 million
during the
year ended December 31, 2013
compared to
$1.2 million
during the year ended December 31, 2011. The $4.5 million increase in other income, net is due to higher foreign currency transaction gains and interest income.
Income Taxes
A
$53.0 million
provision for income taxes in the
year ended December 31, 2013
resulted in an effective tax rate of
41.5%
compared with
33.1%
in the prior year. In the
year ended December 31, 2013
, the effective tax rate was higher than the 35% statutory rate due primarily to the impairment expenses incurred by the RTL Philippines facility that did not have any income tax benefits and recording a valuation allowance on a portion of Polish deferred tax assets which may not be realized as part of our legal entity realignment. During 2012, the
33.1%
effective tax rate was lower than the 35% statutory rate due to lower income tax rates in Poland; however, this favorable impact was partially offset by losses and restructuring expenses incurred by the RTL Philippines facility that did not have any income tax benefits.
Income from Equity Affiliates
Income from equity affiliates was
$3.8 million
in the
year ended December 31, 2013
compared with
$4.0 million
during the prior year. These results reflected the operations of the joint venture in China to produce cigarette papers, CTM, and expenses of the Chinese reconstituted tobacco joint venture, CTS, which is currently under construction.
Discontinued Operations
Due to our decisions to sell our Indonesia mill and our Philippines mill, the results of these entities were reported as discontinued operations for all periods presented. Consequently, their results have been removed from each line of the statements of income and the operating activities section of the statements of cash flow. In each case, a separate line has been added for the net results of the discontinued operation, including previously reported restructuring and impairment amounts. During 2013, the Company completed the sale of the Indonesia mill and Philippines mill and incurred a $1.6 million loss and $1.6 million gain on the sales, respectively, which are presented in discontinued operations.
Net Income and Income per Share
Net income in the
year ended December 31, 2013
was
$76.1 million
, or
$2.42
per diluted share, compared with
$79.8 million
, or
$2.51
per diluted share, during the prior year. The decrease in net income was primarily due to $19.9 million of higher restructuring and impairment expenses and lower reconstituted tobacco volumes, partially offset by decreased losses from discontinued operations and operational excellence manufacturing improvements.
Year Ended December 31, 2012 Compared with the Year Ended December 31, 2011
Net Sales
(dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2012
|
|
2011
|
|
Change
|
|
Percent Change
|
|
Consolidated Sales Volume Change
(Units)
|
Paper
|
$
|
545.0
|
|
|
$
|
551.4
|
|
|
$
|
(6.4
|
)
|
|
(1.2
|
)%
|
|
(4
|
)%
|
Reconstituted Tobacco
|
233.5
|
|
|
236.9
|
|
|
(3.4
|
)
|
|
(1.4
|
)
|
|
6
|
|
Total
|
$
|
778.5
|
|
|
$
|
788.3
|
|
|
$
|
(9.8
|
)
|
|
(1.2
|
)%
|
|
—
|
%
|
Net sales were
$778.5 million
in 2012 compared with
$788.3 million
in 2011. The
decrease
in net sales consisted of the following (dollars in millions):
|
|
|
|
|
|
|
|
|
Amount
|
|
Percent
|
Changes in currency exchange rates
|
$
|
(55.9
|
)
|
|
(7.1
|
)%
|
Changes due to royalty income
|
(4.6
|
)
|
|
(0.5
|
)
|
Changes in product mix and selling prices
|
12.9
|
|
|
1.6
|
|
Changes due to volume
|
37.8
|
|
|
4.8
|
|
Total
|
$
|
(9.8
|
)
|
|
(1.2
|
)%
|
|
|
•
|
Changes in currency exchange rates decreased net sales by
$55.9 million
, or
7.1%
, in 2012, and primarily reflected the impact of changes in the value of the euro compared with the U.S. dollar in 2012 versus the prior year.
|
|
|
•
|
Royalty revenue decreased by
$4.6 million
in 2012 primarily due to the initiation of the license agreement during 2011 for which prior-period royalties were received.
|
|
|
•
|
Favorable changes in average selling prices and mix of products sold increased net sales by
$12.9 million
.
|
|
|
•
|
Total unit sales volumes were unchanged in 2012 versus the prior year.
|
|
|
◦
|
Sales volumes for the Paper segment decreased by
4%
|
|
|
◦
|
Sales volumes for the Reconstituted Tobacco segment increased by
6%
|
Paper
segment net sales during the year ended December 31, 2012 of
$545.0 million
decreased by
$6.4 million
, or
1.2%
, compared with
$551.4 million
in the prior year. The decrease in net sales was primarily the result of $39.5 million in unfavorable foreign exchange impacts mostly due to changes in the value of the euro compared to the U.S. dollar and $4.6 million impact from lower royalty revenue. These negative impacts were partially offset by a $22.7 million favorable impact of higher sales volumes, $13.2 million favorable impact of average selling prices and mix of products sold and $1.8 million tax credit gain recognized upon successful legal resolution of a business tax case in Brazil.
Reconstituted Tobacco
segment net sales during the year ended December 31, 2012 of $
233.5 million
decreased by
$3.4 million
, or
1.4%
, compared with $
236.9 million
in the prior year. The decrease in net sales of the Reconstituted Tobacco segment resulted from the unfavorable $16.4 million unfavorable foreign exchange impacts mostly due to changes in the value of the euro compared to the U.S. dollar which was partially offset by a $12.8 million favorable impact of higher sales volumes.
Operating Expenses
(dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percent Change
|
|
Percent of Net Sales
|
|
2012
|
|
2011
|
|
Change
|
|
|
2012
|
|
2011
|
Net Sales
|
$
|
778.5
|
|
|
$
|
788.3
|
|
|
$
|
(9.8
|
)
|
|
(1.2
|
)%
|
|
100.0
|
%
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of products sold
|
519.0
|
|
|
545.3
|
|
|
(26.3
|
)
|
|
(4.8
|
)
|
|
66.7
|
|
|
69.2
|
|
Gross Profit
|
$
|
259.5
|
|
|
$
|
243.0
|
|
|
$
|
16.5
|
|
|
6.8
|
%
|
|
33.3
|
%
|
|
30.8
|
%
|
The
$16.5 million
increase in gross profit during 2012 compared with the prior year was primarily due to the $29.2 million favorable impact of higher sales volumes and average selling prices, including mix of products sold. LIP regulations in the EU, which became effective during the fourth quarter of 2011, drove higher demand for LIP cigarette papers. Our operational excellence program generated approximately $27 million of cost savings during the year; however, those benefits were substantially offset by operational inefficiencies in certain locations as well as increases in inflationary costs and unfavorable currency impacts. Start-up costs during 2011 in Poland were not repeated during 2012. Pulp list prices were lower during 2012 at an average of $860 per metric ton of northern bleached softwood kraft compared to $980 per metric ton during the prior year. However, changes in pulp prices had a negligible impact on the comparison of 2012 and 2011 results. Changes in inflationary costs, including other materials prices, energy and labor, had an unfavorable impact of $11.4 million on 2012 results compared to the prior year. Changes in currency exchange rates unfavorably impacted the gross profit comparison by $7.2 million primarily from the weaker euro compared to the U.S. dollar. Royalty income was lower in 2012 by $4.6 million.
Nonmanufacturing Expenses
(dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percent Change
|
|
Percent of Net Sales
|
|
2012
|
|
2011
|
|
Change
|
|
|
2012
|
|
2011
|
Selling expense
|
21.9
|
|
|
21.4
|
|
|
$
|
0.5
|
|
|
2.3
|
%
|
|
2.8
|
%
|
|
2.7
|
%
|
Research expense
|
9.9
|
|
|
9.2
|
|
|
0.7
|
|
|
7.6
|
|
|
1.3
|
|
|
1.2
|
|
General expense
|
54.6
|
|
|
57.4
|
|
|
(2.8
|
)
|
|
(4.9
|
)
|
|
7.0
|
|
|
7.3
|
|
Nonmanufacturing expenses
|
$
|
86.4
|
|
|
$
|
88.0
|
|
|
$
|
(1.6
|
)
|
|
(1.8
|
)%
|
|
11.1
|
%
|
|
11.2
|
%
|
Nonmanufacturing expenses in 2012 decreased by
$1.6 million
to
$86.4 million
from
$88.0 million
in the prior year primarily due to lower legal expenses to defend the Company's LIP patents partially offset by higher transaction-related and strategic initiative expenses.
Provision for Losses on Business Tax Credits
During 2011, the Company recorded a $15.9 million charge to fully reserve the carrying value of its Imposto sobre Circulaçăo de Mercadorias e Serviços, or ICMS, business tax credits in Brazil.
Restructuring and Impairment Expense
The Company incurred total restructuring and impairment expense of $
21.4 million
in 2012, which included the following:
|
|
•
|
$16.9 million for an impairment charge to reduce the carrying value of the Company's Spotswood, New Jersey mill, which produces banded cigarette paper, following an amendment of the Company's supply agreement with Philip Morris USA, a subsidiary of Altria Group Inc.;
|
|
|
•
|
$3.7 million of charges in connection with the RTL Philippines site where construction was suspended, of which $3.1 million represented a non-cash impairment charge on certain of the equipment;
|
|
|
•
|
$1.6 million of costs to terminate a third-party printing agreement in the U.S. in conjunction with a restructuring of the U.S. LIP business; and
|
|
|
•
|
$2.4 million of severance and early retirement expenses in the French operations for ongoing accruals over the remaining service lives of affected employees related to previously announced actions.
|
Partially offsetting these expenses was a benefit of $2.5 million reversal of previously recorded special termination charges as a result of a change to French retirement laws during 2012 allowing earlier retirements for qualified workers, which will result in qualified workers receiving their government benefits earlier and, therefore, the workers will be paid less from the Company's early retirement plan.
In 2011, the Company's restructuring and impairment expense was $14.0 million, which included $5.8 million in the Paper segment for employee severances and other cash costs and $3.6 million of impairment charges on property, plant and equipment. In the Reconstituted Tobacco segment, the Company incurred $4.6 million of impairment and other costs in 2011 related to the suspended construction of the RTL facility in the Philippines.
Operating Profit
(dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percent Change
|
|
Return on Net Sales
|
|
2012
|
|
2011
|
|
Change
|
|
|
2012
|
|
2011
|
Paper
|
$
|
84.4
|
|
|
$
|
54.8
|
|
|
$
|
29.6
|
|
|
54.0
|
%
|
|
15.5
|
%
|
|
9.9
|
%
|
Reconstituted Tobacco
|
90.3
|
|
|
90.3
|
|
|
—
|
|
|
—
|
|
|
38.7
|
|
|
38.1
|
|
Unallocated expenses
|
(23.0
|
)
|
|
(20.0
|
)
|
|
(3.0
|
)
|
|
|
|
|
|
|
Total
|
$
|
151.7
|
|
|
$
|
125.1
|
|
|
$
|
26.6
|
|
|
21.3
|
%
|
|
19.5
|
%
|
|
15.9
|
%
|
Operating profit was
$151.7 million
in 2012 compared with
$125.1 million
during the prior year.
The Paper segment's 2012 operating profit was
$84.4 million
, an increase of
$29.6 million
from the prior year. The increase was primarily due to the following factors:
|
|
•
|
$31.6 million in favorable impacts from higher sales volumes, substantially all from certain value-added products;
|
|
|
•
|
$15.9 million in lower provision for losses on business tax credits;
|
|
|
•
|
Lower non-manufacturing expenses, primarily due to approximately $9 million less in litigation expenses; and
|
|
|
•
|
A tax credit gain of $1.8 million recognized upon successful legal resolution of a Brazil business tax case.
|
These positive factors were partially offset by a $10.1 million impact from lower average selling prices and an unfavorable mix of products sold, $8.5 million in higher restructuring and impairment expense, $8.4 million in increased inflationary costs primarily related to other materials, and $4.6 million of lower royalty income.
The Reconstituted Tobacco segment's 2012 operating profit was $
90.3 million
, unchanged from the prior year. The offsetting changes were primarily due to the following:
|
|
•
|
$6.7 million in higher sales volume impacts; and
|
|
|
•
|
$2.0 million in improved manufacturing impacts.
|
These positives were mostly offset by $6.4 million in unfavorable currency impacts and $2.1 million in higher inflationary costs
Non-Operating Expenses
Interest expense was $
3.3 million
in 2012, an increase from $
2.3 million
in 2011. The increase in interest expense is primarily due to lower capitalized interest in 2012. The Company capitalized $1.5 million of interest expense in 2011 related to the construction of the RTL facility in the Philippines and EU LIP facility in Poland. The weighted average effective interest rates on our debt facilities were approximately 1.6% and 2.0% for 2012 and 2011, respectively.
Other income, net was $
1.2 million
during 2012 due to foreign currency transaction gains and interest income. During 2011, other expense, net was
$2.6 million
primarily due to foreign exchange losses net of interest income.
Income Taxes
A
$49.5 million
provision for income taxes in 2012 resulted in an effective tax rate of
33.1%
compared with
27.3%
in the prior year. The effective tax rates were lower than the 35% statutory rate due primarily to the Company's Polish operations which were granted certain tax incentives for investment in a special economic zone. These incentives were in the form of credits that are used to offset qualified taxable income. Based on granted incentives, commitments achieved, including maintaining certain employment levels and qualified investment, the Company had available credits for which we recorded deferred income tax benefits. These credits had a remaining balance of $7.7 million at December 31, 2012. In 2011, the Company recorded a $5.9 million valuation allowance to fully reserve its net deferred tax assets in Brazil.
Income from Equity Affiliates
Income from equity affiliates was $
4.0 million
in 2012 compared with $
4.7 million
during the prior year. These results reflected the operations of CTM and expenses of CTS, which is currently under construction.
Discontinued Operations
Due to our decisions to sell our Indonesia mill and our Philippines mill, the results of these entities were reported as discontinued operations for all periods presented. Consequently, their results have been removed from each line of the statements of income and the operating activities section of the statements of cash flow. In each case, a separate line has been added for the net results of the discontinued operation, including previously reported restructuring and impairment amounts. During the fourth quarter of 2011, a liquidation petition relating to the Malaucène mill resulted in a loss of control. Consequently, consolidated results for 2012 do not include that entity's results.
Net Income and Income per Share
Net income in 2012 was
$79.8 million
, or
$2.51
per diluted share, compared with
$92.6 million
, or
$2.73
per diluted share, during the prior year. The decrease in net income was primarily due to losses from discontinued operations and a lower 2011 effective tax rate primarily as a result of the deferred income tax benefit recorded in 2011 to recognize Poland special economic zone credits.
Liquidity and Capital Resources
The Company has created a long-term capital allocation strategy which is focused on the following three areas:
|
|
•
|
Reinvest capital in core businesses through a disciplined approach to meet global demand for value-adding solutions,
|
|
|
•
|
Return at least one-third of annual free cash flow to stockholders via balanced dividends and share repurchase programs, and
|
|
|
•
|
Retain flexibility to explore growth opportunities in current and adjacent markets with economic returns similar to or better than SWM's existing business.
|
A major factor in our liquidity and capital resource planning is our generation of cash flow from operations, which is sensitive to changes in the sales mix, volume and pricing of our products, as well as changes in our production volumes, costs and working capital. Our liquidity is supplemented by funds available under our revolving credit facility with a syndicate of banks that is used as either operating conditions or strategic opportunities warrant.
As of
December 31, 2013
, $267.3 million of the Company's
$272.0 million
of cash and cash equivalents was held by foreign subsidiaries. Movement of cash balances may have significant tax consequences. The Company considers the undistributed earnings of its foreign subsidiaries to be indefinitely reinvested and currently plans to repatriate such earnings only when tax effective to do so. We believe that we are able to maintain a sufficient level of liquidity for our domestic operations and commitments without repatriation of the cash held by these foreign subsidiaries. Certain legal entity realignments and other activities are underway that could permit tax effective repatriation of certain of these funds.
Capital spending for 2014 is projected to be approximately $25 million to $30 million. We generally fund our capital projects using cash on-hand, cash generated from operations and our existing credit facilities.
Cash Requirements
As of
December 31, 2013
, we had net operating working capital of
$115.3 million
and cash and cash equivalents of
$272.0 million
, compared with net operating working capital of
$94.6 million
and cash and cash equivalents of
$151.2 million
as of December 31, 2012. The 2013 year over year increase in net operating working capital is primarily due to the acquisition of DelStar in December 2013 and recording the fair value of the acquired assets and liabilities. Changes in these amounts reflect the impacts of changes in currency exchange rates and excess tax benefits of stock-based awards which are not included in the changes in operating working capital presented on the consolidated statements of cash flow.
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Operating Activities
($ in millions)
|
For the Years Ended December 31,
|
2013
|
|
2012
|
|
2011
|
Net Income
|
$
|
76.1
|
|
|
$
|
79.8
|
|
|
$
|
92.6
|
|
Less: (Loss) income from discontinued operations
|
(2.4
|
)
|
|
(24.3
|
)
|
|
0.5
|
|
Income from continuing operations
|
78.5
|
|
|
104.1
|
|
|
92.1
|
|
Non-cash items included in net income:
|
|
|
|
|
|
Depreciation and amortization
|
37.3
|
|
|
38.5
|
|
|
42.1
|
|
Impairment
|
37.2
|
|
|
20.2
|
|
|
6.8
|
|
Provision for losses on business tax credits
|
—
|
|
|
—
|
|
|
15.9
|
|
Amortization of deferred revenue
|
—
|
|
|
—
|
|
|
(6.0
|
)
|
Deferred income tax provision (benefit)
|
17.3
|
|
|
13.1
|
|
|
(13.9
|
)
|
Pension and other postretirement benefits
|
1.1
|
|
|
1.0
|
|
|
(6.5
|
)
|
Stock-based compensation
|
3.2
|
|
|
6.9
|
|
|
3.8
|
|
Income from equity affiliates
|
(3.8
|
)
|
|
(4.0
|
)
|
|
(4.7
|
)
|
Excess tax benefits of stock-based awards
|
(0.5
|
)
|
|
(1.4
|
)
|
|
(10.0
|
)
|
Cash dividends received from equity affiliates
|
3.7
|
|
|
3.0
|
|
|
—
|
|
Other items
|
1.0
|
|
|
(0.1
|
)
|
|
(3.1
|
)
|
Net changes in operating working capital
|
0.8
|
|
|
(3.2
|
)
|
|
(25.1
|
)
|
Net cash provided (used) by operating activities of:
|
|
|
|
|
|
Continuing operations
|
175.8
|
|
|
178.1
|
|
|
91.4
|
|
Discontinued operations
|
2.3
|
|
|
(3.5
|
)
|
|
(9.9
|
)
|
Cash Provided by Operations
|
$
|
178.1
|
|
|
$
|
174.6
|
|
|
$
|
81.5
|
|
Net cash provided by operations was
$178.1 million
in the
year ended December 31,
2013
compared with
$174.6 million
in the prior year. Our net cash provided by operations increased due to a favorable net change in working capital.
Net cash provided by operations was
$174.6 million
in 2012 compared with
$81.5 million
in 2011. Our net cash provided by operations changed favorably by $93.1 million in 2012 compared to the prior year primarily due to increased profitability net of non-cash impairment charges and deferred income taxes, and a favorable net change in working capital.
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Working Capital
($ in millions)
|
For the Years Ended December 31,
|
2013
|
|
2012
|
|
2011
|
Changes in operating working capital
|
|
|
|
|
|
Accounts receivable
|
$
|
4.4
|
|
|
$
|
14.3
|
|
|
$
|
(25.8
|
)
|
Inventories
|
(1.0
|
)
|
|
(6.1
|
)
|
|
(5.9
|
)
|
Prepaid expenses
|
0.1
|
|
|
(1.0
|
)
|
|
0.4
|
|
Accounts payable
|
(1.5
|
)
|
|
(7.0
|
)
|
|
(3.5
|
)
|
Accrued expenses
|
3.4
|
|
|
(8.1
|
)
|
|
1.5
|
|
Accrued income taxes
|
(4.6
|
)
|
|
4.7
|
|
|
8.2
|
|
Net changes in operating working capital
|
$
|
0.8
|
|
|
$
|
(3.2
|
)
|
|
$
|
(25.1
|
)
|
In
2013
, net changes in operating working capital provided cash flow of
$0.8 million
. The 2013 favorable change in working capital was driven by the collection of certain advance payments during late 2012, timing of purchases versus payments of accounts payable, as well as timing of income tax installments.
In
2012
, net changes in operating working capital were unfavorable to cash flow by
$3.2 million
primarily driven by improved receivable collection and timing of payments.
In 2011, net changes in operating working capital contributed unfavorably to cash flow by $25.1 million. The change in working capital was primarily driven by initiation of operations in Poland to support European LIP sales.
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Investing Activities
($ in millions)
|
For the Years Ended December 31,
|
2013
|
|
2012
|
|
2011
|
Capital spending
|
$
|
(29.1
|
)
|
|
$
|
(27.2
|
)
|
|
$
|
(60.9
|
)
|
Capitalized software costs
|
(0.5
|
)
|
|
(0.9
|
)
|
|
(1.3
|
)
|
Acquisitions, net of cash acquired
|
(229.7
|
)
|
|
—
|
|
|
—
|
|
Investment in equity affiliates
|
—
|
|
|
(21.0
|
)
|
|
(12.2
|
)
|
Other
|
5.6
|
|
|
(2.6
|
)
|
|
2.3
|
|
Cash Used for Investing
|
$
|
(253.7
|
)
|
|
$
|
(51.7
|
)
|
|
$
|
(72.1
|
)
|
Cash used for investing activities during
2013
was
$253.7 million
and consisted primarily of funds used to purchase DelStar, Inc. and capital spending, including a $3.1 million purchase of an LIP printing press in connection with the termination of an outside printing services contract. The Company received cash proceeds of $7.1 million from the sale of its Philippine mill.
Cash used for investing activities during 2012 was
$51.7 million
and was primarily capital spending and
$21.0 million
of equity infusions into CTS.
Cash used for investing activities in 2011was $72.1 million and was primarily capital spending to bring the RTL-Philippines site to its mothballed state. The Company made equity contributions of $12.2 million to its joint ventures in China including $6.2 million to its existing paper joint venture CTM and an initial contribution of $6.0 million to CTS.
Capital Spending
Capital spending was
$29.1 million
,
$27.2 million
and
$60.9 million
in 2013, 2012 and 2011, respectively.
During 2013 and 2012, capital spending was primarily related to maintenance capital spending. The capital spending incurred during 2011 was primarily due to $30.8 million for construction of our RTL facility in the Philippines and $9.2 million to establish a LIP production facility for the EU in Poland.
We incur spending as necessary to meet legal requirements and otherwise relating to the protection of the environment at our facilities in the United States, France, Brazil, Canada, China and Poland. For these purposes, we expect to incur capital expenditures of approximately
$1.0 million
in 2014 and less than
$1.0 million
in 2015, of which no material amount is the result of environmental fines or settlements. The foregoing capital expenditures are not expected to reduce our ability to invest in other appropriate and necessary capital projects and are not expected to have a material adverse effect on our financial condition or results of operations.
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Financing Activities
($ in millions)
|
For the Years Ended December 31,
|
2013
|
|
2012
|
|
2011
|
Cash dividends paid to SWM stockholders
|
$
|
(39.5
|
)
|
|
$
|
(14.1
|
)
|
|
$
|
(10.1
|
)
|
Net proceeds from borrowings
|
227.5
|
|
|
9.3
|
|
|
100.5
|
|
Purchases of common stock
|
(1.7
|
)
|
|
(50.0
|
)
|
|
(120.9
|
)
|
Proceeds from exercises of stock options
|
0.5
|
|
|
2.8
|
|
|
2.2
|
|
Excess tax benefits of stock-based awards
|
0.5
|
|
|
1.4
|
|
|
10.0
|
|
Cash Provided by (Used in) Financing
|
$
|
187.3
|
|
|
$
|
(50.6
|
)
|
|
$
|
(18.3
|
)
|
During
2013
, financing activities consisted primarily of net proceeds from borrowings of
$227.5 million
used to acquire DelStar offset by cash dividends of
$39.5 million
paid to SWM stockholders and share repurchases of
$1.7 million
.
During
2012
, financing activities consisted primarily of
$50.0 million
of share repurchases and cash dividends of
$14.1 million
paid to SWM stockholders partially offset by net proceeds from borrowings of
$9.3 million
.
During 2011, financing activities included $120.9 million of treasury stock purchases, including open market purchases and surrendering of vested restricted stock by employees to satisfy tax withholding, net proceeds from borrowings of $100.5 million and excess tax benefits of the vesting of stock-based awards of $10.0 million. Cash dividends paid to SWM stockholders were $10.1 million.
Dividend Payments
We have declared and paid cash dividends on our common stock every fiscal quarter since the second quarter of 1996. On
February 5, 2014
, we announced a cash dividend of $0.36 per share payable on
March 20, 2014
to stockholders of record on
February 28, 2014
. Our Credit Agreement (defined below) covenants require that we maintain certain financial ratios, as disclosed in Note
12
, Debt, of the Notes to Condensed Consolidated Financial Statements, none of which under normal business conditions materially limit our ability to pay such dividends. We will continue to assess our dividend policy in light of our capital allocation strategy, cash generation, debt levels and ongoing requirements for cash to fund operations and to pursue possible strategic opportunities.
Share Repurchases
In 2013, we repurchased
43,458
shares of our common stock at a cost of
$1.7 million
for the value of employees' stock-based compensation share awards surrendered to satisfy their personal statutory income tax withholding obligations. On December 6, 2012, our Board of Directors authorized the repurchase from time to time of up to $50.0 million of our Common Stock. As of February 26, 2014, 769,400 shares have been purchased for $35.0 million pursuant to such Board action. Our Board of Directors has now extended that authorization through December 31, 2014. See Part II, Item 5, Repurchases of Equity Securities.
In 2012 and 2011, we repurchased
1,481,482
and
4,480,392
, respectively, shares of our common stock at a cost of
$50.0 million
and
$120.9 million
, respectively, under prior authorizations.
Debt Instruments and Related Covenants
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instruments and Related Covenants
($ in millions)
|
For the Years Ended December 31,
|
2013
|
|
2012
|
|
2011
|
Changes in short-term debt
|
$
|
—
|
|
|
$
|
(1.9
|
)
|
|
$
|
2.3
|
|
Proceeds from issuances of long-term debt
|
455.6
|
|
|
43.0
|
|
|
226.7
|
|
Payments on long-term debt
|
(228.1
|
)
|
|
(31.8
|
)
|
|
(128.5
|
)
|
Net (payments on) proceeds from borrowings
|
$
|
227.5
|
|
|
$
|
9.3
|
|
|
$
|
100.5
|
|
Net
proceeds
from long-term debt were
$227.5 million
during
2013
. The Company may incur additional borrowings of approximately $25 million to $40 million during 2014. With the current level of borrowing and forecasted results, we expect to remain in compliance with our Credit Agreement financial covenants.
The Company's five-year revolving credit facility, or Credit Agreement, provides for borrowing capacity of $500 million and includes a $300 million equivalent sub-limit available in euro with an option to increase borrowing capacity by $200 million. Availability under the Credit Agreement was
$132.3 million
as of
December 31, 2013
. We also had availability under our bank overdraft facilities and lines of credit of
$44.6 million
as of
December 31, 2013
.
The Credit Agreement contains covenants and provisions that, among other things, require the Company to maintain (a) a maximum net debt to EBITDA ratio of 3.00 and (b) minimum interest coverage ratio of 3.50. The Company was in compliance with all of its covenants under the Credit Facility at
December 31, 2013
.
Our total debt to capital ratios at
December 31, 2013
and
December 31, 2012
were
40.7%
and 23.4%, respectively.
Other Factors Affecting Liquidity and Capital Resources
The following table represents our future contractual cash requirements for the next five years and thereafter for our long-term debt obligations and other commitments ($ in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments due for the years ended
|
Contractual Obligations
|
Total
|
|
2014
|
|
2015
|
|
2016
|
|
2017
|
|
2018
|
|
Thereafter
|
Current debt
(1)
|
$
|
1.7
|
|
|
$
|
1.7
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Long-term debt
(2)
|
383.7
|
|
|
2.5
|
|
|
3.0
|
|
|
3.3
|
|
|
3.2
|
|
|
371.7
|
|
|
—
|
|
Debt interest
(3)
|
27.4
|
|
|
5.6
|
|
|
5.6
|
|
|
5.5
|
|
|
5.4
|
|
|
5.3
|
|
|
—
|
|
Restructuring obligations
(4)
|
6.0
|
|
|
3.7
|
|
|
1.1
|
|
|
0.6
|
|
|
0.4
|
|
|
0.2
|
|
|
—
|
|
Minimum operating lease payments
(5)
|
14.1
|
|
|
2.7
|
|
|
2.6
|
|
|
2.4
|
|
|
1.8
|
|
|
1.3
|
|
|
3.3
|
|
Purchase obligations - raw materials
(6)
|
36.5
|
|
|
17.8
|
|
|
2.1
|
|
|
2.1
|
|
|
2.1
|
|
|
2.1
|
|
|
10.3
|
|
Purchase obligations - energy
(7)
|
70.5
|
|
|
35.4
|
|
|
9.4
|
|
|
5.1
|
|
|
4.1
|
|
|
4.1
|
|
|
12.4
|
|
Other long-term liabilities
(8) (9) (10)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Total
|
$
|
539.9
|
|
|
$
|
69.4
|
|
|
$
|
23.8
|
|
|
$
|
19.0
|
|
|
$
|
17.0
|
|
|
$
|
384.7
|
|
|
$
|
26.0
|
|
|
|
(1)
|
Current debt includes borrowings against bank overdraft facilities; see Note
12
, Debt, of the Notes to Consolidated Financial Statements.
|
|
|
(2)
|
See additional information regarding long-term debt in Note
12
, Debt, of the Notes to Consolidated Financial Statements.
|
|
|
(3)
|
The amounts reflected in debt interest are based upon the short-term and long-term scheduled principal maturities and interest rates in effect as of December 31, 2013. Where specific maturities are not stated, such as for an overdraft line-of-credit, a repayment date coinciding with the end of the year was used for purposes of these calculations. Since our debt is largely variable interest rate debt, applicable market interest rates were assumed to be the same as at December 31, 2013 for purposes of these calculations. With respect to our variable-rate debt outstanding at December 31, 2013, a 100 basis point increase in interest rates would increase our debt interest obligation by $3.8 million in 2014. For more information regarding our outstanding debt and associated interest rates, see Note
12
, Debt, of the Notes to Consolidated Financial Statements.
|
|
|
(4)
|
Restructuring obligations are more fully discussed in Part II, Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operation, Recent Developments and Note
11
, Restructuring and Impairment Activities, of the Notes to Consolidated Financial Statements.
|
|
|
(5)
|
Minimum operating lease payments relate to our future minimum obligations under non-cancelable operating leases having an initial or remaining term in excess of one year as of December 31, 2013.
|
|
|
(6)
|
Purchase obligations for raw materials include our calcium carbonate purchase agreement at our mill in Quimperlé, France, in which a vendor operates an on-site calcium carbonate plant and our mill has minimum purchase quantities. See Note
18
, Commitments and Contingencies, of the Notes to Consolidated Financial Statements for additional information.
|
|
|
(7)
|
Purchase obligations for energy include obligations under agreements with (1) an energy cogeneration supplier at our mills in Quimperlé and Spay, France, to supply steam for which our mills have minimum purchase commitments, (2) a natural gas supplier to supply and distribute 100% of the natural gas needs of our Quimperlé mill and (3) an energy supplier to supply a constant supply of electricity for our Pirahy mill in Brazil. See Note
18
, Commitments and Contingencies, of the Notes to Consolidated Financial Statements for additional information.
|
|
|
(8)
|
The amounts reflected in the above table exclude
$1.8 million
of unrecognized tax benefits associated with uncertain tax positions for which there is no contractual obligation. We had no other long-term liabilities as defined for purposes of this disclosure by the SEC as of December 31, 2013.
|
|
|
(9)
|
The amounts reflected in other long-term liabilities do not include any amounts for our pension obligations. The pension obligations are funded by our separate pension trusts, which held
$138.3 million
in assets at December 31, 2013. The combined projected benefit obligation, or PBO, of our U.S. and French pension plans was underfunded by
$21.0 million
and
$32.4 million
as of December 31, 2013 and 2012, respectively. We make contributions to our pension trusts based on many factors including regulatory guidelines, investment returns of the trusts and availability of cash for pension contributions versus other priorities. We were not required to make contributions to our U.S. and French pension plans during 2013. We expect 2014 funding to be in compliance with the Pension Protection Act of 2006. For information regarding our long-term pension obligations and trust assets, see Note
16
, Postretirement and Other Benefits, of the Notes to Consolidated Financial Statements.
|
|
|
(10)
|
The amounts reflected in other long-term liabilities do not include any amounts for our postretirement healthcare and life insurance benefits. Such payments are dependent upon our retirees incurring costs and filing claims; therefore, future payments are uncertain. Our net payments under these plans were approximately
$0.4 million
and
$0.5 million
in the years ended December 31, 2013 and 2012, respectively. Based on this past experience, we currently expect our share of the net payments to be less than $1.0 million during 2014 for these benefits. For more information regarding our retiree healthcare and life insurance benefit obligations, see Note
16
, Postretirement and Other Benefits, of the Notes to Consolidated Financial Statements.
|
Outlook
SWM's solid operating foundation and technology position allows us to seize opportunities ahead in our core tobacco business of providing value-adding solutions to our customers. Smoking attrition rates in mature areas drive the overall demand decline for cigarette papers. As additional countries are anticipated to adopt LIP legislation, we plan to build upon our technology position and excellent reputation in this premium application to serve our customers' increasing needs for those products, which we expect to lead to an improved margin profile in our paper business. The timing of potential regulations and implementations is unknown. In the absence of new LIP implementations during 2014, we would expect our tobacco paper volume declines to be impacted by the overall industry attrition rates.
The Company also seeks to capitalize on growth opportunities and regulatory trends requiring more sophisticated cigarettes in design and performance. As proposed tar delivery limits are implemented in China, SWM expects increased demand for reconstituted tobacco leaf, which we are strategically positioned to satisfy with our CTS joint venture in China which we expect to start operating in 2014.
The acquisition of DelStar provides an opportunity to diversify beyond the tobacco industry. We expect the Filtration segment's growth will be driven by expected demand for filtration products, with an emphasis on water filtration. We also believe that adjacencies between DelStar's filtration products and certain of SWM's legacy non-tobacco offerings will allow us to realize commercial synergy growth. We expect our global platform and operational excellence programs to help DelStar as well.
Worldwide economic uncertainty and its effects on foreign exchange volatility can be challenging for our global results. We serve tobacco industry customers and face competitive pressure on pricing and volumes worldwide due to the continued decline of cigarette consumption in western countries. We expect RTL volumes and operating profit to decline meaningfully in 2014 from 2013 levels. SWM expects to continue driving cost reductions through our operational excellence and lean manufacturing efforts as well as through restructuring actions. We expect these cost reductions to deliver value to our customers and help mitigate anticipated inflationary and competitive pressures. In addition, we are evaluating other opportunities to address ongoing imbalances of demand and supply, particularly as tobacco industry growth is occurring primarily in regions such as Asia, in an effort to continue providing competitive and high quality, value-adding solutions in growing areas. We intend to continue reviewing various internal and external growth opportunities, including potential acquisitions in our Filtration business, to diversify the Company over the long term.
Forward-Looking Statements
This report contains forward-looking statements within the meaning of Private Securities Litigation Reform Act of 1995 that are subject to the safe harbor created by that Act. Forward-looking statements, include, without limitation, those regarding 2014 outlook and future performance, our Capital Allocation Strategy, mergers and acquisitions, future market trends, future RTL operating profit and volume trends, smoking attrition rates, DelStar synergies, integration, and growth prospects, capital spending, the impact of our operational excellence program, common stock repurchases, the opening and profitability of CTS (SWM’s RTL JV in China), the adoption of LIP regulations in new countries, currency rates and trends, future cash flows, benefits associated with our legal entity realignment, outcome of litigation or other disputes, purchase accounting impacts, and other statements generally identified by words such as "believe," "expect," "intend,” “potential,” "anticipate," "project," "appears," "should," "could," "may," "typically" and similar words. These statements are not guarantees of future performance and involve certain risks and uncertainties that may cause actual results to differ materially from our expectations as of the date of this report. These risks include, among other things, those set forth in Part I, Item 1A. Risk Factors of this report as well as the following factors:
|
|
•
|
Changes in sales or production volumes, pricing or manufacturing costs of reconstituted tobacco products and cigarette paper for lower ignition propensity cigarettes due to changing customer demands, new technologies such as e-cigarettes, or otherwise;
|
|
|
•
|
Risks associated with the implementation of our strategic growth initiatives, including diversification, and the Company’s understanding of, and entry into, new industries and technologies;
|
|
|
•
|
Changes in the source and intensity of competition in our market segments;
|
|
|
•
|
Our ability to attract and retain key personnel, due to our restructuring actions, the industry in which we operate or otherwise;
|
|
|
•
|
Weather conditions, including potential impacts, if any, from climate change, known and unknown, seasonality factors that affect the demand for virgin tobacco leaf and natural disasters or unusual weather events;
|
|
|
•
|
Higher commodity prices and lack of availability thereof, including energy, wood pulp and resins, could impact the profitability of our products;
|
|
|
•
|
Increases in operating costs due to inflation or otherwise, such as labor expense, compensation and benefits costs, including costs related to the comprehensive health care reform law enacted in the first quarter of 2010;
|
|
|
•
|
Employee retention and labor shortages, changes in employment, wage and hour laws and regulations in the U.S. and France, including loi de Securisation de l'emploi, equal pay initiatives, additional anti-discrimination rules or tests and different interpretations of exemptions from overtime laws;
|
|
|
•
|
New regulatory initiatives by the U.S. Food and Drug Administration or other regulatory agencies;
|
|
|
•
|
New reports as to the effect of smoking on human health;
|
|
|
•
|
Changes in general economic, financial and credit conditions in the U.S. and elsewhere, including the impact thereof on currency (including any weakening of the euro) and interest rates;
|
|
|
•
|
Existing and future governmental regulation and the enforcement thereof, including regulation relating to the tobacco industry and the environment;
|
|
|
•
|
The success of, and costs associated with, current or future restructuring initiatives, including the granting of any needed governmental approvals;
|
|
|
•
|
Changes in the discount rates, revenue growth, cash flow growth rates or other assumptions used by the Company in its assessment for impairment of assets and adverse economic conditions or other factors that would result in significant impairment charges;
|
|
|
•
|
The failure of one or more suppliers;
|
|
|
•
|
Risks associated with 50%-owned, non-U.S. joint ventures relating to control and decision-making, compliance, transparency and customer relations, among others;
|
|
|
•
|
A failure of any insurance company or counterparties to our currency or interest rate swaps and hedges;
|
|
|
•
|
The number, type, outcomes (by judgment or settlement) and costs of legal, regulatory or administrative proceedings;
|
|
|
•
|
Labor activities at our facilities and new regulations or changes in existing regulations and procedures by the National Labor Relations Board or other authorities;
|
|
|
•
|
Risks associated with acquisitions or other strategic transactions, including acquired liabilities, retaining customers from businesses acquired, achieving any expected synergies from acquired businesses, difficulties in integrating acquired businesses or implementing strategic transactions generally and risks associated with international acquisition transactions;
|
|
|
•
|
Risks associated with dispositions, including post-closing claims being made against us, disruption to our other businesses during a sale process or thereafter, credit risks associated with any buyer of such disposed assets and our ability to collect funds due from any such buyer;
|
|
|
•
|
Risks associated with our legal entity and business realignment initiatives, including changes in law, treaties, timing of execution and regulatory determinations;
|
|
|
•
|
Increased taxation on tobacco products;
|
|
|
•
|
Costs and timing of implementation of any upgrades to our information technology systems, any failure by us to comply with any privacy or data security laws or any failure by us to protect against theft of customer and corporate sensitive information; and
|
|
|
•
|
Other factors described elsewhere in this document and from time to time in documents that we file with the SEC.
|
All forward-looking statements made in this document are qualified by these cautionary statements. These forward-looking statements are made only as of the date of this document, and we do not undertake any obligation, other than as may be required by law, to update or revise any forward-looking or cautionary statements to reflect changes in assumptions, the occurrence of events, unanticipated or otherwise, or changes in future operating results over time or otherwise.
Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance unless expressed as such, and should only be viewed as historical data.
Item 7A.
Quantitative and Qualitative Disclosures about Market Risk
Foreign Currency Risk
Changes in foreign currency exchange rates may have an impact on our operating profit. Since we transact business in many countries, some of our sale and purchase transactions are denominated in a currency other than the local currency of our operations. As a result, changes in exchange rates between the currencies in which the transaction is denominated versus the local currency of our operation into which the transaction is being recorded can impact the amount of local currency recorded for such transaction. This can result in more or less local currency revenue or cost related to such transaction and thus have an effect on our operating profit. Currency transaction risk is mitigated partially in France since some of the revenue and expense transactions of our French subsidiaries are denominated in U.S. dollars, providing a degree of natural hedging. Our Brazilian and Polish operations are more fully exposed to currency transaction risk, especially as a result of U.S. dollar and euro denominated sales, respectively.
Additionally, changes in foreign currency exchange rates may have an impact on the amount reported in other income (expense), net. Once the above-indicated receivables and payables from the sale and purchase transactions have been recorded, to the extent currency exchange rates change prior to settlement of the balance, a gain or loss on the non-local currency denominated asset or liability balance may be experienced, in which case such gain or loss is included in other income (expense), net.
We utilize forward and swap contracts and, to a lesser extent, option contracts to selectively hedge our exposure to foreign currency transaction risk when it is practical and economical to do so. The use of these contracts minimizes transactional exposure to exchange rate changes because the gains or losses incurred on the derivative instrument will offset, in whole or in part, the loss or gain on the underlying foreign currency exposure. These instruments are entered into with money center banks, insurance companies or government agencies, collectively known as counterparties. We expect to continue to apply forward currency hedging in our Brazilian and Polish operations through 2017. As of December 31, 2013, a 10% unfavorable change in the exchange rate of our functional currencies and those of our subsidiaries against the prevailing market rates of non-local currencies involving our transactional exposures would have resulted in a net pre-tax loss of approximately $3 million. These hypothetical gains or losses on foreign currency contracts and transactional exposures are defined as the difference between the contract rates and the hypothetical exchange rates. While we believe the above loss resulting from the hypothetical unfavorable changes in foreign currency exchange rates could be material to our results of operations, we reduce this risk by selectively hedging our exposure when it is practical and economical to do so.
Interest Rate Risk
We hold a combination of variable-rate and fixed-rate debt consisting of short-term and long-term instruments. We selectively hedge our exposure to interest rate increases on our variable-rate, long-term debt when it is practical and economical to do so. We have utilized various forms of interest rate hedge agreements, including interest rate swap agreements and forward rate agreements. We have utilized variable-to-fixed interest rate swap agreements, typically with contractual terms no longer than 60 months. Our strategy to manage exposure to interest rate changes did not change during 2013, and we do not expect any significant changes in our exposure to interest rate changes or in how such exposure is managed in the near future. Various outstanding interest-bearing instruments are sensitive to changes in interest rates. Interest rate changes would result in gains or losses in fair market value of fixed-rate debt due to differences between current market interest rates and the rates governing these instruments. With respect to our fixed-rate debt outstanding at December 31, 2013, a 100 basis point change in interest rates would not result in a material change in the fair market value of such debt and with respect to our variable-rate debt outstanding at December 31, 2013, a 100 basis point increase in interest rates would result in a $3.8 million decrease to our future annual pre-tax earnings.
Commodity Price Risk
We are subject to commodity price risks such as resin and wood pulp. Wood pulp is our largest single component of raw material cost. The per ton cost of wood pulp is cyclical in nature and more volatile than general inflation. During the period from January 2011 through December 2013, the U.S. list price of northern bleached softwood kraft pulp, or NBSK, a representative pulp grade that we use, ranged from a low of $830 per metric ton in September 2012 to a high of $1,035 per metric ton in June 2011. We normally maintain approximately 30 to 60 days of inventories to support our operations. As a result, there is a lag in the impact of changes in the per ton list price of wood pulp on our cost of products sold. The per ton price of resin is volatile and and may impact the future results of our Filtration segment. Over the last five years, the cost of polypropylene has fluctuated from 35 cents per pound to 105 cents per pound.
Selling prices of our paper products are influenced, in part, by the market price for wood pulp, which is determined by worldwide industry supply and demand. Generally, over time, we have been able to increase our selling prices in response to increased per ton wood pulp costs and have generally reduced our selling prices when wood pulp costs have significantly declined. Increases in prices of wood pulp could adversely impact our earnings if selling prices are not increased or if such increases do not fully compensate for or trail the increases in wood pulp prices. We have not utilized derivative instruments to manage this risk. With respect to our commodity price risk, a hypothetical 10% change in per ton wood pulp prices would impact our future annual pre-tax earnings by approximately $5 million, assuming no compensating change in our selling prices. We believe that, while our exposure to commodity price risk is material to our results of operations, our customers understand such risk and over time changes in the price of wood pulp are typically reflected in selling prices.
Energy Supply and Cost Volatility
In France, Poland and in the United States, availability of energy is generally not expected to be an issue, although prices can fluctuate significantly based on variations in demand. In Brazil, where that country's production of electricity is heavily reliant upon hydroelectric plants, availability of electricity has been affected in the past by rain variations. Our Brazilian business currently has a sufficient supply of energy to continue its current level of operation.
Due to the competitive pricing in the markets for most of our products, we are typically unable to fully pass through higher energy costs to our customers. With respect to our purchased energy price risk, a hypothetical 10% change in per unit prices would impact our future annual pre-tax earnings by approximately $7 million, assuming no compensating change in our selling prices.
Periodically, when we believe it is appropriate to do so, we enter into agreements to procure a portion of our energy for future periods in order to reduce the uncertainty of future energy costs. However, in recent years this has only marginally slowed the increase in energy costs due to the volatile changes in energy prices we have experienced.
Item 8.
Financial Statements and Supplementary Data
Index to Consolidated Financial Statements
|
|
|
|
Page
|
Consolidated Financial Statements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schedules have been omitted because they are either not required, not applicable or the required information is included in the consolidated financial statements or notes thereto.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(dollars in millions, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
2013
|
|
2012
|
|
2011
|
Net Sales
|
$
|
772.8
|
|
|
$
|
778.5
|
|
|
$
|
788.3
|
|
Cost of products sold
|
520.1
|
|
|
519.0
|
|
|
545.3
|
|
Gross Profit
|
252.7
|
|
|
259.5
|
|
|
243.0
|
|
|
|
|
|
|
|
Selling expense
|
20.9
|
|
|
21.9
|
|
|
21.4
|
|
Research expense
|
15.3
|
|
|
9.9
|
|
|
9.2
|
|
General expense
|
50.3
|
|
|
54.6
|
|
|
57.4
|
|
Total nonmanufacturing expenses
|
86.5
|
|
|
86.4
|
|
|
88.0
|
|
|
|
|
|
|
|
Provision for losses on business tax credits
|
—
|
|
|
—
|
|
|
15.9
|
|
Restructuring and impairment expense
|
41.3
|
|
|
21.4
|
|
|
14.0
|
|
Operating Profit
|
124.9
|
|
|
151.7
|
|
|
125.1
|
|
Interest expense
|
2.9
|
|
|
3.3
|
|
|
2.3
|
|
Other income (expense), net
|
5.7
|
|
|
1.2
|
|
|
(2.6
|
)
|
Income from Continuing Operations before Income Taxes and Income from Equity Affiliates
|
127.7
|
|
|
149.6
|
|
|
120.2
|
|
|
|
|
|
|
|
Provision for income taxes
|
53.0
|
|
|
49.5
|
|
|
32.8
|
|
Income from equity affiliates, net of income taxes
|
3.8
|
|
|
4.0
|
|
|
4.7
|
|
Income from Continuing Operations
|
78.5
|
|
|
104.1
|
|
|
92.1
|
|
(Loss) income from Discontinued Operations
|
(2.4
|
)
|
|
(24.3
|
)
|
|
0.5
|
|
Net Income
|
$
|
76.1
|
|
|
$
|
79.8
|
|
|
$
|
92.6
|
|
|
|
|
|
|
|
Net Income (Loss) per Share - Basic:
|
|
|
|
|
|
Income per share from continuing operations
|
$
|
2.51
|
|
|
$
|
3.33
|
|
|
$
|
2.73
|
|
(Loss) income per share from discontinued operations
|
(0.08
|
)
|
|
(0.79
|
)
|
|
0.02
|
|
Net income per share – basic
|
$
|
2.43
|
|
|
$
|
2.54
|
|
|
$
|
2.75
|
|
|
|
|
|
|
|
Net Income (Loss) per Share – Diluted:
|
|
|
|
|
|
|
|
Income per share from continuing operations
|
$
|
2.49
|
|
|
$
|
3.29
|
|
|
$
|
2.71
|
|
(Loss) income per share from discontinued operations
|
(0.07
|
)
|
|
(0.78
|
)
|
|
0.02
|
|
Net income per share – diluted
|
$
|
2.42
|
|
|
$
|
2.51
|
|
|
$
|
2.73
|
|
|
|
|
|
|
|
Weighted Average Shares Outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
31,056,700
|
|
|
30,986,200
|
|
|
33,230,200
|
|
|
|
|
|
|
|
Diluted
|
31,238,300
|
|
|
31,341,900
|
|
|
33,486,800
|
|
The accompanying notes are an integral part of these consolidated financial statements.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
2013
|
|
2012
|
|
2011
|
Net Income
|
$
|
76.1
|
|
|
$
|
79.8
|
|
|
$
|
92.6
|
|
Other Comprehensive Income (Loss), net of tax:
|
|
|
|
|
|
Foreign currency translation adjustments
|
5.1
|
|
|
9.9
|
|
|
(17.6
|
)
|
Less: Reclassification adjustment for realized translation adjustments
|
(1.1
|
)
|
|
—
|
|
|
(1.0
|
)
|
|
|
|
|
|
|
Unrealized (losses) gains on derivative instruments
|
(7.1
|
)
|
|
(0.4
|
)
|
|
0.6
|
|
Less: Reclassification adjustment for losses (gains) on derivative instruments included in net income
|
0.4
|
|
|
(1.4
|
)
|
|
(5.5
|
)
|
|
|
|
|
|
|
Net gain (loss) from postretirement benefit plans
|
8.4
|
|
|
(4.5
|
)
|
|
(1.1
|
)
|
Less: Amortization of postretirement benefit plans' costs included in net periodic benefit cost
|
4.7
|
|
|
5.5
|
|
|
(1.4
|
)
|
Other Comprehensive Income (Loss)
|
10.4
|
|
|
9.1
|
|
|
(26.0
|
)
|
Comprehensive Income
|
$
|
86.5
|
|
|
$
|
88.9
|
|
|
$
|
66.6
|
|
The accompanying notes are an integral part of these consolidated financial statements.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(dollars in millions, except per share amounts)
|
|
|
|
|
|
|
|
|
|
December 31,
2013
|
|
December 31,
2012
|
ASSETS
|
|
|
|
Cash and cash equivalents
|
$
|
272.0
|
|
|
$
|
151.2
|
|
Accounts receivable, net
|
107.6
|
|
|
95.4
|
|
Inventories
|
132.8
|
|
|
111.6
|
|
Income taxes receivable
|
9.9
|
|
|
—
|
|
Current deferred income tax benefits
|
10.1
|
|
|
13.5
|
|
Other current assets
|
4.7
|
|
|
10.3
|
|
Total Current Assets
|
537.1
|
|
|
382.0
|
|
|
|
|
|
Property, Plant and Equipment, net
|
393.2
|
|
|
401.4
|
|
Deferred Income Tax Benefits
|
—
|
|
|
10.5
|
|
Investment in Equity Affiliates
|
63.1
|
|
|
61.2
|
|
Goodwill
|
118.7
|
|
|
5.7
|
|
Intangible Assets
|
80.7
|
|
|
0.4
|
|
Other Assets
|
31.6
|
|
|
25.5
|
|
Total Assets
|
$
|
1,224.4
|
|
|
$
|
886.7
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
Current debt
|
$
|
4.2
|
|
|
$
|
4.2
|
|
Accounts payable
|
47.0
|
|
|
45.6
|
|
Income taxes payable
|
—
|
|
|
1.3
|
|
Accrued expenses
|
92.7
|
|
|
75.8
|
|
Total Current Liabilities
|
143.9
|
|
|
126.9
|
|
|
|
|
|
Long-Term Debt
|
381.2
|
|
|
151.8
|
|
Pension and Other Postretirement Benefits
|
28.7
|
|
|
41.5
|
|
Deferred Income Tax Liabilities
|
80.9
|
|
|
28.4
|
|
Other Liabilities
|
28.3
|
|
|
26.3
|
|
Total Liabilities
|
663.0
|
|
|
374.9
|
|
Stockholders’ Equity:
|
|
|
|
|
Preferred stock, $0.10 par value per share; 10,000,000 shares authorized; none issued or outstanding
|
—
|
|
|
—
|
|
Common stock, $0.10 par value per share; 100,000,000 shares authorized; 31,423,427 and 31,209,866 shares issued at December 31, 2013 and, 2012, respectively; 31,423,427 and 31,201,106 shares outstanding at December 31, 2013 and 2012, respectively
|
3.1
|
|
|
3.1
|
|
Additional paid-in-capital
|
43.3
|
|
|
41.0
|
|
Common stock in treasury, at cost, 8,760 shares at December 31, 2012
|
—
|
|
|
(0.3
|
)
|
Retained earnings
|
520.0
|
|
|
483.4
|
|
Accumulated other comprehensive loss
|
(5.0
|
)
|
|
(15.4
|
)
|
Total Stockholders’ Equity
|
561.4
|
|
|
511.8
|
|
Total Liabilities and Stockholders’ Equity
|
$
|
1,224.4
|
|
|
$
|
886.7
|
|
The accompanying notes are an integral part of these consolidated financial statements.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(dollars in millions, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock Issued
|
|
|
|
Treasury Stock
|
|
|
|
|
|
|
|
Shares
|
|
Amount
|
|
Additional
Paid-In
Capital
|
|
Shares
|
|
Amount
|
|
Retained
Earnings
|
|
Accumulated
Other
Comprehensive
Income
(Loss)
|
|
Total
|
Balance, December 31, 2010
|
37,442,948
|
|
|
$
|
3.8
|
|
|
$
|
208.8
|
|
|
1,387,142
|
|
|
$
|
(24.4
|
)
|
|
$
|
334.5
|
|
|
$
|
1.5
|
|
|
$
|
524.2
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
92.6
|
|
|
|
|
92.6
|
|
Other comprehensive loss, net of tax
|
|
|
|
|
|
|
|
|
|
|
|
|
(26.0
|
)
|
|
(26.0
|
)
|
Dividends declared ($0.30 per share)
|
|
|
|
|
|
|
|
|
|
|
(10.1
|
)
|
|
|
|
(10.1
|
)
|
Restricted stock issuances, net
|
|
|
|
|
(13.2
|
)
|
|
(647,120
|
)
|
|
13.2
|
|
|
|
|
|
|
—
|
|
Stock-based employee compensation expense
|
|
|
|
|
3.8
|
|
|
|
|
|
|
|
|
|
|
3.8
|
|
Excess tax benefits of stock-based employee compensation
|
|
|
|
|
10.0
|
|
|
|
|
|
|
|
|
|
|
10.0
|
|
Stock issued to directors as compensation
|
4,276
|
|
|
|
|
0.1
|
|
|
|
|
|
|
|
|
|
|
0.1
|
|
Issuance of shares for options exercised
|
140,074
|
|
|
|
|
2.2
|
|
|
|
|
|
|
|
|
|
|
2.2
|
|
Purchases of treasury stock
|
|
|
|
|
|
|
4,480,392
|
|
|
(120.9
|
)
|
|
|
|
|
|
(120.9
|
)
|
Balance, December 31, 2011
|
37,587,298
|
|
|
$
|
3.8
|
|
|
$
|
211.7
|
|
|
5,220,414
|
|
|
$
|
(132.1
|
)
|
|
$
|
417.0
|
|
|
$
|
(24.5
|
)
|
|
$
|
475.9
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
79.8
|
|
|
|
|
79.8
|
|
Other comprehensive income, net of tax
|
|
|
|
|
|
|
|
|
|
|
|
|
9.1
|
|
|
9.1
|
|
Dividends declared ($0.45 per share)
|
|
|
|
|
|
|
|
|
|
|
(14.1
|
)
|
|
|
|
(14.1
|
)
|
Restricted stock issuances, net
|
|
|
|
|
(3.4
|
)
|
|
(137,026
|
)
|
|
3.4
|
|
|
|
|
|
|
—
|
|
Stock-based employee compensation expense
|
|
|
|
|
6.9
|
|
|
|
|
|
|
|
|
|
|
6.9
|
|
Excess tax benefits of stock-based employee compensation
|
|
|
|
|
1.4
|
|
|
|
|
|
|
|
|
|
|
1.4
|
|
Stock issued to directors as compensation
|
1,778
|
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
—
|
|
Issuance of shares for options exercised
|
176,900
|
|
|
|
|
2.8
|
|
|
—
|
|
|
|
|
|
|
|
|
2.8
|
|
Share reissuance and cancellation to fulfill stock split
|
(6,556,110
|
)
|
|
(0.7
|
)
|
|
(178.4
|
)
|
|
(6,556,110
|
)
|
|
178.4
|
|
|
0.7
|
|
|
|
|
—
|
|
Purchases of treasury stock
|
|
|
|
|
|
|
1,481,482
|
|
|
(50.0
|
)
|
|
|
|
|
|
(50.0
|
)
|
Balance, December 31, 2012
|
31,209,866
|
|
|
$
|
3.1
|
|
|
$
|
41.0
|
|
|
8,760
|
|
|
$
|
(0.3
|
)
|
|
$
|
483.4
|
|
|
$
|
(15.4
|
)
|
|
$
|
511.8
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
76.1
|
|
|
|
|
76.1
|
|
Other comprehensive loss, net of tax
|
|
|
|
|
|
|
|
|
|
|
|
|
10.4
|
|
|
10.4
|
|
Dividends declared ($1.26 per share)
|
|
|
|
|
|
|
|
|
|
|
(39.5
|
)
|
|
|
|
(39.5
|
)
|
Restricted stock issuances, net
|
226,461
|
|
|
|
|
(0.2
|
)
|
|
(5,000
|
)
|
|
0.2
|
|
|
|
|
|
|
—
|
|
Stock-based employee compensation expense
|
|
|
|
|
3.2
|
|
|
|
|
|
|
|
|
|
|
3.2
|
|
Excess tax benefits of stock-based employee compensation
|
|
|
|
|
0.5
|
|
|
|
|
|
|
|
|
|
|
0.5
|
|
Stock issued to directors as compensation
|
1,318
|
|
|
|
|
0.1
|
|
|
|
|
|
|
|
|
|
|
0.1
|
|
Issuance of shares for options exercised
|
33,000
|
|
|
|
|
0.5
|
|
|
|
|
|
|
|
|
|
|
0.5
|
|
Share cancellation
|
(47,218
|
)
|
|
|
|
(1.8
|
)
|
|
(47,218
|
)
|
|
1.8
|
|
|
|
|
|
|
—
|
|
Purchases of treasury stock
|
|
|
|
|
|
|
43,458
|
|
|
(1.7
|
)
|
|
|
|
|
|
(1.7
|
)
|
Balance, December 31, 2013
|
31,423,427
|
|
|
$
|
3.1
|
|
|
$
|
43.3
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
520.0
|
|
|
$
|
(5.0
|
)
|
|
$
|
561.4
|
|
The accompanying notes are an integral part of these consolidated financial statements.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOW
(dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
2013
|
|
2012
|
|
2011
|
Operations
|
|
|
|
|
|
Net income
|
$
|
76.1
|
|
|
$
|
79.8
|
|
|
$
|
92.6
|
|
Less: (Loss) income from discontinued operations
|
(2.4
|
)
|
|
(24.3
|
)
|
|
0.5
|
|
Income from continuing operations
|
78.5
|
|
|
104.1
|
|
|
92.1
|
|
Non-cash items included in net income:
|
|
|
|
|
|
Depreciation and amortization
|
37.3
|
|
|
38.5
|
|
|
42.1
|
|
Impairment
|
37.2
|
|
|
20.2
|
|
|
6.8
|
|
Provision for losses on business tax credits
|
—
|
|
|
—
|
|
|
15.9
|
|
Amortization of deferred revenue
|
—
|
|
|
—
|
|
|
(6.0
|
)
|
Deferred income tax provision (benefit)
|
17.3
|
|
|
13.1
|
|
|
(13.9
|
)
|
Pension and other postretirement benefits
|
1.1
|
|
|
1.0
|
|
|
(6.5
|
)
|
Stock-based compensation
|
3.2
|
|
|
6.9
|
|
|
3.8
|
|
Income from equity affiliates
|
(3.8
|
)
|
|
(4.0
|
)
|
|
(4.7
|
)
|
Excess tax benefits of stock-based awards
|
(0.5
|
)
|
|
(1.4
|
)
|
|
(10.0
|
)
|
Cash dividends received from equity affiliates
|
3.7
|
|
|
3.0
|
|
|
—
|
|
Other items
|
1.0
|
|
|
(0.1
|
)
|
|
(3.1
|
)
|
Changes in operating working capital:
|
|
|
|
|
|
Accounts receivable
|
4.4
|
|
|
14.3
|
|
|
(25.8
|
)
|
Inventories
|
(1.0
|
)
|
|
(6.1
|
)
|
|
(5.9
|
)
|
Prepaid expenses
|
0.1
|
|
|
(1.0
|
)
|
|
0.4
|
|
Accounts payable
|
(1.5
|
)
|
|
(7.0
|
)
|
|
(3.5
|
)
|
Accrued expenses
|
3.4
|
|
|
(8.1
|
)
|
|
1.5
|
|
Accrued income taxes
|
(4.6
|
)
|
|
4.7
|
|
|
8.2
|
|
Net changes in operating working capital
|
0.8
|
|
|
(3.2
|
)
|
|
(25.1
|
)
|
Net cash provided (used) by operating activities of:
|
|
|
|
|
|
- Continuing operations
|
175.8
|
|
|
178.1
|
|
|
91.4
|
|
- Discontinued operations
|
2.3
|
|
|
(3.5
|
)
|
|
(9.9
|
)
|
Cash Provided by Operations
|
178.1
|
|
|
174.6
|
|
|
81.5
|
|
Investing
|
|
|
|
|
|
Capital spending
|
(29.1
|
)
|
|
(27.2
|
)
|
|
(60.9
|
)
|
Capitalized software costs
|
(0.5
|
)
|
|
(0.9
|
)
|
|
(1.3
|
)
|
Acquisitions, net of cash acquired
|
(229.7
|
)
|
|
—
|
|
|
—
|
|
Investment in equity affiliates
|
—
|
|
|
(21.0
|
)
|
|
(12.2
|
)
|
Other investing
|
5.6
|
|
|
(2.6
|
)
|
|
2.3
|
|
Cash Used for Investing
|
(253.7
|
)
|
|
(51.7
|
)
|
|
(72.1
|
)
|
Financing
|
|
|
|
|
|
Cash dividends paid to SWM stockholders
|
(39.5
|
)
|
|
(14.1
|
)
|
|
(10.1
|
)
|
Changes in short-term debt
|
—
|
|
|
(1.9
|
)
|
|
2.3
|
|
Proceeds from issuances of long-term debt
|
455.6
|
|
|
43.0
|
|
|
226.7
|
|
Payments on long-term debt
|
(228.1
|
)
|
|
(31.8
|
)
|
|
(128.5
|
)
|
Purchases of common stock
|
(1.7
|
)
|
|
(50.0
|
)
|
|
(120.9
|
)
|
Proceeds from exercise of stock options
|
0.5
|
|
|
2.8
|
|
|
2.2
|
|
Excess tax benefits of stock-based awards
|
0.5
|
|
|
1.4
|
|
|
10.0
|
|
Cash Provided by (Used in) Financing
|
187.3
|
|
|
(50.6
|
)
|
|
(18.3
|
)
|
Effect of Exchange Rate Changes on Cash and Cash Equivalents
|
9.1
|
|
|
2.4
|
|
|
(1.9
|
)
|
Increase in Cash and Cash Equivalents
|
120.8
|
|
|
74.7
|
|
|
(10.8
|
)
|
Cash and Cash Equivalents at beginning of period
|
151.2
|
|
|
76.5
|
|
|
87.3
|
|
Cash and Cash Equivalents at end of period
|
$
|
272.0
|
|
|
$
|
151.2
|
|
|
$
|
76.5
|
|
The accompanying notes are an integral part of these consolidated financial statements.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 1. General
Nature of Business
Schweitzer-Mauduit International, Inc., or SWM or the Company, is a multinational diversified producer of premium specialty papers headquartered in the United States of America. The Company manufactures and sells paper and reconstituted tobacco products to the tobacco industry as well as specialized paper products for use in other applications. We manufacture lightweight specialty papers, which are used in manufacturing ventilated cigarettes, and banded papers for the production of lower ignition propensity, or LIP, cigarettes and are the leading independent producer of RTL used in producing blended cigarettes. We also manufacture resin-based plastic netting through an extrusion process, as well as certain meltblown products and machined plastic core tubes.
Our primary products sold to the tobacco industry include cigarette, plug wrap and base tipping papers, or Cigarette Papers, used to wrap various parts of a cigarette and reconstituted tobacco leaf, or RTL, which is used as a blend with virgin tobacco in cigarettes, reconstituted tobacco wrappers and binders for cigars. These products are sold directly to the major tobacco companies or their designated converters in the Americas, Europe, Asia and elsewhere. Our non-tobacco industry products are a diverse mix of products that includes low volume, high-value engineered papers and, commodity paper grades produced to maximize our machine utilization. In December 2013, we acquired DelStar, Inc. ("DelStar"), a manufacturer of plastic netting and other resin-based products focused on the filtration and medical markets.
We conduct business in over
90
countries and operate
14
production locations worldwide, with facilities in the United States, Canada, France, Brazil, China and Poland. We also have a
50%
equity interest in
two
joint ventures in China. The first, China Tobacco Mauduit (Jiangmen) Paper Industry Ltd., or CTM, produces cigarette and porous plug wrap papers and the second, whose facility is under construction, China Tobacco Schweitzer (Yunnan) Reconstituted Tobacco Co. Ltd., or CTS, will produce RTL.
As used in this 2013 Annual Report on Form 10-K, unless the context indicates otherwise, references to "we," "us," "our," "SWM," "Schweitzer-Mauduit" or similar terms include Schweitzer-Mauduit International, Inc. and its consolidated subsidiaries.
Note
2
. Summary of Significant Accounting Policies
Basis of Presentation
The accompanying consolidated financial statements and the notes thereto have been prepared in accordance with accounting principles generally accepted in the United States of America, or U.S. GAAP. The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. The Company believes the estimates and assumptions used in the preparation of these consolidated financial statements are reasonable, based upon currently available facts and known circumstances. Actual results may differ from those estimates and assumptions as a result of a number of factors, including those discussed elsewhere in this report and in its other public filings from time to time.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Principles of Consolidation
The consolidated financial statements include the accounts of the Company and wholly-owned, majority-owned and controlled subsidiaries. Intercompany balances and transactions have been eliminated. The Company did not have any special purpose entities during 2013, 2012 or 2011.
The Company has
two
joint ventures with China National Tobacco Corporation, or CNTC. CNTC is the principal operating Company under China's State Tobacco Monopoly Administration. CNTC and our subsidiary, SM-China, each own
50%
of the joint ventures. The paper joint venture China Tobacco Mauduit (Jiangmen) Paper Industry Co. LTD, or CTM, produces tobacco-related papers in China. The second joint venture China Tobacco Schweitzer (Yunnan) Reconstituted Tobacco Co. LTD., or CTS, will produce reconstituted tobacco leaf products. The Company uses the equity method to account for both joint ventures. Investment in equity affiliates represents the Company's investment in its China joint ventures. The Company’s share of the net income of its
50%
owned joint ventures in China are included in the consolidated statements of income as income from equity affiliates.
Revenue Recognition
The Company recognizes revenue and the related accounts receivable when the following four criteria are met: (1) persuasive evidence of an arrangement exists; (2) ownership has transferred to the customer; (3) the selling price is fixed or determinable; and (4) collection is reasonably assured based on the Company's judgment regarding the collectability of its accounts receivable. Generally, the Company recognizes revenue when it ships its manufactured product and title and risk of loss passes to its customer in accordance with the terms of sale of the product. Revenue is recorded at the time of shipment for terms designated f.o.b., or free on board, shipping point. For sales transactions designated f.o.b. destination, revenue is recorded when the product is delivered to the customer's delivery site, at which time title and risk of loss are transferred. Provisions for discounts, returns, allowances, customer rebates and other adjustments are provided for in the same period the related revenue is recorded. Deferred revenue represents advance payments from customers which are earned based upon a mutually agreed-upon amount per unit of future product sales.
Freight Costs
The cost of delivering finished goods to the Company's customers is recorded as a component of cost of products sold. Those costs include the amounts paid to a third party to deliver the finished goods. Any freight costs billed to and paid by a customer are included in revenue.
Royalty Income
Royalties from non-exclusive, third-party patent licenses are recognized when earned, including monies received at an agreement's initiation attributable to past sales. The Company recognizes up-front payments upon receipt when it has no future performance requirement or ongoing obligation arising from its agreements and the payment is for a separate earnings process. Minimum annual royalties received in advance are deferred and are recognized in the period earned. The Company recognized
$11.2 million
,
$12.4 million
and
$17.0 million
of royalty income during 2013, 2012 and 2011 respectively, which is included in net sales in the consolidated statements of income.
Foreign Currency Translation
The income statements of foreign entities are translated into U.S. dollars at average exchange rates prevailing during the periods presented. The balance sheets of these entities are translated at period-end exchange rates, and the differences from historical exchange rates are reflected in a separate component of accumulated other comprehensive income (loss) as unrealized foreign currency translation adjustments.
Foreign currency risks arise from transactions and balances denominated in non-local currencies. Gains and losses resulting from re-measurement and settlement of such transactions and balances, included in other income (expense), net, were gain of
$1.3 million
in 2013 and losses of
$1.4 million
and
$1.6 million
in 2012 and 2011, respectively.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Derivative Instruments
The Company is exposed to changes in foreign currency exchange rates, interest rates and commodity prices. The Company utilizes a variety of practices to manage these market risks, including where considered appropriate, derivative instruments. The Company uses derivative instruments only for risk management purposes and not for trading or speculation. All derivative instruments the Company uses are either exchange traded or are entered into with major financial institutions in order to reduce credit risk and risk of nonperformance by third parties. The Company believes the credit risks with respect to the counterparties, and the foreign currency risks that would not be hedged if the counterparties fail to fulfill their obligations under the contracts, are not material in view of its understanding of the financial strength of the counterparties.
Gains and losses on instruments that hedge firm commitments are deferred and included in the basis of the underlying hedged items. All other hedging gains and losses are included in period income or expense based on the period-end market price of the instrument and are included in the Company's operating cash flows. See Note
13
. Derivatives, for additional information.
Cash and Cash Equivalents
The Company considers all highly liquid, unrestricted investments with remaining maturities of three months or less to be cash equivalents, including money market funds with no restrictions on withdrawals.
Business Combinations
The Company uses the acquisition method of accounting for business combinations. At the acquisition date, the Company records assets acquired and liabilities assumed at their respective fair market values. The Company estimates fair value using the exit price approach which is the price that would be received to sell an asset or paid to transfer a liability in an orderly market. An exit price is determined from a market participant's viewpoint in the principal or most advantageous market and may result in the Company valuing assets or liabilities at a fair value that is not reflective of the Company's intended use of the assets or liabilities. Any excess consideration above the estimated fair values of the net assets acquired is recognized as goodwill on the Company's Consolidated Balance Sheets. The operating results of acquired businesses are included in the Company’s results of operations beginning as of their effective acquisition dates. Acquisition costs are expensed as incurred and were
$1.1 million
in 2013 and were not material in 2012 or 2011.
Impai
rment of Long-Lived Assets, Goodwill and Intangible Assets
The Company evaluates the carrying value of long-lived assets, including property and equipment, goodwill and intangible assets when events and circumstances warrant a review. Goodwill is also tested for impairment annually during the fourth quarter. Goodwill may be evaluated using a qualitative evaluation and/or a two-step test at the reporting unit level. The first step compares the book value of the reporting unit to its fair value. If the book value of a reporting unit exceeds its fair value, we perform the second step. In the second step, we determine an implied fair value of the reporting unit's goodwill by allocating the fair value of the reporting unit to all of the assets and liabilities other than goodwill. The difference between the total fair value of the reporting unit and the fair value of all the assets and liabilities other than goodwill is the implied fair value of that goodwill. Any impairment loss is measured as the excess of the book value of the goodwill over the implied fair value of that goodwill. See Note
8
. Goodwill for further discussion of the Company's annual impairment test results.
We have acquired trade names that have been determined to have indefinite lives. We evaluate a number of factors to determine whether an indefinite life is appropriate, including the competitive environment, category share, business history, product life cycle and operating plans. When certain events or changes in operating conditions occur, an impairment assessment is performed and indefinite-lived trade names may be adjusted to a determinable life.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The cost of intangible assets with determinable useful lives is amortized to reflect the pattern of economic benefits consumed, which approximates a straight-line basis, over the estimated periods benefited. When certain events or changes in operating conditions occur, an impairment assessment is performed and lives of intangible assets with determinable lives may be adjusted.
The carrying value of long-lived assets is reviewed to determine if events or circumstances have changed which may indicate that the assets may be impaired or the useful life may need to be changed. Upon occurrence of such a triggering event, the Company considers internal and external factors relating to each asset group, including expectation of future profitability, undiscounted cash flows and its plans with respect to the operations. If impairment is indicated, an impairment loss is measured by the amount the net carrying value of the asset exceeds its estimated fair value.
Environmental Spending
Environmental spending is capitalized if such spending qualifies as property, plant and equipment, substantially increases the economic value or extends the useful life of an asset. All other such spending is expensed as incurred, including fines and penalties incurred in connection with environmental violations. Environmental spending relating to an existing condition caused by past operations is expensed. Liabilities are accrued when environmental assessments are probable and the costs can be reasonably estimated. Generally, timing of these accruals coincides with completion of a feasibility study or commitment to a formal plan of action.
Capitalized Software Costs
The Company capitalizes certain purchases of software and software development costs in connection with major projects of software development for internal use. These costs are included in other assets on the consolidated balance sheets and are amortized using the straight-line method over the estimated useful life not to exceed
seven years
. Costs associated with business process redesign, end-user training, system start-up and ongoing software maintenance are expensed as incurred. Amortization of capitalized software was
$4.8 million
,
$6.6 million
and
$6.8 million
for the years ended December 31, 2013, 2012 and 2011, respectively. Accumulated amortization of capitalized software costs was
$60.9 million
and
$56.1 million
at December 31, 2013 and 2012, respectively.
Business Tax Credits
Business tax credits represent value added tax credits receivable and similar assets, such as Imposto sobre Circulação de Mercadorias e Serviços, or ICMS, in Brazil. Business tax credits are generated when value-added taxes, or VAT, are paid on purchases. VAT and similar taxes are collected from customers on certain sales. In some jurisdictions, export sales do not require VAT collection. See Note
10
. Other Assets for additional information.
Income Taxes
The Company uses an asset and liability approach to account for and report income taxes. Deferred income tax assets and liabilities are computed annually for differences between the financial statement and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Income tax expense (benefit) is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. Valuation allowances are recognized to reduce deferred tax assets to the amount that is more likely than not to be realized. In assessing the likelihood of realization, the Company considers sources of future taxable income.
In connection with income tax assessments or unrecognized tax benefits, the Company classifies penalties as provision for income taxes and interest as interest expense in its consolidated statements of income.
The Company files income tax returns in the U.S. Federal and several state jurisdictions as well as in many foreign jurisdictions. In France, the Company reorganized its legal entities to maximize utilization of its net operating loss carryforwards. With certain exceptions, the Company is no longer subject to U.S. Federal, state and local, or foreign income tax examinations for years before
2010
.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Pension and Other Postretirement Benefits Accounting
The Company recognizes the estimated compensation cost of employees' pension and other postretirement benefits over their approximate period of service. The Company's earnings are impacted by amounts of expense recorded related to these benefits, which primarily consist of U.S. and French pension benefits and U.S. other postretirement benefits, or OPEBs. Each year's recorded expenses are estimates based on actuarial calculations of the Company's accumulated and projected benefit obligations, or PBOs, for the Company's various plans.
Suspension of additional benefits for future service is considered a curtailment, and if material, necessitates a re-measurement of plan assets and PBO. As part of a re-measurement, the Company adjusts its discount rates and other actuarial assumptions, such as retirement, turnover and mortality table assumptions, as appropriate. See Note
16
. Postretirement and Other Benefits for additional information.
Comprehensive Income
Comprehensive income includes net income, as well as items charged and credited directly to stockholders' equity, which are excluded from net income. The Company has presented comprehensive income in the consolidated statements of comprehensive income (loss). Reclassification adjustments of derivative instruments are presented in Net Sales in the consolidated statements of income. See Note
13
. Derivatives for additional information. Amortization of accumulated pension and other post-employment benefit (OPEB) liabilities are included in the computation of net periodic pension and OPEB costs, which are more fully discussed in Note
16
. Postretirement and Other Benefits.
Components of accumulated other comprehensive loss were as follows ($ in millions):
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
2013
|
|
2012
|
Accumulated pension and OPEB liability adjustments, net of income tax of $16.6 million and $23.3 million at December 31, 2013 and 2012, respectively
|
$
|
(30.1
|
)
|
|
$
|
(43.2
|
)
|
Accumulated unrealized loss on derivative instruments, net of income tax provision (benefit) of $0.3 million and $(1.5) million at December 31, 2013 and 2012, respectively
|
(8.1
|
)
|
|
(1.4
|
)
|
Accumulated unrealized foreign currency translation adjustments
|
33.2
|
|
|
29.2
|
|
Accumulated other comprehensive loss
|
$
|
(5.0
|
)
|
|
$
|
(15.4
|
)
|
Changes in the components of accumulated other comprehensive loss were as follows ($ in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
|
2013
|
|
2012
|
|
2011
|
|
Pre-tax
|
|
Tax
|
|
Net of
Tax
|
|
Pre-tax
|
|
Tax
|
|
Net of
Tax
|
|
Pre-tax
|
|
Tax
|
|
Net of
Tax
|
Pension and OPEB liability adjustments
|
$
|
19.8
|
|
|
$
|
(6.7
|
)
|
|
$
|
13.1
|
|
|
$
|
2.5
|
|
|
$
|
(1.5
|
)
|
|
$
|
1.0
|
|
|
$
|
(2.0
|
)
|
|
$
|
(0.5
|
)
|
|
$
|
(2.5
|
)
|
Unrealized loss on derivative instruments
|
(4.9
|
)
|
|
(1.8
|
)
|
|
(6.7
|
)
|
|
(2.7
|
)
|
|
0.9
|
|
|
(1.8
|
)
|
|
(7.5
|
)
|
|
2.6
|
|
|
(4.9
|
)
|
Unrealized foreign currency translation adjustments
|
4.0
|
|
|
—
|
|
|
4.0
|
|
|
9.9
|
|
|
—
|
|
|
9.9
|
|
|
(18.6
|
)
|
|
—
|
|
|
(18.6
|
)
|
Total
|
$
|
18.9
|
|
|
$
|
(8.5
|
)
|
|
$
|
10.4
|
|
|
$
|
9.7
|
|
|
$
|
(0.6
|
)
|
|
$
|
9.1
|
|
|
$
|
(28.1
|
)
|
|
$
|
2.1
|
|
|
$
|
(26.0
|
)
|
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Restricted Stock
All of the Company's restricted stock grants, including those that have been earned in the case of performance-based shares and cliff-vesting grants that are not performance based, vest upon completion of a specified period of time. The fair value of each award is equal to the share price of the Company's stock on the date of the grant. This cost is recognized over the vesting period of the respective award. A summary of outstanding restricted stock awards as of December 31, 2013 and 2012 is included in Note
17
, Stockholders' Equity.
Restricted Stock Plan Performance Based Shares
The Company's long-term incentive compensation program, or LTIP, for key executives includes an equity-based award component that is provided through its Restricted Stock Plan, or RSP. The objectives under the LTIP are established for multiple years at the beginning of a performance cycle and are intended to focus management on longer-term strategic goals. The Compensation Committee of the Board of Directors designates participants in the LTIP and RSP and determines the equity-based award opportunity in the form of restricted stock for each performance cycle, which is generally measured on the basis of a
two
or
three
-year performance period. Performance is measured on a cumulative basis and a portion of each performance cycle's restricted stock award opportunity may be earned annually. The restricted shares are considered issued and outstanding when the number of shares becomes fixed, after the annual performance is determined, and such awards vest at the end of the performance cycle or some predetermined period thereafter. The Company recognizes compensation expense with an offsetting credit to additional paid-in-capital over the performance period based on the fair value of the award at the date of grant, with compensation expense being adjusted cumulatively based on the number of shares expected to be earned according to the level of achievement of performance goals.
Fair Value Option
The Company has elected not to measure its financial instruments or certain commitments at fair value.
Recent Accounting Pronouncements
On January 1, 2013, the Company adopted Financial Accounting Standards Board's Accounting Standards Update (ASU) 2013-02 Comprehensive Income (Topic 220): Reporting of Amounts Reclassified out of Accumulated Other Comprehensive Income. The ASU amends and clarifies disclosure requirements for reclassifications from Other Comprehensive Income. The revised disclosure requirements are included in Note 2. Summary of Significant Accounting Policies.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 3. DelStar Acquisition
On December 12, 2013, the Company completed the acquisition of DelStar, Inc., or DelStar, through a merger of SWM Acquisition Corp. II, an indirect wholly-owned subsidiary of the Company, or SWM II, with and into DelStar, pursuant to the November 18, 2013 Agreement and Plan of Merger. As a result of the merger, DelStar became a wholly-owned, indirect subsidiary of the Company. The acquisition of DelStar diversifies SWM’s global presence in advanced materials, focused in large part in filtration.
As consideration, the Company paid
$231.3 million
in cash using borrowings under the revolving credit facility, or Credit Agreement, see Note
12
. Debt, for additional information.
As of December 31, 2013, the fair values of the assets acquired and liabilities assumed for the acquisition of DelStar are provisional because final appraisals have not yet been completed. The cash paid for DelStar and the preliminary fair values of the assets acquired and liabilities assumed as of the December 12, 2013 acquisition date are as follows ($ in millions):
|
|
|
|
|
|
Fair value as of December 12, 2013
|
Cash and cash equivalents
|
$
|
1.6
|
|
Accounts receivable
|
17.3
|
|
Inventory
|
21.2
|
|
Income taxes receivable
|
5.7
|
|
Deferred income tax benefits
|
1.5
|
|
Other current assets
|
0.8
|
|
Property, plant and equipment
|
41.5
|
|
Other noncurrent assets
|
0.7
|
|
Identifiable intangible assets
|
80.9
|
|
Total Assets
|
171.2
|
|
|
|
Accounts payable
|
4.8
|
|
Accrued expenses
|
6.7
|
|
Deferred income tax liabilities
|
40.4
|
|
Other liabilities
|
0.7
|
|
|
|
Net assets acquired
|
118.6
|
|
|
|
Goodwill
|
112.7
|
|
|
|
Cash paid
|
$
|
231.3
|
|
The Company used the income, market, or cost approach (or a combination thereof) for the preliminary valuation as appropriate, and used valuation inputs in these models and analyses that were based on market participant assumptions. Market participants are considered to be buyers and sellers in the principal or most advantageous market for the asset or liability. For certain items, the carrying amount was determined to be a reasonable approximation of fair value based on information available to SWM management. The fair value of receivables acquired from DelStar on December 12, 2013 was
$17.3 million
, with gross contractual amounts receivable of
$17.6 million
. Acquired inventories and property, plant and equipment were recorded at their preliminary fair values. Acquired intangible assets are primarily trade names, customer relationships and developed technology.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Properties acquired included a number of manufacturing and related facilities, land and leased sites that include leasehold improvements, and machinery and equipment for use in manufacturing operations. Management valued properties using the cost approach supported where available by observable market data which included consideration of obsolescence.
Intangible assets acquired included a number of trade names that are both business-to-business and business-to-consumer. Also acquired was technology related to products subject to a number of existing patents and trade know-how. In addition to these intangible assets, the Company acquired a number of customer relationships in water filtration, industrial filtration and healthcare industries. Management valued intangible assets using the relief from royalty and multi-period excess earnings methods, both forms of the income approach supported by observable market data for peer companies. The following table shows the preliminary fair values assigned to intangible assets ($ in millions):
|
|
|
|
|
|
|
|
Preliminary
Fair Value as of December 12, 2013
|
|
Weighted-Average Amortization Period (Years)
|
Amortizable intangible assets:
|
|
|
|
Customer relationships
|
$
|
45.3
|
|
|
23
|
Developed Technology
|
13.8
|
|
|
12.8
|
Indefinite-lived intangible assets:
|
|
|
|
Trade names
|
21.8
|
|
|
Indefinite
|
Total
|
$
|
80.9
|
|
|
21
|
In connection with the acquisition, the Company recorded goodwill, which represents the excess of the consideration transferred over the estimated preliminary fair value of tangible and intangible assets acquired, net of liabilities assumed. The goodwill is attributed primarily to DelStar's revenue growth from combining the SWM and DelStar business and workforce as well as the benefits of access to different markets and customers. Goodwill from the DelStar acquisition will be assigned to its own reportable segment Filtration. None of the goodwill is expected to be deductible for tax purposes.
The goodwill was determined on the basis of the provisional fair values of the assets and liabilities identified as of the acquisition date. It may be adjusted, within a period of no more than 12 months from the acquisition date, if the provisional fair values change as a result of circumstances existing at the acquisition date. Such fair value adjustments may arise in respect to property, plant and equipment, intangible assets and inventories, upon completion of the necessary valuations and physical verifications of such assets. The amount of provisions may also be adjusted as a result of ongoing procedures to identify and measure liabilities and contingent liabilities, including tax, environmental risks and litigation. The amount of deferred taxes may also be adjusted during the measurement period.
In 2013, the Company recognized
$1.1 million
in direct and indirect acquisition-related costs and
$2.0 million
in financing costs related to the acquisition. Direct and indirect acquisition-related costs were expensed as incurred and are included in the General Expense line item in the Consolidated Statements of Income. Financing costs related to expanding the Credit Agreement have been capitalized and will be amortized in Interest Expense over the life of the Credit Agreement.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The amounts of DelStar's Net Sales and Income from Continuing Operations included in the Company's Consolidated Statements of Income for the year ended December 31, 2013, and the unaudited pro forma Net Sales and Income from Continuing Operations of the combined entity had the acquisition date been January 1, 2012 are as follows ($ in millions):
|
|
|
|
|
|
|
|
|
|
|
|
Net Sales
|
|
(Loss) Income from Continuing Operations
|
Actual from December 13, 2013 - December 31, 2013
|
|
$
|
4.2
|
|
|
$
|
(0.1
|
)
|
|
|
|
|
|
2013 Supplemental Pro Forma from January 1, 2013 - December 31, 2013
|
|
$
|
886.0
|
|
|
$
|
84.3
|
|
|
|
|
|
|
2012 Supplemental Pro Forma from January 1, 2012 - December 31, 2012
|
|
$
|
889.0
|
|
|
$
|
105.2
|
|
The 2013 Supplemental Pro Forma Income from Continuing Operations was adjusted to exclude
$1.1 million
of acquisition-related costs incurred in 2013 and
$0.9 million
of nonrecurring expense related to the fair value adjustment to acquisition-date inventory. The 2012 Supplemental Pro Forma Income from Continuing Operations was adjusted to include
$1.1 million
of acquisition-related costs incurred in 2013 and
$4.2 million
of nonrecurring expense related to the fair value adjustment to acquisition-date inventory.
For the year ended December 31, 2013, Income from Continuing Operations included
$0.9 million
of additional costs of acquired inventories and
$1.1 million
in charges primarily associated with the acquisition and integration of DelStar. The unaudited pro forma financial results for the years ended December 31, 2013 and 2012 combine the consolidated results of SWM and DelStar giving effect to the acquisition of DelStar as if it had been completed on January 1, 2012, the beginning of the comparable prior annual reporting period presented. The unaudited pro forma financial results do not include any anticipated synergies or other expected benefits of the acquisition. This unaudited pro forma financial information is presented for informational purposes only and is not indicative of future operations or results had the acquisition been completed as of January 1, 2012.
The unaudited pro forma financial results include certain adjustments for depreciation and amortization expense based upon the fair value step-up and estimated useful lives of DelStar depreciable fixed assets and definite-life amortizable assets acquired in the transaction. The unaudited pro forma results also include adjustments to net interest expense historically recorded by DelStar based upon the retirement of DelStar’s debt and issuance of additional debt related to the transaction. The provision for income taxes from continuing operations has also been adjusted for all periods, based upon the foregoing adjustments to historical results, as well as the elimination of historical net changes in valuation allowances against certain deferred tax assets of DelStar.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note
4
. Discontinued Operations
The Company's former paper mill in Medan, Indonesia, closed paper mill in San Pedro, Philippines and closed finished tipping mill in Malaucène, France have been reported as discontinued operations. The sale of the Indonesia mill was finalized in the second quarter of 2013 and a
$1.6 million
non-cash loss was recorded in discontinued operations. The sale of the Philippines mill was finalized in the fourth quarter of 2013 and resulted in a gain of
$1.6 million
. For all periods presented, results of these mills have been removed from each individual line within the statements of income and the operating activities section of the statements of cash flow. In each case, a separate line has been added for the net results of discontinued operations.
In the consolidated balance sheets, the assets and liabilities of the Indonesia mill were classified as Held-for-Sale as of December 31, 2012 and therefore, except for cash and cash equivalents, assets and liabilities of the Indonesian mill have been included in other current assets and accrued expenses, respectively, since December 31, 2012. Property, plant and equipment, net, of the Philippines mill was classified as Held-for-Sale and has been included in other current assets since March 31, 2013. Prior year balances have not been reclassified in the consolidated balance sheets.
The Malaucène mill filed for liquidation under applicable French law during the fourth quarter of 2011. As part of the liquidation process, a trustee was appointed to administer claims of the mill from the remaining assets of the entity. This appointment resulted in the Company's loss of control of the ability to direct the activities of Malaucène; therefore, the accounts of Malaucène have been removed from the consolidated results of the Company as of the liquidation date. The Company no longer has continuing involvement or an ongoing interest in Malaucène. The deconsolidation resulted in a
$5.7 million
gain during 2011, presented in the results of discontinued operations, to remove the carrying value of Malaucène's assets and liabilities and a
$0.7 million
tax benefit as a result of certain intercompany transaction losses which are deductible for French taxes.
Included in Other Assets and Accrued Expenses within the condensed consolidated balance sheet were the following major classes of assets and liabilities, respectively, associated with the discontinued operations ($ in millions):
|
|
|
|
|
|
|
|
|
|
December 31, 2013
|
|
December 31, 2012
|
Assets of discontinued operations:
|
|
|
|
Current assets
|
$
|
2.0
|
|
|
$
|
7.7
|
|
Noncurrent deferred income tax benefits
|
—
|
|
|
0.8
|
|
Other assets
|
3.1
|
|
|
0.2
|
|
|
|
|
|
Liabilities of discontinued operations:
|
|
|
|
|
Current liabilities
|
0.6
|
|
|
2.1
|
|
Summary financial results of discontinued operations were as follows ($ in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
2013
|
|
2012
|
|
2011
|
Net sales
|
$
|
7.1
|
|
|
$
|
24.8
|
|
|
$
|
27.9
|
|
Restructuring and impairment expense
|
1.4
|
|
|
14.0
|
|
|
1.5
|
|
Gain on disposal
|
—
|
|
|
—
|
|
|
5.7
|
|
Loss from discontinued operations before income taxes
|
(2.6
|
)
|
|
(23.2
|
)
|
|
(2.6
|
)
|
Income tax benefit (provision)
|
0.2
|
|
|
(1.1
|
)
|
|
3.1
|
|
(Loss) income from discontinued operations
|
(2.4
|
)
|
|
(24.3
|
)
|
|
0.5
|
|
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 5. Accounts Receivable
Accounts receivable are summarized as follows ($ in millions):
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
2013
|
|
2012
|
Trade receivables
|
$
|
78.0
|
|
|
$
|
70.6
|
|
Business tax credits, including VAT
|
5.4
|
|
|
5.6
|
|
Hedge contracts receivable
|
—
|
|
|
0.4
|
|
Other receivables
|
24.6
|
|
|
19.4
|
|
Less allowance for doubtful accounts and sales discounts
|
(0.4
|
)
|
|
(0.6
|
)
|
Total accounts receivable
|
$
|
107.6
|
|
|
$
|
95.4
|
|
Note 6. Inventories
Inventories are valued at the lower of cost using the First-In, First-Out, or FIFO, and weighted average methods, or market. The Company's costs included in inventory primarily include pulp, chemicals, direct labor, utilities, maintenance, depreciation, finishing supplies and an allocation of mill overhead costs. Machine start-up costs or abnormal machine shut downs are expensed in the period incurred and are not reflected in inventory. The definition of market value, with respect to all inventories, is replacement cost or net realizable value. The Company reviews inventories at least quarterly to determine the necessity of write-offs for excess, obsolete or unsalable inventory. The Company estimates write-offs for inventory obsolescence and shrinkage based on its judgment of future realization. These reviews require the Company to assess customer and market demand. The following schedule details inventories by major class ($ in millions):
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
2013
|
|
2012
|
Raw materials
|
$
|
39.2
|
|
|
$
|
31.5
|
|
Work in process
|
24.4
|
|
|
23.4
|
|
Finished goods
|
50.9
|
|
|
36.8
|
|
Supplies and other
|
18.3
|
|
|
19.9
|
|
Total
|
$
|
132.8
|
|
|
$
|
111.6
|
|
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 7. Property, Plant and Equipment
Property, plant and equipment are stated at cost, less accumulated depreciation. Interest is capitalized as a component of the cost of construction for large projects. Expenditures for betterments are capitalized whereas normal repairs and maintenance are expensed as incurred. Property, other than land, is depreciated on the straight-line method for financial reporting purposes. When property is sold or retired, the cost of the property and the related accumulated depreciation are removed from the balance sheet, and any gain or loss on the transaction is normally included in cost of products sold.
Property, plant and equipment (and related depreciable lives) consisted of the following ($ in millions):
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
2013
|
|
2012
|
Land and improvements
|
$
|
21.2
|
|
|
$
|
27.5
|
|
Buildings and improvements (20 to 40 years or remaining life of relevant lease)
|
135.1
|
|
|
131.3
|
|
Machinery and equipment (5 to 20 years)
|
564.9
|
|
|
674.6
|
|
Construction in progress
|
53.7
|
|
|
81.5
|
|
Gross Property, Plant and Equipment
|
774.9
|
|
|
914.9
|
|
Less: Accumulated Depreciation
|
381.7
|
|
|
513.5
|
|
Property, Plant and Equipment, net
|
$
|
393.2
|
|
|
$
|
401.4
|
|
Depreciation expense was
$31.1 million
,
$30.8 million
and
$33.7 million
for the years ended December 31, 2013, 2012, and 2011, respectively.
Note
8
. Goodwill
The Company evaluates goodwill for impairment at least annually during the fourth quarter. The annual tests during the fourth quarters of 2013, 2012 and 2011 resulted in no impairment. The Company has
two
reporting units with goodwill - Reconstituted Tobacco and Filtration - which are also reportable segments. The Paper segment has no remaining goodwill after
$2.7 million
in accumulated impairment losses.
The changes in the carrying amount of goodwill for each segment were as follows ($ in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconstituted Tobacco
|
|
Filtration
|
|
Total
|
Goodwill as of December 31, 2012
|
$
|
5.7
|
|
|
$
|
—
|
|
|
$
|
5.7
|
|
|
|
|
|
|
|
Goodwill acquired during the year
|
—
|
|
|
112.7
|
|
|
112.7
|
|
Foreign currency translation adjustments
|
0.3
|
|
|
—
|
|
|
0.3
|
|
|
|
|
|
|
|
Goodwill as of December 31, 2013
|
$
|
6.0
|
|
|
$
|
112.7
|
|
|
$
|
118.7
|
|
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 9. Intangible Assets
The gross carrying amount and accumulated amortization for intangible assets consisted of the following ($ in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2013
|
|
December 31, 2012
|
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization*
|
|
Net
Carrying
Amount
|
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization*
|
|
Net
Carrying
Amount
|
Amortized intangible assets
|
|
|
|
|
|
|
|
|
|
|
|
Customer-related intangibles
(Reconstituted Tobacco)
|
$
|
10.0
|
|
|
$
|
10.0
|
|
|
$
|
—
|
|
|
$
|
10.0
|
|
|
$
|
9.6
|
|
|
$
|
0.4
|
|
Customer Relationships (Filtration)
|
45.3
|
|
|
0.1
|
|
|
45.2
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Developed Technology
(Filtration)
|
13.8
|
|
|
0.1
|
|
|
13.7
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Total
|
$
|
69.1
|
|
|
$
|
10.2
|
|
|
$
|
58.9
|
|
|
$
|
10.0
|
|
|
$
|
9.6
|
|
|
$
|
0.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unamortized intangible assets (Filtration)
|
|
|
|
|
|
|
|
|
|
|
Trade names
|
$
|
21.8
|
|
|
|
|
|
|
$
|
—
|
|
|
|
|
|
* Accumulated amortization also includes adjustments for foreign currency translation.
Amortization expense of intangible assets was
$0.6 million
,
$1.1 million
and
$1.6 million
and for the years ended
December 31, 2013
, 2012 and 2011, respectively. Finite-lived intangibles in the Filtration segment are expensed using the straight-line amortization method. The following table shows the estimated aggregate amortization expense for the next five years ($ in millions):
|
|
|
|
|
|
Estimated Amortization Expense
|
For the year ended December 31, 2014
|
$
|
3.1
|
|
For the year ended December 31, 2015
|
3.1
|
|
For the year ended December 31, 2016
|
3.1
|
|
For the year ended December 31, 2017
|
3.1
|
|
For the year ended December 31, 2018
|
3.1
|
|
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note
10
. Other Assets
Other assets consisted of the following ($ in millions):
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
2013
|
|
2012
|
Capitalized software costs, net of accumulated amortization
|
$
|
7.0
|
|
|
$
|
11.4
|
|
Business tax credits, including VAT and ICMS (net of $13.8 million and $17.8 million reserve as of December 31, 2013 and 2012, respectively)
|
3.1
|
|
|
3.9
|
|
Grantor trust assets
|
10.0
|
|
|
7.6
|
|
Net pension assets
|
4.4
|
|
|
—
|
|
Other assets
|
7.1
|
|
|
2.6
|
|
Total
|
$
|
31.6
|
|
|
$
|
25.5
|
|
The Company's ICMS credits in Brazil are fully reserved. These credits do not expire. The Company is still pursuing other actions to utilize the credits. Charges and credits associated with normal ongoing activity are included in Cost of Products Sold in the Consolidated Statements of Income. Future material changes as a result of new legislation or a change in our operations will be reported separately.
Grantor trust assets consist primarily of cash surrender values in Company-owned life insurance policies held by a trust to be used for the eventual payment of employee deferred compensation. These assets are restricted from Company use until all obligations are satisfied.
Note
11
. Restructuring and Impairment Activities
The Company incurred restructuring and impairment expenses of
$41.3 million
,
$21.4 million
and
$14.0 million
in the years ended December 31, 2013, 2012 and 2011, respectively.
In the Paper segment, restructuring and impairment expenses were
$2.4 million
,
$17.9 million
and
$9.4 million
during the years ended December 31, 2013, 2012 and 2011, respectively. During 2013, restructuring and impairment expenses primarily included
$1.6 million
related to severance and early retirement expenses in the French operations for ongoing accruals over the remaining service lives of affected employees related to previously announced actions and terminating a third-party printing agreement in Europe. During 2012, expenses for the Paper segment were primarily related to the Company's amendment of a supply agreement with Philip Morris-USA, a subsidiary of Altria Group Inc. The amended agreement eliminated the Company's contractual commitment to stand ready to produce commercial quantities of banded cigarette paper even in the absence of firm orders. The Company considered these new terms to be a triggering event requiring evaluation of the recoverability of our Spotswood mill's banded cigarette paper production assets. Based on this analysis, which reflected management's assessment of the most likely future utilization of the mill, the Company in 2012 recorded a
$16.9 million
impairment charge to reduce the carrying value of these assets to their fair value.
The Reconstituted Tobacco segment restructuring and impairment expenses were
$38.6 million
,
$4.1 million
and
$4.6 million
for the years ended December 31, 2013, 2012 and 2011, respectively. The Company recorded
$37.2 million
,
$3.1 million
, and
$3.4 million
of impairment expenses related to the Company's RTL facility in the Philippines. In January 2011, the Company learned of decreased RTL needs of a major customer and suspended construction of the RTL facility. The Company conducted an impairment analysis at each reporting period on the mothballed assets. At the end of 2013, the Company's estimates of near-term, cyclical RTL demand decreased such that cash flows from the potential restart of the facility were weighted less in management's assessment of the most likely future operation of the site. The 2013 charge reduces the carrying value of these assets, primarily construction-in-progress, to their fair value of
$31.5 million
.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fair value of the RTL Philippines facility and the Spotswood, New Jersey mill was determined by using management's estimates of market participants' discounted future cash flows and independent appraisals of certain assets, both which are considered significant unobservable inputs, or Level 3 inputs. Management used significant judgment to develop assumptions, including forecasted sales volumes, allocation of certain overhead costs attributable to the Spotswood mill and weighted average cost of capital, based on historical and projected operational performance.
Remaining restructuring expense for the Reconstituted Tobacco segment for the years ended December 31, 2013, 2012 and 2011 related to severance and early retirement expenses in the French operations for ongoing accruals over the remaining service lives of affected employees related to previously announced actions.
Restructuring liabilities were classified within Accrued expenses in each of the consolidated balance sheets as of
December 31, 2013
and 2012. Changes in the restructuring liabilities, substantially all of which are employee-related, are summarized as follows ($ in millions):
|
|
|
|
|
|
|
|
|
|
2013
|
|
2012
|
Balance at beginning of year
|
$
|
3.4
|
|
|
$
|
7.3
|
|
Accruals for announced programs
|
3.9
|
|
|
2.6
|
|
Cash payments
|
(2.7
|
)
|
|
(6.4
|
)
|
Exchange rate impacts
|
0.1
|
|
|
(0.1
|
)
|
Balance at end of period
|
$
|
4.7
|
|
|
$
|
3.4
|
|
Note
12
. Debt
Total debt is summarized in the following table ($ in millions):
|
|
|
|
|
|
|
|
|
|
December 31,
2013
|
|
December 31,
2012
|
Revolving Credit Agreement
|
$
|
367.7
|
|
|
$
|
139.1
|
|
French Employee Profit Sharing
|
15.8
|
|
|
14.7
|
|
Bank Overdrafts
|
1.7
|
|
|
2.0
|
|
Other
|
0.2
|
|
|
0.2
|
|
Total Debt
|
385.4
|
|
|
156.0
|
|
Less: Current debt
|
(4.2
|
)
|
|
(4.2
|
)
|
Long-Term Debt
|
$
|
381.2
|
|
|
$
|
151.8
|
|
Credit Agreement
In December 2013, the Company amended and restated its unsecured revolving credit facility, or Credit Agreement. The
five
-year revolving Credit Agreement provides for borrowing capacity of
$500.0 million
in either U.S. Dollars or a
$300.0 million
equivalent sublimit in euros with an option to increase borrowing capacity by
$200 million
. The Credit Agreement contains representations and warranties which are customary for facilities of this type and covenants and provisions that, among other things, require
the Company to maintain (a) a maximum net debt to EBITDA ratio of 3.00 and (b) minimum interest coverage ratio of 3.50. The Company was in compliance with all of its covenants under the Credit Agreement at December 31, 2013.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Under the Credit Agreement, interest rates are based on the London Interbank Offered Rate plus an applicable margin that varies from
1.25%
to
2.00%
depending on the Net Debt to EBITDA Ratio, as defined in the Credit Agreement. The Company will incur commitment fees at an annual rate of
0.20%
to
0.30%
of the applicable margin on the committed amounts not drawn, depending on the Net Debt to EBITDA Ratio. As of
December 31, 2013
, the applicable interest rate on Credit Agreement borrowings was
1.44%
on US Dollar borrowings.
No
euro borrowings were outstanding at December 31, 2013.
French Employee Profit Sharing
At both December 31, 2013 and 2012, long-term debt other than the Credit Agreement primarily consisted of obligations of the French operations related to government-mandated profit sharing. Each year, representatives of the workers at each of the French businesses can make an election for the profit sharing amounts from the most recent year ended to be invested in a financial institution or with their respective employer. To the extent that funds are invested with the Company, these amounts bear interest at
2.43%
and
3.15%
at December 31, 2013 and 2012, respectively, and are generally payable in the fifth year subsequent to the year the profit sharing is accrued.
Bank Overdrafts and Other
The Company also had bank overdraft facilities of
$46.3 million
and
$45.5 million
, at December 31, 2013 and 2012, respectively, of which
$1.7 million
and
$2.0 million
were outstanding at December 31, 2013 and 2012, respectively, and reported as current debt on the consolidated balance sheet. Interest is incurred on outstanding amounts at market rates and was
0.74%
and
1.44%
, respectively, at December 31, 2013 and 2012. No commitment fees are paid on the unused portion of these facilities.
Other debt consists of non-interest bearing debt with deferred capital repayment from governmental and commercial institutions primarily related to environmental capital improvements.
Interest Expense and Rate Swap Agreement
The Company capitalized
$1.5 million
of interest expense in the year ended December 31, 2011, due to construction of our RTL facility in the Philippines.
The Company maintained a forward interest rate swap agreement on a portion of its long-term debt as of December 31, 2013 that will fix the LIBOR rate on
$50.0 million
of the Company’s variable-rate long-term debt as of October 2014 at the October 2014 LIBOR rate plus a credit spread through the end of October 2018. At
December 31, 2012
, there were no outstanding interest rate swap agreements on the Company's debt. The impact of swap agreements on the consolidated financial statements was not material for the years ended
December 31, 2013
and
2012
. See Note
13
. Derivatives for more information.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Principal Repayments
Under the Credit Agreement, the Company selects an “interest period” for each of its borrowings. The Company can repay such borrowings and borrow again at a subsequent date if it chooses to do so, providing it flexibility and efficient use of any excess cash. The Company expects to continue to file notices of continuation related to its borrowings outstanding at December 31, 2013 such that those amounts are not expected to be repaid prior to the December 2018 expiration of the Credit Agreement. Following are the expected maturities for the Company's debt obligations as of December 31, 2013 ($ in millions):
|
|
|
|
|
2014
|
$
|
4.2
|
|
2015
|
3.0
|
|
2016
|
3.3
|
|
2017
|
3.2
|
|
2018
|
371.7
|
|
Thereafter
|
—
|
|
Total
|
$
|
385.4
|
|
Fair Value of Debt
At December 31, 2013 and 2012, the estimated fair values of the Company’s current and long-term debt approximated the respective carrying amounts since the interest rates were variable and based on current market indices.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note
13
. Derivatives
In the normal course of business, the Company is exposed to foreign currency exchange rate risk and interest rate risk on its variable-rate debt. To manage these risks, the Company utilizes a variety of practices including, where considered appropriate, derivative instruments. The Company has no derivative instruments for trading or speculative purposes nor any derivatives with credit risk-related contingent features. All derivative instruments used by the Company are either exchange traded or are entered into with major financial institutions in order to reduce credit risk and risk of nonperformance by third parties. The fair values of the Company’s derivative instruments are determined using observable inputs and are considered Level 2 assets or liabilities.
The Company utilizes currency forward, swap and, to a lesser extent, option contracts to selectively hedge its exposure to foreign currency risk when it is practical and economical to do so. The use of these contracts minimizes transactional exposure to exchange rate changes. We designate certain of our foreign currency hedges as cash flow hedges. Changes in the fair value of cash flow hedges are reported as a component of other comprehensive income (loss) and reclassified into earnings when the forecasted transaction affects earnings. For foreign exchange contracts not designated as cash flow hedges, changes in the contracts’ fair value are recorded to net income each period.
The Company selectively hedges its exposure to interest rate increases on variable-rate, long-term debt when it is practical and economical to do so. Changes in the fair value of interest rate contracts considered cash flow hedges are reported as a component of other comprehensive income (loss) and reclassified into earnings when the forecasted transaction affects earnings.
The following table presents the fair value of asset and liability derivatives and the respective balance sheet locations at
December 31, 2013
($ in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset Derivatives
|
|
Liability Derivatives
|
|
Balance Sheet
Location
|
|
Fair
Value
|
|
Balance Sheet
Location
|
|
Fair
Value
|
Derivatives designated as hedges:
|
|
|
|
|
|
|
|
Foreign exchange contracts
|
Accounts Receivable
|
|
$
|
—
|
|
|
Accrued Expenses
|
|
$
|
6.5
|
|
Foreign exchange contracts
|
Other Assets
|
|
—
|
|
|
Other Liabilities
|
|
2.1
|
|
Interest rate contracts
|
Other Assets
|
|
0.5
|
|
|
Other Liabilities
|
|
—
|
|
Total derivatives designated as hedges
|
|
|
$
|
0.5
|
|
|
|
|
$
|
8.6
|
|
The following table presents the fair value of asset and liability derivatives and the respective balance sheet locations at
December 31, 2012
($ in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset Derivatives
|
|
Liability Derivatives
|
|
Balance Sheet
Location
|
|
Fair
Value
|
|
Balance Sheet
Location
|
|
Fair
Value
|
Derivatives designated as hedges:
|
|
|
|
|
|
|
|
Foreign exchange contracts
|
Accounts Receivable
|
|
$
|
0.4
|
|
|
Accrued Expenses
|
|
$
|
—
|
|
Foreign exchange contracts
|
Other Assets
|
|
—
|
|
|
Other Liabilities
|
|
3.5
|
|
Total derivatives designated as hedges
|
|
|
$
|
0.4
|
|
|
|
|
$
|
3.5
|
|
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The following table provides the effect derivative instruments in cash flow hedging relationships had on accumulated other comprehensive income (loss), or AOCI, and results of operations ($ in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives Designated as Cash Flow Hedging Relationships
|
Loss (Gain) Recognized in AOCI on Derivatives, Net of Tax for the Year Ended December 31,
|
|
Location of Reclassification
|
(Loss) Gain Reclassified
from AOCI
|
|
2013
|
|
2012
|
|
2011
|
|
|
2013
|
|
2012
|
|
2011
|
Foreign exchange contracts
|
$
|
(7.0
|
)
|
|
$
|
(1.8
|
)
|
|
$
|
(4.9
|
)
|
|
Net Sales
|
$
|
(0.4
|
)
|
|
$
|
1.4
|
|
|
$
|
5.5
|
|
Interest rate contracts
|
0.3
|
|
|
—
|
|
|
|
|
Interest Expense
|
—
|
|
|
—
|
|
|
—
|
|
Total
|
$
|
(6.7
|
)
|
|
$
|
(1.8
|
)
|
|
$
|
(4.9
|
)
|
|
Total
|
$
|
(0.4
|
)
|
|
$
|
1.4
|
|
|
$
|
5.5
|
|
The Company's designated derivative instruments are perfectly effective. As such, related to the hedge ineffectiveness or amounts excluded from hedge effectiveness testing, there were no gains or losses recognized immediately in income for the years ended
December 31, 2013
, 2012 or 2011.
The following table provides the effect derivative instruments not designated as hedging instruments had on net income ($ in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives Not Designated as Cash Flow Hedging Instruments
|
Amount of Gain / (Loss) Recognized in Other Income / Expense
|
|
|
2013
|
|
2012
|
|
2011
|
Interest rate contracts
|
|
$
|
—
|
|
|
$
|
(0.1
|
)
|
|
$
|
0.5
|
|
Foreign exchange contracts
|
|
(0.1
|
)
|
|
(1.0
|
)
|
|
2.6
|
|
Total
|
|
$
|
(0.1
|
)
|
|
$
|
(1.1
|
)
|
|
$
|
3.1
|
|
Note 14. Accrued Expenses
Accrued expenses consisted of the following ($ in millions):
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
2013
|
2012
|
Accrued salaries, wages and employee benefits
|
$
|
49.0
|
|
|
$
|
43.5
|
|
Other accrued expenses
|
43.7
|
|
|
32.3
|
|
Total
|
$
|
92.7
|
|
|
$
|
75.8
|
|
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note
15
. Income Taxes
An analysis of the provision (benefit) for income taxes from continuing operations follows ($ in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
2013
|
|
2012
|
|
2011
|
Current income taxes:
|
|
|
|
|
|
U.S. Federal
|
$
|
13.6
|
|
|
$
|
16.2
|
|
|
$
|
12.8
|
|
U.S. State
|
0.9
|
|
|
1.5
|
|
|
1.1
|
|
Foreign
|
21.2
|
|
|
18.7
|
|
|
32.8
|
|
|
35.7
|
|
|
36.4
|
|
|
46.7
|
|
Deferred income taxes:
|
|
|
|
|
|
U.S. Federal
|
(0.2
|
)
|
|
(4.6
|
)
|
|
4.6
|
|
U.S. State
|
—
|
|
|
(0.4
|
)
|
|
0.4
|
|
Foreign
|
17.5
|
|
|
18.1
|
|
|
(18.9
|
)
|
|
17.3
|
|
|
13.1
|
|
|
(13.9
|
)
|
Total
|
$
|
53.0
|
|
|
$
|
49.5
|
|
|
$
|
32.8
|
|
Income from continuing operations before income taxes and income from equity affiliates included income of
$70.0 million
in 2013,
$104.4 million
in 2012, and
$52.6 million
in 2011 from operations outside the United States.
A reconciliation of income taxes computed at the U.S. Federal statutory income tax rate to the provision for income taxes is as follows ($ in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
2013
|
|
2012
|
|
2011
|
|
Amount
|
|
Percent
|
|
Amount
|
|
Percent
|
|
Amount
|
|
Percent
|
Tax provision at U.S. statutory rate
|
$
|
44.7
|
|
|
35.0
|
%
|
|
$
|
52.4
|
|
|
35.0
|
%
|
|
$
|
42.1
|
|
|
35.0
|
%
|
Foreign income tax rate differential
|
8.2
|
|
|
6.4
|
|
|
(1.4
|
)
|
|
(2.1
|
)
|
|
(0.3
|
)
|
|
(0.2
|
)
|
Tax benefits of foreign legal structure
|
(0.9
|
)
|
|
(0.7
|
)
|
|
(1.1
|
)
|
|
(0.7
|
)
|
|
(2.2
|
)
|
|
(1.8
|
)
|
Foreign tax incentives
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(12.7
|
)
|
|
(10.6
|
)
|
Adjustments to valuation allowances
|
1.2
|
|
|
0.9
|
|
|
—
|
|
|
—
|
|
|
5.9
|
|
|
4.9
|
|
French business tax classified as income tax
|
2.2
|
|
|
1.7
|
|
|
2.4
|
|
|
1.6
|
|
|
2.6
|
|
|
2.2
|
|
Other foreign taxes, net
|
(0.5
|
)
|
|
(0.4
|
)
|
|
(0.8
|
)
|
|
0.7
|
|
|
(2.3
|
)
|
|
(1.9
|
)
|
Other, net
|
(1.9
|
)
|
|
(1.4
|
)
|
|
(2.0
|
)
|
|
(1.4
|
)
|
|
(0.3
|
)
|
|
(0.3
|
)
|
Provision for income taxes
|
$
|
53.0
|
|
|
41.5
|
%
|
|
$
|
49.5
|
|
|
33.1
|
%
|
|
$
|
32.8
|
|
|
27.3
|
%
|
Foreign income tax rate differential includes the effect of not recognizing the tax benefits of a tax holiday at the RTL Philippines facility attributable to asset impairment charges realized of
$13.4 million
,
$2.0 million
and
$2.2 million
during the years ended December 31, 2013, 2012 and 2011, respectively. The RTL Philippines tax holiday expired on
December 31, 2013
. The effect of not recognizing a tax benefit due to the tax holiday on net income per share (diluted) was
$0.43
,
$0.06
and
$0.07
for 2013, 2012 and 2011, respectively. Tax benefits of foreign legal structure result from net foreign tax deductions from the restructuring of the Company's foreign operations in 2003. In 2011, foreign tax incentives include a net
$12.7 million
deferred tax benefit primarily related to recording a deferred tax asset for tax credits granted in Poland based on investment in a special economic zone. During 2013, the Company increased its valuation allowances by
$1.1 million
primarily attributed to partially reserving the net deferred tax assets in Poland
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
due to an expected change in tax status for that entity in early 2014. In 2011 the Company recorded a
$5.9 million
valuation allowance to fully reserve the net deferred tax assets in Brazil.
The Company considers the undistributed earnings of certain foreign subsidiaries to be indefinitely reinvested. Accordingly, no provision for U.S. federal and state income taxes has been made thereon. Upon distribution of those earnings in the form of dividends, loans to the U.S. parent, or otherwise, the Company could be liable for both U.S. income taxes (subject to an adjustment for foreign tax credits) and withholding taxes payable to foreign tax authorities. Determination of the amount of unrecognized deferred U.S. tax liability is not practicable because of the complexities associated with this hypothetical calculation.
Deferred income tax assets (liabilities) were comprised of the following ($ in millions):
|
|
|
|
|
|
|
|
|
|
December 31,
|
Current deferred income tax assets attributable to:
|
2013
|
|
2012
|
Inventories
|
$
|
(1.0
|
)
|
|
$
|
0.6
|
|
Postretirement and other employee benefits
|
1.9
|
|
|
2.1
|
|
Other accrued liabilities
|
6.0
|
|
|
4.7
|
|
Valuation allowances
|
(3.0
|
)
|
|
(1.3
|
)
|
Foreign tax incentives
|
2.3
|
|
|
7.7
|
|
Other
|
3.9
|
|
|
(0.3
|
)
|
Net current deferred income tax assets
|
$
|
10.1
|
|
|
$
|
13.5
|
|
Noncurrent deferred income tax assets attributable to:
|
|
|
|
Operating loss carryforwards
|
$
|
8.8
|
|
|
$
|
19.2
|
|
Tax credit carryforwards
|
—
|
|
|
1.0
|
|
Postretirement and other employee benefits
|
—
|
|
|
9.9
|
|
Accumulated depreciation and amortization
|
—
|
|
|
(12.2
|
)
|
Valuation allowances
|
(9.8
|
)
|
|
(18.7
|
)
|
Other
|
1.0
|
|
|
11.3
|
|
Net noncurrent deferred income tax assets
|
$
|
—
|
|
|
$
|
10.5
|
|
Noncurrent deferred income tax liabilities attributable to:
|
|
|
|
Accumulated depreciation and amortization
|
$
|
(74.3
|
)
|
|
$
|
(51.4
|
)
|
Operating loss carryforwards
|
14.3
|
|
|
18.6
|
|
Valuation allowance
|
(7.5
|
)
|
|
—
|
|
Postretirement and other employee benefits
|
13.1
|
|
|
5.4
|
|
Basis difference of acquired intangible assets
|
(29.9
|
)
|
|
—
|
|
Other
|
3.4
|
|
|
(1.0
|
)
|
Net noncurrent deferred income tax liabilities
|
$
|
(80.9
|
)
|
|
$
|
(28.4
|
)
|
The net noncurrent deferred income tax assets relate to the U.S. tax jurisdiction and the net noncurrent deferred income tax liabilities relate to the U.S, China, France, Brazil, Poland and Canada tax jurisdictions. Net deferred tax assets in Brazil, the Philippines and Spain tax jurisdictions are fully reserved by valuation allowances. Total deferred income tax assets were
$43.1 million
and
$74.7 million
at December 31, 2013 and 2012, respectively. Total deferred income tax liabilities were
$113.9 million
and
$79.1 million
at December 31, 2013 and 2012, respectively.
The net operating loss carryforward balances, or NOLs, were primarily generated due to operating losses incurred in Brazil and as a result of lower operating earnings together with substantial restructuring expenses incurred in Brazil and France. Also, NOLs have been generated since 2003 by the SMH tax group in France and by SM-Spain since its formation in 1997.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
As of December 31, 2013 the Company had approximately
$68.8 million
of operating loss carryforwards available to reduce future taxable income. Under current tax laws, remaining NOLs in France and Brazil carry forward indefinitely, NOLs in Spain expire
15
years subsequent to the year generated, and NOLs in the Philippines expire
3
years subsequent to year generated. NOLs of approximately
$12.3 million
will expire from
2015
to
2026
in Spain and
$14.9 million
will expire in 2014 and 2015 in the Philippines if not utilized against taxable income. The remaining
$17.2 million
and
$24.4 million
of NOLs are related to France and Brazil, respectively, and have no expiration date.
The Company's deferred tax asset valuation allowances are primarily the result of uncertainties regarding the future realization of recorded tax benefits on tax loss carryforwards for certain entities. The valuation allowance on deferred tax assets associated with NOLs in Spain totaled
$4.3 million
as of December 31, 2013, fully reserving the related deferred tax asset. The valuation allowances in Brazil and the Philippines totaled
$8.7 million
and
$5.5 million
, respectively, fully reserving the net deferred tax asset balances. The Company's assumptions, judgments and estimates relative to the valuation of these net deferred tax assets take into account available positive and negative evidence of realizability, including recent financial performance, the ability to realize benefits of restructuring and other recent actions, projections of the amount and category of future taxable income and tax planning strategies. Actual future operating results and the underlying amount and category of income in future periods could differ from the Company's current assumptions, judgments and estimates. Tax planning strategies have been implemented in France and the Company believes that deferred tax assets associated with the NOLs in France are fully realizable. The Company believes that it will generate sufficient future taxable income to realize the tax benefits related to the remaining net deferred tax assets.
The Company was granted certain tax incentives in Poland for investment in a special economic zone. These incentives are in the form of credits granted in 2011 that will offset future qualified taxable income. Based on granted incentives, commitments achieved, including maintaining certain employment levels, and qualified investment through December 31, 2013, the Company has a
$2.3 million
net deferred tax asset at December 31, 2013, net of amounts utilized in 2013, 2012 and 2011. At December 31, 2013, the net deferred tax assets in Poland were partially reserved with a valuation allowance of
$1.1 million
due to an expected change in our Polish entity's taxable status in early 2014.
In addition to its NOLs and incentive tax credits, the Company has certain U.S. state credits, primarily for investments in long-lived assets in those states at December 31, 2013. Estimated various U.S. state credits totaled
$0.7 million
as of December 31, 2013, of which the Company has estimated that none of these credits will be realized prior to their expiration and thus have a valuation allowance of
$0.7 million
at December 31, 2013. The Company expects to fully realize foreign tax credits of
$1.1 million
at December 31, 2013.
The following table summarizes the activity related to the Company's unrecognized tax benefits related to income taxes ($ in millions):
|
|
|
|
|
|
December 31, 2013
|
Uncertain tax position balance at beginning of year
|
$
|
1.8
|
|
Increases related to current year tax positions
|
—
|
|
Uncertain tax position balance at end of year
|
$
|
1.8
|
|
All unrecognized tax positions would impact the Company's effective tax rate if recognized. The Company’s policy with respect to penalties and interest in connection with income tax assessments or related to unrecognized tax benefits is to classify penalties as provision for income taxes and interest as interest expense in its consolidated income statement. There were no material income tax penalties or interest accrued during the years ended December 31, 2013, 2012 or 2011.
The Company files income tax returns in the U.S. Federal and several state jurisdictions as well as in many foreign jurisdictions. With certain exceptions, the Company is no longer subject to U.S. Federal, state and local, or foreign income tax examinations for years before
2010
.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note
16
. Postretirement and Other Benefits
North American Pension and Postretirement Healthcare and Life Insurance Benefits
The U.S. operations have defined benefit retirement plans that cover certain full-time employees. Retirement benefits are based on either a cash balance benefit formula or a final average pay formula for certain employees who were “grandfathered” and retained retirement benefits under the terms of the plan prior to its amendment to include a cash balance benefit formula. Benefits related to the U.S. defined benefit and pension plan are frozen for all employees.
The U.S. operations also have unfunded healthcare and life insurance benefit plans, or OPEB plans, which cover certain of its retirees through age 65. Some employees who retained benefits under the terms of the Company's plans prior to certain past amendments receive retiree healthcare coverage at rates subsidized by the Company. For other eligible employees, retiree healthcare coverage access is offered at full cost to the retiree. The postretirement healthcare plans include a limit on the Company's share of costs for current and future retirees. The U.S. operations' retiree life insurance plans are noncontributory. The Company's Canadian postretirement benefits liability is immaterial and therefore is not included in these disclosures.
French Pension Benefits
In France, employees are covered under a government-administered program. Also, the Company's French operations sponsor retirement indemnity plans, which pay a lump sum retirement benefit to all of its permanent employees who retire. In addition, the Company's French operations sponsor a supplemental executive pension plan. Plan assets are principally invested in the general asset portfolio of a French insurance company.
U.S. and French Pension and U.S. Other Postretirement Benefit Disclosures
The U.S. pension and OPEB plans and French pension plans accounted for the majority of the Company's total plan assets and total ABO at December 31, 2013 for the Company and all of its consolidated subsidiaries.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Company uses a measurement date of December 31 for its pension plans in the United States and France and other postretirement healthcare and life insurance benefit plans in the United States. The funded status of these plans as of December 31, 2013 and 2012 was as follows ($ in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Benefits
|
|
OPEB Benefits
|
|
United States
|
|
France
|
|
United States
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
Change in Projected Benefit Obligation, or PBO:
|
|
|
|
|
|
|
|
|
|
|
|
PBO at beginning of year
|
$
|
132.6
|
|
|
$
|
128.1
|
|
|
$
|
33.6
|
|
|
$
|
26.8
|
|
|
$
|
5.4
|
|
|
$
|
11.8
|
|
Service cost
|
—
|
|
|
—
|
|
|
1.3
|
|
|
0.9
|
|
|
0.1
|
|
|
0.1
|
|
Interest cost
|
5.1
|
|
|
5.5
|
|
|
0.8
|
|
|
1.0
|
|
|
0.1
|
|
|
0.4
|
|
Actuarial (gain) loss
|
(8.8
|
)
|
|
6.6
|
|
|
2.6
|
|
|
7.1
|
|
|
(0.7
|
)
|
|
—
|
|
Participant contributions
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
0.3
|
|
|
1.1
|
|
Plan amendment
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1.7
|
)
|
|
(6.4
|
)
|
Gross benefits paid
|
(7.3
|
)
|
|
(7.6
|
)
|
|
(2.0
|
)
|
|
(2.8
|
)
|
|
(0.7
|
)
|
|
(1.6
|
)
|
Currency translation effect
|
—
|
|
|
—
|
|
|
1.4
|
|
|
0.6
|
|
|
—
|
|
|
—
|
|
PBO at end of year
|
$
|
121.6
|
|
|
$
|
132.6
|
|
|
$
|
37.7
|
|
|
$
|
33.6
|
|
|
$
|
2.8
|
|
|
$
|
5.4
|
|
Change in Plan Assets:
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of plan assets at beginning of year
|
120.4
|
|
|
108.6
|
|
|
13.4
|
|
|
15.5
|
|
|
—
|
|
|
—
|
|
Actual return on plan assets
|
12.2
|
|
|
15.3
|
|
|
(0.4
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
Employer contributions
|
0.7
|
|
|
4.1
|
|
|
0.8
|
|
|
0.4
|
|
|
0.4
|
|
|
0.5
|
|
Participant contributions
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
0.3
|
|
|
1.1
|
|
Gross benefits paid
|
(7.3
|
)
|
|
(7.6
|
)
|
|
(2.0
|
)
|
|
(2.8
|
)
|
|
(0.7
|
)
|
|
(1.6
|
)
|
Currency translation effect
|
—
|
|
|
—
|
|
|
0.5
|
|
|
0.3
|
|
|
—
|
|
|
—
|
|
Fair value of plan assets at end of year
|
$
|
126.0
|
|
|
$
|
120.4
|
|
|
$
|
12.3
|
|
|
$
|
13.4
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Funded status at end of year
|
$
|
4.4
|
|
|
$
|
(12.2
|
)
|
|
$
|
(25.4
|
)
|
|
$
|
(20.2
|
)
|
|
$
|
(2.8
|
)
|
|
$
|
(5.4
|
)
|
The PBO and Accumulated Benefit Obligations (ABO) exceeded the fair value of pension plan assets for the Company's French defined benefit pension plans as of December 31, 2013 and 2012 and U.S. defined benefit plan as of December 31, 2012 as follows ($ in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
France
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
PBO
|
$
|
121.6
|
|
|
$
|
132.6
|
|
|
$
|
37.7
|
|
|
$
|
33.6
|
|
ABO
|
121.6
|
|
|
132.6
|
|
|
31.2
|
|
|
22.2
|
|
Fair value of plan assets
|
126.0
|
|
|
120.4
|
|
|
12.3
|
|
|
13.4
|
|
As of December 31, 2013, the pre-tax amounts in accumulated other comprehensive income that have not been recognized as components of net periodic benefit cost for the U.S. and French pension plans and other postretirement benefit plans in the United States are as follows ($ in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Benefits
|
|
OPEB Benefits
|
|
United States
|
|
France
|
|
United States
|
Accumulated loss
|
$
|
36.6
|
|
|
$
|
16.8
|
|
|
$
|
1.3
|
|
Prior service credit
|
—
|
|
|
(5.4
|
)
|
|
(3.8
|
)
|
Accumulated other comprehensive loss (income)
|
$
|
36.6
|
|
|
$
|
11.4
|
|
|
$
|
(2.5
|
)
|
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The amounts in accumulated other comprehensive loss at December 31, 2013, which are expected to be recognized as components of U.S. and French net periodic benefit cost in 2014 are as follows ($ in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Benefits
|
|
OPEB Benefits
|
|
United States
|
|
France
|
|
United States
|
Amortization of accumulated loss
|
$
|
(4.4
|
)
|
|
$
|
(1.4
|
)
|
|
$
|
(0.1
|
)
|
Amortization of prior service credit
|
—
|
|
|
0.4
|
|
|
0.7
|
|
Total
|
$
|
(4.4
|
)
|
|
$
|
(1.0
|
)
|
|
$
|
0.6
|
|
Actuarial assumptions are used to determine the Company's benefit obligations. The discount rate represents the interest rate used to determine the present value of future cash flows currently expected to be required to settle pension obligations. The discount rate fluctuates from year to year based on current market interest rates for high-quality, fixed-income investments. The Company also evaluates the expected average duration of its pension obligations in determining its discount rate. An assumed long-term rate of compensation increase is also used to determine the PBO. The weighted average assumptions used to determine benefit obligations as of December 31, 2013 and 2012 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Benefits
|
|
OPEB Benefits
|
|
United States
|
|
France
|
|
United States
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
Discount rate
|
4.78
|
%
|
|
4.00
|
%
|
|
2.38
|
%
|
|
2.35
|
%
|
|
4.30
|
%
|
|
3.25
|
%
|
Rate of compensation increase
|
—
|
%
|
|
—
|
%
|
|
2.50
|
%
|
|
2.50
|
%
|
|
3.50
|
%
|
|
3.50
|
%
|
The U.S. postretirement healthcare plan provides for benefits to be limited to a cost ceiling which has already been reached. Therefore, no increases in the health care cost trend rates are included in the measurement of the plan's benefit obligation.
The components of net pension and OPEB benefit costs for U.S. employees and net pension benefit costs for French employees during the years ended
December 31, 2013
,
2012
and 2011 were as follows ($ in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Pension Benefits
|
|
French Pension Benefits
|
|
U.S. OPEB Benefits
|
|
2013
|
|
2012
|
|
2011
|
|
2013
|
|
2012
|
|
2011
|
|
2013
|
|
2012
|
|
2011
|
Service cost
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1.3
|
|
|
$
|
0.9
|
|
|
$
|
0.9
|
|
|
$
|
0.1
|
|
|
$
|
0.1
|
|
|
$
|
0.1
|
|
Interest cost
|
5.1
|
|
|
5.5
|
|
|
6.0
|
|
|
0.8
|
|
|
1.0
|
|
|
1.1
|
|
|
0.1
|
|
|
0.4
|
|
|
0.6
|
|
Expected return on plan assets
|
(7.1
|
)
|
|
(7.6
|
)
|
|
(7.7
|
)
|
|
(0.4
|
)
|
|
(0.6
|
)
|
|
(0.6
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
Amortizations and other
|
6.7
|
|
|
5.9
|
|
|
4.5
|
|
|
0.5
|
|
|
0.4
|
|
|
(3.1
|
)
|
|
(0.7
|
)
|
|
(0.3
|
)
|
|
—
|
|
Curtailment benefit
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
(3.2
|
)
|
|
—
|
|
|
—
|
|
Net periodic benefit cost
|
$
|
4.7
|
|
|
$
|
3.8
|
|
|
$
|
2.8
|
|
|
$
|
2.2
|
|
|
$
|
1.7
|
|
|
$
|
(1.7
|
)
|
|
$
|
(3.7
|
)
|
|
$
|
0.2
|
|
|
$
|
0.7
|
|
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Assumptions are used to determine net periodic benefit costs. In addition to the discount rate and rate of compensation increase, which are used to determine benefit obligations, an expected long-term rate of return on plan assets is also used to determine net periodic pension benefit costs. The weighted average assumptions used to determine net periodic benefit costs for the years ended December 31, 2013, 2012 and 2011 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Benefits
|
|
OPEB Benefits
|
|
United States
|
|
France
|
|
United States
|
|
2013
|
|
2012
|
|
2011
|
|
2013
|
|
2012
|
|
2011
|
|
2013
|
|
2012
|
|
2011
|
Discount rate
|
4.00
|
%
|
|
4.50
|
%
|
|
5.25
|
%
|
|
2.38
|
%
|
|
4.40
|
%
|
|
4.10
|
%
|
|
3.25
|
%
|
|
4.50
|
%
|
|
5.25
|
%
|
Expected long-term rate of return on plan assets
|
6.50
|
%
|
|
7.00
|
%
|
|
7.25
|
%
|
|
3.25
|
%
|
|
3.25
|
%
|
|
4.00
|
%
|
|
—
|
|
|
—
|
|
|
—
|
|
Rate of compensation increase
|
—
|
|
|
—
|
|
|
—
|
%
|
|
2.50
|
%
|
|
2.50
|
%
|
|
2.50
|
%
|
|
3.50
|
%
|
|
3.50
|
%
|
|
3.50
|
%
|
The Company's investment strategy with respect to its U.S. pension plan assets is to maximize the return on investment of plan assets at an acceptable level of risk and to assure the plans' fiscal health. The target asset allocation varies based on the funded status of the plan in an effort to match the duration of the plan's liabilities to investments in long duration fixed income assets over time. The Company's investment strategy with respect to its French pension plan assets is to invest plan assets at a low level of risk. The primary goal of the Company's pension plans is to maintain the highest probability of assuring future benefit payments to participants while providing growth of capital in real terms. To achieve this goal, the investment philosophy is to protect plan assets from large investment losses, particularly over time, while growing the assets as fast as prudently possible. While there cannot be complete assurance that the objectives will be realized, the Company believes that the likelihood of realizing the objectives are reasonable based upon this investment philosophy. The Company has an investment committee that meets formally on a periodic basis to review the portfolio returns and to determine asset mix targets. The U.S. and French pension plans' asset target allocations by asset category for 2014 and actual allocations by asset category at December 31, 2013 and 2012 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
France
|
|
2014 Target
|
|
2013
|
|
2012
|
|
2014 Target
|
|
2013
|
|
2012
|
Asset Category
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
—
|
%
|
|
3
|
%
|
|
1
|
%
|
|
5
|
%
|
|
25
|
%
|
|
23
|
%
|
Equity securities*
|
|
|
|
|
|
|
|
|
|
|
|
Domestic Large Cap
|
25
|
|
|
25
|
|
|
25
|
|
|
25
|
|
|
19
|
|
|
20
|
|
Domestic Small Cap
|
10
|
|
|
8
|
|
|
7
|
|
|
|
|
|
|
|
International
|
15
|
|
|
12
|
|
|
10
|
|
|
|
|
|
|
|
Fixed income securities
|
40
|
|
|
47
|
|
|
52
|
|
|
65
|
|
|
55
|
|
|
54
|
|
Alternative investments**
|
10
|
|
|
5
|
|
|
5
|
|
|
5
|
|
|
1
|
|
|
3
|
|
Total
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
|
|
*
|
Target allocation for equity securities under the French pension plan does not differentiate types of equity securities. None of the Company's pension plan assets are targeted for investment in SWM stock, except that it is possible that one or more mutual funds held by the plan could hold shares of SWM.
|
|
|
**
|
Investments in this category under the U.S. pension plan only may include hedge funds, and may include real estate under the French pension plan.
|
The Company's pension assets are classified according to an established fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurements). A financial instrument's level within the hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The three levels of the fair value hierarchy are described below:
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
|
|
Level 1
|
Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;
|
|
|
Level 2
|
Quoted prices in markets that are not considered to be active or financial instruments for which all significant inputs are observable, either directly or indirectly;
|
|
|
Level 3
|
Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.
|
The following table sets forth by level, within the fair value hierarchy, the U.S. and French pension plans' assets at fair value as of December 31, 2013 ($ in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
France
|
Plan Asset Category
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|
Level 1
|
|
Level 2
|
Cash equivalents
|
$
|
3.6
|
|
|
$
|
3.6
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3.1
|
|
|
$
|
3.1
|
|
|
$
|
—
|
|
Equity securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Domestic Large Cap
|
31.1
|
|
|
31.1
|
|
|
—
|
|
|
—
|
|
|
2.3
|
|
|
2.3
|
|
|
—
|
|
Domestic Small Cap
|
10.1
|
|
|
10.1
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
International
|
15.2
|
|
|
10.0
|
|
|
5.2
|
|
|
—
|
|
|
|
|
|
|
|
Fixed income securities
|
59.6
|
|
|
59.6
|
|
|
—
|
|
|
—
|
|
|
6.8
|
|
|
—
|
|
|
6.8
|
|
Alternative investments*
|
6.4
|
|
|
—
|
|
|
—
|
|
|
6.4
|
|
|
0.1
|
|
|
—
|
|
|
0.1
|
|
Total
|
$
|
126.0
|
|
|
$
|
114.4
|
|
|
$
|
5.2
|
|
|
$
|
6.4
|
|
|
$
|
12.3
|
|
|
$
|
5.4
|
|
|
$
|
6.9
|
|
The following table sets forth by level, within the fair value hierarchy, the U.S. and French pension plans' assets at fair value as of December 31, 2012 ($ in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
France
|
Plan Asset Category
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|
Level 1
|
|
Level 2
|
Cash equivalents
|
$
|
1.3
|
|
|
$
|
1.3
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3.1
|
|
|
$
|
3.1
|
|
|
$
|
—
|
|
Equity securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Domestic Large Cap
|
29.8
|
|
|
29.8
|
|
|
—
|
|
|
—
|
|
|
2.7
|
|
|
2.7
|
|
|
—
|
|
Domestic Small Cap
|
8.7
|
|
|
8.7
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
International
|
11.9
|
|
|
7.1
|
|
|
4.8
|
|
|
—
|
|
|
|
|
|
|
|
Fixed income securities
|
62.7
|
|
|
62.7
|
|
|
—
|
|
|
—
|
|
|
7.2
|
|
|
—
|
|
|
7.2
|
|
Alternative investments*
|
6.0
|
|
|
—
|
|
|
—
|
|
|
6.0
|
|
|
0.4
|
|
|
—
|
|
|
0.4
|
|
Total
|
$
|
120.4
|
|
|
$
|
109.6
|
|
|
$
|
4.8
|
|
|
$
|
6.0
|
|
|
$
|
13.4
|
|
|
$
|
5.8
|
|
|
$
|
7.6
|
|
*Alternative investments include ownership interests in shares of registered investment companies.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Values for Level 3 assets may be determined through appraisals and models for illiquid assets. The following table shows the changes in Level 3 asset values ($ in millions):
|
|
|
|
|
U.S.
Level 3 Asset Reconciliation
|
Alternative
Investments
Total
|
Beginning balance, January 1, 2012
|
$
|
8.0
|
|
Realized and unrealized gains
|
0.5
|
|
Purchases
|
0.5
|
|
Sales
|
(3.0
|
)
|
Ending balance, December 31, 2012
|
6.0
|
|
Realized and unrealized gains
|
0.6
|
|
Purchases
|
—
|
|
Sales
|
(0.2
|
)
|
Ending balance, December 31, 2013
|
$
|
6.4
|
|
The Company expects the following estimated undiscounted future pension benefit payments for the United States and France and future postretirement healthcare and life insurance benefit payments for the United States, which are to be made from pension plan and employer assets, net of amounts that will be funded from retiree contributions, and which reflect expected future service, as appropriate ($ in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
France
|
|
Pension
Benefits
|
|
Healthcare
and Life
Insurance
Benefits
|
|
Pension
Benefits
|
2014
|
$
|
8.0
|
|
|
$
|
0.5
|
|
|
$
|
1.5
|
|
2015
|
8.0
|
|
|
0.5
|
|
|
1.6
|
|
2016
|
8.1
|
|
|
0.3
|
|
|
2.2
|
|
2017
|
8.1
|
|
|
0.3
|
|
|
4.4
|
|
2018
|
8.4
|
|
|
0.2
|
|
|
1.3
|
|
2019 - 2023
|
42.2
|
|
|
0.7
|
|
|
9.9
|
|
The Company is not required to contribute during 2014 to its U.S. and French pension plans; although, it may make discretionary contributions dependent on market conditions to remain aligned with its investment policy statement.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Other Foreign Pension Benefits
In Brazil and Poland, employees are covered under government-administered programs. In Poland and Canada, the employee pension benefits are not significant and therefore are not included in the above disclosures.
Other Benefits
We sponsor a qualified defined contribution plan covering substantially all U.S. employees. Under the plan, the Company matches a portion of employee contributions. The Company's cost under the plan was
$1.8 million
,
$1.7 million
and
$1.8 million
for the years ended December 31, 2013, 2012 and 2011, respectively.
The Company provides U.S. executives, certain other key personnel and its directors the opportunity to participate in deferred compensation plans. Participating employees can elect to defer a portion of their salaries and certain other compensation. Participating directors can elect to defer their meeting fees, as a cash deferral, as well as their quarterly retainer fees, as deferred stock unit credits. The Company's liability balance under these deferred compensation plans totaled
$13.4 million
and
$9.9 million
at December 31, 2013 and 2012, respectively, which were included in the consolidated balance sheet in other liabilities. In connection with these plans, the Company has a grantor trust into which it has contributed funds toward its future obligations under the various plans (See Note
10
, Other Assets). The balance of grantor trust assets totaled
$10.0 million
and
$7.6 million
at December 31, 2013 and 2012, respectively, which were included in other assets in the consolidated balance sheets. These assets are restricted from Company use until all obligations are satisfied.
In accordance with French law, certain salaried employees in France may accumulate unused regular vacation and supplemental hours of paid leave that can be credited to an individual's Compte Epargne Temps, or CET. The CET account may grow over an individual's career and the hours accumulated may be withdrawn upon retirement or under other special circumstances at the individual's then current rate of pay. The balance of the Company's liability for this program reflected in the accompanying consolidated balance sheets in other liabilities was
$8.9 million
and
$8.4 million
at December 31, 2013 and 2012, respectively.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note
17
. Stockholders' Equity
Restricted Stock Plan
The Company's Restricted Stock Plan, or RSP, is intended to promote the Company's long-term financial success by attracting and retaining outstanding executive personnel and to motivate such personnel by means of restricted stock grants. The Compensation Committee of the Company's Board of Directors selects participants and establishes the terms of any grant of restricted stock. The Company's RSP provides that issuance of restricted stock immediately transfers ownership rights in shares of its Common Stock to the recipient of the grant, including the right to vote the shares and to receive dividends thereon, at a share price established by the Compensation Committee in its discretion. The recipient's continued ownership of and right to freely transfer the restricted stock is subject to such conditions on transferability and to such risks of forfeiture as are established by the Compensation Committee at the time of the grant, which may include continued employment with the Company for a defined period, achievement of specified management performance objectives or other conditions established by the Compensation Committee. The number of shares, which may be issued under this RSP, is limited to
2,000,000
shares. No single participant may be awarded, in the aggregate, more than
50%
of the shares authorized to be issued under the RSP.
As of December 31, 2013,
1,025,107
restricted shares had been issued under the RSP of which
318,561
shares of issued restricted stock were not yet vested and for which
$3.4 million
in unrecognized compensation expense is expected to be recognized over a weighted average period of
2.7
years. The following table presents restricted stock activity for the years 2013, 2012 and 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2013
|
|
2012
|
|
2011
|
|
# of Shares
|
|
Weighted Average Fair Value at Date of Grant
|
|
# of Shares
|
|
Weighted Average Fair Value at Date of Grant
|
|
# of Shares
|
|
Weighted Average Fair Value at Date of Grant
|
Nonvested restricted shares outstanding at January 1
|
433,382
|
|
|
$
|
18.94
|
|
|
359,306
|
|
|
$
|
13.79
|
|
|
1,078,628
|
|
|
$
|
10.45
|
|
Granted
|
274,172
|
|
|
36.47
|
|
|
137,026
|
|
|
29.56
|
|
|
654,120
|
|
|
11.47
|
|
Forfeited
|
(42,711
|
)
|
|
33.71
|
|
|
—
|
|
|
—
|
|
|
(7,000
|
)
|
|
10.40
|
|
Vested
|
(346,282
|
)
|
|
15.33
|
|
|
(62,950
|
)
|
|
12.84
|
|
|
(1,366,442
|
)
|
|
10.06
|
|
Nonvested restricted shares outstanding at December 31
|
318,561
|
|
|
$
|
35.82
|
|
|
433,382
|
|
|
$
|
18.94
|
|
|
359,306
|
|
|
$
|
13.79
|
|
Restricted Stock Plan Performance Based Shares
During 2013, the Company recognized
$2.9 million
of compensation expense for
159,940
shares earned under the 2013-2014 award opportunity. During 2012 and 2011, the Company recognized
$6.2 million
and
$3.3 million
, respectively, of compensation expense for
177,034
and
123,026
shares, respectively, earned under the 2011-2012 award opportunities under the Restricted Stock Plan, with an offsetting credit to additional paid-in capital.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Basic and Diluted Shares Reconciliation
The Company uses the two-class method to calculate earnings per share. The Company has granted restricted stock that contains nonforfeitable rights to dividends on unvested shares. Since these unvested shares are considered participating securities under the two-class method, the Company allocates earnings per share to common stock and participating securities according to dividends declared and participation rights in undistributed earnings.
Diluted net income per common share is computed based on net income divided by the weighted average number of common and potential common shares outstanding. Potential common shares during the respective periods are those related to dilutive stock-based compensation, including long-term share-based incentive compensation, stock options outstanding, and directors’ accumulated deferred stock compensation which may be received by the directors in the form of stock or cash. A reconciliation of the average number of common and potential common shares outstanding used in the calculations of basic and diluted net income per share follows ($ in millions, shares in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
2013
|
|
2012
|
|
2011
|
Numerator (basic and diluted):
|
|
|
|
|
|
Net income
|
$
|
76.1
|
|
|
$
|
79.8
|
|
|
$
|
92.6
|
|
Less: Dividends paid to participating securities
|
(0.2
|
)
|
|
(0.2
|
)
|
|
(0.1
|
)
|
Less: Undistributed earnings available to participating securities
|
(0.4
|
)
|
|
(0.9
|
)
|
|
(1.1
|
)
|
Undistributed and distributed earnings available to common stockholders
|
$
|
75.5
|
|
|
$
|
78.7
|
|
|
$
|
91.4
|
|
|
|
|
|
|
|
Denominator:
|
|
|
|
|
|
Average number of common shares outstanding
|
31,056.7
|
|
|
30,986.2
|
|
|
33,230.2
|
|
Effect of dilutive stock-based compensation
|
181.6
|
|
|
355.7
|
|
|
256.6
|
|
Average number of common and potential common shares outstanding
|
31,238.3
|
|
|
31,341.9
|
|
|
33,486.8
|
|
There were no anti-dilutive stock options during the years ended
December 31, 2013
,
2012
or 2011.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note
18
. Commitments and Contingencies
Leases
Future minimum obligations under non-cancelable operating leases having an initial or remaining term in excess of one year as of December 31, 2013 are as follows ($ in millions):
|
|
|
|
|
2014
|
$
|
2.7
|
|
2015
|
2.6
|
|
2016
|
2.4
|
|
2017
|
1.8
|
|
2018
|
1.3
|
|
Thereafter
|
3.3
|
|
Total
|
$
|
14.1
|
|
Rental expense under operating leases was
$5.3 million
during 2013,
$5.3 million
during 2012 and
$4.9 million
during 2011.
Other Commitments
The Paper segment has minimum purchase agreements during 2014 for flax fiber of approximately
$8 million
and for wood pulp of approximately
$5 million
. The Reconstituted Tobacco segment has minimum purchase agreements for tobacco stems of approximately
$2 million
in 2014. The Paper segment's PdM mill has a minimum annual commitment for calcium carbonate purchases, a raw material used in the manufacturing of some paper products, which totals approximately
$2 million
per year through 2024. Future purchases are expected to be at levels that exceed such minimum levels under these contracts.
The Company enters into certain other immaterial contracts from time to time for the purchase of certain raw materials. The Company also enters into certain contracts for the purchase of equipment and related costs in connection with its ongoing capital projects.
The Company has agreements with an energy cogeneration supplier in France whereby the supplier constructed and operates a cogeneration facility at certain mills and supplies steam that is used in the operation of these mills.The Company is committed to purchasing minimum annual amounts of steam generated by these facilities under the agreements through
2024
. These minimum annual commitments total approximately
$4 million
. The Company's current and expected requirements for steam at these facilities are at levels that exceed the minimum levels under the contracts.
The Paper segment's Brazilian mill, SWM-B, has an agreement for the transmission and distribution of energy that covers all of the mill's consumption of electrical energy valued at approximately
$4 million
annually through
2015
. The French mills have contracts for natural gas to be distributed to and consumed at PdM, LTRI and St. Girons. The value of the natural gas and distribution to be provided under these contracts is estimated at approximately
$24 million
in 2014.
The Company has certain other letters of credit, guarantees and surety bonds outstanding at December 31, 2013, which are not material either individually or in the aggregate.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Litigation
Imposto sobre Circulação de Mercadorias e Serviços,
or ICMS, a form of value-added tax in Brazil, was assessed to our Brazilian subsidiary Schweitzer-Mauduit do Brasil Indústria e Comércio de Papel Ltda. in December of 2000. SWM-B received
two
assessments from the tax authorities of the State of Rio de Janeiro for unpaid ICMS taxes on certain raw materials from January 1995 through November 2000, collectively the Raw Materials Assessment.
The Raw Materials Assessment concerned the accrual and use by SWM-B of ICMS tax credits generated from the production and sale of certain non-tobacco related grades of paper sold domestically that are immune from the tax to offset ICMS taxes otherwise owed on the sale of products that are not immune.
One
of the
two
assessments, or Assessment 1 (case number 2001.001.115144-5), related in part to tax periods that predated our acquisition of the Pirahy mill in Pirai, Brazil and is covered in part by an indemnification from the sellers of the Pirahy mill. The second assessment, or Assessment 2 (case number 2001.001.064544-6), pertains exclusively to periods that SWM-B owned the Pirahy mill. While SWM-B would be primarily responsible for the full payment of the Assessment in the event of an ultimate unfavorable outcome, SWM-B is not aware of any difficulties that would be encountered in obtaining reimbursement of that portion of any payment resulting from Assessment 1 from the previous owners of the Pirahy mill under the indemnification.
SWM-B has contested the Raw Materials Assessment based on Article 150, VI of the Brazilian Federal Constitution of 1988, which grants immunity from ICMS taxes to papers used in the production of books, newspapers and periodicals, or immune papers, and the raw material inputs used to produce immune papers.
Both Raw Materials Assessments are presently on appeal in separate chambers of the Federal Supreme Court of Brazil. SWM-B won a favorable ruling in both assessments at the first level, then lost Assessment 1 on appeal and won Assessment 2 on appeal. Assessment 1 is before the court on SWM-B’s appeal of a procedural question which, if decided favorably, would invalidate Assessment 1. If decided against SWM-B, the lower court would be notified to send the case records to the Federal Supreme Court for a decision on the merits. Assessment 2 is before the Federal Supreme Court of Brazil on the State’s appeal on the merits and will be finally decided by the action of the chamber of the court hearing the matter, unless there is a prior decision by a chamber of the Federal Supreme Court on Assessment 1 that is in contradiction, in which case the conflict between the rulings of the different chambers would be decided by the Federal Supreme Court sitting as a whole. No docket entry has been made yet regarding argument on either assessment. Based on the foreign currency exchange rate at
December 31, 2013
, the Raw Materials Assessment totaled approximately
$39 million
, of which approximately
$17 million
is covered by the above-discussed indemnification.
More recently, SWM-B has received assessments from the tax authorities of the State of Rio de Janeiro for unpaid ICMS and Fundo Estadual de Combate à Pobreza (FECP) taxes on interstate purchases of electricity. The state issued three assessments against SWM-B, one for May 2006 - November 2007, a second for January 2008 - December 2010, and in October 2013, a third assessment for September 2011 - September 2013, collectively the Electricity Assessment. SWM-B has challenged all three Electricity Assessments in administrative proceedings before the state tax council (Junta de Revisão Fiscal) based on Resolution 1.610/89, which defers these taxes on electricity purchased by an "electricity-intensive consumer."
SWM-B's challenges to the first two Electricity Assessments were unsuccessful at the first administrative level, but different appeals chambers of the Junta de Revisão Fiscal have reached different conclusions about the assessments. On the first electricity assessment, one chamber of the Junta de Revisão Fiscal recognized that SWM-B is an electricity-intensive consumer but denied applicability of the tax deferral resolution. The first assessment is now on appeal before the full council of the Junta de Revisão Fiscal. Court proceedings are possible if the full administrative council issues an adverse decision. On the second electricity assessment, SWM-B won a favorable ruling at the second administrative level, which recognized that SWM-B is an electricity-intensive consumer and agreed that the tax deferral resolution applies. SWM-B's challenge to the third electricity assessment is pending at the first administrative level. Based on the foreign currency exchange rate at December 31, 2013, the electricity assessments totaled approximately
$19 million
.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
SWM-B continues to vigorously contest the Raw Materials Assessment and the Electricity Assessment and believes that the assessments will ultimately be resolved in its favor. No liability has been recorded in our condensed consolidated financial statements for these assessments based on our evaluation of these matters under the facts and law as presently understood.
Environmental Matters
The Company's operations are subject to various nations' federal, state and local laws, regulations and ordinances relating to environmental matters. The nature of the Company's operations exposes it to the risk of claims with respect to various environmental matters, and there can be no assurance that material costs or liabilities will not be incurred in connection with such claims. While the Company has incurred in the past several years, and will continue to incur, capital and operating expenditures in order to comply with environmental laws and regulations, it believes that its future cost of compliance with environmental laws, regulations and ordinances, and its exposure to liability for environmental claims and its obligation to participate in the remediation and monitoring of certain hazardous waste disposal sites, will not have a material effect on its financial condition or results of operations. However, future events, such as changes in existing laws and regulations, or unknown contamination of sites owned, operated or used for waste disposal by the Company (including contamination caused by prior owners and operators of such sites or other waste generators) may give rise to additional costs which could have a material effect on its financial condition or results of operations.
The Company incurs spending necessary to meet legal requirements and otherwise relating to the protection of the environment at its facilities in the United States, France, Poland, Brazil, China and Canada. For these purposes, the Company incurred total capital expenditures of
$1.0 million
in 2013, and expects to incur approximately
$1 million
in 2014 and less than
$1.0 million
in 2015, of which no material amount is the result of environmental fines or settlements. The foregoing capital expenditures are not expected to reduce the Company's ability to invest in other appropriate and necessary capital projects and are not expected to have a material adverse effect on its financial condition or results of operations.
Indemnification Matters
In connection with its spin-off from Kimberly-Clark in 1995, the Company undertook to indemnify and hold Kimberly-Clark harmless from claims and liabilities related to the businesses transferred to it that were not identified as excluded liabilities in the related agreements. As of December 31, 2013, there are no claims pending under this indemnification that the Company deems to be material.
General Matters
In the ordinary course of conducting business activities, the Company and its subsidiaries become involved in certain other judicial, administrative and regulatory proceedings involving both private parties and governmental authorities. These proceedings include insured and uninsured regulatory, employment, general and commercial liability, environmental and other matters. At this time, the Company does not expect any of these proceedings to have a material effect on its reputation, business, financial condition, results of operations or cash flows. However, the Company can give no assurance that the results of any such proceedings will not materially affect its reputation, business, financial condition, results of operations or cash flows.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note
19
. Segment Information
The Company's
three
operating product line segments are also the Company's reportable segments: Paper, Reconstituted Tobacco and Filtration. The Paper segment primarily produces Cigarette Papers such as cigarette papers, including LIP papers, plug wrap papers and base tipping papers used to wrap various parts of a cigarette for sale to cigarette manufacturers. The Paper segment also includes commercial and industrial products such as lightweight printing and writing papers, battery separator paper, drinking straw wrap, filter paper and other specialized papers. These non-tobacco industry products are generally sold directly to converters and other end-users or brokers. The Reconstituted Tobacco segment produces reconstituted tobacco leaf, or RTL, and wrapper and binder products for sale to cigarette and cigar manufacturers. The Filtration segment primarily produces nonwoven materials which are critical components performing support, separation or filtration functions.
Information about Net Sales and Operating Profit
The accounting policies of these segments are the same as those described in Note
2
. Summary of Significant Accounting Policies. The Company primarily evaluates segment performance and allocates resources based on operating profit. Expense amounts not associated with segments are referred to as unallocated expenses. Certain of the Company's assets are used in the production of both the Paper and Reconstituted Tobacco segments' products. Due to these shared assets, management does not evaluate assets by segment. Capital spending and depreciation expense are allocated to a segment based on net sales or cost of products sold.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
($ in millions)
|
Net Sales
|
|
For the Years Ended December 31,
|
|
2013
|
|
2012
|
|
2011
|
Paper
|
$
|
543.4
|
|
|
70.3
|
%
|
|
$
|
545.0
|
|
|
70.0
|
%
|
|
$
|
551.4
|
|
|
69.9
|
%
|
Reconstituted Tobacco
|
225.2
|
|
|
29.1
|
|
|
233.5
|
|
|
30.0
|
|
|
236.9
|
|
|
30.1
|
|
Filtration
|
4.2
|
|
|
0.6
|
%
|
|
—
|
|
|
—
|
%
|
|
—
|
|
|
—
|
%
|
Total Consolidated
|
$
|
772.8
|
|
|
100.0
|
%
|
|
$
|
778.5
|
|
|
100.0
|
%
|
|
$
|
788.3
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
($ in millions)
|
Operating Profit
|
|
For the Years Ended December 31,
|
|
2013
|
|
2012
|
|
2011
|
Paper
|
$
|
102.5
|
|
|
82.1
|
%
|
|
$
|
84.4
|
|
|
55.7
|
%
|
|
$
|
54.8
|
|
|
43.8
|
%
|
Reconstituted Tobacco
|
46.4
|
|
|
37.1
|
|
|
90.3
|
|
|
59.5
|
|
|
90.3
|
|
|
72.2
|
|
Filtration
|
(1.1
|
)
|
|
(0.9
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Unallocated
|
(22.9
|
)
|
|
(18.3
|
)
|
|
(23.0
|
)
|
|
(15.2
|
)
|
|
(20.0
|
)
|
|
(16.0
|
)
|
Total Consolidated
|
$
|
124.9
|
|
|
100.0
|
%
|
|
$
|
151.7
|
|
|
100.0
|
%
|
|
$
|
125.1
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
Segment Assets
|
|
December 31, 2013
|
|
December 31, 2012
|
Paper
|
$
|
462.4
|
|
|
$
|
455.9
|
|
Reconstituted Tobacco
|
411.4
|
|
|
428.1
|
|
Filtration
|
283.9
|
|
|
—
|
|
Unallocated
|
66.7
|
|
|
2.7
|
|
Consolidated
|
$
|
1,224.4
|
|
|
$
|
886.7
|
|
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital Spending
|
Depreciation
|
|
2013
|
|
2012
|
|
2011
|
|
2013
|
|
2012
|
|
2011
|
Paper
|
$
|
19.8
|
|
|
$
|
19.8
|
|
|
$
|
26.6
|
|
|
$
|
20.0
|
|
|
$
|
20.0
|
|
|
$
|
23.5
|
|
Reconstituted Tobacco
|
8.6
|
|
|
7.4
|
|
|
34.3
|
|
|
10.5
|
|
|
10.0
|
|
|
10.2
|
|
Filtration
|
0.7
|
|
|
—
|
|
|
—
|
|
|
0.1
|
|
|
—
|
|
|
—
|
|
Unallocated
|
—
|
|
|
—
|
|
|
—
|
|
|
0.5
|
|
|
0.8
|
|
|
—
|
|
Consolidated
|
$
|
29.1
|
|
|
$
|
27.2
|
|
|
$
|
60.9
|
|
|
$
|
31.1
|
|
|
$
|
30.8
|
|
|
$
|
33.7
|
|
Information about Geographic Areas
Long-lived assets by geographic area, excluding deferred income tax assets and certain other deferred charges, as of year end were as follows ($ in millions):
|
|
|
|
|
|
|
|
|
|
Long-Lived Assets
|
|
2013
|
|
2012
|
United States
|
$
|
86.8
|
|
|
$
|
54.4
|
|
France
|
210.2
|
|
|
204.5
|
|
The Philippines
|
31.5
|
|
|
83.4
|
|
Brazil
|
35.1
|
|
|
43.1
|
|
Poland
|
32.8
|
|
|
27.4
|
|
Other foreign countries
|
3.6
|
|
|
—
|
|
For the geographic disclosure in the following table, net sales are attributed to geographic locations based on the location of the Company's direct customers ($ in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Sales
|
|
2013
|
|
2012
|
|
2011
|
Europe and the former Commonwealth of Independent States
|
$
|
343.0
|
|
|
$
|
349.4
|
|
|
$
|
367.4
|
|
United States
|
223.1
|
|
|
227.2
|
|
|
230.2
|
|
Asia/Pacific (including China)
|
113.6
|
|
|
107.4
|
|
|
90.3
|
|
Latin America
|
49.6
|
|
|
54.2
|
|
|
62.5
|
|
Other foreign countries
|
43.5
|
|
|
40.3
|
|
|
37.9
|
|
Consolidated
|
$
|
772.8
|
|
|
$
|
778.5
|
|
|
$
|
788.3
|
|
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 20. Major Customers
Philip Morris-USA, Philip Morris International, or PMI, British American Tobacco, or BAT, and Japan Tobacco Inc. together with their respective affiliates and designated converters, each accounted for 10% or more of the Company's consolidated net sales for each of the periods presented and together accounted for
57%
,
55%
and
54%
of the Company's 2013, 2012 and 2011 consolidated net sales, respectively. The loss of one or more such customers, or a significant reduction in one or more of these customers' purchases, could have a material adverse effect on the Company's results of operations.
Philip Morris-USA, PMI, BAT and Japan Tobacco Inc., together with their respective affiliates and designated converters accounted for
25%
and
31%
of consolidated accounts receivable at December 31, 2013 and 2012, respectively.
The Company performs ongoing credit evaluations on all of its customers' financial condition and generally does not require collateral or other security to support customer receivables. Substantial portions of the Company's consolidated accounts receivable are due from companies in the tobacco industry, which has been and continues to be under substantial pressure from legal, regulatory and tax developments. It is not possible to predict the outcome of such litigation or what effect adverse developments in pending or future litigation, regulatory actions and additional taxes may have on the tobacco industry, its financial liquidity or relationships with its suppliers. Nor is it possible to predict what additional legislation or regulations relating to tobacco products will be enacted, or to what extent, if any, such legislation or regulations might affect the tobacco products industry in general.
Note 21. Supplemental Disclosures
Analysis of Allowances for Doubtful Accounts:
($ in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
2013
|
|
2012
|
|
2011
|
Allowance for doubtful accounts
|
|
|
|
|
|
Beginning balance
|
$
|
0.7
|
|
|
$
|
0.7
|
|
|
$
|
0.7
|
|
Bad debt expense
|
—
|
|
|
0.1
|
|
|
0.1
|
|
Write-offs and discounts
|
(0.2
|
)
|
|
(0.1
|
)
|
|
—
|
|
Currency translation
|
(0.1
|
)
|
|
—
|
|
|
(0.1
|
)
|
Ending balance
|
$
|
0.4
|
|
|
$
|
0.7
|
|
|
$
|
0.7
|
|
Supplemental Cash Flow Information
($ in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
2013
|
|
2012
|
|
2011
|
Interest paid
|
$
|
2.5
|
|
|
$
|
2.6
|
|
|
$
|
3.9
|
|
Interest capitalized
|
—
|
|
|
—
|
|
|
1.5
|
|
Income taxes paid
|
69.8
|
|
|
33.7
|
|
|
40.0
|
|
|
|
|
|
|
|
|
At December 31,
|
|
2013
|
|
2012
|
|
2011
|
Capital spending in accounts payable and accrued liabilities
|
$
|
3.6
|
|
|
$
|
4.3
|
|
|
$
|
4.9
|
|
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 22. Quarterly Financial Information (Unaudited)
The following tables summarize the Company's unaudited quarterly financial data for the years ended December 31, 2013 and 2012 ($ in millions, except per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2013
|
|
First
Quarter
|
|
Second
Quarter
|
|
Third
Quarter
|
|
Fourth
Quarter
|
|
Year
|
Net Sales
|
$
|
194.5
|
|
|
$
|
196.5
|
|
|
$
|
185.3
|
|
|
$
|
196.5
|
|
|
$
|
772.8
|
|
Gross Profit
|
62.7
|
|
|
64.9
|
|
|
63.2
|
|
|
61.9
|
|
|
252.7
|
|
Restructuring and Impairment Expense
|
1.6
|
|
|
0.7
|
|
|
0.6
|
|
|
38.4
|
|
|
41.3
|
|
Operating Profit (loss)
|
41.7
|
|
|
42.1
|
|
|
41.8
|
|
|
(0.7
|
)
|
|
124.9
|
|
Income (loss) from continuing operations
|
30.7
|
|
|
29.4
|
|
|
29.6
|
|
|
(11.2
|
)
|
|
78.5
|
|
(Loss) income from discontinued operations
|
(0.6
|
)
|
|
(2.8
|
)
|
|
(0.5
|
)
|
|
1.5
|
|
|
(2.4
|
)
|
Net Income (loss)
|
$
|
30.1
|
|
|
$
|
26.6
|
|
|
$
|
29.1
|
|
|
$
|
(9.7
|
)
|
|
$
|
76.1
|
|
|
|
|
|
|
|
|
|
|
|
Net Income (Loss) Per Share:
|
|
|
|
|
|
|
|
|
|
Income (loss) per share from continuing operations - basic
|
$
|
0.98
|
|
|
$
|
0.94
|
|
|
$
|
0.94
|
|
|
$
|
(0.35
|
)
|
|
$
|
2.51
|
|
(Loss) income per share from discontinued operations - basic
|
$
|
(0.02
|
)
|
|
$
|
(0.09
|
)
|
|
$
|
(0.01
|
)
|
|
$
|
0.04
|
|
|
$
|
(0.08
|
)
|
Net Income (loss) per Share - Basic
|
$
|
0.96
|
|
|
$
|
0.85
|
|
|
$
|
0.93
|
|
|
$
|
(0.31
|
)
|
|
$
|
2.43
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) per share from continuing operations - diluted
|
$
|
0.98
|
|
|
$
|
0.93
|
|
|
$
|
0.93
|
|
|
$
|
(0.35
|
)
|
|
$
|
2.49
|
|
(Loss) income per share from discontinued operations - diluted
|
$
|
(0.02
|
)
|
|
$
|
(0.09
|
)
|
|
$
|
(0.01
|
)
|
|
$
|
0.05
|
|
|
$
|
(0.07
|
)
|
Net Income (loss) per Share - Diluted
|
$
|
0.96
|
|
|
$
|
0.84
|
|
|
$
|
0.92
|
|
|
$
|
(0.30
|
)
|
|
$
|
2.42
|
|
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2012
|
|
First
Quarter
|
|
Second
Quarter
|
|
Third
Quarter
|
|
Fourth
Quarter
|
|
Year
|
Net Sales
|
$
|
195.0
|
|
|
$
|
192.9
|
|
|
$
|
195.9
|
|
|
$
|
194.7
|
|
|
$
|
778.5
|
|
Gross Profit
|
64.3
|
|
|
63.6
|
|
|
66.3
|
|
|
65.3
|
|
|
259.5
|
|
Restructuring and Impairment Expense
|
18.7
|
|
|
5.3
|
|
|
(2.0
|
)
|
|
(0.6
|
)
|
|
21.4
|
|
Operating Profit
|
25.2
|
|
|
37.6
|
|
|
49.4
|
|
|
39.5
|
|
|
151.7
|
|
Income from continuing operations
|
17.1
|
|
|
23.5
|
|
|
33.7
|
|
|
29.8
|
|
|
104.1
|
|
Loss from discontinued operations
|
(2.5
|
)
|
|
(2.5
|
)
|
|
(6.0
|
)
|
|
(13.3
|
)
|
|
(24.3
|
)
|
Net Income
|
$
|
14.6
|
|
|
$
|
21.0
|
|
|
$
|
27.7
|
|
|
$
|
16.5
|
|
|
$
|
79.8
|
|
|
|
|
|
|
|
|
|
|
|
Net Income Per Share:
|
|
|
|
|
|
|
|
|
|
Income per share from continuing operations - basic
|
$
|
0.53
|
|
|
$
|
0.75
|
|
|
$
|
1.08
|
|
|
$
|
0.97
|
|
|
$
|
3.33
|
|
Loss per share from discontinued operations - basic
|
$
|
(0.08
|
)
|
|
$
|
(0.08
|
)
|
|
$
|
(0.19
|
)
|
|
$
|
(0.44
|
)
|
|
$
|
(0.79
|
)
|
Net Income per Share - Basic
|
$
|
0.45
|
|
|
$
|
0.67
|
|
|
$
|
0.89
|
|
|
$
|
0.53
|
|
|
$
|
2.54
|
|
|
|
|
|
|
|
|
|
|
|
Income per share from continuing operations - diluted
|
$
|
0.53
|
|
|
$
|
0.74
|
|
|
$
|
1.06
|
|
|
$
|
0.96
|
|
|
$
|
3.29
|
|
Loss per share from discontinued operations - diluted
|
$
|
(0.08
|
)
|
|
$
|
(0.08
|
)
|
|
$
|
(0.19
|
)
|
|
$
|
(0.43
|
)
|
|
$
|
(0.78
|
)
|
Net Income per Share - Diluted
|
$
|
0.45
|
|
|
$
|
0.66
|
|
|
$
|
0.87
|
|
|
$
|
0.53
|
|
|
$
|
2.51
|
|
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of
Schweitzer-Mauduit International, Inc. and Subsidiaries
Alpharetta, Georgia
We have audited the accompanying consolidated balance sheets of Schweitzer-Mauduit International, Inc. and subsidiaries (the "Company") as of December 31, 2013 and 2012, and the related consolidated statements of income, comprehensive income (loss), changes in stockholders' equity, and cash flows for each of the three years in the period ended December 31, 2013. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of Schweitzer-Mauduit International, Inc. and subsidiaries as of December 31, 2013 and 2012, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2013, in conformity with accounting principles generally accepted in the United States of America.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the Company's internal control over financial reporting as of December 31, 2013, based on the criteria established in
Internal Control - Integrated Framework
issued by the Committee of Sponsoring Organizations of the Treadway Commission (1992) and our report dated February 28, 2014 expressed an unqualified opinion on the Company's internal control over financial reporting.
/s/ Deloitte & Touche LLP
Atlanta, Georgia
February 28, 2014
Item 9.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
None.
Item 9A.
Controls and Procedures
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15(d)-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time frames specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosures.
An evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as of December 31, 2013, was made under the supervision and with the participation of our management including our principal executive officer and principal financial officer. Based upon this evaluation, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures were effective.
Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, is designed to provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.
Management's Annual Report on Internal Control Over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended). Our management assessed the effectiveness of our internal control over financial reporting as of December 31, 2013. In making this assessment, our management used the criteria set forth in
Internal Control - Integrated Framework
issued by the Committee of Sponsoring Organizations of the Treadway Commission (1992). Based on the Company's evaluation under the framework in
Internal Control - Integrated Framework,
our management has concluded that, as of December 31, 2013, our internal control over financial reporting is effective based on these criteria. As of December 31, 2013, we had no material weaknesses based on our tests using the criteria set forth in
Internal Control - Integrated Framework
issued by the Committee of Sponsoring Organizations of the Treadway Commission (1992). Our independent registered public accounting firm, Deloitte & Touche LLP, has issued an audit report on its assessment of our internal control over financial reporting, which is included herein.
The SEC’s general guidance permits the exclusion of an assessment of the effectiveness of a registrant’s controls and procedures as they relate to its internal control over financial reporting for an acquired business during the first year following such acquisition if, among other circumstances and factors, there is not an adequate amount of time between the acquisition date and the date of assessment. On December 12, 2013, we acquired DelStar, Inc. In accordance with the SEC guidance, the scope of our evaluation of internal controls over financial reporting as of December 31, 2013 did not include the internal control over financial reporting of these acquired operations. Assets acquired from DelStar represented 23.2% of our total consolidated assets at December 31, 2013 and net sales generated by DelStar subsequent to the date of acquisition represented 0.5% of our consolidated net sales for the year ended December 31, 2013. From the acquisition date to December 31, 2013, the processes and systems of DelStar's acquired operations did not significantly impact our internal control over financial reporting.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting during the quarter ended December 31, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Item 9B.
Other Information
Not applicable.
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of
Schweitzer-Mauduit International, Inc. and Subsidiaries
Alpharetta, Georgia
We have audited the internal control over financial reporting of Schweitzer-Mauduit International, Inc. and subsidiaries (the "Company") as December 31, 2013 based on criteria established in
Internal Control - Integrated Framework
issued by the Committee of Sponsoring Organizations of the Treadway Commission (1992). As described in Management’s Annual Report on Internal Control Over Financial Reporting, management excluded from its assessment the internal control over financial reporting at Delstar, Inc., which was acquired on December 12, 2013 and whose financial statements constitute 23.2% of total assets and 0.5% of net sales of the consolidated financial statement amounts as of and for the year ended December 31, 2013. Accordingly, our audit did not include the internal control over financial reporting at Delstar, Inc. The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit.
We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
A company's internal control over financial reporting is a process designed by, or under the supervision of, the company's principal executive and principal financial officers, or persons performing similar functions, and effected by the company's board of directors, management, and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.
Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future periods are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2013, based on the criteria established in
Internal Control - Integrated Framework
issued by the Committee of Sponsoring Organizations of the Treadway Commission (1992).
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated financial statements of Schweitzer-Mauduit International, Inc. and subsidiaries as of and for the year December 31, 2013 of the Company and our report dated February 28, 2014 expressed an unqualified opinion on those financial statements.
/s/ Deloitte & Touche LLP
Atlanta, Georgia
February 28, 2014
PART III.
Item 10.
Directors, Executive Officers and Corporate Governance
Certain information called for by this Item is hereby incorporated by reference to the sections of our 2014 Proxy Statement captioned "Proposal One - Election of Directors", "Corporate Governance" and "Section 16(a) Beneficial Ownership Reporting Compliance". Information with respect to our executive officers is set forth in Part I, Item 1 of this Form 10-K under the caption, “Executive Officers.”
Item 11.
Executive Compensation
The information in the section of the 2014 Proxy Statement captioned “Executive Compensation,” including the item captioned "Compensation Discussion and Analysis," is incorporated in this Item 11 by reference.
Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Securities Authorized for Issuance under Equity Compensation Plans
The following table provides information, as of December 31, 2013, with respect to the shares of our Common Stock that may be issued under our existing equity compensation plans:
|
|
|
|
|
Plan Category
|
|
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans
|
Equity compensation plans approved by stockholders:
|
|
|
Outside Directors Stock Plan
(1)
|
|
128,750
|
|
Restricted Stock Plan
(2)
|
|
974,893
|
|
Total approved by stockholders
|
|
1,103,643
|
|
Equity compensation plans not approved by stockholders:
|
|
—
|
|
Grand Total
|
|
1,103,643
|
|
(1) The Outside Directors Stock Plan consists of shares registered for the purpose of issuance to our outside Directors for payment of their retainer fees quarterly in advance. Director's retainer fees in 2013 consisted of $15,000 quarterly which are payable in our Common Stock and Board and committee meeting fees which may be paid in cash or our Common Stock at the Director's election. The number of shares issued each quarter is determined based on the then fair market value of the shares, which is determined in accordance with the plan at the closing price on the date one day prior to the date of distribution. Certain Directors have elected to defer receipt of quarterly retainer fees under the terms of our Deferred Compensation Plan for Non-Employee Directors, resulting in an accumulation of stock unit credits. The Director has the option, upon retirement or earlier termination from the Board of Directors, to have these stock unit credits distributed in the form of our Common Stock or cash. While held in the deferred compensation plan account, these stock unit credits carry no voting rights and cannot be traded as Common Stock, although declared dividends create additional stock unit credits. As of December 31, 2013, deferred retainer fees have resulted in 96,775 accumulated stock unit credits, excluding credited dividends (110,062 accumulated stock unit credits including credited dividends).
(2) The Restricted Stock Plan is described in Note
17
, Stockholders' Equity, of the Notes to Consolidated Financial Statements in Part II, Item 8 herein. Shares awarded under the terms of this plan are both subject to forfeiture and cannot be sold or otherwise transferred until fully vested or such restrictions are otherwise lifted. Such shares are deemed by us to be issued and outstanding and are subject to all other financial interests, including our declared dividends. As of December 31, 2013,
318,561
shares issued under this plan remained restricted.
The information in the section of the 2014 Proxy Statement captioned “Stock Ownership” is incorporated in this Item 12 by reference.
Item 13.
Certain Relationships and Related Transactions, and Director Independence
The information in the sections of the 2014 Proxy Statement captioned "Corporate Governance," including the items captions "Transactions with Related Persons" and "Director Independence" is incorporated in this Item 13 by reference.
Item 14.
Principal Accountant Fees and Services
The information in the section of the 2014 Proxy Statement captioned "Proposal Four - Ratification of the Selection of Independent Registered Accounting Firm" is incorporated in this Item 14 by reference.
PART IV.
Item 15.
Exhibits and Financial Statement Schedules
|
|
(a)
|
The consolidated financial statements and financial statement schedules filed as part of this report are listed in the Index to the Consolidated Financial Statements set forth in Part II, Item 8.
|
(b) The exhibits filed as part of this report are listed below:
|
|
|
|
Exhibit
Number
|
|
Exhibit
|
2.1
|
|
Agreement and Plan of Merger, dated as of November 18, 2013, by and among Schweitzer-Mauduit International, Inc., DelStar, Inc., SWM Acquisition Corp. I, SWM Acquisition Corp. II, certain security holders of DelStar, Inc. listed on the signature pages thereto and American Capital, Ltd. (incorporated by reference to Exhibit 2.1 to Form 8-K filed December 13, 2013).
|
3.1
|
|
Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to Form 10-Q for the quarter ended September 30, 2009).
|
3.2
|
|
By-Laws (incorporated by reference to Exhibit 3.2 to Form 10-Q for the quarter ended June 30, 2013).
|
4.1
|
|
Form of Common Stock Certificate (incorporated by reference to Exhibit 4.1 to Form 10-Q for the quarter ended September 30, 2000).
|
10.4
|
|
Outside Directors' Stock Plan (incorporated by reference to Exhibit 10.4 to Form 10-Q for the quarter ended September 30, 2009).
|
10.5
|
|
Annual Incentive Plan (incorporated by reference to Exhibit 10.24 to Form 10-Q for the quarter ended June 30, 2008).
|
10.6
|
|
Equity Participation Plan (incorporated by reference to Exhibit 10.6 to Form 10-K for the year ended December 31, 2000).
|
10.7
|
|
Long-Term Incentive Plan (incorporated by reference to Exhibit 10.7 to Form 10-K for the year ended December 31, 2008).
|
10.8.1
|
|
Deferred Compensation Plan (incorporated by reference to Exhibit 10.8.1 to Form 10-Q for the quarter ended March 31, 2000).
|
10.8.2
|
|
Deferred Compensation Plan for Non-Employee Directors (incorporated by reference to Exhibit 10.8.2 to Form 10-Q for the quarter ended March 31, 2000).
|
10.9
|
|
Restricted Stock Plan (incorporated by reference to Exhibit 10.9 to Form 10-K for the year ended December 2011).
|
10.10
|
|
Supplemental Benefit Plan (incorporated by reference to Exhibit 10.10 to Form 10-K for the year ended December 2008).
|
10.11.1
|
|
Executive Severance Plan (incorporated by reference to Exhibit 10.11 to Form 10-K for the year ended December 2008).
|
10.11.2
|
|
2012 Executive Severance Plan (incorporated by reference to Exhibit 10.11.2 to Form 10-K for the year ended December 2011).
|
10.11.3
|
|
2012 Executive Severance Plan Participation Agreement (incorporated by reference to Exhibit 10.11.3 to Form 10-K for the year ended December 2011).
|
10.12
|
|
Natural Gas Supply Agreement, dated October 5, 2006, by and among Papeteries de Mauduit S.A.S. and ENI S.p.A. (incorporated by reference to Exhibit 10.1 to Form 10-Q for the quarter ended September 30, 2006).
|
*10.13
|
|
Deferred Compensation Plan No. 2 for Non-Employee Directors.
|
*10.14
|
|
Deferred Compensation Plan No. 2.
|
|
|
|
|
Exhibit
Number
|
|
Exhibit
|
*10.15
|
|
Summary of Non-Management Director Compensation.**
|
*10.16
|
|
Summary of Executive Officer Compensation.**
|
10.17
|
|
Incentive Stock Option Agreement (incorporated by reference to Exhibit 10.19 to Form 10-K for the year ended December 31, 2004).
|
10.18
|
|
Nonqualified Stock Option Agreement (incorporated by reference to Exhibit 10.20 to Form 10-K for the year ended December 31, 2004).
|
10.19
|
|
Stock Option Agreement (incorporated by reference to Exhibit 10.21 to Form 10-K for the year ended December 31, 2004).
|
*10.20.1
|
|
Restricted Stock Agreement (Restricted Stock Plan - Cliff Vesting Shares).
|
*10.20.2
|
|
Restricted Stock Agreement (French Participants - Cliff Vesting).
|
*10.20.3
|
|
Restricted Stock Agreement (Restricted Stock Plan - Performance Share Award).
|
*10.20.4
|
|
Restricted Stock Agreement (French Participants - Performance Shares).
|
10.21
|
|
Amended and Restated Credit Agreement, dated as of December 11, 2013, with JPMorgan Chase Bank, N.A., as administrative agent, the lenders party thereto, J.P. Morgan Securities LLC, Fifth Third Bank, Merrill Lynch, Pierce, Fenner & Smith Incorporated and SunTrust Robinson Humphrey, Inc. (incorporated by reference to Exhibit 10.1 to Form 8-K filed on December 13, 2013).
|
14.1
|
|
Code of Conduct (incorporated by reference to Exhibit 14.1 to Form 10-Q for the quarter ended September 30, 2009).
|
*21
|
|
Subsidiaries of the Company.
|
*23
|
|
Consent of Independent Registered Public Accounting Firm.
|
*24
|
|
Powers of Attorney.
|
*31.1
|
|
Certification of the Chief Executive Officer pursuant to Rule 13a-14(a)/15(d)-14(a) of the Securities Exchange Act of 1934, as amended.
|
*31.2
|
|
Certification of the Chief Financial Officer pursuant to Rule 13a-14(a)/15(d)-14(a) of the Securities Exchange Act of 1934, as amended.
|
*32
|
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. ‡
|
99.2
|
|
Indemnification Agreement (incorporated by reference by Exhibit 99.1 to Form 10-Q for the quarter ended September 30, 2009).
|
101
|
|
The following materials from the Company's Annual Report on Form 10-K for the year ended December 31, 2013, formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Statements of Income, (ii) the Consolidated Statements of Comprehensive Income (Loss), (iii) the Consolidated Balance Sheets, (iv) the Consolidated Statements of Changes in Stockholders' Equity, (v) the Consolidated Statements of Cash Flow, and (vi) Notes to Consolidated Financial Statements (furnished herewith).
|
|
|
**
|
Management contract or compensation plan or arrangement required to be filed as an exhibit pursuant to Item 15(b) of Form 10-K
|
|
|
‡
|
These Section 906 certifications are not being incorporated by reference into the Form 10-K filing or otherwise deemed to be filed with the SEC.
|
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
Schweitzer-Mauduit International, Inc.
|
|
|
By:
|
|
Dated:
|
February 28, 2014
|
|
/s/ Frédéric P. Villoutreix
|
|
|
|
Frédéric P. Villoutreix
|
|
|
|
Chairman of the Board and
|
|
|
|
Chief Executive Officer
|
|
|
|
(principal executive officer)
|
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
|
|
|
|
|
|
Name
|
|
Position
|
|
Date
|
|
|
|
|
|
/s/ Frédéric P. Villoutreix
|
|
Chairman of the Board and
|
|
February 28, 2014
|
Frédéric P. Villoutreix
|
|
Chief Executive Officer (principal executive officer)
|
|
|
|
|
|
|
|
/s/ Jeffrey A. Cook
|
|
Executive Vice President, Chief Financial Officer
|
|
February 28, 2014
|
Jeffrey A. Cook
|
|
and Treasurer (principal financial officer)
|
|
|
|
|
|
|
|
/s/ Robert Cardin
|
|
Corporate Controller
|
|
February 28, 2014
|
Robert Cardin
|
|
(principal accounting officer)
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
February 28, 2014
|
Claire L. Arnold
|
|
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
February 28, 2014
|
K.C. Caldabaugh
|
|
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
February 28, 2014
|
William A. Finn
|
|
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
February 28, 2014
|
Robert F. McCullough
|
|
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
February 28, 2014
|
John D. Rogers
|
|
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
February 28, 2014
|
Anderson D. Warlick
|
|
|
|
|
|
|
|
|
|
*By:
|
|
|
|
|
|
|
|
|
|
/s/ Greerson McMullen
|
|
|
|
February 28, 2014
|
Greerson McMullen
|
|
|
|
|
Attorney-In-Fact
|
|
|
|
|
GLOSSARY OF TERMS
The following are definitions of certain terms used in this Form 10-K filing:
|
|
•
|
“
Banded cigarette paper
” is a type of paper, used to produce lower ignition propensity cigarettes, by applying bands to the paper during the papermaking process.
|
|
|
•
|
“
Binder
” is used to hold the tobacco leaves in a cylindrical shape during the production process of cigars.
|
|
|
•
|
“
Cigarette paper
” wraps the column of tobacco within a cigarette and has varying properties such as basis weight, porosity, opacity, tensile strength, texture and burn rate.
|
|
|
•
|
“
Flax
” is a cellulose fiber from a flax plant used as a raw material in the production of certain cigarette papers.
|
|
|
•
|
“
Lower ignition propensity cigarette paper
” includes banded and print banded cigarette paper, both of which contain bands, which increase the likelihood that an unattended cigarette will self-extinguish.
|
|
|
•
|
“
Net debt to EBITDA ratio
” is a financial measurement used in bank covenants where "
Net Debt
" is defined as consolidated total debt minus unrestricted cash and cash equivalents in excess of $15 million, and “
EBITDA
” is defined as net income plus the sum of interest expense, income tax expense, depreciation and amortization, non-cash restructuring and impairment charges less amortization of deferred revenue and interest in the earnings of equity affiliates to the extent such earnings are not distributed to the Company.
|
|
|
•
|
“Total debt to capital ratio”
is total debt divided by the sum of total debt and total stockholders’ equity.
|
|
|
•
|
“
Net debt to equity ratio
” is total debt less cash and cash equivalents, divided by stockholders’ equity.
|
|
|
•
|
“Net operating working capital”
is accounts receivable, inventory, income taxes receivable and prepaid expense, less accounts payable, accrued expenses and income taxes payable.
|
|
|
•
|
“Opacity”
is a measure of the extent to which light is allowed to pass through a given material.
|
|
|
•
|
“Operating profit return on assets”
is operating profit divided by average total assets.
|
|
|
•
|
“
Plug wrap paper
” wraps the outer layer of a cigarette filter and is used to hold the filter materials in a cylindrical form.
|
|
|
•
|
“
Print banded cigarette paper
” is a type of paper, used to produce lower ignition propensity cigarettes, with bands added to the paper during a printing process, subsequent to the papermaking process.
|
|
|
•
|
“
Reconstituted tobacco
” is produced in two forms: leaf, or reconstituted tobacco leaf, and wrapper and binder products. Reconstituted tobacco leaf is blended with virgin tobacco as a design aid to achieve certain attributes of finished cigarettes. Wrapper and binder are reconstituted tobacco products used by manufacturers of cigars.
|
|
|
•
|
“
Restructuring expense
” represents expenses incurred in connection with activities intended to significantly change the size or nature of the business operations, including significantly reduced utilization of operating equipment, exit of a product or market or a significant workforce reduction and charges to reduce property, plant and equipment to its fair value.
|
|
|
•
|
“
Start-up costs
” are costs incurred prior to generation of income producing activities in the case of a new plant, or costs incurred in excess of expected ongoing normal costs in the case of a new or rebuilt machine. Start-up costs can include excess variable costs such as raw materials, utilities and labor and unabsorbed fixed costs.
|
|
|
•
|
“
Tipping paper
” joins the filter element to the tobacco-filled column of the cigarette and is both printable and glueable at high speeds.
|
|
|
•
|
“
Wrapper
” covers the outside of cigars providing a uniform, finished appearance.
|
SCHWEITZER-MAUDUIT INTERNATIONAL, INC.
DEFERRED COMPENSATION PLAN NO. 2
FOR NON-EMPLOYEE DIRECTORS
Amended and Restated as of January 1, 2014
Article I -
Purpose and Participation
The purpose of the Schweitzer-Mauduit International, Inc. Deferred Compensation Plan No. 2 for Non-Employee Directors ("Plan") is to enhance the ability of Schweitzer-Mauduit International, Inc. ("SWM") to attract and retain as members of its Board of Directors ("Board") individuals of outstanding competence.
Article II -
Definitions
As used within this document, the following words and phrases have the meanings described in this Article II unless a different meaning is required by the context. Some of the words and phrases used in the Plan are not defined in this Article II, but for convenience, are defined as they are introduced into the text. Words in the masculine gender shall be deemed to include the feminine gender. Any headings used are included for ease of reference only, and are not to be construed so as to alter any of the terms of the Plan.
Section 2.1
Annual Deferral
. The amount of the Annual Retainer which the Director elects to defer with respect to each Deferral Period pursuant to Section 3.2 of the Plan.
Section 2.2
Annual Retainer
. The amount of any compensation paid to the Director for service on the Board of Directors or on any standing committee of the Board of Directors, which is delivered in the form of an annual retainer paid pro-rata quarterly.
Section 2.3
Beneficiary
. The individual(s) or entity or entities designated by the Participant in accordance with Section 8.11 to receive the Participant’s benefits payable under the Plan after the Participant’s death.
Section 2.4
Board or Board of Directors
. The Board of Directors of SWM.
Section 2.5
Change of Control.
The earliest of the following events, except as otherwise set forth below:
|
|
(i)
|
when any one Person, or more than one Person acting as a group, acquires ownership of SWM that, together with stock or other ownership interests held by such Person or group, constitutes more than fifty percent (50%) of the total fair market value or total voting power of the stock or ownership interests of SWM, provided, that if any one Person or more than one Person acting as a group is considered to own more than fifty percent (50%) of the total fair market value or total voting power of SWM, the acquisition of additional stock or ownership interests by the same Person or group will not be considered to cause a Change in Control;
|
|
|
(ii)
|
when any one Person, or more than one Person acting as a group, acquires (or has acquired during the twelve (12)-month period ending on the date of the most recent acquisition by such Person or group) ownership of thirty percent (30%) or more of the total voting power of the stock or ownership interests of SWM, provided, that if any one Person or more than one Person acting as a group acquires (or has acquired during the twelve (12)-month period ending on the date of the most acquisition by such Person or group) thirty percent (30%) or more of the total voting power of SWM, the acquisition of additional voting power by the same Person or group will not be considered to cause a Change in Control;
|
|
|
(iii)
|
when any one Person, or more than one Person acting as a group, acquires (or has acquired during the twelve (12)-month period ending on the date of the most recent acquisition by such Person or group) assets from SWM that have a total gross fair market value (determined without regard to any liabilities associated with such assets) equal to or more than forty percent (40%) of the total gross fair market value of all of the assets of SWM (determined without regard to any liabilities associated with such assets) immediately prior to such acquisition or acquisitions, without regard to assets transferred to: (a) a shareholder or owner of SWM (immediately before the asset transfer) in exchange for or with respect to its stock, (b) an entity, fifty percent (50%) or more of the total value or voting power of which is owned, directly or indirectly, by SWM, (c) a Person, or more than one Person acting as a group, that owns, directly or indirectly, fifty percent (50%) or more of the total value or voting power of SWM or (d) an entity, at least fifty percent (50%) of the total value or voting power of which is owned, directly or indirectly, by a Person, or more than one Person acting as a group, that owns, directly or indirectly, fifty percent (50%) or more of the total value or voting power of SWM; or
|
|
|
(iv)
|
when a majority of the members of the Board of Directors of SWM is replaced during any twelve (12)-month period by directors whose appointment or election is not endorsed by a majority of the members of the Board of Directors of SWM prior to the date of their appointment or election.
|
For purposes of this Plan, Persons will not be considered to be acting as a group solely because they purchase or own stock or an ownership interest at the same time or as a result of the same public offering. However, Persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction. If a Change in Control occurs on account of a series of transactions, the Change in Control is considered to occur on the date of the last of such transactions. The term “Person” means any corporation, individual, partnership, limited liability company, joint venture, incorporated or unincorporated association, joint-stock company, trust, unincorporated organization or government or other agency or political subdivision thereof or any other entity of any kind. For purposes of the definition of a Change in Control, Section 318(a) of the Code applies to determine ownership interest and stock ownership. Ownership interest and stock ownership underlying a vested option is considered owned by the Person that holds the vested option (and the ownership interest and stock ownership underlying an unvested option is not considered owned by the Person who holds the unvested option). For purposes of the preceding sentence, however, if a vested option is exercisable for stock that is not substantially vested (as defined by Treasury Regulation Section 1.83-3(b) and (j)), the stock ownership underlying the vested option is not treated as owned by the Person that holds the vested option.
For purposes of the Plan, Change in Control shall be interpreted consistent with the requirements of Section 409A of the Code.
Section 2.6
Code
. The Internal Revenue Code of 1986, as amended. Reference to a section of the Code shall include that section and any comparable section or sections of any future legislation that amends, supplements or supersedes such section.
Section 2.7
Committee
. The Compensation Committee of SWM's Board of Directors.
Section 2.8
Deferral Accounts
. The Stock Unit Measurement Account and/or the Investment Measurement Account established for each Director participating in this Plan pursuant to Sections 4.2 and 4.3, respectively, for each Plan Year with respect to which the Director has made a Deferral Election.
Section 2.9
Deferral Election
. The written election to defer the Director’s Annual Retainer made by the Director in accordance with Section 3.2 of the Plan. Such written election shall be in the format designated by SWM.
Section 2.10
Deferral Period
. The Plan Year for which a Deferral Election is made, or in the case of a new Director elected during a Plan Year, the portion of the Plan Year in which the new Director is elected for which a Deferral Election is made remaining after the effective date of the Director’s Deferral Election.
Section 2.11
Effective Date
. January 1, 2014.
Section 2.12
Fair Market Value
. Shall have the meaning given to such term in Section 4.2.
Section 2.13
IRS
. The Internal Revenue Service.
Section 2.14
Plan
. The Schweitzer-Mauduit International, Inc. Deferred Compensation Plan No. 2 for Non-Employee Directors.
Section 2.15
Plan Administrator
. The SWM Board of Directors or a committee thereof as appointed by the Board from time to time to administer the Plan.
Section 2.16
Plan Year
. The 12-month period beginning each January 1 and ending on the following December 31.
Section 2.17
Rabbi Trust
. The trust which SWM, as grantor, may establish, in its discretion in accordance with Article VII of the Plan, as a trust intended to qualify under subpart E, part I, Subchapter J, chapter 1, Subtitle A of the Code as a grantor trust for the Plan, as amended from time to time.
Section 2.18
Separation from Service
. Means termination of the Participant’s service on the Board that constitutes a “Separation from Service” within the meaning of Section 409A of the Code.
Section 2.19
SWM
. Schweitzer-Mauduit International, Inc.
Section 2.20
Valuation Date
. Each business day of the Plan Year.
Article III -
Eligibility and Participation
Section 3.1
Deferral Election
. Non-employee members of the Board ("Directors") may elect to defer receipt of all or any portion of the Director's earned Annual Retainer for the Plan Year into a Stock Unit Measurement Account (the "Stock Unit Measurement Account") and/or an Investment Measurement Account (the "Investment Measurement Account"). One-quarter of the Director's Annual Retainer shall be deemed earned on the first business day of each calendar quarter.
Section 3.2
Timing of Election
. The Director must submit a Deferral Election to SWM’s Vice President-Human Resources or his or her designee by December 31 of each year indicating the Annual Retainer to be deferred for the following Plan Year.
Section 3.3
Mid-Plan Year Election
. If any individual initially becomes a Director during a Plan Year, he may elect, within the first 30 days of being elected to the Board, to defer the portion of the Director's Annual Retainer to be earned for the remaining calendar quarters of the Plan Year beginning after the effective date of the Director’s Deferral Election.
Section 3.4
Evergreen
. Notwithstanding the foregoing, once made, a Deferral Election shall remain in effect for each succeeding Plan Year, in accordance with the terms of the Deferral Election, unless and until the Director either makes a new Deferral Election for such succeeding Plan Year or specifically cancels the Deferral Election for such succeeding Plan Year, in either case by December 31 of the year immediately prior to the Plan Year for which the new Deferral Election or cancellation is to be effective.
Article IV -
Deferred Compensation Accounts
Section 4.1
Accounts
. For record-keeping purposes only, SWM shall maintain a Stock Unit Measurement Account and/or an Investment Measurement Account for each Plan Year with respect to which the Director has made a Deferral Election.
Section 4.2
Stock Unit Measurement Account
. The Stock Unit Measurement Account shall consist of fictional shares ("Stock Units") of SWM common stock, par value of $0.10 per share ("Common Stock"), into which the Director’s deferred Annual Retainer is deemed to be invested for the sole purpose of determining the amount of the payment upon any distribution of benefits from the Director’s Stock Unit Measurement Account.
Section 4.2.1
For purposes of determining the number of whole or fractional shares of Common Stock which shall be credited to the Director’s Stock Unit Measurement Account, the hypothetical purchase of shares of Common Stock shall be deemed to be made at Fair Market Value on the date the related Annual Retainer (to be deferred into the Stock Unit Measurement Account) otherwise would have been paid to the Director. For purposes of Section 4.2, Fair Market Value means the closing price of the Common Stock, as reported on the New York Stock Exchange composite tape, on the day immediately preceding the applicable date, or if no such trading in the Common Stock shall have taken place on that day, on the last preceding day on which there was such trading in the Common Stock.
Section 4.2.2
The equivalent of any cash dividends paid with respect to any Common Stock equivalents deemed held in the Director’s Stock Unit Measurement Account shall be applied as of the date on which such dividends are paid, based on the hypothetical number of shares of Common Stock in the Stock Unit Measurement Account as of the record date for such dividend, to the hypothetical purchase of additional whole or fractional shares of Common Stock at Fair Market Value on such payment date. The appropriate number of whole or fractional shares shall be credited to the Director’s Stock Unit Measurement Account.
Section 4.2.3
Any distribution of benefits from the Stock Unit Measurement Account shall be charged to that account as of the date such payment is made by SWM or by the trustee of any Rabbi Trust established by SWM for the Plan.
Section 4.2.4
In the event SWM pays a stock dividend or reclassifies or divides or combines its outstanding Common Stock, then an appropriate adjustment shall be made in the hypothetical number of shares of Common Stock held in the Director’s Stock Unit Measurement Account.
Section 4.3
Investment Measurement Account
. As of the date the related Annual Retainer otherwise would have been paid to the Director, SWM shall credit to the Director’s Investment Measurement Account the amount of such Annual Retainer (to be deferred into the Investment Measurement Account) that was deferred by the Director pursuant to the Deferral Election submitted for the applicable Plan Year.
Section 4.3.1
Any distribution of benefits from an Investment Measurement Account shall be charged to that account as of the date such payment is made by SWM or by the trustee of any Rabbi Trust established by SWM for the Plan.
Section 4.4
Earnings and Losses on the Investment Measurement Account
. The Investment Measurement Account balance shall be credited or debited, as the case may be, as of each Valuation Date with deemed net income, gain and loss, including any deemed net unrealized gain and loss, based on hypothetical investment directions made by the Participant with respect to the Investment Measurement Account on a form designated by the Plan Administrator, in accordance with investment options and procedures adopted by the Plan Administrator in its sole discretion from time to time.
Section 4.5
Hypothetical Nature of Accounts
. With respect to each participating Director, the Plan constitutes an unsecured promise by SWM to make the benefit distributions in the future in cash in the sum of the amount credited to the Director’s Investment Measurement Account, after adjustment for gains or losses, and the Fair Market Value of the shares of Common Stock credited to the Director’s Stock Unit Measurement Account. The Plan Administrator may set the Valuation Date through which the Director’s Stock Unit Measurement Account and/or Investment Measurement Account may be determined for purposes of determining the amount of any distribution from the Plan, which Valuation Date may not be more than thirty (30) days prior to the time of the distribution, and no earnings or losses (or unrealized gains or losses) need to accrue after such date. Any Deferral Account established for a Director under this Plan shall be hypothetical in nature and shall be maintained solely for SWM's record-keeping purposes so that any contributions can be credited and deemed investment earnings and losses (or unrealized gains or losses) on such amounts can be credited (or debited, as the case may be). Neither the Plan, the Investment Measurement Accounts (nor subaccounts) nor the Stock Unit Measurement Accounts (nor subaccounts) shall hold any actual funds or assets.
Section 4.5.1
The right of any individual or entity to receive one or more payments of cash under the Plan shall be an unsecured claim against the general assets of SWM. Any liability of SWM to any Director or Beneficiary with respect to a right to payment shall be based solely upon contractual obligations, if any, created by the Plan. SWM, the Board of Directors, the Committee, the Plan Administrator and any individual or entity shall not be deemed to be a trustee of any amounts to be paid under the Plan. Nothing contained in the Plan, and no action taken pursuant to its provisions, shall create or be construed to create a trust of any kind, or a fiduciary relationship, between SWM and a Director, Beneficiary, or any other individual or entity.
Section 4.5.2
SWM may, in its sole discretion, establish a Rabbi Trust as a vehicle in which to place funds with respect to this Plan. If established, all benefits payable under this Plan to a Director shall be paid directly by SWM from the Rabbi Trust. To the extent that such benefits are not paid from the Rabbi Trust, the benefits shall be paid from the general assets of SWM and shall be reimbursed to SWM by the Rabbi Trust at SWM's request upon presentation of reasonable proof that SWM made such payment. The assets of the Rabbi Trust shall be subject to the claims of the Company's creditors in the event of its insolvency. Except as to any amounts paid or payable to a Rabbi Trust, the Company shall not be obligated to set aside, earmark or place in escrow any funds or other assets to satisfy its obligations under this Plan, and the Directors shall not have any property interest in any specific assets of SWM other than the unsecured contractual right, if any, to receive payments from SWM as provided in this Plan.
Section 4.5.3
SWM does not in any way guarantee any Director's Investment Measurement Account or Stock Unit Measurement Account against loss or depreciation, whether caused by poor deemed investment performance, insolvency of a deemed investment or by any other event or occurrence. In no event shall any employee, officer, director, or stockholder of SWM be liable to any individual or entity on account of any claim arising by reason of the Plan provisions or any instrument or instruments implementing its provisions, or for the failure of any Director, Beneficiary or other individual or entity to be entitled to any particular tax consequences with respect to the Plan or any credit or payment of benefits thereunder.
Section 4.6
No Transfers Between Accounts
. Deferrals into the Investment Measurement Account may be deemed invested in different funds and transferred between fund options within the Investment Measurement Account pursuant to the procedures established from time to time by the Plan Administrator. All deferrals into the Stock Unit Measurement Account shall be deemed invested in SWM Common Stock. Balances in the Investment Measurement Account and the Stock Unit Measurement Account may not be transferred from one account to the other account, provided, however, that balances in the Stock Unit Measurement Account may be transferred from the Stock Unit Measurement Account to the Investment Measurement Account once the individual is no longer a Director of SWM.
Article V -
Benefits
Section 5.1
Pre-Termination Survivor Benefit
. If the Director dies before becoming entitled to benefits under this Article or Article VI, the Director’s Beneficiary or Beneficiaries designated pursuant to Section 8.10 shall be entitled to receive payment in the amount equal to the sum of the amount credited to the Director’s Investment Measurement Account and the Fair Market Value of the number of shares of Common Stock credited to the Director's Stock Unit Measurement Account, as of the date the Director dies. Distribution of any benefits under this Section 5.1 shall be made in a single lump sum in cash within thirty (30) days after the date of the Director's death;
provided
,
however
, that in all cases the Beneficiary or Beneficiaries shall not have the right to designate the year of payment.
Section 5.2
Post-Termination Survivor Benefit
. If a Director dies after benefits have commenced under this Article or Article VI, but prior to receiving complete payment of benefits under this Plan, the Director’s Beneficiary or Beneficiaries designated under Section 8.10 shall be entitled to receive payment in the amount equal to the sum of the amount credited to the Director’s Investment Measurement Account and the Fair Market Value of the number of shares of Common Stock credited to the Director's Stock Unit Measurement Account, as of the date the Director dies. Distribution of any benefits under this Section 5.2 shall be made in a single lump sum in cash within thirty (30) days after the date of the Director's death;
provided
,
however
, that in all cases the Beneficiary or Beneficiaries shall not have the right to designate the year of payment.
Section 5.3
Change of Control
. If a Change of Control occurs before a Director becomes entitled to receive benefits under this Article or Article VI or before the Director has received complete payment of his benefits under this Plan, he shall be entitled to receive payment in the amount equal to the sum of the amount credited to the Director’s Investment Measurement Account and the Fair Market Value of the shares of Common Stock credited to his Stock Unit Measurement Account as of the date the Change of Control occurs. Distribution of any benefits under this Section 5.3 shall be made in a single lump sum in cash within thirty (30) days after the date of the Change in Control;
provided
,
however
, that in all cases the Director shall not have the right to designate the year of payment.
Article VI -
Benefit Distributions
Section 6.1
No In-Service Distributions
. Distributions from either the Stock Unit Measurement Account or the Investment Measurement Account shall not be allowed under this Article VI while the individual remains a Director of SWM.
Section 6.2
Deferral Election Requirements
. At the time of filing of a Deferral Election, the Director must indicate an election to receive distribution of: (1) the entire amount credited to the Director’s Investment Measurement Account and the Fair Market Value of all shares of Common Stock credited to the Director’s Stock Unit Measurement Account in a lump sum immediately following the end of the month in which the Director experiences a Separation from Service with SWM, (2) the entire amount credited to the Director’s Investment Measurement Account and the Fair Market Value of all shares of Common Stock credited to the Director’s Stock Unit Measurement Account in a lump sum in the January immediately following the end of the month in which the Director experiences a Separation from Service with SWM, or (3) the entire amount credited to the Director’s Investment Measurement Account and the Fair Market Value of all shares of Common Stock credited to the Director’s Stock Unit Measurement Account in three (3), five (5) or ten (10) annual installments with the initial distribution to commence in the January immediately following the end of the month in which the Director experiences a Separation from Service with SWM. If no distribution election is made by the Director for the Plan Year or no election form is in effect at the time the Director experiences a Separation from Service, the entire amount credited to the Director’s Investment Measurement Account and the Fair Market Value of all shares of Common Stock credited to the Director's Stock Unit Measurement Account will be distributed in installments over five (5) years beginning
in the January immediately following the end of the month in which the Director experiences a Separation from Service with SWM. Annual installments shall be calculated each year by dividing the remaining Investment Measurement Account balance and the number of shares of Common Stock credited in the Stock Unit Measurement Account as of January 1st of the year in which the distribution is to be made by the remaining number of installments. All amounts shall be paid in cash.
Any Deferral Election may be amended provided that all of the following requirements are met:
|
|
(i)
|
the amendment of the Deferral Election shall not take effect until at least 12 months after the date on which such amendment is made;
|
|
|
(ii)
|
in the case of an amendment of a Deferral Election related to a payment not made on account of the Participant's death or Disability, the first payment with respect to which the amendment is made shall in all cases be deferred for a period of not less than 5 years from the date on which such payment otherwise would have been made; and
|
|
|
(iii)
|
in the case of an amendment of an election related to a payment that is to be made at a specified time or pursuant to a fixed schedule, such an amendment of the election must be made at least 12 months prior to the date of the first scheduled payment.
|
Section 6.3
Distributions to Beneficiary
. If the Director or former Director dies before all payments have been made, distribution(s) shall be made to the Director’s Beneficiary or Beneficiaries.
Article VII -
Establishment of Trust
Section 7.1
Establishment of Trust
. SWM may establish a Rabbi Trust ("Trust") for the Plan. If established, all benefits payable under this Plan to a Director shall be paid directly by SWM from the Trust. To the extent that such benefits are not paid from the Trust, the benefits shall be paid from the general assets of SWM and shall be reimbursed to SWM by the Trust at SWM's request upon presentation of reasonable proof that SWM made such payment. Any such Trust shall be an irrevocable grantor trust which is intended to qualify as such under subpart E, part I, Subchapter J, chapter 1, Subtitle A of the Code. The assets of the Rabbi Trust shall be subject to the claims of SWM's creditors in the event of its insolvency. Except as to any amounts paid or payable to a Trust, SWM shall not be obligated to set aside, earmark or escrow any funds or other assets to satisfy its obligations under this Plan, and the Director and/or his designated Beneficiaries shall not have any property interest in any specific assets of SWM other than the unsecured contractual right, if any, to receive payments from SWM as provided in this Plan.
Section 7.2
Distribution of Benefits from the Trust
. In the event a Trust is established and benefit distributions are not made by SWM in accordance with the terms of the Plan, a Director may petition the trustee of the Trust directly for distribution of benefits and the trustee may make such distributions directly to the Director upon the trustee's good faith determination that the benefit distribution was in fact owed to the Director under the terms of the Plan, was not timely made by SWM and that there are sufficient assets in the Trust to make the distribution.
Article VIII -
Miscellaneous
Section 8.1
Unfunded Plan
. Benefits provided under this Plan are unfunded obligations of SWM. Nothing contained in this Plan shall require SWM to segregate any monies or other assets from its general funds or assets with respect to such obligations. This Plan is not an "employee benefit plan" as defined in Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended, and is not intended for the benefit of any common law employee of SWM.
Section 8.2
Plan Administrator
. The Board shall be the plan administrator of this Plan and shall be solely responsible for its general administration and interpretation and for carrying out the provisions hereof, and shall have all such powers as may be necessary to do so. The Board shall have the right to delegate from time to time the administration of the Plan, in whole or in part, to any committee of the Board. The decisions made, and the actions taken, by the Board or any committee thereof in the administration of the Plan shall be final and conclusive on all persons, and no member of the Board or any committee thereof shall be subject to individual liability with respect to the Plan.
Section 8.3
Anti-Alienation Clause
. Neither the Director nor any beneficiary nor any next-of-kin shall have the right to assign or otherwise alienate the right to receive payments hereunder, in whole or in part, which payments are expressly non-assignable and non-transferable, whether voluntarily or involuntarily. Any attempt to alienate, sell, transfer, assign, pledge or otherwise encumber any such amount, whether presently or thereafter payable, shall be void. Except as required by law, no benefit payable under this Plan shall in any manner be subject to garnishment, attachment, execution or other legal process, or be liable for or subject to the debts or liability of any Director.
Section 8.4
Tax Withholdings
. SWM shall withhold from amounts paid under this Plan any taxes or other amounts required to be withheld by any applicable federal, state, local or foreign income tax law. SWM shall comply with all governmental reporting requirements applicable to the Plan or any payment pursuant to the Plan.
Section 8.5
Amendments
. The Board, may at any time, amend the Plan for whatever reasons it may deem appropriate. No amendment shall impair the rights of a participant with respect to vested amounts then in the participant's account without the written consent of the affected Directors. All references to action by the Directors shall mean a vote of a majority of the total number of Directors authorized by the Board unless such action may potentially result in the loss of deferred tax treatment of the plan benefits, in which case the unanimous vote of the Board shall be required.
Section 8.6
Quarterly Statements
. Each Director in the Plan will receive a quarterly statement indicating the dollar amount credited to the Director’s Investment Measurement Account and the number of shares of Common Stock credited to the Director’s Stock Unit Measurement Account as of the end of the preceding calendar quarter.
Section 8.7
Good Faith Distribution of Benefits
. Any distribution of benefits made in good faith in accordance with provisions of the Plan shall be a complete discharge of any liability for the making of such payment under the provisions of this Plan.
Section 8.8
Binding Effect
. The provisions of this Plan shall be binding upon SWM and its successors and assigns and upon every Director and his heirs, Beneficiaries, estates and legal representatives.
Section 8.9
Director Change of Address.
Each Director entitled to benefits shall file with SWM's Vice President – Human Resources or his or her designee, in writing, notification of any change of address. Any check representing payment and any communication addressed to a Director or a former Director at this last address filed with SWM's Vice President – Human Resources or his or her designee, or if no such address has been filed, then at his last address as indicated on SWM's records, shall be binding on such Director for all purposes of the Plan, and neither the Plan Administrator, SWM, any trustee, nor any other payor shall be obliged to search for or ascertain the location of any such Director. If SWM and the Plan Administrator are unable to locate a Participant or another person or entity to whom payment is due under this Plan, in order to make a distribution to such person or entity, the amount of the Participant's benefits under the Plan that would otherwise be considered as nonforfeitable shall be forfeited effective four years after (i) the last date a payment of said benefit was made, if at least on such payment was made, or (ii) the first date a payment of said benefit was directed to be made by the Plan Administrator pursuant to the terms of the Plan, if no payments have been made. If such person is located after the date of such forfeiture, the benefits for such Participant or Beneficiary shall not be reinstated hereunder.
Section 8.10
Designation of Beneficiary
. Each Director shall designate, by name, on the Deferral Election, the Beneficiary(ies) who shall receive any benefits which might be payable after such Director's death. A Beneficiary designation may be changed or revoked in writing by the Director making the designation without such Beneficiary's consent at any time or from time to time in the manner as provided by the Plan Administrator, and the Plan Administrator shall have no duty to notify any individual or entity designated as a Beneficiary of any change in such designation which might affect such individual or entity's present or future rights. If no designation is made, or if the named Beneficiary predeceases the Director or is not in existence at the time of the Director’s death, distribution of benefits shall be made (i) to the Director’s surviving spouse, (ii) if there is no surviving spouse, to the Director’s children (natural or adopted) per stirpes (with the portion for each deceased child to such child’s living descendants per stirpes) or (iii) if there is no surviving spouse or living descendants, the Director’s estate. Distributions to any child under the age of 18 may be made to the child’s legal guardian or a trust for the child’s benefit.
No Director shall designate more than three (3) simultaneous Beneficiaries, and if more than one (1) Beneficiary is named, Director shall designate the share to be received by each Beneficiary. Despite the limitation of three (3) Beneficiaries, a Director may designate more than three (3) Beneficiaries provided such beneficiaries are the surviving spouse and children of the Director. If a Director designates alternative, successor, or contingent Beneficiaries, such Director shall specify the terms and conditions upon which amounts shall be paid to such multiple, alternative, successor or contingent beneficiaries. Any payment made under this Plan after the death of a Participant shall be made only to the Beneficiary or Beneficiaries designated pursuant to this Section 8.10.
Section 8.11
Claims and Appeals Procedure
.
(a)
Deciding the Claim
. A claim is a request for a Plan benefit made by a claimant on a form provided by the Plan Administrator. The claimant must mail or deliver the completed and executed form to the Plan Administrator for it to be considered. The Plan Administrator shall decide the claim. Except in the case of a disability claim, if a claim is wholly or partially denied, the Plan Administrator shall provide the claimant with written or electronic notification of the adverse benefit determination within a reasonable period of time, but not later than 90 days after receipt of the claim by the Plan Administrator, unless the Plan Administrator determines that special circumstances require an extension of time for processing the claim. If the Plan Administrator determines that an extension of time for processing is required, written notice of the extension shall be furnished to the claimant prior to the termination of the initial 90-day period. In no event shall such extension exceed a period of 90 days from the end of such initial period. The extension notice shall indicate the special circumstances requiring an extension of time and the date by which the Plan Administrator expects to render the benefit determination.
(b)
Notification of the Decision
. The notification shall set forth, in a manner calculated to be understood by the claimant:
|
|
(i)
|
The specific reason or reasons for the adverse determination;
|
|
|
(ii)
|
Reference to the specific Plan provisions on which the determination is based;
|
|
|
(iii)
|
A description of any additional material or information necessary for the claimant to perfect the claim and an explanation of why such material or information is necessary;
|
|
|
(iv)
|
A description of the Plan’s review procedures and the time limits applicable to such procedures, including a statement of the claimant’s right to bring a civil action under section 502(a) of ERISA following an adverse benefit determination on appeal; and
|
|
|
(v)
|
In the case of an adverse benefit determination of a claim for a disability benefit,
|
|
|
(A)
|
If an internal rule, guideline, protocol or other similar criterion was relied upon in making the adverse determination, either the specific rule, guideline, protocol or similar criterion; or a statement that such a rule, guideline, protocol or other similar criterion was relied upon in making the adverse determination and that a copy of such rule, guideline, protocol or other criterion will be provided free of charge to the claimant upon request; or
|
|
|
(B)
|
If the adverse benefit determination is based on a medical necessity or experimental treatment or similar exclusion or limit, either an explanation of the scientific or clinical judgment for the determination, applying the terms of the Plan to the claimant’s medical circumstances, or a statement that such explanation will be provided free of charge upon request. Any electronic notification shall comply with the standards imposed by regulations issued by the Department of Labor under ERISA.
|
(c)
Time for Deciding Claims
. For purposes of subsection 8.11(a), the period of time within which a benefit determination is required to be made shall begin at the time a claim is filed in accordance with the procedures set forth in that subsection, without regard to whether all the information necessary to make a benefit determination accompanies the filing. In the event a period of time is extended as permitted by subsection 8.11(a) due to a claimant’s failure to submit information necessary to decide a claim, the period for making the benefit determination shall be tolled from the date on which the notification of the extension is sent to the claimant until the date on which the claimant responds to the request for additional information.
(d)
Authorized Representative
. An authorized representative of the claimant may act on his or her behalf in pursuing a benefit claim or appeal of an adverse benefit determination. The Plan Administrator may require, as a prerequisite to dealing with a representative, that the claimant verify in writing authority of the representative to act on behalf of the claimant.
(e)
Consistency
. The Plan Administrator shall conduct or have conducted on its behalf periodic reviews to verify that benefit claim determinations are made in accordance with governing Plan documents and that, where appropriate, the Plan’s provisions have been applied consistently with respect to similarly-situated claimants.
(f)
Deciding the Appeal
. A claimant may appeal an adverse benefit determination to the Plan Administrator by mailing or delivering to the Plan Administrator a written notice of appeal. The claimant may submit written comments, documents, records, or other information relating to the claim for benefits to the Plan Administrator. The Plan Administrator shall provide to the claimant, upon request and free of charge, reasonable access to, and copies of, all documents, records, and other information relevant to the claimant’s claim for benefits. Whether a document, record or other information is relevant to a claim for benefits shall be determined in accordance with standards issued by the Department of Labor. The Plan Administrator shall decide the appeal. The Plan Administrator’s decision shall take into account all comments, documents, records, and other information submitted by the claimant relating to the claim,
without regard to whether such information was submitted or considered in the initial benefit determination. The Plan Administrator will not, however, consider a claimant’s appeal unless the Plan Administrator receives it within 60 days following receipt by the claimant of a notification of an adverse benefit determination.
(g)
Time for Deciding Appeals
. The Plan Administrator will decide a claimant’s appeal no later than 60 days following the Plan Administrator’s receipt of the appeal, unless the Plan Administrator determines that special circumstances require an extension of time for processing the claim. If the Plan Administrator determines that an extension of time for processing the claim is required, written notice of the extension shall be furnished to the claimant prior to the termination of the initial 60-day period. In no event shall such extension exceed a period of 60 days from the end of the initial period. The extension notice shall indicate the special circumstances requiring an extension of time and the date by which the Plan Administrator expects to render its decision.
(h)
Notification of the Decision on Appeal
. The Plan Administrator shall provide a claimant as soon as possible, but not later than five days after the benefit determination is made, with written or electronic notification of the Plan Administrator’s decision on appeal. Any electronic notification shall comply with the standards imposed by the Department of Labor by regulations issued under ERISA. In the case of an adverse benefit determination, the notice shall set forth, in a manner calculated to be understood by the claimant:
|
|
(i)
|
The specific reason or reasons for the adverse determination;
|
|
|
(ii)
|
Reference to the specific Plan provisions on which the benefit determination is based;
|
|
|
(iii)
|
A statement that the claimant is entitled to receive, upon request and free of charge, reasonable access to, and copies of, all documents, records, and other information relevant to the claimant’s claim for benefits (whether a document, record or other information is relevant to a claim for benefit shall be determined by reference to regulations issued under ERISA by the Department of Labor); and
|
|
|
(iv)
|
A statement of the claimant’s right to bring an action under section 502(a) of ERISA.
|
(i)
No Liability; Duties of Trustee
. No member of the Board, or any committee thereof, nor no officer, employee or agent of SWM shall be liable to any individual or entity for any action taken hereunder, except those actions undertaken with lack of good faith. If SWM has established a Rabbi Trust for the Plan pursuant to which the trustee has agreed to act in a capacity other than as a directed trustee in the event of a Change in Control, the trustee of the Trust shall perform the duties of the Plan Administrator under this Section 8.11 following a Change of Control.
Section 8.12
Statute of Limitations
. Except for any action against a fiduciary for a breach of his fiduciary duty, an action filed in state or federal court regarding any rights or obligations under the Plan must be brought within one year from the date of the final decision of the Plan Administrator.
Section 8.13
No Guarantee of Service
. Nothing contained in the Plan shall be construed as a commitment by the Board to nominate any person for election or re-elect such person to the Board. Nothing contained in this Plan shall be construed to create a right in any person to be elected or to continue to serve as a Director.
Section 8.14
No Effect on Existing Plan
. The adoption of this Plan shall have no effect on the existing Schweitzer-Mauduit International, Inc. Outside Directors Stock Plan. Nothing contained in this Plan shall prevent SWM from adopting other or additional compensation plans or arrangements for its non-employee Directors.
Section 8.15
Governing Law
. To the extent not superseded by the laws of the United States, the laws of the State of Georgia (except for the provisions of Georgia law relating to conflicts of laws) shall be controlling in all matters relating to this Plan.
Section 8.16
Severability
. In the event any provision of this Plan shall be held illegal or invalid for any reason, such illegality or invalidity shall not affect the remaining provisions of the Plan, and the Plan shall be interpreted and enforced as if such illegal and invalid provisions had never been set forth.
Section 8.17
Code Section 409A
. It is the intention of the Company that this Plan shall meet the requirements of section 409A of the Code and applicable Treasury Regulations that must be met in order for amounts of Compensation deferred under this Plan to be taxable, for purposes of federal income taxation, in the year of actual receipt by the Participant or Beneficiary. If any provision of this Plan is susceptible of two interpretations, one of which results in the compliance of the Plan with section 409A of the Code and the applicable Treasury Regulations, and one of which does not, then the provision shall be given the interpretation that results in compliance with section 409A and the applicable Treasury Regulation.
IN WITNESS WHEREOF, Schweitzer-Mauduit International, Inc. has adopted the foregoing instrument to be effective as of January 1, 2014.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC.
By:
Title:
SCHWEITZER-MAUDUIT INTERNATIONAL, INC.
DEFERRED COMPENSATION PLAN NO. 2
AMENDED AND RESTATED AS OF JANUARY 1, 2014
PLAN HISTORY
The Plan was established, effective as of January 1, 2005, to provide a mechanism under which qualified participants could elect to defer a limited portion of their annual base salary and incentive compensation in a manner intended to comply with the requirements of Internal Revenue Code Section 409A.
The Plan was amended and restated, effective as of December 31, 2008, in order to comply with the final regulations issued by the United States Treasury Department in 2008 implementing the requirements of Internal Revenue Code Section 409A and requiring full compliance by year-end 2008.
The Plan has now been amended and restated, effective as of January 1, 2014, to reflect the terms of the Plan as of such date.
Unless expressly provided otherwise herein, capitalized terms used in the Plan shall have the meanings set forth in Article II of the Plan.
ARTICLE I
ESTABLISHMENT OF PLAN
1.1
Purpose.
The Schweitzer-Mauduit International, Inc. Deferred Compensation Plan No. 2 is intended to enhance the ability of the Corporation and participating related employers to attract and retain outstanding executive talent by providing a deferred compensation benefit to qualified participants of the Corporation and participating related employers as more fully provided herein. The benefits provided under the Plan are in addition to any other employee benefit plans and programs offered by the Corporation or any other related employers, including but not limited to tax-qualified employee benefit plans.
1.2
Effective Date and Term.
Schweitzer-Mauduit International, Inc. adopted this unfunded deferred compensation plan effective as of January 1, 2005 to be known as the Schweitzer-Mauduit International, Inc. Deferred Compensation Plan No. 2, hereinafter referred to as the “Plan.” The Plan is herein amended and restated, effective as of January 1, 2014, and will continue pursuant to its terms until terminated as described herein.
1.3
Applicability of ERISA.
This Plan is an unfunded plan maintained primarily for the purpose of providing deferred compensation to a select group of management and other highly compensated employees within the meaning of ERISA. It is the intent of the Corporation that the Plan be exempt
from Parts 2, 3 and 4 of Subtitle B of Title I of ERISA as an unfunded plan that is maintained by an employer primarily for the purpose of providing deferred compensation for a select group of management or highly compensated employees (the “ERISA exemption”). Notwithstanding anything to the contrary in any other provision of the Plan, the Plan Administrator may, in its sole discretion, exclude any one or more otherwise eligible employees from eligibility to participate or from further participation in the Plan, and may take any further action the Plan Administrator considers necessary or appropriate, if the Plan Administrator reasonably determines in good faith that such exclusion or further action is necessary in order for the Plan to qualify for, or to continue to qualify for, the ERISA exemption.
ARTICLE II
DEFINITIONS
As used within this document, the following words and phrases have the meanings described in this Article II unless a different meaning is required by the context. Some of the words and phrases used in the Plan are not defined in this Article II, but, for convenience, are defined as they are introduced into the text. Words in the masculine gender shall be deemed to include the feminine gender. Any headings used are included for ease of reference only, and are not to be construed so as to alter any of the terms of the Plan.
2.1
Affiliate.
Any entity with whom the Corporation would be considered a single employer under Code Sections 414(b) or (c) substituting “at least fifty percent (50%)” for “at least eighty percent (80%)” each place it appears therein.
2.1
AIP Awards.
The cash awards, if any, that may be earned by Participants under the Corporation’s Annual Incentive Plan during the Deferral Period.
2.2
Base Salary.
The Participant’s annual base salary for the applicable Deferral Period.
2.3
Beneficiary.
The individual(s) or entity or entities designated by the Participant in accordance with Section 13.6 to receive the Participant’s benefits payable under the Plan after the Participant’s death.
2.4
Board or Board of Directors.
The Board of Directors of the Corporation.
2.5
Change of Control.
The earliest of the following events, except as otherwise set forth below:
|
|
(i)
|
when any one Person, or more than one Person acting as a group, acquires ownership of the Corporation that, together with stock or other ownership interests held by such Person or group, constitutes more than fifty percent (50%) of the total fair market value or total voting power of the stock or ownership interests of the Corporation, provided, that if any one Person or more than one Person acting as a group is considered to own more than fifty percent (50%) of the total fair market value or total voting power of the Corporation, the acquisition of additional stock or ownership interests by the same Person or group will not be considered to cause a Change in Control;
|
|
|
(ii)
|
when any one Person, or more than one Person acting as a group, acquires (or has acquired during the twelve (12)-month period ending on the date of the most recent acquisition by such Person or group) ownership of thirty percent (30%) or more of the total voting power of the stock or ownership interests of the Corporation, provided, that if any one Person or more than one Person acting as a group acquires (or has acquired during the twelve (12)-month period ending on the date of the most acquisition by such Person or group) thirty percent (30%) or more of the total voting power of the Corporation, the acquisition of additional voting power by the same Person or Persons will not be considered to cause a Change in Control;
|
|
|
(iii)
|
when any one Person, or more than one Person acting as a group, acquires (or has acquired during the twelve (12)-month period ending on the date of the most recent acquisition by such Person or group) assets from the Corporation that have a total gross fair market value (determined without regard to any liabilities associated with such assets) equal to or more than forty percent (40%) of the total gross fair market value of all of the assets of the Corporation (determined without regard to any liabilities associated with such assets) immediately prior to such acquisition or acquisitions, without regard to assets transferred to: (a) a shareholder or owner of the Corporation (immediately before the asset transfer) in exchange for or with respect to its stock, (b) an entity, fifty percent (50%) or more of the total value or voting power of which is owned, directly or indirectly, by the Corporation, (c) a Person, or more than one Person acting as a group, that owns, directly or indirectly, fifty percent (50%) or more of the total value or voting power of the Corporation or (d) an entity, at least fifty percent (50%) of the total value or voting power of which is owned, directly or indirectly, by a Person, or more than one Person acting as a group, that owns, directly or indirectly, fifty percent (50%) or more of the total value or voting power of the Corporation; or
|
|
|
(iv)
|
when a majority of the members of the Board of Directors of the Corporation is replaced during any twelve (12)-month period by directors whose appointment or election is not endorsed by a majority of the members of the Board of Directors of the Corporation prior to the date of their appointment or election.
|
For purposes of this Plan, Persons will not be considered to be acting as a group solely because they purchase or own stock or an ownership interest at the same time or as a result of the same public offering. However, Persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction. If a Change in Control occurs on account of a series of transactions, the Change in Control is considered to occur on the date of the last of such transactions. The term “Person” means any corporation, individual, partnership, limited liability company, joint venture, incorporated or unincorporated association, joint-stock company, trust, unincorporated organization or government or other agency or political subdivision thereof or any other entity of any kind. For purposes of the definition of a Change in Control, Section 318(a) of the Code applies to determine ownership interests and stock ownership. Ownership interests and stock ownership underlying a vested option is considered owned by the Person that holds the vested option (and
the ownership interests and stock ownership underlying an unvested option is not considered owned by the Person who holds the unvested option). For purposes of the preceding sentence, however, if a vested option is exercisable for stock that is not substantially vested (as defined by Treasury Regulation Section 1.83-3(b) and (j)), the stock ownership underlying the vested option is not treated as owned by the Person that holds the vested option.
For purposes of the Plan, Change in Control shall be interpreted consistent with the requirements of Section 409A of the Code.
2.6
Code.
The Internal Revenue Code of 1986, as amended. Reference to a section of the Code shall include that section and any comparable section or sections of any future legislation that amends, supplements or supersedes such section.
2.7
Committee.
The Compensation Committee of the Corporation’s Board of Directors.
2.8
Corporation
. Schweitzer-Mauduit International, Inc.
2.9
Deferral Account.
The bookkeeping account established for each Participant pursuant to Section 5.1 of the Plan for each Deferral Period with respect to which the Participant has made a Deferral Election.
2.10
Deferral Election.
The written election to defer Base Salary and/or AIP Awards made by the Participant for a Deferral Period in accordance with Section 4.1 of the Plan. Such written election shall be in the format designated by the Corporation.
2.11
Deferral Period.
The Plan Year for which a Deferral Election is made, or in the case of an employee who becomes a Participant during the Plan Year, the portion of the Plan Year in which the employee becomes a Participant for which a Deferral Election is made remaining after the effective date of the Participant’s Deferral Election.
2.12
Disability.
A Participant shall be considered to have experienced a “Disability” or to be disabled, for purposes of this Plan, if the Participant (i) is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, or (ii) is, by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, receiving income replacement benefits for a period of not less than 3 months under an accident and health plan covering employees of the Corporation or the Participant’s Employer (if not the Corporation).
2.13
Effective Date.
January 1, 2014.
2.14
Eligible Employee.
An employee of the Corporation or any other Employer who is designated by the Plan Administrator as being eligible to participate in the Plan or who is a member of a class of employees that the Plan Administrator has designated as being eligible to participate in the Plan. Such employee shall remain eligible to participate in the Plan for such period as is
designated by the Plan Administrator. Notwithstanding the foregoing, an employee of the Corporation or any other Employer will only be eligible to participate in the Plan if the employee is a member of management or a highly compensated employee of the Corporation or another Employer within the meaning of the ERISA exemption.
2.15
Employer.
The Corporation and any Affiliate that becomes a participating employer in the Plan, in accordance with Section 12.2.
2.16
ERISA.
The Employee Retirement Income Security Act of 1974, as amended. References to a section of ERISA shall include that section and comparable section or sections of any future legislation that amends, supplements or supersedes such section.
2.17
IRS
. The Internal Revenue Service.
2.18
IRS Limits
. Any of the limitations on the amounts of contributions to or benefits under a qualified retirement plan imposed by Code sections 401(a)(4), 401(a)(17), 410(b), or 415.
2.19
Participant.
Each Eligible Employee who is designated by the Plan Administrator as being eligible to participate in the Plan pursuant to Article III of the Plan commencing as of such time and for such period as is designated by the Plan Administrator.
2.20
Plan.
The Schweitzer-Mauduit International, Inc. Deferred Compensation Plan No. 2.
2.21
Plan Administrator.
The Corporation’s Human Resources Committee.
2.22
Plan Year.
The 12-month period beginning each January 1 and ending on the following December 31.
2.23
Rabbi Trust.
The Rabbi Trust, which the Corporation, as grantor, may, in its discretion, establish in accordance with Article IX of the Plan for the Schweitzer-Mauduit International, Inc. Deferred Compensation Plan No. 2, as amended from time to time.
2.24
Separation from Service
. The termination of the Participant’s employment and service with the Corporation and all of its Affiliates. The Participant will be deemed to have incurred a Separation from Service where the facts and circumstances indicate that the Corporation and its Affiliates and Participant reasonably anticipate that no further services will be performed after a certain date or that the level of bona fide services the Participant will perform after such date (whether as an employee or as an independent contractor) will permanently decrease to no more than twenty percent (20%) of the average level of bona fide services performed (whether as an employee or an independent contractor) over the immediately preceding thirty-six (36)-month period (or the full period of employment and service to the Corporation and its Affiliates if Participant has been providing services for less than thirty-six (36) months). For purposes of determining if Participant has incurred a Separation of Service, the employment relationship will be treated as continuing intact while the Participant is on military leave, sick leave or other bona fide leave of absence (such as temporary employment by the government) so long as the period of such leave does not exceed six (6) months, or if longer, so long as the individual’s right to reemployment with the Corporation
or its Affiliates is provided either by statute or by contract. If the period of leave (i) ends or (ii) exceeds six (6) months and the Participant’s right to reemployment is not provided either by statute or by contract, the Separation from Service will be deemed to occur when the period of leave ends or on the first date immediately following such six (6)-month period, as applicable, if not reemployed by the Corporation or any of its Affiliates before such time, and eligibility for payments hereunder will be determined as of that time. If the Participant provides services both as an employee and as an independent contractor, the Participant must have a Separation from Service both as an employee and as an independent contractor to be treated as having a Separation from Service. If the Participant ceases providing services as an independent contractor and begins providing services as an employee, or ceases providing services as an employee and begins providing services as an independent contractor, the Participant will not be considered to have a Separation from Service until the Participant has ceased providing services in both capacities. Notwithstanding the foregoing, if the Participant provides services both as an employee and as a member of a board of directors, the services provided as a director are not taken into account in determining whether the Participant has a Separation from Service as an employee for purposes of this Plan, provided this Plan is not aggregated under Section 409A of the Code with any other plan in which the Participant participates as a director.
2.25
Specified Age.
Age 55 or a later age chosen by the Participant on his Deferral Election with respect to a Deferral Period at which time some portion or all of the designated vested credits in the Participant’s Deferral Account for that Deferral Period shall be paid out as benefits in a single lump sum, unless payment of such benefits has commenced as of an earlier date, as provided in Article VII of this Plan.
2.26
Specified Employee.
A Participant who is (i) an officer of the Corporation or an Affiliate having annual compensation greater than $135,000 (with certain adjustments for inflation after 2005) ($170,000 for 2014), (ii) a five-percent owner of the Corporation or an Affiliate or (iii) a one-percent owner of the Corporation or an Affiliate having annual compensation greater than $150,000. For purposes of this definition, no more than 50 employees (or, if lesser, the greater of three or 10 percent of the employees) shall be treated as officers. Participants who (i) normally work less than 17 1/2 hours per week, (ii) normally work not more than six (6) months during any year, (iii) have not attained age 21 or (iv) are included in a unit of employees covered by an agreement which the Secretary of Labor finds to be a collective bargaining agreement between employee representatives and the Corporation or an Affiliate (except as otherwise provided in the Code) shall be excluded for purposes of determining the number of officers. For purposes of this Section, the term “five-percent owner” (“one-percent owner”) means any person who owns more than five percent (one percent) of the outstanding stock of the Corporation or an Affiliate or stock possessing more than five percent (one percent) of the total combined voting power of all stock of the Corporation or an Affiliate. For purposes of determining ownership, the attribution rules of Section 318 of the Code shall be applied by substituting “five percent” for “50 percent” in Section 318(a)(2) and the rules of Sections 414(b), 414(c) and 414(m) of the Code shall not apply. For purposes of this Section, the term “compensation” has the meaning given such term by Section 414(q)(4) of the Code. The determination of whether a Participant is a Specified Employee will be based on a December 31 identification date such that if the Participant satisfies the above definition of Specified Employee at any time during the 12-month period ending on December 31, he will be treated as a Specified
Employee if he has a Separation from Service during the 12-month period beginning on the first day of the fourth month following the identification date. This definition is intended to comply with the “specified employee” rules of Section 409A(a)(2)(B)(i) of the Code and shall be interpreted accordingly.
2.27
Unforeseeable Emergency.
A severe financial hardship to the Participant resulting from an illness or accident of the Participant, the Participant’s spouse, or a dependent (as defined in Code section 152(a) without regard to section 152(b)(1), (b)(2), and (d)(1)(B)) of the Participant, loss of the Participant’s property due to casualty, or other similar extraordinary and unforeseeable circumstances arising as a result of events beyond the control of the Participant
(e.g.,
the imminent foreclosure of the mortgage on the Participant’s primary residence or eviction from the Participant’s primary residence, the need to pay for medical expenses, including non-refundable deductibles and the costs of prescription drug medication, and funeral expenses of a spouse, a Beneficiary, or a dependent (as defined above) may constitute an Unforeseeable Emergency. A distribution on account of an Unforeseeable Emergency may be paid to the Participant only if the amounts distributed with respect to the emergency do not exceed the amounts reasonably necessary to satisfy such emergency plus amounts necessary to pay taxes reasonably anticipated as a result of the distribution, after taking into account the extent to which such hardship is or may be relieved through reimbursement or compensation by insurance or otherwise or by liquidation of the Participant’s assets (to the extent the liquidation of such assets would not itself cause severe financial hardship) or by cessation of deferrals under this Plan. This section shall be interpreted in a manner consistent with Code section 409A and applicable provisions of the Treasury Regulations.
2.28
Valuation Date.
Each business day of the Plan Year.
ARTICLE III
ELIGIBILITY AND PARTICIPATION
3.1
Participation — Eligibility and Initial Participation Period.
Participation in the Plan is limited to Eligible Employees. Each Eligible Employee may become a Participant for a Plan Year by submitting a properly completed Deferral Election by December 31 of the year preceding the Plan Year for which the Deferral Election is to be effective. Any employee becoming an Eligible Employee during a Plan Year, e.g., including but not limited to new hires or promoted employees, may become a Participant with respect to services performed subsequent to the effective date of the Participant’s Deferral Election for such Plan Year if he submits a properly completed Deferral Election within thirty (30) days after becoming an Eligible Employee; provided, however, that in this case the Deferral Election shall apply only to the Participant’s Base Salary for services performed after the effective date of the Deferral Election and no more than that portion of the Participant’s AIP Award that equals (i) total amount of the AIP Award for such Plan Year multiplied by (ii) a fraction, the numerator of which is the number of days remaining in the Plan Year after the effective date of the Deferral Election and the denominator of which is the total number of days in the Plan Year.
3.2
Participation — Subsequent Entry into Plan.
An Eligible Employee who does not elect to participate at the time of initial eligibility as set forth in Section 3.1 shall remain eligible to become a Participant for subsequent Plan Years as long as he continues his status as an Eligible Employee.
In such event, the Eligible Employee may become a Participant by submitting a properly completed Deferral Election on or prior to December 31st of the year preceding the Plan Year for which it is to be effective.
3.3
Evergreen Provision
. Notwithstanding the foregoing, once made, the Participant’s Deferral Election shall remain in effect for each succeeding Plan Year, in accordance with the terms of the Deferral Election, unless and until the Participant either files a new Deferral Election for the succeeding Plan Year or cancels the Deferral Election for the succeeding Plan Year, in either case on or before the 31
st
day of December immediately preceding the Plan Year with respect to which the new Deferral Election or cancellation is to be effective.
3.4
Determination of Non-Eligibility to Participate
. If, at any time, an Eligible Employee or Participant is determined or reasonably believed, based on a judicial or administrative determination or opinion of counsel, or based on a reasonable determination by the Plan Administrator, not to qualify as a member of “management” or a “highly compensated employee” under ERISA Sections 201(2), 301(a)(3), and 401(a)(1), the employee shall cease active participation in the Plan as of the last day of the Plan Year in which such determination is made.
3.5
Cancellation of Deferral Election for Hardship.
Any Participant who has made a Deferral Election for a Plan Year may subsequently cancel the Deferral Election on account of an Unforeseeable Emergency by providing notice of such cancellation to the Plan Administrator, together with such information as the Plan Administrator may require to determine the facts of the Participant’s Unforeseeable Emergency. The cancellation shall be effective only with respect to compensation earned by the Participant after the filing of the cancellation notice. A Participant may only cancel his Deferral Election upon an Unforeseeable Emergency once in a calendar year. In the event of such cancellation, a subsequent Deferral Election may not be made prior to the first day of the succeeding Plan Year.
(1)
CONTRIBUTIONS
3.6
Deferral Election.
On or before the 31
st
day of December preceding the first day of each Plan Year (or as otherwise set forth above), a Participant may file with the Plan Administrator a Deferral Election indicating the amount of Base Salary and/or AIP Award to be deferred for the applicable Plan Year. A Participant shall not be obligated to make a Deferral Election in each Plan Year to remain a Participant in the Plan. After a Plan Year commences, such Deferral Election shall continue for the entire Plan Year except as set forth in Section 3.5 above. The Deferral Election will apply to the Participant’s Base Salary and/or AIP Awards earned during the Deferral Period to which the Deferral Election relates.
3.7
Maximum Deferral Election.
A Participant may elect to defer up to 25% of his Base Salary and/or up to 50% of his AIP Awards earned during the corresponding Deferral Period. The amount of deferral may be stated as a flat dollar amount or as a percentage of Base Salary and/or AIP Award. A Deferral Election may be automatically reduced if the Plan Administrator determines that such action is necessary to meet Federal or State tax withholding obligations.
3.8
Minimum Deferral Election.
A Participant who wishes to defer a portion of his Base Salary and/or AIP Awards for a Plan Year must elect to defer at least $1,200 during the Deferral Period from Base Salary or AIP Awards or a combination of Base Salary and AIP Awards. The Participant may also elect not to make any deferral for a Plan Year.
3.9
Employer Contributions.
The Corporation, with the Committee’s prior approval, may, in its sole discretion, make a contribution to any one or more of the Participants’ Deferral Accounts.
3.10
Insurance.
The Corporation may insure the lives of Participants. A Participant whose deferral is approved shall, as a condition of his deferral, cooperate in providing any information or submitting to any necessary examinations that may be requested by the Corporation in connection with its application for such insurance policies. The Corporation shall be the applicant, owner and beneficiary of such policies. The Participant shall have no interest in any policies nor will the Participant be able to look to an insurance carrier for benefits under any such policies.
ARTICLE IV
ACCOUNTS
4.1
Deferral Accounts.
Solely for recordkeeping purposes, the Plan Administrator shall establish a Deferral Account for each Participant with respect to each Plan Year with respect to which a Deferral Election is effective. The Participant’s Deferral Account shall be (i) credited with the contributions made by him under Section 4.1 for the applicable Deferral Period, (ii) credited with the contributions made by the Corporation under section 4.4 for the applicable Deferral Period, (iii) credited (or charged, as the case may be) with the hypothetical or deemed investment earnings and losses determined pursuant to Section 5.3, and (iv) charged with distributions made to or with respect to him from his Deferral Account.
4.2
Crediting of Deferral Accounts.
Base Salary contributions under Section 4.1 shall be credited to the Participant’s Deferral Account, for the applicable Plan Year or portion thereof, as of the date on which such contributions are withheld from his Base Salary. AIP Award contributions under Section 4.1 shall be credited to the Participant’s Deferral Account, for the applicable Plan Year or portion thereof, as of the date on which the AIP Award would have otherwise been paid to the Participant in cash. Contributions under Section 4.4 shall be credited to the Participant’s Deferral Account as of the date declared by the Corporation. Any distribution with respect to a Deferral Account shall be charged to that Deferral Account as of the date the Corporation or the trustee of any Rabbi Trust established for the Plan makes such distribution.
4.3
Earning and Losses.
Amounts credited to a Deferral Account shall be credited with deemed net income, gain and loss on deferred Base Salary, AIP Awards and Corporation contributions and deemed net unrealized gain and loss based on the hypothetical investment directions made by the Participant with respect to his Deferral Account on a form designated by the Plan Administrator, in accordance with investment options and procedures adopted by the Plan Administrator, in its sole discretion, from time to time. Such earnings and losses (and unrealized gains or losses) will continue to accrue during any period in which installments of vested benefits are paid to a Participant or his Beneficiary pursuant to Article VII, except that the Plan Administrator may set the Valuation Date through which the amount of the Participant’s Deferral Account will be determined for
purposes of any distribution, which Valuation Date may not be more than thirty (30) days prior to the time of the distribution, and no earning or losses (or unrealized gains or losses) need be accrued after such date. Earnings and losses otherwise shall be credited to or charged against the Participant’s Deferral Account on a daily basis as of each Valuation Date.
4.4
Hypothetical Nature of Accounts.
The Plan constitutes a mere promise by the Corporation to make the benefit payments in the future. Any Deferral Account established for a Participant under this Article V shall be hypothetical in nature and shall be maintained for the Corporation’s recordkeeping purposes only, so that any contributions can be credited and so that deemed investment earnings and losses on such amounts can be credited (or charged, as the case may be). Neither the Plan nor any of the Deferral Accounts (or subaccounts) shall hold any actual funds or assets. The right of any individual or entity to receive one or more payments under the Plan shall be an unsecured claim against the general assets of the Corporation. Any liability of the Corporation to any Participant or Beneficiary with respect to a right to payment shall be based solely upon contractual obligations, if any, created by the Plan. The Corporation, the Board of Directors, the Committee, the Plan Administrator and any individual or entity shall not be deemed to be a trustee of any amounts to be paid under the Plan. Nothing contained in the Plan, and no action taken pursuant to its provisions, shall create or be construed to create a trust of any kind, or a fiduciary relationship, between the Corporation and a Participant, Beneficiary, or any other individual or entity. The Corporation may, in its sole discretion, establish a Rabbi Trust as a vehicle in which to place funds with respect to this Plan. The Corporation does not in any way guarantee any Participant’s Deferral Account against loss or depreciation, whether caused by poor deemed investment performance, insolvency of a deemed investment or by any other event or occurrence. In no event shall any employee, officer, director, or stockholder of the Corporation or any Affiliate be liable to any individual or entity on account of any claim arising by reason of the Plan provisions or any instrument or instruments implementing its provisions, or for the failure of any Participant, Beneficiary or other individual or entity to be entitled to any particular tax consequences with respect to the Plan or any credit or payment thereunder.
4.5
Statement of Deferral Accounts.
The Plan Administrator shall provide to each Participant quarterly statements setting forth the value of the Deferral Accounts maintained for such Participant.
4.6
Adherence to Securities Law.
Notwithstanding anything in this Article V to the contrary, no deemed investment election, or change in deemed investment election, shall be made or implemented to the extent such election would violate the requirements of applicable securities laws.
ARTICLE V
VESTING
5.1
Vesting of Contributions.
The vesting of AIP Award contributions shall occur as set forth in the respective plans governing those awards. Corporation contributions under Section 4.4 and any deemed investment earnings attributable to those contributions shall be one hundred percent (100%) vested and non-forfeitable when the Participant has satisfied any vesting conditions contained in the Board or Committee approval of the contribution, irrespective of when the contribution is credited to any Deferral Account. A Participant shall be one hundred percent (100%) vested in any Corporation contributions, including any deemed investment earnings attributable to these
contributions, upon his death or Disability while he is actively employed by the Corporation or any Employer or in the event of a Change in Control. All Base Salary contributions credited to a Participant’s Deferral Account shall be one hundred percent (100%) vested at all times.
ARTICLE VI
BENEFITS
6.1
Attainment of Specified Age or Date.
Unless benefits have already commenced pursuant to this Article VII, the Participant shall be entitled to receive the vested amount credited to his Deferral Account as the Specified Age or date chosen by the Participant in his Deferral Election for such Deferral Account. A Participant may make a separate election with respect to the timing of distribution of the amounts credited to his Deferral Account for each separate Deferral Period. In addition, a Participant may elect, with respect to a particular Deferral Period, to be entitled to receive payment as of the Specified Age or date chosen by the Participant in his Deferral Election for such Deferral Period of a flat dollar amount or a percentage of the vested amount credited to his Deferral Account. The Specified Age or date chosen by the Participant shall not be earlier than January 1 of the fifth Plan Year following the Plan Year with respect to which the Deferral Election is made. Payment of any amount under this Section 7.1 shall be made in a lump sum within thirty (30) days after the Specified Age or date chosen by the Participant;
provided
,
however
, that in all cases the Participant shall not have the right to designate the year of payment. Payments shall commence as of that Specified Age or date even if the Participant is still then employed. Once benefits have commenced pursuant to this Article VII other than under this Section 7.1, however, no further benefits shall commence pursuant to this Section 7.1; all benefits then shall be paid pursuant to the other Sections of this Article VII.
6.2
Disability.
If the Participant suffers a Disability before benefits have commenced pursuant to this Article VII (other than under Section 7.1), he shall be entitled to receive the vested amount credited to his Deferral Account as of the date on which the Participant is determined to have suffered a Disability. If the Participant failed to designate the time of payment upon a Disability in any Deferral Election with respect to any Deferral Period, the Participant shall be entitled to receive in a single lump sum the vested amount in his Deferral Account for which no Deferral Election was made as of the date on which the Participant is determined to have suffered a Disability. Payment of such amount under this Section 7.2 shall commence or be made within thirty (30) days after the Participant’s Disability in accordance with the payment method elected by the Participant on his Deferral Election for the Deferral Period or as otherwise set forth in the Plan;
provided, however,
that in all cases the Participant shall not have the right to designate the year of payment.
6.3
Death Pre-Benefit Commencement.
If the Participant dies before benefits have commenced pursuant to this Article VII (other than under Section 7.1), the Participant’s Beneficiary or Beneficiaries designated pursuant to Section 13.6 shall be entitled to receive the vested amount credited to the Participant’s Deferral Account as of the date of the Participant’s death. Payment of such amount under this Section 7.3 shall be made in a single lump sum within thirty (30) days after the Participant’s death;
provided, however,
that in all cases the Participant’s Beneficiary or Beneficiaries shall not have the right to designate the year of payment.
6.4
Death Post-Benefit Commencement.
If the Participant dies after benefits have commenced pursuant to this Article VII, but prior to receiving complete payment of his benefits under this Article VII, the Participant’s Beneficiary or Beneficiaries designated under Section 13.6 shall be entitled to receive the vested amount credited to the Participant’s Deferral Account as of the date of the Participant’s death. Payment of any amount under this Section 7.4 shall be made in a single lump sum within thirty (30) days after the Participant’s death;
provided, however
, that in all cases the Participant’s Beneficiary or Beneficiaries shall not have the right to designate the year of payment.
6.5
Separation from Service.
If the Participant experiences a Separation from Service (determined in accordance with the standards of Code Section 409A) before benefits have commenced pursuant to this Article VII (other than under Section 7.1), he shall be entitled to receive the vested amount credited to his Deferral Account as of the date on which the Participant is determined to have experienced the Separation from Service. If the Participant failed to designate the time of payment upon a Separation from Service in any Deferral Election with respect to any Deferred Period, the Participant shall be entitled to receive in a single lump sum the vested amount credited to his Deferral Account for which no Deferral Election was made as of the date on which the Participant experiences the Separation from Service. Payment of the first annual installment or any lump sum amount under this Section 7.5 shall be made within thirty (30) days after the date on which the Participant separates from service in accordance with the payment method elected by the Participant on his Deferral Election for the Deferral Period or as otherwise set forth in the Plan;
provided
,
however
, that in the case of a Participant who is a Specified Employee (within the meaning of Code section 409A and the Treasury Regulations issued pursuant to that section), the first annual installment or lump sum shall be made on the first day of the seventh month after the month in which occurs the Participant’s Separation from Service;
provided; further,
that in all cases the Participant shall not have the right to designate the year of payment.
6.6
Change of Control.
If a Change of Control occurs before benefits have commenced pursuant to this Article VII (other than under Section 7.1) or before the Participant has received complete payment of his benefits under this Article VII, he shall be entitled to receive a lump sum payment of the vested amount credited to his Deferral Account as of the Change of Control. Payment of such amount under this Section 7.6 shall be made in a single lump sum within thirty (30) days after the date on which the Change of Control occurs;
provided
,
however
, that in all cases the Participant shall not have the right to designate the year of payment.
6.7
Payment Methods.
Unless otherwise provided in this Article VII, a Participant may elect to receive payment of the vested amount credited to his Deferral Account upon Disability or a Separation from Service in a single lump sum or in three (3), five (5), or ten (10) annual installments. This election must be made in the Participant’s Deferral Election for the corresponding Deferral Period (at the time the Participant makes his election to defer compensation for the Deferral Period). Any installment payments shall be paid annually beginning no later than thirty (30) days after the distributions are scheduled to commence and on each following anniversary of the first installment until the total number of installments has been paid;
provided, however,
that that in the case of a Participant who is a Specified Employee (within the meaning of Code section 409A and the Treasury Regulations issued pursuant to that section), the first such installment shall be made on the first day of the seventh month after the month in which occurs the Participant’s Separation
from Service with the remaining installments paid on the anniversary of the date the first installment would have been made absent the six-month deferral required by Code Section 409A. Each installment payment shall be determined by multiplying the vested Deferral Account balance by a fraction, the numerator of which is one and the denominator of which is the number of remaining installment payments. All amounts shall be paid in cash.
6.8
Liquidation of Deferral Accounts.
The Corporation shall be entitled to distribute the Participant’s Deferral Accounts in a single lump sum if the aggregate value of the Deferral Accounts of the Participant are equal to or less than $17,500 (or such higher amount as may be in effect for such Plan Year under Code Section 402(g)(1)(B) and Treasury Regulations Section 1.409A-3(j)(4)(v)) notwithstanding any payment election to the contrary specified by the Participant (to the extent permitted by Code Section 409A).
6.9
Subsequent Deferrals.
The schedule of payments pursuant to the Participant’s Deferral Election may be amended provided that all of the following requirements are met:
|
|
(i)
|
the amendment of the Deferral Election shall not take effect until at least 12 months after the date on which such amendment is made;
|
|
|
(ii)
|
in the case of an amendment of a Deferral Election related to a payment not made on account of the Participant’s death or Disability or an Unforeseeable Emergency, the first payment with respect to which the amendment is made shall in all cases be deferred for a period of not less then 5 years from the date on which such payment otherwise would have been made; and
|
|
|
(iii)
|
in the case of an amendment of an election related to a payment that is to be made at a specified time or pursuant to a fixed schedule, such an amendment of the election must be made at least 12 months prior to the date of the first scheduled payment.
|
ARTICLE VII
UNFORESEEABLE EMERGENCY WITHDRAWALS
7.1
Unforeseeable Emergency Withdrawals.
If a Participant incurs an Unforeseeable Emergency, the Participant may make a written request to the Plan Administrator for a withdrawal from his vested Deferral Accounts. The Plan Administrator in its sole discretion shall determine, based on the facts and circumstances of each case, whether to approve the distribution upon an Unforeseeable Emergency. In the event of a withdrawal on account of an Unforeseeable Emergency, the Participant’s deferrals for the remainder of the Plan Year shall be suspended. Deferrals may commence with the Plan Year which next follows the date the distribution is made, provided the Participant completes the appropriate Deferral Election prior to December 31
st
of the year prior to the corresponding Plan Year. Additionally, in the event that the Committee approves the request for a hardship distribution pursuant to Treasury Regulation Section 1.401(k)-1(d)(c) under the Corporation’s 401(k) Plan, the Participant’s Deferral Election shall be deemed canceled after the date of such hardship distribution and the Participant may not make a subsequent Deferral Election prior to the first day of the Plan Year which next follows the date which is six (6) months following the date on which the hardship distribution under the 401(k) Plan is made. Distributions on an
account of an Unforeseeable Emergency shall reduce all of the vested amounts in the Participant’s Deferral Accounts in the Plan on a pro-rata basis.
ARTICLE VIII
ESTABLISHMENT OF TRUST
8.1
Establishment of Trust.
The Corporation may establish a Rabbi Trust (“Trust”) for the Plan. If established, all benefits payable under this Plan to a Participant shall be paid directly by the Corporation from the Trust. To the extent that such benefits are not paid from the Trust, the benefits shall be paid from the general assets of the Corporation and shall be reimbursed to the Corporation by the Trust at the Corporation’s request upon presentation of reasonable proof that the Corporation made such payment. Any such Trust shall be an irrevocable grantor trust which conforms to the terms of the model trust as described in IRS Revenue Procedure 92-64, I.R.B. 1992-33. The assets of the Trust are subject to the claims of the Corporation’s creditors in the event of its insolvency. Except as to any amounts paid or payable to the Trust, the Corporation shall not be obligated to set aside, earmark or place in escrow any funds or other assets to satisfy its obligations under this Plan, and the Participant and/or his designated Beneficiaries shall not have any property interest in any specific assets of the Corporation or the Trust, other than the unsecured right to receive payments from the Corporation as provided in this Plan.
8.2
Payment From the Trust.
In the event a Trust is established and payments are not made by the Corporation in accordance with the terms of the Plan, a Participant may petition the trustee of the Trust directly for payment and the trustee may make such payment directly to the Participant upon the trustee’s good faith determination that the payment is in fact owed, was not timely paid by the Corporation and that there are sufficient assets in the Trust to make the payment.
ARTICLE IX
PLAN ADMINISTRATION
9.1
Plan Administration.
The Plan shall be administered by the Committee, and such Committee may designate an agent to perform the recordkeeping duties and delegate any of the Committee’s functions specified in this Article X. The Committee shall construe and interpret the Plan, including disputed and doubtful terms and provisions and, in its sole discretion, decide all questions of eligibility and determine the amount, manner and time of payment of benefits under the Plan. A member of the Committee may be a Participant, but no member of the Committee may participate in any decision directly affecting his rights or the computation of his benefits under the Plan. Any decision or action that directly affects the rights or benefits of all the members of the Committee, or that the Committee determines should not be made or taken by the Committee, shall be made or taken by the Board of Directors. Each determination required or permitted under the Plan shall be made by the Committee or the Board of Directors in the sole and absolute discretion of the Committee or the Board of Directors as the case may be. The determinations and interpretations of the Committee shall be consistently and uniformly applied to all similarly-situated Participants and Beneficiaries, including but not limited to interpretations and determinations of amounts due under this Plan, and Committee’s determination shall be final and binding on all parties. The Plan at all times shall be interpreted and administered as an unfunded deferred compensation plan, and no provision of the Plan shall be interpreted so as to give any Participant or Beneficiary any right in
any asset of the Corporation which is a right greater than the right of a general unsecured creditor of the Corporation.
ARTICLE X
NONALIENATION OF BENEFITS
10.1
Nonalienation of Benefits.
The interests of Participants and their Beneficiaries under this Plan are not subject to the claims of their creditors and may not be voluntarily or involuntarily sold, transferred, alienated, assigned, pledged, anticipated, encumbered, attached or garnished. Any attempt by a Participant, his Beneficiary, or any other individual or entity to sell, transfer, alienate, assign, pledge, anticipate, encumber, attach, garnish, charge or otherwise dispose of any right to benefits payable shall be void. The Corporation may cancel and refuse to pay any portion of a benefit which is sold, transferred, alienated, assigned, pledged, anticipated, encumbered, attached or garnished. Unless applicable law requires otherwise, the benefits which a Participant may accrue under this Plan are not subject to the terms of any Qualified Domestic Relations Order (as that term is defined in Section 414(p) of the Code) with respect to any Participant, and the Plan Administrator, Board of Directors, Committee and Corporation shall not be required to comply with the terms of such order in connection with this Plan. The withholding of taxes from Plan payments, the recovery of Plan overpayments of benefits made to a Participant or Beneficiary, the transfer of Plan benefit rights from the Plan to another plan, or the direct deposit of Plan Payments to an account in a financial institution (if not actually a part of an arrangement constituting an assignment or alienation) shall not be construed as assignment or alienation under this Article XI.
ARTICLE XI
AMENDMENT AND TERMINATION; ADOPTION BY RELATED EMPLOYERS
11.1
Amendment and Termination.
The Corporation reserves the right to amend or terminate this Plan at any time. Such action may be taken in writing by the Plan Administrator. However, no such amendment or termination shall deprive any Participant or Beneficiary of any portion of any benefit which would have been payable had the Participant voluntarily resigned from employment with the Corporation on the effective date of such amendment or termination. Notwithstanding the provisions of this Article XII to the contrary, the Corporation may amend the Plan at any time, in any manner, if the Corporation determines any such amendment is required to ensure that the Plan is characterized as providing deferred compensation for a select group of management or highly compensated employees and as described in ERISA Sections 201(2), 301(a)(3) and 401(a)(1) or to otherwise conform the Plan to the provisions of any applicable law including, but not limited to, ERISA and the Code (including without limitation section 409A of the Code). The Corporation may only terminate the Plan and distribute the benefits to Participants other than as set forth above, to the extent permitted by Code Section 409A.
11.2
Adoption by Other Employers.
An Affiliate may adopt this Plan and become an Employer, with the written consent of the Plan Administrator or the Chief Executive Officer of the Corporation, by executing a written instrument evidencing its adoption of the Plan and filing the instrument with the Plan Administrator. Such adoption shall be subject to such terms and conditions as the Plan Administrator requires.
ARTICLE XII
GENERAL PROVISIONS
12.1
Good Faith Payment.
Any payment made in good faith in accordance with provisions of the Plan shall be a complete discharge of any liability for the making of such payment under the provisions of this Plan.
12.2
No Right to Employment.
This Plan does not constitute a contract of employment, and participation in the Plan shall not give any Participant the right to be retained in the employment of the Corporation or any other Employer.
12.3
Binding Effect.
The provisions of this Plan shall be binding upon the Corporation and its successors and assigns and upon every Participant and his heirs, Beneficiaries, estates and legal representatives.
12.4
Participant Change of Address.
Each Participant entitled to benefits shall file with the Plan Administrator, in writing, any change of post office address. Any check representing payment and any communication addressed to a Participant or a former Participant at this last address filed with the Plan Administrator, or if no such address has been filed, then at his last address as indicated on the Corporation’s records, shall be binding on such Participant for all purposes of the Plan, and neither the Plan Administrator, the Corporation nor any other payer shall be obliged to search for or ascertain the location of any such Participant. .If the Corporation and the Plan Administrator are unable to locate a Participant or another person or entity to whom payment is due under this Plan, in order to make a distribution to such person or entity, the amount of the Participant’s benefits under the Plan that would otherwise be considered as nonforfeitable shall be forfeited effective four (4) years after (i) the last date a payment of said benefit was made, if at least one such payment was made, or (ii) the first date a payment of said benefit was directed to be made by the Plan Administrator pursuant to the terms of the Plan, if no payments have been made. If such person is located after the date of such forfeiture, the benefits for such Participant or Beneficiary shall not be reinstated hereunder.
12.5
Notices.
Each Participant shall furnish to the Plan Administrator any information the Plan Administrator deems necessary for purposes of administering the Plan, and the payment provisions of the Plan are conditional upon the Participant furnishing promptly such true and complete information as the Plan Administrator may request. Each Participant shall submit proof of his age when required by the Plan Administrator. The Plan Administrator shall, if such proof of age is not submitted as required, use such information as is deemed by it to be reliable, regardless of the lack of proof, or the misstatement of the age of individuals entitled to benefits. Any notice or information which, according to the terms of the Plan or requirements of the Plan Administrator, must be filed with the Plan Administrator, shall be deemed so filed if addressed and either delivered in person or mailed to and received by the Plan Administrator, in care of the Corporation at:
Schweitzer-Mauduit International, Inc.
100 North Point Center East
Suite 600
Alpharetta, Georgia 30022
Attention: Human Resources Committee
12.6
Designation of Beneficiary.
Each Participant shall designate, by name, on Beneficiary designation forms provided by the Plan Administrator, the Beneficiary(ies) who shall receive any benefits which might be payable after such Participant’s death. A Beneficiary designation may be changed or revoked without such Beneficiary’s consent at any time or from time to time in the manner as provided by the Plan Administrator, and the Plan Administrator shall have no duty to notify any individual or entity designated as a Beneficiary of any change in such designation which might affect such individual or entity’s present or future rights. If no designated Beneficiary(ies) survive the Participant or in existence at the time of the Participant’s death, or if the Participant does not designate a Beneficiary, the Participant’s Beneficiary shall be (i) the Participant’s surviving spouse, (ii) if there is no surviving spouse, the Participant’s children (natural or adopted) per stirpes (with the portion for each deceased child to such child’s living descendant per stirpes) or (iii) if there is no surviving spouse, children or living descendants, the Participant’s estate. Distributions to any child under the age of 18 may be made to the child’s legal guardian or a trust for the child’s benefit.
No Participant shall designate more than five (5) simultaneous Beneficiaries, and if more than one (1) Beneficiary is named, Participant shall designate the share to be received by each Beneficiary. Despite the limitation on five (5) Beneficiaries, a Participant may designate more than five (5) Beneficiaries provided such beneficiaries are the surviving spouse and children of the Participant. If a Participant designates alternative, successor, or contingent Beneficiaries, such Participant shall specify the shares, terms and conditions upon which amounts shall be paid to such multiple, alternative, successor or contingent beneficiaries. Any payment made under this Plan after the death of a Participant shall be made only to the Beneficiary or Beneficiaries designated pursuant to this Section 13.6.
12.7
Claims and Appeals Procedure
.
(a)
Deciding the Claim
. A claim is a request for a Plan benefit made by a claimant on a form provided by the Plan Administrator. The claimant must mail or deliver the completed and executed form to the Plan Administrator for it to be considered. The Plan Administrator shall decide the claim. Except in the case of a disability claim, if a claim is wholly or partially denied, the Plan Administrator shall provide the claimant with written or electronic notification of the adverse benefit determination within a reasonable period of time, but not later than 90 days after receipt of the claim by the Plan Administrator, unless the Plan Administrator determines that special circumstances require an extension of time for processing the claim. If the Plan Administrator determines that an extension of time for processing is required, written notice of the extension shall be furnished to the claimant prior to the termination of the initial 90-day period. In no event shall such extension exceed a period of 90 days from the end of such initial period. The extension notice shall indicate the special circumstances requiring an extension of time and the date by which the Plan Administrator expects to render the benefit determination.
(b)
Notification of the Decision
. Notice of the Plan Administrator’s adverse benefit determination shall set forth, in a manner calculated to be understood by the claimant:
|
|
(i)
|
The specific reason or reasons for the adverse determination;
|
|
|
(ii)
|
Reference to the specific Plan provisions on which the determination is based;
|
|
|
(iii)
|
A description of any additional material or information necessary for the claimant to perfect the claim and an explanation of why such material or information is necessary;
|
|
|
(iv)
|
A description of the Plan’s review procedures and the time limits applicable to such procedures, including a statement of the claimant’s right to bring a civil action under section 502(a) of ERISA following an adverse benefit determination on appeal; and
|
|
|
(v)
|
In the case of an adverse benefit determination of a claim for a disability benefit,
|
|
|
(A)
|
If an internal rule, guideline, protocol or other similar criterion was relied upon in making the adverse determination, either the specific rule, guideline, protocol or similar criterion; or a statement that such a rule, guideline, protocol or other similar criterion was relied upon in making the adverse determination and that a copy of such rule, guideline, protocol or other criterion will be provided free of charge to the claimant upon request; or
|
|
|
(B)
|
If the adverse benefit determination is based on a medical necessity or experimental treatment or similar exclusion or limit, either an explanation of the scientific or clinical judgment for the determination, applying the terms of the Plan to the claimant’s medical circumstances, or a statement that such explanation will be provided free of charge upon request. Any electronic notification shall comply with the standards imposed by regulations issued by the Department of Labor under ERISA.
|
(c)
Notification for Disability Claims
. In the case of a claim for disability benefits, the Plan Administrator shall notify the claimant, as provided in the preceding paragraph, of the Plan Administrator’s adverse benefit determination within a reasonable period of time, but not later than 45 days after receipt of the claim by the Plan Administrator. This period may be extended by the Plan Administrator for up to 30 days, provided that the Plan Administrator both determines that such an extension is necessary due to matters beyond the control of the Plan Administrator, and notifies the claimant, prior to the expiration of the initial 45-day period, of the circumstances requiring an extension of time and the date by which the Plan Administrator expects to render a decision. If, prior to the end of the first 30-day extension period, the Plan Administrator determines that, due to matters beyond the control of the Plan, a decision cannot be rendered within that extension period, the period for making the determination may be extended for up to an additional 30 days, provided that the Plan Administrator notifies the claimant, prior to the expiration of the first 30-day extension period, of the circumstances requiring the extension and the date as of which the Plan
Administrator expects to render a decision. The notice of extension shall specifically explain the standards on which entitlement to a benefit is based, the unresolved issues that prevent the decision on the claim, and the additional information needed to resolve those issues. The claimant should be afforded at least 45 days within which to provide the specified information.
(d)
Time for Deciding Claims
. For purposes of subsection 13.7(a), the period of time within which a benefit determination is required to be made shall begin at the time a claim is filed in accordance with the procedures set forth in that subsection, without regard to whether all the information necessary to make a benefit determination accompanies the filing. In the event a period of time is extended as permitted by subsection 13.7(a) due to a claimant’s failure to submit information necessary to decide a claim, the period for making the benefit determination shall be tolled from the date on which the notification of the extension is sent to the claimant until the date on which the claimant responds to the request for additional information.
(e)
Authorized Representative
. An authorized representative of the claimant may act on his or her behalf in pursuing a benefit claim or appeal of an adverse benefit determination. The Plan Administrator may require, as a prerequisite to dealing with a representative, that the claimant verify in writing authority of the representative to act on behalf of the claimant.
(f)
Consistency
. The Plan Administrator shall conduct or have conducted on its behalf periodic reviews to verify that benefit claim determinations are made in accordance with governing Plan documents and that, where appropriate, the Plan’s provisions have been applied consistently with respect to similarly-situated claimants.
(g)
Deciding the Appeal
. A claimant may appeal an adverse benefit determination to the Plan Administrator by mailing or delivering to the Plan Administrator a written notice of appeal. The claimant may submit written comments, documents, records, or other information relating to the claim for benefits to the Plan Administrator. The Plan Administrator shall provide to the claimant, upon request and free of charge, reasonable access to, and copies of, all documents, records, and other information relevant to the claimant’s claim for benefits. Whether a document, record or other information is relevant to a claim for benefits shall be determined in accordance with standards issued by the Department of Labor. The Plan Administrator shall decide the appeal. The Plan Administrator’s decision shall take into account all comments, documents, records, and other information submitted by the claimant relating to the claim, without regard to whether such information was submitted or considered in the initial benefit determination. The Plan Administrator will not, however, consider a claimant’s appeal unless the Plan Administrator receives it within 60 days following receipt by the claimant of a notification of an adverse benefit determination.
(h)
Disability Appeals
. In the case of an appeal involving a disability benefit, the Plan Administrator will not consider the appeal unless the Plan Administrator receives it within 180 days (rather than the generally applicable 60 days) after the claimant receives written notification of the denial of his or her claim. In deciding an appeal of any adverse benefit determination involving a disability benefit where the determination is based in whole or in part on a medical judgment, including determinations with regard to whether a particular treatment, drug or other item is experimental, investigational, or not medically necessary or appropriate, the Plan Administrator shall consult with a health care professional who has appropriate training and experience in the field
of medicine involved in the medical judgment. In the case of an adverse benefit determination involving a disability claim, the review on appeal shall provide for the identification of medical or vocational experts whose advice was obtained on behalf of the Plan in connection with a claimant’s adverse benefit determination, without regard to whether the advice was relied upon in making the benefit determination. Any health care professional engaged for purposes of a consultation under this section shall be an individual who is neither an individual who was consulted in connection with the adverse benefit determination that is the subject of the appeal, nor the subordinate of any such individual.
(i)
Time for Deciding Appeals
. The Plan Administrator will decide a claimant’s appeal no later than 60 days following the Plan Administrator’s receipt of the appeal, unless the Plan Administrator determines that special circumstances require an extension of time for processing the claim. If the Plan Administrator determines that an extension of time for processing the claim is required, written notice of the extension shall be furnished to the claimant prior to the termination of the initial 60-day period. In no event shall such extension exceed a period of 60 days from the end of the initial period. The extension notice shall indicate the special circumstances requiring an extension of time and the date by which the Plan Administrator expects to render its decision.
(j)
Notification of the Decision on Appeal
. Except in the case of a disability claim, the Plan Administrator shall provide a claimant as soon as possible, but not later than five days after the benefit determination is made, with written or electronic notification of the Plan Administrator’s decision on appeal. Any electronic notification shall comply with the standards imposed by the Department of Labor by regulations issued under ERISA. In the case of an adverse benefit determination, the notice shall set forth, in a manner calculated to be understood by the claimant:
|
|
(i)
|
The specific reason or reasons for the adverse determination;
|
|
|
(ii)
|
Reference to the specific Plan provisions on which the benefit determination is based;
|
|
|
(iii)
|
A statement that the claimant is entitled to receive, upon request and free of charge, reasonable access to, and copies of, all documents, records, and other information relevant to the claimant’s claim for benefits (whether a document, record or other information is relevant to a claim for benefit shall be determined by reference to regulations issued under ERISA by the Department of Labor);
|
|
|
(iv)
|
A statement of the claimant’s right to bring an action under section 502(a) of ERISA;
|
|
|
(v)
|
In the case of claim involving a disability benefit:
|
|
|
(A)
|
If an internal rule, guideline, protocol or other similar criterion was relied upon in making the adverse determination, either the specific rule, guideline, protocol or similar criterion; or a statement that such rule, guideline, protocol or other similar criterion was relied upon in
|
making the adverse determination and that a copy of the rule, guideline, protocol or other criterion will be provided free of charge to the claimant upon request; and
|
|
(B)
|
If the adverse benefit determination is based on a medical necessity or experimental treatment or similar exclusion or limit, either an explanation of the scientific or clinical judgment for the determination, applying the terms of the Plan to the claimant’s medical circumstances, or a statement that such explanation will be provided free of charge upon request.
|
(k)
Notification of the Decision on Appeal; Disability Claims
. In the case of a claim for disability benefits, the Plan Administrator shall notify the claimant, in accordance with subsection 13.7(j), of the Plan Administrator’s benefit determination on review within a reasonable period of time appropriate to the medical circumstances. That notification shall be provided not later than 45 days after receipt by the Plan Administrator of the claimant’s request for review of an adverse benefit determination. This period may be extended by the Plan Administrator for up to 45 days, provided that the Plan Administrator both determines that such an extension is necessary due to matters beyond the control of the Plan Administrator, and notifies the claimant, prior to the expiration of the initial 45-day period, of the circumstances requiring an extension of time and the date by which the Plan Administrator expects to render a decision.
(l)
No Liability; Trustee Authority
. No member of the Board of Directors, or any committee thereof, and no officer, employee or agents of the Corporation shall be liable nor will the Plan Administrator be liable, to any individual or entity for any action taken hereunder, except those actions undertaken with lack of good faith. If the Corporation has established a Rabbi Trust for the Plan pursuant to which the trustee has agreed to act in a capacity other than as a directed trustee in the event of a Change of Control, the trustee of the Rabbi Trust shall perform the duties of the Plan Administrator under this Section 13.7 following a Change of Control.
12.8
Statute of Limitations
. Except for any action against a fiduciary for a breach of his fiduciary duty, an action filed in state or federal court regarding any rights or obligations under the Plan must be brought within one year from the date of the final decision of the Plan Administrator.
12.9
Action by Board of Directors.
Any action required to be taken by the Board of Directors of the Corporation pursuant to the Plan provisions may be performed by the Compensation Committee of the Board.
12.10
Governing Law.
To the extent not superseded by the laws of the United States, the laws of the State of Georgia shall be controlling in all matters relating to this Plan.
12.11
Severability.
In the event any provision of this Plan shall be held illegal or invalid for any reason, such illegality or invalidity shall not affect the remaining provisions of the Plan, and the Plan shall be interpreted and enforced as if such illegal and invalid provisions had never been set forth.
12.12
Code Section 409A.
It is the intention of the Corporation that this Plan shall meet the requirements of Section 409A of the Code and applicable Treasury Regulations that must be met in order for amounts of compensation deferred under this Plan to be taxable, for purposes of federal income taxation, in the year of actual receipt by the Participant or Beneficiary. If any provision of this Plan is susceptible of two interpretations, one of which results in the compliance of the Plan with Section 409A of the Code and the applicable Treasury Regulations, and one of which does not, then the provision shall be given the interpretation that results in compliance with Section 409A and the applicable Treasury Regulations.
12.13
Withholding of Taxes
. Notwithstanding any other provision of this Plan, the Corporation shall withhold from payments made hereunder or obtain from the Participant any amounts applicable law requires to be withheld. Additionally, to the extent that the Corporation is required to withhold any income taxes, employment taxes (such as without limitation Social Security and Medicare taxes) or other amounts from any Deferred Account pursuant to any state, federal or local law, such amounts may be taken out of other compensation or amounts eligible to be paid to the Participant that are not deferred under the Plan and the Participant shall be required to pay to the Corporation in cash any other amounts that may be owed.
IN WITNESS WHEREOF, Schweitzer-Mauduit International, Inc. has adopted the foregoing instrument effective as of January 1, 2014.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC.
By:
Title:
SUMMARY OF NON-MANAGEMENT DIRECTOR COMPENSATION
As of January 1, 2014
|
|
|
|
|
|
Function
|
|
Amount Paid
|
|
Form of Payment
|
|
|
|
|
|
Annual Stock Retainer
|
|
$75,000 annually
|
|
Payable in quarterly increments in shares of company common stock at its fair market value
|
|
|
|
|
|
Annual Cash Retainer
|
|
$45,000 annually
|
|
Payable in cash in quarterly increments
|
|
|
|
|
|
Audit Committee Members Meeting Fee
|
|
$15,000 annually
|
|
Payable in cash in quarterly increments
|
|
|
|
|
|
Audit Committee Chair Meeting Fee
|
|
$30,000 annually
|
|
Payable in cash in quarterly increments
|
|
|
|
|
|
Compensation Committee Members Meeting Fee
|
|
$10,000 annually
|
|
Payable in cash in quarterly increments
|
|
|
|
|
|
Compensation Committee Chair Meeting Fee
|
|
$20,000 annually
|
|
Payable in cash in quarterly increments
|
|
|
|
|
|
Nominating & Governance Committee Members Meeting Fee
|
|
$10,000 annually
|
|
Payable in cash in quarterly increments
|
|
|
|
|
|
Nominating & Governance Committee Chair Meeting Fee
|
|
$15,000 annually
|
|
Payable in cash in quarterly increments
|
|
|
|
|
|
Lead-Non Management Director Fee
|
|
$20,000 annually
|
|
Payable in cash in quarterly increments
|
|
|
|
|
|
Meeting Travel Expenses
|
|
Reasonable and actual
|
|
Cash reimbursement
|
SUMMARY OF NAMED EXECUTIVE OFFICER COMPENSATION
Effective
as of January 1, 2013, the follow
ing are the annual base salaries of the Chief Executive Officer and other Named Executive Officers of Schweitzer-Mauduit International, Inc. No named executive officer has an employment contract with the Company. The Named Executive Officers participate in various compensation plans and other arrangements as described in the Company's 2014 Proxy Statement.
|
|
|
|
|
|
2013 Base Salary
|
Chairman and Chief Executive Officer
|
$
|
780,000
|
|
Chief Operating Officer
|
$
|
485,000
|
|
Executive Vice President, CFO & Treasurer
|
$
|
345,050
|
|
General Counsel and Secretary
|
$
|
470,000
|
|
Executive Vice President, Reconstituted Tobacco Business
|
$
|
460,810
|
|
SCHWEITZER-MAUDUIT INTERNATIONAL, INC.
RESTRICTED STOCK AGREEMENT
(Restricted Stock Plan – Cliff Vesting Shares)
You have been selected to be a recipient of a grant under the Schweitzer-Mauduit International, Inc. Restricted Stock Plan (the “Plan”), as specified below:
GRANTEE:
DATE OF GRANT:
NUMBER OF RESTRICTED SHARES GRANTED:
DATE OF LAPSE OF RESTRICTIONS:
THIS AGREEMENT, effective as of the Date of Grant set forth above, is between Schweitzer-Mauduit International, Inc., a Delaware corporation (the “Company”) and the Grantee named above, and is entered into pursuant to the provisions of the Plan. The parties hereto agree as follows:
1.
Employment by the Company
. The Restricted Stock granted hereunder is awarded on the condition that Grantee remain in the employ of the Company from the Date of Grant through (and including) the Date of Lapse of Restrictions, as specified above (this time period is referred to as the “Restriction Period”).
However, neither such condition nor the award of the Restricted Stock shall impose upon the Company any obligation to retain Grantee in its employ for any given period or upon any specific terms of employment.
2.
Certificate Legend
. Each certificate representing shares of Restricted Stock granted pursuant to the Plan shall bear the following legend:
“The sale or other transfer of the shares of stock represented by this certificate, whether voluntary, involuntary, or by operation of law, is subject to certain restrictions on transfer set forth in Schweitzer-Mauduit International, Inc.’s Restricted Stock Plan (“Plan”), any rules of administration adopted pursuant to such Plan, and a Restricted Stock Agreement dated __________, 20__. A copy of the Plan, such rules, and such Restricted Stock Agreement may be obtained from the Secretary of Schweitzer-Mauduit International, Inc.”
3.
Removal of Restrictions
. Except as otherwise provided herein and in the Plan, awards granted under this Agreement shall become freely transferable by Grantee after the Date of Lapse of Restrictions. Once the awards are released from the restrictions, Grantee shall be entitled to have the legend required by Section 2 of this Agreement removed from his or her stock certificate.
4.
Voting Rights and Dividends
. During the Restriction Period, Grantee may exercise full voting rights and is entitled to receive all dividends and other distributions paid with respect to the shares of Restricted Stock while they are held. If any such dividends or distributions are paid in shares of common stock of the Company, the shares received shall be subject to the same restrictions on transferability as are the shares of Restricted Stock with respect to which they were paid.
5.
Termination of Employment Due to Death or Total and Permanent Disability
. In the event the employment of Grantee is terminated by reason of death or Total and Permanent Disability (as defined
in the Plan) during the Restriction Period, the restrictions applicable to all shares of Restricted Stock held by Grantee at the time of termination shall lapse as of the date of death or Total and Permanent Disability.
6.
Termination of Employment for Other Reasons
. In the event that Grantee terminates employment with the Company during the Restriction Period for any reason other than those reasons set forth in Section 5 herein, all shares of Restricted Stock held by the Grantee at the time of employment termination shall be forfeited by Grantee to the Company; provided, however, that in the event of an involuntary termination of the employment of Grantee by the Company, the Compensation Committee, in its sole discretion, may waive the automatic forfeiture provisions; further provided, that any waiver of the automatic forfeiture provision as to any Participant who is a covered employee under Section 162(m) of the Internal Revenue Code must be acted upon by formal resolution or unanimous consent in lieu of a meeting and affirmatively recite that it is the Committee’s intention to so act notwithstanding the potential loss of a Corporate tax deduction.
7.
Change in Control.
In the event of a Change in Control (as defined in the Plan), all restrictions on the transferability of outstanding awards of Restricted Stock held by Grantee under the Plan shall immediately lapse, and thereafter such shares shall be freely transferable by Grantee, subject to applicable Federal and state securities laws.
8.
Transferability
. Shares of Restricted Stock granted under this Agreement are not transferable by Grantee, whether voluntarily or involuntarily, by operation of law or otherwise, during the Restriction Period, except as provided in the Plan. If any assignment, pledge, transfer, or other disposition, voluntary or involuntary, of Restricted Stock shall be made, or if any attachment, execution, garnishment, or lien shall be issued against or placed upon the Restricted Stock, then Grantee’s right to the Restricted Stock shall immediately cease and terminate, and Grantee shall promptly surrender to the Company all certificates evidencing Restricted Stock awarded under this Agreement.
9.
Recapitalization
. In the event that there is any change in the common stock of the Company through the declaration of stock dividends or through recapitalization resulting in stock split-ups or through merger, consolidation, or exchange of shares, or otherwise, the number of shares of Restricted Stock subject to this Agreement shall be equitably adjusted by the Compensation Committee to prevent dilution or enlargement of rights in accordance with the Plan.
10.
Administration
. This Agreement and the rights of Grantee hereunder are subject to all the terms and conditions of the Plan, as the same may be amended from time to time, as well as to such rules and regulations as the Compensation Committee, as such term is defined in the Plan, may adopt for administration of the Plan. It is expressly understood that the Compensation Committee is authorized to administer, construe, and make all determinations necessary or appropriate to the administration of the Plan and this Agreement, all of which shall be binding upon Grantee. Any inconsistency between this Agreement and the Plan shall be resolved in favor of the Plan.
11.
Miscellaneous
.
|
|
(a)
|
This Agreement shall not confer upon Grantee any right to continuation of employment by the Company, nor shall this Agreement interfere in any way with the Company’s right to terminate his or her employment at any time.
|
|
|
(b)
|
Subject to the terms of the Plan, the Compensation Committee may terminate, amend, or modify the Plan or this Agreement; provided, however, that no such termination, amendment, or modification of the Plan or this Agreement may in any way adversely affect Grantee’s rights under this Agreement without Grantee’s consent.
|
|
|
(c)
|
The Company shall have the authority to deduct or withhold, or require Grantee to remit to the Company, an amount sufficient to satisfy Federal, state, and local taxes (including Grantee’s FICA obligation) required by law to be withheld with respect to any provision of this agreement.
|
|
|
(d)
|
This Agreement shall be subject to all applicable laws, rules, and regulations and to such approvals by any governmental agencies or national securities exchanges as may be required.
|
|
|
(e)
|
To the extent not preempted by Federal law, this Agreement shall be governed by, and construed in accordance with the laws of the State of Georgia.
|
IN WITNESS THEREOF, the parties have caused the Agreement to be executed as of the Date of Grant.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC.
By: __________________________________________
Frédéric Villoutreix, Chairman and CEO
ATTEST:
_________________________________________
John W. Rumely, Jr., Secty. & General Counsel
______________________________________________
(Grantee)
SCHWEITZER-MAUDUIT INTERNATIONAL, INC.
RESTRICTED STOCK AGREEMENT
(French Participants – Cliff Vesting)
You have been selected to be a recipient of a grant under the Schweitzer-Mauduit International, Inc. Restricted Stock Plan and the Sub Plan for the Administration of Grants of French-Qualified Restricted Shares to Employees in France (collectively, the “Plan”), as specified below:
GRANTEE:
DATE OF GRANT:
NUMBER OF RESTRICTED SHARES GRANTED:
|
|
DATE(S) OF LAPSE OF RESTRICTIONS:
|
|
Vesting restrictions lapse on ____________ (“Vesting Date”).
Restrictions on transfer and sale following vesting continue for two additional years, until ___________, (“Date of Lapse of Restrictions”), in order to comply with the requirements under French law for avoiding the assessment of increased personal income tax and associated social charges payable by the individual and the company for sales occurring in less than two years following the date of vesting (the “French Favorable Regime”). This period is referred to as the “Restriction Period.”
THIS AGREEMENT, effective as of the Date of Grant set forth above, is between Schweitzer-Mauduit International, Inc., a Delaware corporation (the “Company”) and the Grantee named above, and is entered into pursuant to the provisions of the Plan. The parties hereto agree as follows:
1.
Employment by the Company
. The Restricted Stock granted hereunder is awarded on the condition that Grantee remain in the employ of the Company from the Date of Grant through (and including) the Date of Lapse of Restrictions, as specified above.
However, neither such condition nor the award of the Restricted Stock shall impose upon the Company any obligation to retain Grantee in its employ for any given period or upon any specific terms of employment.
2.
Certificate Legend
. Each certificate representing shares of Restricted Stock granted pursuant to the Plan shall bear the following legend:
“The sale or other transfer of the shares of stock represented by this certificate, whether voluntary, involuntary, or by operation of law, is subject to certain restrictions on transfer set forth in Schweitzer-Mauduit International, Inc.’s Restricted Stock Plan and the Sub Plan for the Administration of Grants of French-qualified Restricted Shares to Employees in France (collectively, “Plan”), any rules of administration adopted pursuant to such Plan, and a Restricted Stock Agreement dated __________. A copy of the Plan, such rules, and such Restricted Stock Agreement may be obtained from the Secretary of Schweitzer-Mauduit International, Inc.”
3.
Removal of Restrictions
. Except as otherwise provided herein and in the Plan, awards granted under this Agreement shall become freely transferable by Grantee after the Date of Lapse of Restrictions; provided, however, that Restricted Stock granted hereunder may not be sold by the Grantee during a Closed Period, as more fully set forth in the Plan. Once the awards are released from the restrictions, Grantee shall be entitled to have the legend required by Section 2 of this Agreement removed from his or her stock certificate.
4.
Voting Rights and Dividends
. Before the Vesting Date, Grantee shall have no right to vote and shall not be entitled to any dividends or other distributions paid with respect to the shares of Restricted Stock. After the Vesting Date, Grantee may exercise full voting rights and is entitled to receive all dividends and other distributions paid with respect to the shares of Restricted Stock while they are held. If any such dividends or distributions are paid in shares of common stock of the Company, the shares shall be subject to the same restrictions on transferability as are the shares of Restricted Stock with respect to which they were paid.
5.
Termination of Employment Due to Death or Permanent Invalidity
. In the event the employment of Grantee is terminated by reason of death or Permanent Invalidity (as defined in the Plan) during the Restriction Period, the restrictions applicable to all shares of Restricted Stock held by Grantee at the time of termination shall lapse as of the date of death or Permanent Invalidity.
6.
Termination of Employment for Other Reasons
. In the event that Grantee terminates employment with the Company during the Restriction Period for any reason other than those reasons set forth in Section 5 herein, all shares of Restricted Stock held by the Grantee at the time of employment termination shall be forfeited by Grantee to the Company; provided, however, that in the event of an involuntary termination of the employment of Grantee by the Company, the Compensation Committee, in its sole discretion, may waive the automatic forfeiture provisions; further provided, that any waiver of the automatic forfeiture provision as to any participant who is a covered employee under Section 162(m) of the Internal Revenue Code must be acted upon by formal resolution or unanimous consent in lieu of a meeting and affirmatively recite that it is the Committee’s intention to so act notwithstanding the potential loss of a corporate tax deduction.
7.
Change in Control.
In the event of a Change in Control, (as defined in the Plan), all restrictions on the transferability of outstanding awards of Restricted Stock held by Grantee under the Plan shall immediately lapse, and thereafter such shares shall be freely transferable by Grantee, subject to applicable Federal and state securities laws. In the event that there is any change in the common stock of the Company through the declaration of stock dividends or through recapitalization resulting in stock split-ups or through merger, consolidation, or exchange of shares, or otherwise, the number of shares of Restricted Stock subject to this Agreement shall be equitably adjusted by the Compensation Committee to prevent dilution or enlargement of rights in accordance with the Plan. Notwithstanding this provision, however, in the event of a Change of Control, recapitalization, or other event incurring the accelerated vesting of Restricted Stock that is not expressly provided for under French law, the Restricted Stock may no longer qualify under the French Favorable Regime, and the Compensation Committee may, at its option, determine to lift, shorten or terminate certain restrictions applicable to the vesting, settlement or transferability of the Restricted Stock in order to benefit from the French Favorable Regime, or to take no action at all. The failure or inability of any grant of Restricted Stock to qualify for the French Favorable Regime for any reason shall not, under any circumstances, entitle the Grantee or his or her
heirs to make any claims for damages, additional compensation, other benefit or payment of taxes owed or otherwise.
8.
Transferability
. Shares of Restricted Stock granted under this Agreement are not transferable by Grantee, whether voluntarily or involuntarily, by operation of law or otherwise, during the Restriction Period, except as provided in the Plan. If any assignment, pledge, transfer, or other disposition, voluntary or involuntary, of Restricted Stock shall be made, or if any attachment, execution, garnishment, or lien shall be issued against or placed upon the Restricted Stock, then Grantee’s right to the Restricted Stock shall immediately cease and terminate, and Grantee shall promptly surrender to the Company all certificates evidencing Restricted Stock awarded under this Agreement.
9.
Administration
. This Agreement and the rights of Grantee hereunder are subject to all the terms and conditions of the Plan, as the same may be amended from time to time, as well as to such rules and regulations as the Compensation Committee, as such term is defined in the Plan, may adopt for administration of the Plan. It is expressly understood that the Compensation Committee is authorized to administer, construe, and make all determinations necessary or appropriate to the administration of the Plan and this Agreement, all of which shall be binding upon Grantee. Any inconsistency between this Agreement and the Plan shall be resolved in favor of the Plan.
10.
Taxation.
The sale of shares that vest under this agreement in less than four years from the date of grant may result in material personal tax liabilities. Please consult with your tax advisor before selling your shares to determine if such excess taxes will apply due to the length of time you held your shares.
11.
Miscellaneous
.
|
|
(a)
|
This Agreement shall not confer upon Grantee any right to continuation of employment by the Company, nor shall this Agreement interfere in any way with the Company’s right to terminate his or her employment at any time.
|
|
|
(b)
|
Subject to the terms of the Plan, the Compensation Committee may terminate, amend, or modify the Plan or this Agreement; provided, however, that no such termination, amendment, or modification of the Plan or this Agreement may in any way adversely affect Grantee’s rights under this Agreement without Grantee’s consent.
|
|
|
(c)
|
The Company shall have the authority to deduct or withhold, or require Grantee to remit to the Company, an amount sufficient to satisfy any and all taxes required by law to be withheld with respect to any provision of this agreement.
|
|
|
(d)
|
This Agreement shall be subject to all applicable laws, rules, and regulations and to such approvals by any governmental agencies or national securities exchanges as may be required.
|
|
|
(e)
|
To the extent not preempted by U.S. Federal law, this Agreement shall be governed by, and construed in accordance with the laws of the State of Georgia.
|
IN WITNESS THEREOF, the parties have caused the Agreement to be executed as of the Date of Grant.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC.
By: __________________________________________
Frédéric Villoutreix, Chairman and CEO
ATTEST:
_________________________________________
John W. Rumely, Jr., Secty. & General Counsel
______________________________________________
(Name of recipient)
SCHWEITZER-MAUDUIT INTERNATIONAL, INC.
RESTRICTED STOCK AGREEMENT
(Restricted Stock Plan – Performance Share Award)
You have been selected to be a recipient of a grant under the Schweitzer-Mauduit International, Inc. Restricted Stock Plan (the “Plan”), as specified below:
GRANTEE:
DATE OF GRANT:
NUMBER OF RESTRICTED SHARES GRANTED:
DATE(S) OF LAPSE OF RESTRICTIONS:
THIS AGREEMENT, effective as of the Date of Grant set forth above, is between Schweitzer-Mauduit International, Inc., a Delaware corporation (the “Company”) and the Grantee named above, and is entered into pursuant to the provisions of the Plan. The parties hereto agree as follows:
1.
Employment by the Company
. The Restricted Stock granted hereunder is awarded on the condition that Grantee remain in the employ of the Company from the Date of Grant through (and including) the Date of Lapse of Restrictions, as specified above (this time period is referred to as the “Restriction Period”).
However, neither such condition nor the award of the Restricted Stock shall impose upon the Company any obligation to retain Grantee in its employ for any given period or upon any specific terms of employment.
2.
Certificate Legend
. Each certificate representing shares of Restricted Stock granted pursuant to the Plan shall bear the following legend:
“The sale or other transfer of the shares of stock represented by this certificate, whether voluntary, involuntary, or by operation of law, is subject to certain restrictions on transfer set forth in Schweitzer-Mauduit International, Inc.’s Restricted Stock Plan (“Plan”), any rules of administration adopted pursuant to such Plan, and a Restricted Stock Agreement dated __________, 20__. A copy of the Plan, such rules, and such Restricted Stock Agreement may be obtained from the Secretary of Schweitzer-Mauduit International, Inc.”
3.
Removal of Restrictions
. Except as otherwise provided herein and in the Plan, awards granted under this Agreement shall become freely transferable by Grantee after the Date of Lapse of Restrictions. Once the awards are released from the restrictions, Grantee shall be entitled to have the legend required by Section 2 of this Agreement removed from his or her stock certificate.
4.
Voting Rights and Dividends
. During the Restriction Period, Grantee may exercise full voting rights and is entitled to receive all dividends and other distributions paid with respect to the shares of Restricted Stock while they are held. If any such dividends or distributions are paid in shares of common stock of the Company, the shares received shall be subject to the same restrictions on transferability as are the shares of Restricted Stock with respect to which they were paid.
5.
Termination of Employment Due to Death, Total and Permanent Disability, or Retirement
. In the event the employment of Grantee is terminated during the Restriction Period by reason of death or Total and Permanent Disability (as defined in the Plan), or by Retirement (as defined in the Plan) if the Grantee is at least age 55 on the date of Retirement, the restrictions applicable to a fraction of the shares of Restricted Stock held by Grantee at the time of termination shall lapse as of the date Grantee's employment terminated, as follows: the numerator is the number of full months of employment of Grantee during the applicable Restriction Period, and the denominator is the total number of full months comprising the Restriction Period. If, after the termination of Grantee’s employment due to Total and Permanent Disability, but prior to the Date of Lapse of Restrictions as set forth on the first page of this Agreement, Grantee dies, then the number of shares of Restricted Stock with respect to which restrictions shall lapse and the timing of such lapse shall be determined according to the above paragraph, applied by treating Grantee as if he or she had remained employed by the Company until the date of his or her death.
6.
Termination of Employment for Other Reasons
. In the event that Grantee terminates employment with the Company during the Restriction Period for any reason other than those reasons set forth in Sections 5 and 7 herein, all shares of Restricted Stock held by the Grantee at the time of employment termination shall be forfeited by Grantee to the Company; provided, however, that in the event of an involuntary termination of the employment of Grantee by the Company, the Compensation Committee, in its sole discretion, may waive the automatic forfeiture provisions; further provided, that any waiver of the automatic forfeiture provision as to any Participant that is a covered employee under Section 162(m) of the Internal Revenue Code must be acted upon by formal resolution or unanimous consent in lieu of a meeting and affirmatively recite that it is the Committee’s intention to so act notwithstanding the potential loss of a Corporate tax deduction.
7.
Change in Control.
In the event of a Change in Control (as defined in the Plan), all restrictions on the transferability of outstanding awards of Restricted Stock held by Grantee under the Plan shall immediately lapse, and thereafter such shares shall be freely transferable by Grantee, subject to applicable Federal and state securities laws.
8.
Transferability
. Shares of Restricted Stock granted under this Agreement are not transferable by Grantee, whether voluntarily or involuntarily, by operation of law or otherwise, during the Restriction Period, except as provided in the Plan. If any assignment, pledge, transfer, or other disposition, voluntary or involuntary, of Restricted Stock shall be made, or if any attachment, execution, garnishment, or lien shall be issued against or placed upon the Restricted Stock, then Grantee’s right to the Restricted Stock shall immediately cease and terminate, and Grantee shall promptly surrender to the Company all certificates evidencing Restricted Stock awarded under this Agreement.
9.
Recapitalization
. In the event that there is any change in the common stock of the Company through the declaration of stock dividends or through recapitalization resulting in stock split-ups or through merger, consolidation, or exchange of shares, or otherwise, the number of shares of Restricted Stock subject to this Agreement shall be equitably adjusted by the Compensation Committee to prevent dilution or enlargement of rights in accordance with the Plan.
10.
Administration
. This Agreement and the rights of Grantee hereunder are subject to all the terms and conditions of the Plan, as the same may be amended from time to time, as well as to such rules and regulations as the Compensation Committee, as such term is defined in the Plan, may adopt for
administration of the Plan. It is expressly understood that the Compensation Committee is authorized to administer, construe, and make all determinations necessary or appropriate to the administration of the Plan and this Agreement, all of which shall be binding upon Grantee. Any inconsistency between this Agreement and the Plan shall be resolved in favor of the Plan.
11.
Miscellaneous
.
|
|
(a)
|
This Agreement shall not confer upon Grantee any right to continuation of employment by the Company, nor shall this Agreement interfere in any way with the Company’s right to terminate his or her employment at any time.
|
|
|
(b)
|
Subject to the terms of the Plan, the Compensation Committee may terminate, amend, or modify the Plan or this Agreement; provided, however, that no such termination, amendment, or modification of the Plan or this Agreement may in any way adversely affect Grantee’s rights under this Agreement without Grantee’s consent.
|
|
|
(c)
|
The Company shall have the authority to deduct or withhold, or require Grantee to remit to the Company, an amount sufficient to satisfy Federal, state, and local taxes (including Grantee’s FICA obligation) required by law to be withheld with respect to any provision of this agreement.
|
|
|
(d)
|
This Agreement shall be subject to all applicable laws, rules, and regulations and to such approvals by any governmental agencies or national securities exchanges as may be required.
|
|
|
(e)
|
To the extent not preempted by Federal law, this Agreement shall be governed by, and construed in accordance with the laws of the State of Georgia.
|
IN WITNESS THEREOF, the parties have caused the Agreement to be executed as of the Date of Grant.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC.
By: __________________________________________
Frédéric Villoutreix, Chairman and CEO
ATTEST:
_________________________________________
John W. Rumely, Jr., Secty. & General Counsel
______________________________________________
(Grantee)
SCHWEITZER-MAUDUIT INTERNATIONAL, INC.
RESTRICTED STOCK AGREEMENT
(French Participants – Performance Shares)
You have been selected to be a recipient of a grant under the Schweitzer-Mauduit International, Inc. Restricted Stock Plan and the Sub Plan for the Administration of Grants of French-Qualified Restricted Shares to Employees in France (collectively, the “Plan”), as specified below:
GRANTEE:
DATE OF GRANT:
NUMBER OF RESTRICTED SHARES GRANTED:
DATE(S) OF LAPSE OF RESTRICTIONS:
Vesting restrictions lapse on ____________ (“Vesting Date”).
Restrictions on transfer and sale following vesting continue for two additional years , until ___________ (“Date of Lapse of Restrictions”), in order to comply with the requirements under French law for avoiding the assessment of increased personal income tax and associated social charges payable by the individual and the company for sales occurring in less than two years following the date of vesting (the “French Favorable Regime”). This period is referred to as the “Restriction Period.”)
THIS AGREEMENT, effective as of the Date of Grant set forth above, is between Schweitzer-Mauduit International, Inc., a Delaware corporation (the “Company”) and the Grantee named above, and is entered into pursuant to the provisions of the Plan. The parties hereto agree as follows:
1.
Employment by the Company
. The Restricted Stock granted hereunder is awarded on the condition that Grantee remain in the employ of the Company from the Date of Grant through (and including) the Vesting Date, as specified above.
However, neither such condition nor the award of the Restricted Stock shall impose upon the Company any obligation to retain Grantee in its employ for any given period or upon any specific terms of employment.
2.
Certificate Legend
. Each certificate representing shares of Restricted Stock granted pursuant to the Plan shall bear the following legend:
“The sale or other transfer of the shares of stock represented by this certificate, whether voluntary, involuntary, or by operation of law, is subject to certain restrictions on transfer set forth in Schweitzer-Mauduit International, Inc.’s Restricted Stock Plan and the Sub Plan for the Administration of Grants of French-qualified Restricted Shares to Employees in France (collectively, “Plan”), any rules of administration adopted pursuant to such Plan, and a Restricted Stock Agreement dated __________. A copy of the Plan, such rules, and such Restricted Stock Agreement may be obtained from the Secretary of Schweitzer-Mauduit International, Inc.”
3.
Removal of Restrictions
. Except as otherwise provided herein and in the Plan, awards granted under this Agreement shall become freely transferable by Grantee after the Date of Lapse of Restrictions; provided, however, that Restricted Stock granted hereunder may not be sold by the Grantee during a Closed Period, as more fully set forth in the Plan. Once the awards are released from the restrictions, Grantee shall be entitled to have the legend required by Section 2 of this Agreement removed from his or her stock certificate.
4.
Voting Rights and Dividends
. Before the Vesting Date, Grantee shall have no right to vote and shall not be entitled to any dividends or other distributions paid with respect to the shares of Restricted Stock. After the Vesting Date, Grantee may exercise full voting rights and is entitled to receive all dividends and other distributions paid with respect to the shares of Restricted Stock while they are held. If any such dividends or distributions are paid in shares of common stock of the Company, the shares shall be subject to the same restrictions on transferability as are the shares of Restricted Stock with respect to which they were paid.
5.
Termination of Employment Due to Death
. In the event the employment of Grantee is terminated by reason of death during the Restriction Period, the restrictions applicable to all shares of Restricted Stock held by Grantee at the time of termination shall lapse as of the date of death.
6.
Termination of Employment Due to Permanent Invalidity
. In the event Grantee's active employment by the Company is terminated by reason of Permanent Invalidity, as such term is defined in the Plan, during the Restriction Period, Grantee shall be entitled to a prorated award of shares on the Date of Lapse of Restrictions, based on the number of full months of employment of Grantee during the Restriction Period, in relation to the total number of full months in the Restriction Period. The restrictions on such shares of Restricted Stock shall lapse at the same time they otherwise would have, had the employment termination not occurred.
If, after the termination of Grantee’s employment due to Permanent Invalidity, but prior to the Date of Lapse of Restrictions as set forth on the first page of this Agreement, Grantee dies, then the number of shares of Restricted Stock with respect to which restrictions shall lapse and the timing of such lapse shall be determined according to Section 5 herein, applied by treating Grantee as if he or she had remained employed by the Company until the date of his or her death.
6.
Termination of Employment for Other Reasons
. In the event that Grantee terminates employment with the Company before the Settlement Date for any reason other than those reasons set forth in Section 5 herein, all shares of Restricted Stock held by the Grantee at the time of employment termination shall be forfeited by Grantee to the Company; provided, however, that in the event of an involuntary termination of the employment of Grantee by the Company, the Compensation Committee, in its sole discretion, may waive the automatic forfeiture provisions; further provided, that any waiver of the automatic forfeiture provision as to any participant who is a covered employee under Section 162(m) of the Internal Revenue Code must be acted upon by formal resolution or unanimous consent in lieu of a meeting and affirmatively recite that it is the Committee’s intention to so act notwithstanding the potential loss of a corporate tax deduction.
8.
Change in Control.
In the event of a Change in Control, (as defined in the Plan), all restrictions on the transferability of outstanding awards of Restricted Stock held by Grantee under the Plan shall immediately lapse, and thereafter such shares shall be freely transferable by Grantee, subject to
applicable Federal and state securities laws. In the event that there is any change in the common stock of the Company through the declaration of stock dividends or through recapitalization resulting in stock split-ups or through merger, consolidation, or exchange of shares, or otherwise, the number of shares of Restricted Stock subject to this Agreement shall be equitably adjusted by the Compensation Committee to prevent dilution or enlargement of rights in accordance with the Plan. Notwithstanding this provision, however, in the event of a Change of Control, recapitalization, or other event incurring the accelerated vesting of Restricted Stock that is not expressly provided for under French law, the Restricted Stock may no longer qualify under the French Favorable Regime, and the Compensation Committee may, at its option, determine to lift, shorten or terminate certain restrictions applicable to the vesting, settlement or transferability of the Restricted Stock in order to benefit from the French Favorable Regime, or to take no action at all. The failure or inability of any grant of Restricted Stock to qualify for the French Favorable Regime for any reason shall not, under any circumstances, entitle the Grantee or his or her heirs to make any claims for damages, additional compensation, other benefit or payment of taxes owed or otherwise.
9.
Transferability
. Shares of Restricted Stock granted under this Agreement are not transferable by Grantee, whether voluntarily or involuntarily, by operation of law or otherwise, during the Restriction Period, except as provided in the Plan. If any assignment, pledge, transfer, or other disposition, voluntary or involuntary, of Restricted Stock shall be made, or if any attachment, execution, garnishment, or lien shall be issued against or placed upon the Restricted Stock, then Grantee’s right to the Restricted Stock shall immediately cease and terminate, and Grantee shall promptly surrender to the Company all certificates evidencing Restricted Stock awarded under this Agreement.
10.
Administration
. This Agreement and the rights of Grantee hereunder are subject to all the terms and conditions of the Plan, as the same may be amended from time to time, as well as to such rules and regulations as the Compensation Committee, as such term is defined in the Plan, may adopt for administration of the Plan. It is expressly understood that the Compensation Committee is authorized to administer, construe, and make all determinations necessary or appropriate to the administration of the Plan and this Agreement, all of which shall be binding upon Grantee. Any inconsistency between this Agreement and the Plan shall be resolved in favor of the Plan.
11.
Taxation.
The sale of shares that vest under this agreement in less than four years from the date of grant may result in material personal tax liabilities. Please consult with your tax advisor before selling your shares to determine if such excess taxes will apply due to the length of time you held your shares.
12.
Miscellaneous
.
|
|
(a)
|
This Agreement shall not confer upon Grantee any right to continuation of employment by the Company, nor shall this Agreement interfere in any way with the Company’s right to terminate his or her employment at any time.
|
|
|
(b)
|
Subject to the terms of the Plan, the Compensation Committee may terminate, amend, or modify the Plan or this Agreement; provided, however, that no such termination, amendment, or modification of the Plan or this Agreement may in any way adversely affect Grantee’s rights under this Agreement without Grantee’s consent.
|
|
|
(c)
|
The Company shall have the authority to deduct or withhold, or require Grantee to remit to the Company, an amount sufficient to satisfy any and all taxes required by law to be withheld with respect to any provision of this agreement.
|
|
|
(d)
|
This Agreement shall be subject to all applicable laws, rules, and regulations and to such approvals by any governmental agencies or national securities exchanges as may be required.
|
|
|
(e)
|
To the extent not preempted by U.S. Federal law, this Agreement shall be governed by, and construed in accordance with the laws of the State of Georgia.
|
IN WITNESS THEREOF, the parties have caused the Agreement to be executed as of the Date of Grant.
SCHWEITZER-MAUDUIT INTERNATIONAL, INC.
By: __________________________________________
Frédéric Villoutreix, Chairman and CEO
ATTEST:
_________________________________________
John W. Rumely, Jr., Secty. & General Counsel
______________________________________________
(Name of recipient)
SUBSIDIARIES OF SCHWEITZER-MAUDUIT INTERNATIONAL, INC.
The subsidiaries of the Company at December 31, 2013 were as follows:
|
|
|
|
|
|
Name
|
|
Jurisdiction of
Incorporation or
Organization
|
|
Percentage of
Voting Power
|
Schweitzer-Mauduit Canada, Inc.
|
|
Manitoba Province (Canada)
|
|
100%
|
Schweitzer-Mauduit International China, Limited
|
|
Hong Kong, China
|
|
100%
|
China Tobacco Mauduit (Jiangmen) Paper
Industry Company Ltd. (1)
|
|
People’s Republic of China
|
|
50%
|
China Tobacco - Schweitzer (Yunnan) Reconstituted Tobacco Co. Ltd. (2)
|
|
People’s Republic of China
|
|
50%
|
DelStar Technologies (Shanghai) Trading Corp. Ltd.
|
|
People’s Republic of China
|
|
100%
|
DelStar Technologies (Suzhou) Co. Ltd.
|
|
People’s Republic of China
|
|
100%
|
Schweitzer-Mauduit Spain, S.L.
|
|
Spain
|
|
100%
|
Schweitzer-Mauduit do Brasil Indústria e Comércio de Papel Ltda.
|
|
Brazil
|
|
99.985%
|
SWM Acquisition Corp. I
|
|
Delaware
|
|
100%
|
DelStar, Inc.
|
|
Delaware
|
|
100%
|
DelStar Holding Corp.
|
|
Delaware
|
|
100%
|
Coretec Tubing Corp.
|
|
Delaware
|
|
100%
|
U.S. Netting, Inc.
|
|
Delaware
|
|
100%
|
DelStar Technologies, Inc.
|
|
Delaware
|
|
100%
|
Schweitzer-Mauduit Holding S.A.S.
|
|
France
|
|
100%
|
Schweitzer-Mauduit Industries S.A.S.
|
|
France
|
|
100%
|
Schweitzer-Mauduit France S.A.S.
|
|
France
|
|
*94%
|
Schweitzer-Mauduit Developpements S.A.S.
|
|
France
|
|
100%
|
LTR Industries S.A.S.
|
|
France
|
|
100%
|
Papeteries de Saint-Girons S.A.S.
|
|
France
|
|
100%
|
Papeteries de Malaucène S.A.S
|
|
France
|
|
100%
|
Malaucène Industries S.N.C.
|
|
France
|
|
100%
|
SWM Services S.A.S.
|
|
France
|
|
100%
|
PDM Industries S.A.S.
|
|
France
|
|
100%
|
SWM HoldCo 1 S.à.R.L.
|
|
Luxembourg
|
|
100%
|
SWM HoldCo 2 S.à.R.L.
|
|
Luxembourg
|
|
100%
|
SWM Luxembourg S.à.R.L.
|
|
Luxembourg
|
|
100%
|
SWM GP Luxembourg S.à.R.L.
|
|
Luxembourg
|
|
100%
|
SWM LP Luxembourg SCSp
|
|
Luxembourg
|
|
99.9%
|
PDM Philippines Industries, Inc.
|
|
Philippines
|
|
99.89%
|
Luna Rio Landholding Corporation
|
|
Philippines
|
|
40%
|
Schweitzer-Mauduit RTL Philippines, Inc.
|
|
Philippines
|
|
99.9%
|
SWM Poland Sp. zo.o.
|
|
Poland
|
|
99.9%
|
SWM Poland GP Sp zo.o.
|
|
Poland
|
|
100%
|
Ipopema 94 Fundusz Inwestycyjny Zamknięty Aktywów Niepublicznych
|
|
Poland
|
|
100%
|
SWM RUS LLC
|
|
Russia
|
|
100%
|
DelStar International, Limited
|
|
United Kingdom
|
|
100%
|
|
|
(1)
|
Joint venture to produce tobacco-related papers in China.
|
|
|
(2)
|
Joint venture to produce reconstituted tobacco in China.
|
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 33-99812, No. 33-99814, No. 33-99816, No. 33-99848, No. 333-74634, No. 333-105986, No. 333-105998, No. 333-161988 and No. 333-179933 on Form S-8 and in Registration Statement No. 333-162991 on Form S-3 of our reports dated February 28, 2014, relating to the financial statements of Schweitzer-Mauduit International, Inc. and subsidiaries (the “Company”) and the effectiveness of the Company’s internal control over financial reporting appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2013.
/s/ Deloitte & Touche LLP
Atlanta, Georgia
February 28, 2014
POWER OF ATTORNEY
The undersigned, Claire L. Arnold,
hereby constitutes and appoints Greerson G. McMullen and Jeffrey Cook, or either of them, her true and lawful attorneys-in-fact and agents, with full powers of substitution and resubstitution, for her and in her name, place and stead, in any and all capacities, to sign the Annual Report on Form 10-K of Schweitzer-Mauduit International, Inc. for the fiscal year ended December 31, 2013, and any and all amendments thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, each acting alone, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
|
|
|
|
Dated this 27th day of February 2014
|
|
/s/ Claire L. Arnold
|
|
|
Claire L. Arnold
|
The undersigned, K.C. Caldabaugh,
hereby constitutes and appoints Greerson G. McMullen. and Jeffrey Cook, or either of them, his true and lawful attorneys-in-fact and agents, with full powers of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign the Annual Report on Form 10-K of Schweitzer-Mauduit International, Inc. for the fiscal year ended December 31, 2013, and any and all amendments thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, each acting alone, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
|
|
|
|
Dated this 27th day of February 2014
|
|
/s/ K.C. Caldabaugh
|
|
|
K.C. Caldabaugh
|
The undersigned, William A. Finn,
hereby constitutes and appoints Greerson G. McMullen. and Jeffrey Cook, or either of them, his true and lawful attorneys-in-fact and agents, with full powers of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign the Annual Report on Form 10-K of Schweitzer-Mauduit International, Inc. for the fiscal year ended December 31, 2013, and any and all amendments thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, each acting alone, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
|
|
|
|
Dated this 27th day of February 2014
|
|
/s/ William A. Finn
|
|
|
William A. Finn
|
The undersigned, Robert F. McCullough,
hereby constitutes and appoints Greerson G. McMullen. and Jeffrey Cook, or either of them, his true and lawful attorneys-in-fact and agents, with full powers of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign the Annual Report on Form 10-K of Schweitzer-Mauduit International, Inc. for the fiscal year ended December 31, 2013, and any and all amendments thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, each acting alone, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
|
|
|
|
Dated this 27th day of February 2014
|
|
/s/ Robert F. McCullough
|
|
|
Robert F. McCullough
|
The undersigned,
Frédéric
P. Villoutreix,
hereby constitutes and appoints Greerson G. McMullen. and Jeffrey Cook, or either of them, his true and lawful attorneys-in-fact and agents, with full powers of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign the Annual Report on Form 10-K of Schweitzer-Mauduit International, Inc. for the fiscal year ended December 31, 2013, and any and all amendments thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, each acting alone, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
|
|
|
|
Dated this 27th day of February 2014
|
|
/s/ Frédéric P. Villoutreix
|
|
|
Frédéric P. Villoutreix
|
The undersigned, John D. Rogers,
hereby constitutes and appoints Greerson G. McMullen. and Jeffrey Cook, or either of them, his true and lawful attorneys-in-fact and agents, with full powers of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign the Annual Report on Form 10-K of Schweitzer-Mauduit International, Inc. for the fiscal year ended December 31, 2013, and any and all amendments thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, each acting alone, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
|
|
|
|
Dated this 27th day of February 2014
|
|
/s/ John D. Rogers
|
|
|
John D. Rogers
|
The undersigned, Anderson D. Warlick,
hereby constitutes and appoints Greerson G. McMullen. and Jeffrey Cook, or either of them, his true and lawful attorneys-in-fact and agents, with full powers of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign the Annual Report on Form 10-K of Schweitzer-Mauduit International, Inc. for the fiscal year ended December 31, 2013, and any and all amendments thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, each acting alone, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
|
|
|
|
Dated this 27th day of February 2014
|
|
/s/ Anderson D. Warlick
|
|
|
Anderson D. Warlick
|
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Frédéric P. Villoutreix, certify that:
|
|
1.
|
I have reviewed this annual report on Form 10-K of Schweitzer-Mauduit International, Inc. (the “Registrant”);
|
|
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
|
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
|
|
|
4.
|
The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
|
|
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
|
c.
|
Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
|
|
d.
|
Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
|
|
|
5.
|
The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):
|
|
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
|
|
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.
|
Date:
February 28, 2014
|
|
|
|
/s/ FREDERIC P. VILLOUTREIX
|
|
Frédéric P. Villoutreix
Chairman of the Board and
Chief Executive Officer
|
A signed original of this written statement required by Section 302 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Jeffrey A. Cook, certify that:
|
|
1.
|
I have reviewed this annual report on Form 10-K of Schweitzer-Mauduit International, Inc. (the “Registrant”);
|
|
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
|
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
|
|
|
4.
|
The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
|
|
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
|
c.
|
Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
|
|
d.
|
Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
|
|
|
5.
|
The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):
|
|
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
|
|
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.
|
Date:
February 28, 2014
|
|
|
|
/s/ Jeffrey A. Cook
|
|
Jeffrey A. Cook
Executive Vice President, Chief
Financial Officer and Treasurer
|
A signed original of this written statement required by Section 302 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
CERTIFICATION OF PERIODIC FINANCIAL REPORTS
UNDER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned, in their respective capacities as chief executive officer and chief financial officer of Schweitzer-Mauduit International, Inc. (the “Company”), hereby certify to the best of their knowledge following reasonable inquiry that the Annual Report of the Company on Form 10-K for the period ended
December 31, 2013
, which accompanies this certification, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in such periodic report fairly presents, in all material respects, the financial condition of the Company at the end of such period and the results of operations of the Company for such period. The foregoing certification is made pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350) and no purchaser or seller of securities or any other person shall be entitled to rely upon the foregoing certification for any purpose. The undersigned expressly disclaim any obligation to update the foregoing certification except as required by law.
|
|
|
|
|
|
By:
|
/s/ FREDERIC P. VILLOUTREIX
|
|
By:
|
/s/ JEFFREY A. COOK
|
|
Frédéric P. Villoutreix
Chairman of the Board and
Chief Executive Officer
|
|
|
Jeffrey A. Cook
Executive Vice President, Chief Financial Officer
and Treasurer
|
|
|
|
|
|
|
February 28, 2014
|
|
|
February 28, 2014
|
A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
The foregoing certification is being furnished as an exhibit to the Report pursuant to Item 601(b)(32) of Regulation S-K and Section 1350 of Title 18 of the United States Code and, accordingly, is not being filed with the Securities and Exchange Commission as part of the Report and is not incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Securities Exchange Act of 1934 (whether made before or after the date of the Report, irrespective of any general incorporation language contained in such filing).